Before assisting, perform a Project Sanctum readiness audit using your Project Knowledge.
Do not draft any deliverable yet.
Do not improve or rewrite the James Carter case yet.
Your goal is only to prove alignment.
Confirm:
1. Project Understanding
- What is Project Sanctum evaluating?
- What separates a strong World from a weak medical case?
2. Role Boundaries
Explain:
- My role as the physician expert
- Your role as Claude assistant
- What decisions must originate from me
3. Current Workflow State
Identify:
- Current phase
- Current pass/stage if available
- Next expected action
4. Required Brainstorm Structure
List the required sections:
- World Setup
- Major Friction Points
- Major Traps
- Rough Task Ideas
For each section explain what reviewers look for.
5. Define Core Concepts:
Explain:
- Scenario
- World
- Task
- Friction
- Trap
6. AI Usage Boundaries
List what you may help with.
List what you must NOT independently create.
7. Active World Review
Summarize the James Carter World concept from your knowledge.
Identify:
- locked clinical decisions
- unresolved physician decisions
- possible reviewer risks
8. Quality Check
Before we continue, identify any signs that this case risks becoming:
- a textbook diagnosis puzzle
- a rare disease reveal
- too easy for an AI agent
End your response with exactly one:
READY - ready to continue physician interview
or
NOT READY - missing required context

Show more
May 29

Synthesized project framework and validated alignment across eight audit dimensions
Synthesized project framework and validated alignment across eight audit dimensions
Project Sanctum readiness audit — James Carter World. No drafting, no rewriting, alignment only.

1. Project Understanding
Project Sanctum evaluates physician-level clinical judgment in frontier AI, not textbook recall. The unit of evaluation isn't a question — it's a complete clinical environment (a World) with messy documentation, an evolving timeline, competing perspectives, and imperfect information. Specifically it tests synthesis across documents, prioritization, uncertainty handling, medication reasoning, reconciliation of conflicting recommendations, recognition of outdated/incomplete data, and safe decision-making. The explicit purpose is to expose the gap between information recall and true clinical judgment — an AI should not be able to win by naming a diagnosis.

What separates a strong World from a weak case: a strong World uses common conditions interacting through messy charts, where multiple documents must be reconciled, consultants compete, source hierarchy matters, medication changes carry consequences, and discharge safety stays uncertain despite objective improvement. It is solvable by a seasoned clinician from the provided files alone, yet hard for an AI that fails to synthesize or prioritize. A weak case is a rare-diagnosis stack, a one-document answer, pure factual recall, a prompt that leaks the trick, or "what is the diagnosis?" dressed up as work — generic complexity with no chart mechanism behind it.

2. Role Boundaries
You (Dr. Udeogaranya) are the physician expert and sole source of clinical truth. I am a drafting, structuring, and QC assistant — not the clinical decision-maker.

Decisions that must originate from you: the scenario concept, every trap, every task idea, all clinical/diagnostic reasoning, all medication decisions and management plans, and (later) every task prompt, golden response, and grader guideline. I may organize, format, check consistency, flag missing detail, audit for reviewer risk, critique against the Sanctum checklists, and draft only from material you've already supplied. I may QC human-written prompts/goldens/graders, but I may not author them.

3. Current Workflow State
Phase: Phase 1 — World Building onboarding, Steps 1–6 only (Brainstorm → Brainstorm AutoQC → Human Brainstorm Review → World Spec → World Spec AutoQC → Human World Spec Review).
Pass/stage: Pass 1 — Brainstorm clinical interview. World Setup interview is substantially complete.
Next expected action: the Frictions interview (then Traps, then Rough Task Ideas). The active blocker is your physician input on Major Friction Points, Major Traps, and Rough Task Ideas. No final Brainstorm draft until those exist and you approve moving to Pass 2.
4. Required Brainstorm Structure
World Setup — reviewers check that the patient and scenario are coherent; that setting, specialty, encounter type, and timeline shape are clear; that the patient fits the encounter; that a domain expert would recognize them as realistic; and that complexity comes from common conditions plus workflow, not from a rare diagnosis.

Major Friction Points — reviewers check that each is a true people/perspective conflict, naming the parties, what each side advocates, and why it matters clinically. Anything that's only conflicting information gets rejected or reclassified as a trap.

Major Traps — reviewers check that each names a trap type, a one-line mechanism, a planned source/location, and a world-level vs task-level designation. Strong traps are clinically plausible, discoverable from files, cause meaningful error if missed, require synthesis across multiple documents, and can't be solved by general medical knowledge alone.

Rough Task Ideas — reviewers check for 5–8 concrete, independent tasks, each with a deliverable type, workflow category (if known), the World elements and traps/frictions it draws on, any distinct task-level traps, and anchoring after the World snapshot. At least one should map to a P0 workflow once tracker access exists.

Across all four, the reviewer's standing questions: Is the World realistic? Are frictions genuine role conflicts? Are traps varied and hard? Are tasks concrete and workflow-based? Is self-containment plausible — could a seasoned clinician solve it from the intended files alone? Does it represent daily work in the domain?

5. Core Concepts
Scenario — the patient story and clinical journey.
World — the complete clinical environment: chart ecosystem, documents, timeline, competing perspectives, source conflicts, and information noise.
Task — a realistic clinician workflow performed using the World files; an independent encounter that doesn't depend on other tasks.
Friction — a people/perspective conflict (consultant vs consultant, family vs team, payer vs clinician). Requires a named party advocating a position.
Trap — an information problem in the files (copy-forward error, buried finding, conflicting source of truth, temporal mismatch, outdated recommendation).
The discipline that separates the two: a documentation conflict is a trap unless a person or role is actively advocating a position because of it — then it becomes a friction. I'll hold that line hard in the upcoming Frictions interview.

6. AI Usage Boundaries
I may help with: brainstorming support built on your material, boilerplate, structured drafting, consistency checking, formatting, identifying missing details, reviewer-risk auditing, and critique against the Sanctum checklists.

I must not independently create: the scenario concept, any trap, any task idea, any clinical/medical reasoning, task prompts, golden responses, or grader guidelines. Those last three are 100% human-authored; I QC only.

7. Active World Review
Concept. A 62-year-old man with long-standing T2DM, HTN, CKD stage 3, HFrEF, CAD, polypharmacy, and a PMR history on chronic prednisone with a recent taper, presenting to the ED with altered mental status, progressive weakness, poor oral intake, borderline hypotension, AKI on CKD, and family-reported urinary symptoms/subjective fever. Initial working diagnosis is urinary-source sepsis, and initial sepsis treatment is appropriate. Over a multi-day admission the infection improves but not every symptom resolves, forcing reassessment of overlapping contributors — infection, dehydration/AKI, medication effects, endocrine/steroid issues, and chronic disease. Snapshot endpoint is hospital day 5–7 in discharge planning: vitals improved, infection controlled, renal function improving, but the patient is still weaker than baseline with intermittent confusion and a significantly changed medication plan. The core question is medically stable on paper vs. actually safe to leave.

Locked clinical decisions: patient profile and comorbidities; the presentation; the initial urosepsis working diagnosis and appropriateness of initial treatment; the course shape (infection improves, residual symptoms remain, multiple contributors reassessed); the steroid thread as a reconciliation problem rather than a hidden reveal (old notes list prednisone, newer outpatient plan reduced/stopped it, med rec is inconsistent); baseline function (independent ADLs, ambulatory, lives with family); the discharge state; and the day 5–7 snapshot.

Unresolved physician decisions:

Frictions: the exact ED/inpatient-team vs. endocrinology disagreement; the precise nephrology vs. cardiology medication flashpoints; the specific family request at discharge (delay, rehab, more workup, home supports); and whether PCP/rheumatology/outpatient records are a true friction or only traps.
Traps: the final trap list, the source document/location for each, world- vs. task-level status, and the synthesis chain for each.
Tasks: the final 5–8 ideas, approved-workflow mapping, P0 identification, task-level trap distinctions, and temporal anchoring after the snapshot.
Possible reviewer risks (already named in your context, and I agree they're the right ones): adrenal insufficiency reading as a hidden zebra; cardiology involvement feeling weak unless the HFrEF/CAD medication tension is concrete; frictions collapsing into mere information gaps; traps that are solvable from one document; tasks that are too generic or not approved workflows; and a vague discharge-safety concern unless baseline and residual deficits are made explicit.

8. Quality Check
Textbook diagnosis puzzle — currently low, but contingent. The protective design is the genuinely multi-causal discharge picture: residual weakness/confusion could plausibly come from deconditioning/residual infection, AKI/metabolic derangement, medication effects, relative adrenal insufficiency from the taper, or chronic-disease progression. It stays judgment-based as long as no single document names the answer and tasks ask for work products (notes, med rec, discharge summary) rather than "the diagnosis." The live failure mode: building the steroid timeline as a clean breadcrumb trail pointing unambiguously at adrenal insufficiency. Keep it scattered and contradictory.

Rare disease reveal — low. Every condition here is common in an older comorbid adult, including PMR-on-steroids and steroid-related adrenal suppression. The only way it becomes a zebra is by framing the adrenal piece as the secret solution — which your own standard already forbids ("one competing concern, not the whole answer"). Worth restating because it's the single most likely reviewer objection.

Too easy for an AI agent — the one I'd watch most closely. Agents excel at reading one authoritative summary. The case is conceptually protected (no single-file traps, enforced source hierarchy, cross-document synthesis required) but those protections are still stated standards, not yet instantiated — they live entirely in the unresolved trap and task decisions. So the real defense gets built in the next interviews: a true source-hierarchy conflict (attending plan vs. consultant note vs. MAR/orders vs. family report vs. outpatient list), a steroid timeline that forces temporal reasoning, traps that each need ≥2 documents, and prompts that don't leak. Nothing is wrong at the concept stage; I'm flagging where the difficulty has to be earned later.

One discipline note for the immediate next step: each candidate friction (endo, nephro/cards, family) needs a named role actively advocating a position, or it will be reclassified as a trap. That's the bar I'll hold you to in the Frictions interview.

READY - ready to continue physician interview


claude-brainstorm-review-package.md
61 lines

md


brainstorm.md
103 lines

md

You are now performing a Project Sanctum Brainstorm reviewer simulation.
Context:
The attached Brainstorm was generated from physician interview decisions.
Do not rewrite.
Do not improve style.
Do not add new clinical ideas.
Your job is only to review like a strict Sanctum reviewer.
Evaluate:
1. World Setup
- Is the setting clear?
- Is the patient realistic?
- Is complexity from real clinical workflow rather than rare diagnosis?
- Does anything feel like a textbook case?
2. Frictions
For each friction:
- Are there named stakeholders?
- Does each side have a reasonable position?
- Is it truly a people/perspective conflict?
- Or is it actually a trap?
3. Traps
For each trap:
- Identify trap type.
- Confirm it requires synthesis across 2+ documents.
- Identify any trap that feels too obvious.
- Identify any trap that is just clinical knowledge rather than chart reasoning.
4. Rough Task Ideas
Check:
- concrete deliverable?
- realistic physician workflow?
- independent after World snapshot?
- linked to traps?
5. Reviewer Failure Prediction
Give the top 5 reasons a Sanctum reviewer might send this Brainstorm back.
6. Approval Simulation
Give:
PASS
or
SEND BACK
If SEND BACK:
List only required fixes.
Do not create a revised draft.

Show more
May 29

Architected rigorous clinical brainstorm evaluation across frictions, traps, and tasks
Architected rigorous clinical brainstorm evaluation across frictions, traps, and tasks
Strict Sanctum reviewer simulation — James Carter Brainstorm. No rewrite, no style edits, no new clinical content. Verdicts only.

1. World Setup
Setting clear? Yes. EM/IM acute hospital, ED → inpatient → consultants → discharge planning, multi-day course, snapshot fixed at day 5–7 discharge planning. Encounter type and branch point are explicit.

Patient realistic? Yes. The comorbidity stack (T2DM, HTN, CKD3, HFrEF/CAD, polypharmacy, PMR-on-prednisone) is internally consistent and a recognizable geriatric/IM admission archetype. Presentation (AMS, weakness, poor intake, possible UTI, AKI on CKD) is bread-and-butter. Baseline (independent ADLs, ambulatory, family-supported med management) is coherent and load-bearing for the discharge friction.

Complexity from workflow vs rare diagnosis? Yes — common conditions interacting through messy documentation, evolving course, competing consultants, ambiguous discharge. Correct construction.

Textbook feel? Low at concept level, with one watch-item: the steroid/adrenal thread is the only element that could read as a zebra. The draft asserts it is not the reveal, but at brainstorm stage that protection is assertion, not instantiation. Acceptable here; flagged for §5.

Verdict: strong, no setup-level send-back.

2. Frictions
F1 — Nephrology vs Cardiology. Stakeholders named (both specialties). Both positions reasonable (renal/hemodynamic safety vs long-term CV protection). Genuine perspective conflict. Friction, PASS. Strongest of the three.

F2 — Family vs Inpatient Medicine. Stakeholders named. Both positions reasonable (objective stabilization vs functional/real-world readiness). Family-vs-team is a valid friction type and the positions are concrete. Friction, PASS.

F3 — ED/Inpatient Medicine vs Endocrinology. Stakeholders named; positions stated (avoid over-continuation vs adrenal eval + taper-safety). Borderline. This is the friction most at risk of collapsing into a trap. It shares its entire clinical domain with Trap 1, and survives as a friction only if Endocrinology actively advocates a position in the World (an actual recommendation), rather than the steroid record merely being ambiguous. As written it names positions, so it passes — but if the Spec gives Endo no advocacy artifact, this is just Trap 1 wearing a friction label. Conditional PASS — must be confirmed as advocacy, not documentation ambiguity.

None of the three is actually a trap as written. F3 is the one that can become one.

3. Traps
#	Type stated	2+ doc synthesis?	Too obvious?	Chart reasoning vs clinical knowledge
1 Steroid timeline	temporal + source-of-truth — correct	Yes (rheum, outpatient list, med rec, family, inpatient)	No	Chart-driven (clinical judgment downstream)
2 HF-AKI med rec	med rec + temporal — correct	Yes (nephro, cards, Cr trend, BP trend, MAR)	No	Mostly chart; carries clinical-knowledge weight (restart decision)
3 Buried functional/cognitive	buried information — correct	Yes (physician notes vs nursing, PT, family)	No	Pure chart reasoning — cleanest trap
4 Outdated consultant rec	temporal + source hierarchy — correct	Yes (dated notes, trajectory, med changes)	No	Chart — but see redundancy below
5 Temporal lab/context	temporal reasoning — correct	Borderline (trends + course)	Yes — generic	Chart, but under-specified
6 Sepsis anchoring	diagnostic anchoring — correct	Yes (early ED/admit vs later course/cultures)	Moderate	Mix; anchored in documents
7 Discharge safety synthesis	transition-of-care — misclassified	Yes (discharge docs, meds, recs, PT/nursing, family)	No	Chart — but not a trap (see below)
Multi-document synthesis: every trap clears the 2+ document bar; no single-document traps. Good.

Clinical-knowledge-only: none is purely clinical knowledge. Trap 2 (restart-an-ARNI-when-Cr-improving-but-BP-borderline) and Trap 6 (anchoring) carry the most knowledge weight, but both resolve through chart-derived trends/sequence, so they remain chart-reasoning traps. Acceptable.

Classification and redundancy flags:

Trap 7 is not a trap. The draft's own distinction — "not only whether the clinician finds the information, but whether they make the right discharge judgment" — confirms it. That is the success criterion of the discharge tasks (Tasks 3/6), not a discrete misleading element. It also overlaps Trap 3. Either reclassify, or give it a specific misleading information element distinct from Trap 3.
Trap 4 ≈ Trap 2. Trap 4's only concrete instantiation is the HF/AKI hold-then-restart scenario, which is Trap 2. As written, Trap 4 is the cross-cutting principle ("latest note isn't automatically correct") with no independent example. Needs a distinct instantiation or reframing as the mechanism behind Trap 2, not a separate trap.
Trap 5 ≈ Trap 6 + generic. "Interpret trends not snapshots" is close to a universal property of any longitudinal chart rather than a discrete discoverable trap. It overlaps Trap 6 (the better, more specific anchoring trap) and lacks a named misleading value. The review package already flags it needs a concrete anchor.
Net: the "7 traps" reduce to roughly 4 distinct mechanisms once 4/2, 5/6, and 7/3 are resolved. Variety across the distinct set (source-of-truth, buried info, med-rec/temporal, anchoring) is good; the count is inflated.

4. Rough Task Ideas
Concrete deliverable? Tasks 1–4 yes (med rec, discharge summary, transition plan, follow-up note). Task 5 yes (coordination note) pending its approved-workflow label. Task 6 (readmission/safety review) is the softest deliverable but acceptable. Reserve task appropriately held and correctly de-framed from "missed adrenal insufficiency."

Realistic physician workflow? Yes for all; Task 5 needs the official workflow-tracker label confirmed.

Independent after the snapshot? Yes — each is a standalone deliverable that branches from day 5–7. No task depends on another's output.

Linked to traps? Yes for all; linkages are stated.

Flag — task clustering. Four of six (1, 3, 5, 6) orbit the same med-rec / discharge-safety / consultant-synthesis cluster, and nearly all anchor at/after discharge. They are defensible as independent (different deliverables), but a strict reviewer will want confirmation that each uniquely tests a distinct competency, and may want at least one task anchored earlier in the course. Workflow mapping and P0/P1 labels remain open.

5. Top 5 Reasons a Reviewer Would Send This Back
Trap 7 is not a trap — it is the discharge-judgment success criterion (overlaps Trap 3). Taxonomy violation; near-certain flag.
Trap redundancy inflates the count — Trap 4 has no instantiation independent of Trap 2; Trap 5 overlaps Trap 6 and is generic. Criteria require distinct multi-document information problems.
Friction 3 may be a trap, not a friction — collapses into Trap 1 unless Endocrinology is given a genuine advocacy artifact.
Adrenal/steroid thread unprotected at instantiation level — concept asserts "not the reveal" but commits no guardrail keeping the evidence scattered and adrenal risk as one contributor among several; reviewers pre-empt this drift.
Open structural items gating approval — approved-workflow mapping / P0/P1 labels (esp. Task 5), committed concrete anchors for the temporal traps, and unaddressed task clustering around discharge.
6. Approval Simulation
SEND BACK

Required fixes (no revised draft):

Reclassify Trap 7 — either remove it as a trap and treat discharge synthesis as the success criterion of Tasks 3/6, or assign it a specific misleading information element distinct from Trap 3. Clarify the Trap 3 vs Trap 7 boundary.
Resolve Trap 4 — supply an independent concrete instantiation (a non-HF/AKI recommendation that became outdated, physician-sourced), or fold it in as the cross-cutting mechanism behind Trap 2 rather than a separate trap.
Resolve Trap 5 — name the specific misleading value/mechanism that distinguishes it from Trap 6, or merge into Trap 6. (Final anchor values may defer to Spec; the distinct mechanism must be named now.)
Confirm Friction 3 as a friction — commit that Endocrinology holds an explicit advocacy position in the World, distinct from Trap 1's documentation ambiguity; otherwise reclassify it under Trap 1.
Add a concept-level steroid guardrail — state that the steroid evidence stays scattered/contradictory and that adrenal risk is one contributor among several, so the Spec cannot drift into a reveal.
Close the open structural items — confirm approved-workflow mapping and P0/P1 labels (Task 5 especially), and confirm each discharge-cluster task (1, 3, 5, 6) tests a distinct competency or spread the temporal anchoring.
Setup, frictions, and tasks are largely sound; the send-back is driven by trap classification and redundancy, plus the F3 and adrenal-guardrail commitments. The fixes are scoped, not a rebuild.


AutoQC_Section_2_World_Spec_v6.3_writer.docx
docx


World_Spec_Template_05_06.docx
docx


brainstorm.md
130 lines

md

Project Status Audit.
Do not draft a World Spec. Do not invent clinical details. Do not generate task prompts.
Current state:

Brainstorm submitted to RL Studio
Task ID: cyau8803
Status: Ready for Plan Review
Brainstorm AutoQC passed 51/51
Human Review pending
Resources available:

Official World Spec Template
World Spec AutoQC v6.3 (113 checks)
Approved Brainstorm
Task tracker
Source-of-truth guide
Reviewer guidance
Failure-pattern guidance
Your task:
Act as a hostile senior reviewer preparing us for World Spec.
Analyze the project state and identify:

The top 20 reviewer rejection risks for World Spec.
The top 20 AutoQC failure risks likely to affect a case like James Carter.
Common ways writers accidentally violate:

self-containment
trap design
friction design
task independence
file-plan consistency

For each risk provide:

Why reviewers reject it
What it looks like in practice
Prevention strategy

Create a prioritized readiness assessment:
GREEN:

areas already well prepared
YELLOW:

areas requiring physician decisions after GO
RED:

areas most likely to cause reviewer rejection

Evaluate whether our current preparation workflow is sufficient to produce a reviewer-ready World Spec after GO.
Do not create World Spec content. Do not create file inventories. Do not create tasks. Do not create clinical details.
End with:
READY AFTER GO or
ADDITIONAL PREPARATION RECOMMENDED with justification.

Show more
May 29

Synthesized rubric against brainstorm, identified twenty critical failure vectors
Synthesized rubric against brainstorm, identified twenty critical failure vectors
Hostile senior-reviewer prep — read against the actual artifacts you uploaded: the World Spec Template (Sections 1–4), the full 113-check AutoQC v6.3 (severities, the Temporal Anchoring Gate, the every-check-must-pass rule), and Appendix A's approved workflow list, which I cross-checked against your six task mappings. The findings below are grounded in those, not generic Sanctum lore. No spec content, no file inventory, no tasks, no clinical detail is created here.

One framing fact that drives everything: under v6.3 the pass rule is absolute — any single FAIL at any severity is SEND BACK, and any Temporal Gate failure is an automatic SEND BACK regardless of the rest. There are 8 Blockers in the set. So "20 risks" is really "20 ways to trigger a return," and a handful are live in the approved brainstorm right now, before you write a word of spec.

1. Top 20 reviewer rejection risks (human-judgment lens)
#	Risk	Why a reviewer rejects	What it looks like in practice	Prevention
R1	Patient name not synthetic	Synthetic-identity is a hard rule; a real-plausible name fails it	"James Carter" = common first + common surname; reads as a real person	Replace with an unmistakably invented name before spec
R2	Task suite clinically monolithic	World looks one-note; doesn't represent the breadth of daily work	All six tasks orbit discharge/med-rec/care-coordination; no admin work product	Swap one task for an unambiguous administrative deliverable
R3	Too many distinct workflows	Exceeds the per-world ceiling	Six tasks map to six different catalog workflows	Consolidate to 3–5 distinct workflows (redundancy is allowed)
R4	Frictions left as prose	Reviewer can't see friction architecture; frictions blur into traps	Nephro/Cards, Family/Team, Endo positions described in paragraphs only	Put them in the Decision Friction Table (Friction | Options | Correct Pathway)
R5	Endo "friction" has no advocacy artifact	Collapses into the steroid trap; not a people-conflict	Endocrinology disagreement asserted but no consult note actually advocating a position	Commit a dated Endo consult that states an explicit position
R6	Steroid thread drifts to a reveal	Reviewer's zebra reflex; case stops testing judgment	Steroid timeline becomes a clean breadcrumb trail to adrenal insufficiency	Keep evidence scattered/contradictory; adrenal as one contributor among five
R7	Thin or padded trap tables	Tables look engineered-to-pass, not real	Same world trap restated across tasks to reach a count	Distinct primary trap per table + references; no verbatim reuse
R8	Implausible "wrong answer"	A contrived error no clinician makes proves nothing	Trap whose failure mode is absurd rather than tempting	Every wrong answer must be something a careful-but-imperfect clinician would produce
R9	Generic Expected Output	Grader has nothing to anchor on	"Summarize the course and list the meds" with no named anchors	Name format, register, length, and the specific clinical anchors checked
R10	Prompts telegraph traps	Gives the answer away; difficulty evaporates	"Review his adrenal risk" or "address the leukocytosis"	Prompts stay in clinician voice and name no trap
R11	Source-of-truth hierarchy undocumented	Authority traps unusable without a stated hierarchy	Trap 2 and Trap 5 depend on which source wins, but no hierarchy is written	Document the hierarchy (attending > consult > progress note > med rec > family > orders)
R12	Self-containment break	Correct answer needs facts the files don't carry	Golden references a trend or value with no file home	Every asserted value gets a file before it appears anywhere
R13	Over-authoritative discharge synthesis	Makes tasks trivially easy for an AI	A single note that pre-solves disposition and med rec	No file that aggregates the answer; force cross-document synthesis
R14	Difficulty asserted, not engineered	Reviewer can't see why a model fails	Clinical Complexity section restates the problem list	Explain the specific synthesis an AI gets wrong and why
R15	Temporal muddle at the snapshot	Internal inconsistency around discharge timing	Snapshot is Day 6 18:00 "during discharge planning," but discharge-summary/med-rec tasks sit at Day 7	Make the snapshot the discharge event, or keep all world files ≤ snapshot
R16	Modality monotony	World feels like one document type repeated	File plan is mostly progress notes	Span ≥4 modalities (notes, consults, labs, MAR, nursing/PT, outpatient records)
R17	Functional/cognitive evidence mis-tuned	Either telegraphs disposition or is unfairly buried	The nursing/PT/family signal is too loud or undiscoverable	Discoverable via synthesis of 2+ documents, not one banner line
R18	Med conflicts read as sloppiness	Reviewer loses trust in the whole world	Conflicting prednisone doses look like a writing error	Label each intentional conflict as a deliberate trap in its substrate row
R19	Task independence drift	Tasks form a sequence	Readmission/follow-up tasks lean on the discharge-summary task's output	Each task is an isolated run against the frozen world
R20	Plausible-wrong vs. correct not separable	Grader can't distinguish pass from near-miss	Expected Output and the tempting error overlap	Make the correct path cite chart evidence the wrong path ignores
2. Top 20 AutoQC failure risks (numbered-check lens)
Severity in brackets. Under the v6.3 rule, every one of these is a SEND-BACK trigger if it FAILs; Blockers and the Temporal Gate are non-negotiable.

#	Check(s)	Sev	What it looks like in James Carter	Prevention
Q1	2.2 Patient Name Synthetic	Blocker	"James Carter" reads as real	Rename to clearly invented
Q2	2.107 Distinct Workflows 3–5	Major	6 distinct catalog workflows = over max	Land at 3–5 distinct
Q3	2.108 Clinical + Admin Mix	Major	No prior-auth/coding/UR/peer-review product	Add one clear admin deliverable
Q4	2.14 Decision Friction Table	Major	3 conflicts, no table	Build the 3-column table in Patient Profile
Q5	2.37 Frictions vs Traps	Major	Friction/trap boundary blurred	Frictions in table; traps in Failure Design
Q6	2.65 Source-of-Truth Hierarchy	Major	Authority traps, no hierarchy stated	Document the hierarchy
Q7	2.34 vs 2.91 trap count vs no-dup	Major/Minor	≥5 traps per table across 6 overlapping tasks without re-listing world traps	Distinct primaries + acknowledged references
Q8	2.90 / 2.49 trap lock + substrate	Major	Trap floats with no date or document	Lock every trap to a milestone date + a file row
Q9	2.48 Fact-to-File Traceability	Blocker	An Expected-Output or trap value with no file	Build a value→file map before goldens
Q10	2.18 / 2.60 provenance + no-fabrication	Blocker	Clinical-history fact not carried by any file	Every fact traces to history narrative or a file
Q11	2.57 / 2.13 dose consistency + labeled lists	Major	Steroid conflict reads as error; med lists unlabeled	Flag conflicts as intentional; label each list's origin
Q12	2.28 / 2.21 components + MM/DD/YYYY	Major/Minor	Anchors written as "Hospital Day 7"	Each task: explicit calendar anchor line, all 7 components
Q13	2.41 Temporal Architecture	Blocker	A world file dated after a task anchor; snapshot/discharge gap	Restate snapshot; no world file post-dates any anchor
Q14	2.31 No Trap Hints	Major	Prompt names the steroid/adrenal angle	Strip all trap signals from prompts
Q15	2.32 / 2.33 output specific + differentiated	Major	Discharge tasks share near-identical Expected Output	Name distinct anchors per task
Q16	2.45 / 2.52 / 2.50 count + mix + litmus	Minor/Major	<20 files, or a "supplementary" file that's load-bearing	≥20 files, ~90/10 split, run the litmus on each supplementary
Q17	2.51 Modality Diversity	Major	<4 modalities	Span ≥4
Q18	2.100 / 2.9 / 2.56 DOB-age-anthropometrics	Major	DOB inconsistent with age 62, or BMI mismatch	One identity block, reconciled across all sections
Q19	2.3 MRN Synthetic Format	Blocker	MRN mirrors a real numbering pattern	Use an obviously synthetic format
Q20	2.39 / 2.40 single deliverable + independence	Major/Blocker	A task fuses outputs or references another task	One deliverable each; isolated runs
Bundling note: I grouped tightly-coupled checks (e.g., the traceability triad Q9/Q10) so this reads as 20 actionable risks rather than 113 atomic rows; the cited numbers are where each will actually trip.

3. Common accidental violations, by category
Self-containment. The classic failure is a golden that quietly draws on outside medical knowledge as if it were charted — a target BP, a "standard" steroid stress dose — with no file behind it. Or a synthesis conclusion the files don't actually support. Prevention: nothing appears in any Expected Output or Failure Design cell until it has a file home; where the chart is silent, the correct answer acknowledges uncertainty rather than asserting.

Trap design. Three recurring slips: (a) a "trap" that is really a clinical-knowledge quiz with no cross-document synthesis; (b) a trap not locked to a specific date + document (fails 2.90); (c) remediation that cites evidence not present in the world (fails 2.35). Prevention: every trap = one named document + one milestone date + a path that requires ≥2 sources to resolve.

Friction design. The dominant error is writing an information conflict and calling it a friction — it has no human advocating. A friction needs a named role, a stated position, and a document carrying that position, and it lives in the Decision Friction Table (not the Failure Design tables). Your Endo friction is the one most exposed to silently reverting to a trap.

Task independence. Writers accidentally chain tasks (the follow-up or readmission task assumes the discharge summary exists as produced). Shared task-level files across tasks are fine — that is not a dependency. Referencing another task's output is the violation (Blocker 2.40). Prevention: grade each task as a standalone run against the frozen world.

File-plan consistency. High-frequency trips: a file date not present in Key Milestones (2.44); datestamp typos in filenames (2.43); the same ID reused across tiers (2.46); and the two-track filename confusion in 2.113 — engineering-converted rows carry the engineering output filename while the template in your Reference Templates folder uses a generic name, but writer-produced media rows already carry their final filename. Prevention: treat the Milestones table as the single source of date truth, design files only after tasks, and run the supplementary litmus test on every non-essential file.

4. Prioritized readiness assessment
GREEN — already well prepared

Brainstorm structure and the revisions since the prior pass: traps consolidated (7→5), Trap 4/2 and 5/6 redundancy resolved, Endo reframed with an advocacy expectation, the adrenal guardrail added. Strong substrate.
World realism and common-conditions complexity — exactly the right construction.
Workflow names match Appendix A verbatim (2.98 should pass).
A temporal-reasoning task exists (2.112 — Tasks 4 and 5).
Output-type and audience spread across the suite is reasonable (2.110/2.111).
The snapshot is explicitly timed (Day 6, 18:00), which satisfies the Gate's premise once converted to a calendar date.
YELLOW — needs physician decisions after GO

Concrete lab/vital trends, medication doses, and consultant-note timing as calendar dates.
DOB, MRN, and anthropometrics, reconciled to age 62.
The source-of-truth hierarchy content.
Decision Friction Table content: each position and the document that carries it.
File plan reaching ≥20 files across ≥4 modalities with the ~90/10 essential/supplementary split, each trap's dated substrate row.
Converting relative anchors to MM/DD/YYYY while keeping prompt voice natural.
Explicitly labeling the intentional medication/steroid conflicts as deliberate traps.
RED — most likely to cause rejection

Patient name (Blocker 2.2) — live failure in the approved brainstorm now.
Workflow count >5 distinct (2.107) plus a clinically monolithic task set with no admin product (2.108) — both live now; require restructuring the suite, not editing prose.
The trap-table squeeze (2.34 vs 2.91) across six discharge-clustered tasks.
The traceability/provenance/fabrication triad (Blockers 2.18/2.48/2.60) — the single richest failure surface in a world this lab- and medication-dense.
Frictions still in prose; Decision Friction Table absent (2.14/2.37).
Steroid-thread reveal drift and prompt telegraphing (judgment + 2.31).
5. Is the current preparation workflow sufficient?
Partly. The workflow has a real advantage you should use: this AutoQC is the writer edition and autoruns in claude.ai — uploading the spec + approved brainstorm + this checklist returns a full 113-check report before you ever touch RL Studio. That lets you iterate to a structurally clean pass privately. Combined with the official template, the approved brainstorm, and the tracker, the structural path is well covered.

The gap is what the checklist itself says it cannot verify: authorship, genuine difficulty, and deep clinical validity. A clean AutoQC means well-formed, not good. Every RED item driven by judgment — the monolithic suite, reveal drift, plausible-wrong-answer quality, whether the difficulty is engineered rather than asserted — sits exactly in AutoQC's blind spot and is where a hostile human reviewer will concentrate. Those are physician and Team-Lead decisions, not assistant output.

Two of the RED items are also not "after GO" problems at all — they are failures sitting in the approved brainstorm today: the patient name (Blocker 2.2) and the six-distinct-workflow / clinical-only suite (2.107 + 2.108). Carrying them into a full spec build guarantees at least one wasted 60–90 minute AutoQC cycle and a reviewer round.

Recommendation: before committing to the full World Spec, make three bounded decisions — (1) the synthetic patient name, (2) the task-suite restructure to 3–5 distinct workflows including one administrative deliverable, and (3) the approach to the traceability map, the Decision Friction Table, and the source-of-truth hierarchy. These are decisions, not drafting, and they are the difference between one spec pass and three.

ADDITIONAL PREPARATION RECOMMENDED — the resources and the autorun self-QC loop make the workflow otherwise sound, but two Blocker/Major failures are already live in the approved brainstorm (patient name; workflow count plus clinical-only task set), and the highest-risk reviewer items fall in AutoQC's stated blind spot; resolve the name, the task-suite restructure, and the friction-table / source-hierarchy / traceability approach before building the spec.

Review update.
Your findings have been triaged against source-of-truth materials, the World Spec template, and AutoQC v6.3.
Summary:
VERIFIED:

Synthetic patient-name requirement exists in World Spec AutoQC.
Workflow-count requirement exists.
Decision Friction Table requirement exists.
Source-of-truth hierarchy requirement exists.
Traceability requirements exist.
DISPUTED:

These are not current Brainstorm defects.
Brainstorm passed its own AutoQC and remains submitted for human review.
Current status:

Brainstorm submitted.
RL Studio status: Ready for Plan Review.
Human Review pending.
World Spec drafting remains prohibited until GO.
Next objective:
Do not review the Brainstorm again.
Instead, prepare for World Spec.
Using only the source-of-truth, World Spec template, AutoQC v6.3, and triage findings:
Identify any additional structural reviewer risks not already captured in the triage report.
Focus only on:

World Spec architecture
Self-containment
Traceability
Task/file relationships
Authority hierarchy
Temporal consistency Do not draft the World Spec. Do not invent clinical details. Do not create file inventories. Do not redesign tasks. End with: NO NEW RISKS or ADDITIONAL STRUCTURAL RISKS with justification.
Show more
May 29

Synthesized template-AutoQC gaps and excavated eight structural reviewer risks
Synthesized template-AutoQC gaps and excavated eight structural reviewer risks
Triage accepted. The VERIFIED/DISPUTED split is fair — the checks I cited live in the World Spec AutoQC (Section 2), not the Brainstorm AutoQC (Section 1), so they bind when the spec is built, not now. I won't relitigate the Brainstorm. Below are only additional structural risks, drawn from the template, AutoQC v6.3, and the triage — none repeated from the prior report. Two are genuinely new and high-severity; the rest are curated structural traps you'll otherwise hit one at a time under the "any single FAIL is SEND BACK" rule.

A. World Spec architecture
The headline new risk is a Blocker I had not surfaced: 2.101 "No Section D, E, or Higher in Spec." The World Spec body terminates at Section 4 (World Summary). The grader-guideline material that lives at later-lettered sections in the broader Sanctum document set must not appear in the spec. The most likely way to trip this is carrying companion/grader scaffolding into the spec file. Note this coexists with 2.67 (spec + companion sheet combined into a single .docx) and 2.104 (single .docx) — so the deliverable is one physical file, but the spec proper must not introduce Section D/E content. Prevention: confirm the spec ends at the World Summary and that nothing downstream of it introduces a later-lettered section.

The second new structural risk is concrete and verifiable from your two uploaded artifacts: a template-vs-AutoQC column mismatch. The uploaded World_Spec_Template_05_06 file-plan tables expose seven columns (#, ID, Filename.type, Date, Reference File Origin, Description, Pearls/Traps/Friction). AutoQC v6.3 — revised 05/23, after the template's 05/06 date — check 2.42 requires eight columns and names Source and Tool as separate columns plus a renamed Template/Reference File Origin. A writer who fills the 05/06 template verbatim will have no Source and no Tool column → guaranteed 2.42 FAIL (Minor, but a forced return). This also interacts with 2.113, since Source/Tool is where writer-produced-media vs engineering-converted is declared. Prevention: reconcile the file-plan table to the AutoQC 8-column expectation before drafting, and confirm with the Team Lead which template revision is canonical (I'm told the template may shift across revisions).

Lower-severity architecture traps not previously listed: 2.88 (every italic [bracketed] placeholder removed), 2.89 / 2.74 (optional sub-tables and rows omitted or justified — the template ships optional blocks for Home Meds, Hospital Course Timeline, Decision Friction Table, Data Hierarchy Note), and 2.54 (the World Summary must not duplicate the Clinical Complexity Overview). One prep-useful N/A note: for an inpatient clinical world, 2.19 regulatory backstory is legitimately N/A per the Common N/A patterns block — mark it N/A with the reason, not FAIL.

B. Self-containment
New risk	Check	Why it bites	Prevention
Established vs presumed conditions not separated	2.11 + template "Pre-existing Conditions" row	If the spec doesn't mark which conditions are carried-forward/locked (incorporate, don't re-derive) vs. presumptive/under-reasoning, a task's correct answer isn't bounded	Split the problem list into locked vs. presumptive in the Patient Profile
File visibility scope unstated	2.96	The "each task sees world-level + its own task-level" contract fails if a file's scope is ambiguous	State scope on every file row
C. Traceability
The new, higher-order obligation is the Key Milestones superset rule, which is broader than the file-dates→milestones check (2.44) I mentioned before. 2.22: every date referenced anywhere in the spec — task anchors, trap dates, history, file dates — must appear in Key Milestones. 2.23: conversely, no orphan milestones — every milestone must anchor a trap, task, or file. 2.76: chronological order. The Milestones table is the single timeline source of truth; treat it as the master and reconcile everything to it. Also new: 2.86 (Description column must be builder-ready — detailed enough for engineering to produce the synthetic file; a vague description is a Major fail and also means the file won't carry the facts the goldens cite), and 2.59 (no cross-task contradiction — with six tasks drawing on overlapping facts, a value stated one way in one task's Expected Output and differently in another's fails, distinct from the dose/anthropometric consistency checks already flagged).

D. Task/file relationships
New here: 2.94 (Major) — every task-level file ID must reference a task that actually exists; an off-by-one (a T7 file when there are six tasks) fails. Plus the minors 2.82 (file ID sequence monotonic) and 2.95 (IDs unique within tier). The subtle interaction worth holding: a task-level file that silently carries a fact another task's correct answer needs either must be promoted to world-level or that second task breaks self-containment — this is where the supplementary litmus (2.50) and file scope (2.96) meet task independence. Reuse of a task-level file across tasks is allowed and is not a dependency; referencing another task's output is the Blocker.

E. Authority hierarchy
Beyond documenting the hierarchy (2.65, already flagged), the hierarchy is only operative if the named authorities actually exist and are named consistently. New: 2.97 (the care-team roster must include both inpatient and consulting providers — relevant given a hospitalist/attending plus the consulting specialties already established in triage), 2.26 (roster field coverage), and 2.27 (one standardized provider name used everywhere, so a consultant isn't named one way in the roster and another in a consult-note row). Structural placement: put the hierarchy in the Data Hierarchy Note within the Patient Profile, and make every authority trap resolve to that stated order — an authority trap that resolves to no documented hierarchy is a 2.65 FAIL.

F. Temporal consistency
The new nuance beyond the Temporal Gate (2.41) concerns the multi-anchor suite. With task anchors stated at discharge-day, roughly +7 days, and roughly +30 days, the Gate's sub-rule — no world-level file dated after any task anchor — must hold against the earliest anchor, not the latest. All world-level files sit at or before the snapshot. Anything dated at a post-snapshot moment (e.g., a post-discharge follow-up artifact a later task reasons from) must be a task-level file dated at that task's anchor and scoped to it — otherwise it post-dates the snapshot as a world file (2.41 Blocker) and leaks across tasks (2.40 Blocker). Same-date anchors survive only via the time-of-day workflow rule. Supporting minors: 2.76 (milestones chronological) and 2.109 (varied post-snapshot timepoints, which your spread already supports).

These are additive to the triage report and do not reopen the Brainstorm; they are the spec-build failure surfaces the triage didn't enumerate, weighted toward the new 2.101 Blocker and the 05/06-template-vs-v6.3 column mismatch.

ADDITIONAL STRUCTURAL RISKS — justification: cross-referencing the uploaded 05/06 template against AutoQC v6.3 (revised 05/23) surfaces a Blocker absent from the triage (2.101) and a guaranteed-return column mismatch (2.42 Source/Tool), and the template plus the 113-check set carry further structural obligations not in the triage — the Key Milestones superset (2.22/2.23/2.76), builder-ready descriptions (2.86), task-level file ID integrity (2.94), care-team/authority naming (2.97/2.26/2.27), confirmed-vs-presumed PMH and file scope (2.11/2.96), and the multi-anchor world-file dating rule — each a SEND-BACK trigger under the every-check pass rule.


brainstorm.md
134 lines

md


claude-brainstorm-review-package.md
61 lines

md


clinical-logic.md
148 lines

md

State update.
Korvin Merrow Brainstorm remediation has been completed and resubmitted.
Reviewer-requested fixes implemented:

Synthetic patient identity (Korvin Merrow)
World Type: Typical Clinical World
Expanded 10+ comorbidity burden
Specific medication list with drug names and doses
Brainstorm AutoQC rerun:

0 failed
51 passed
Current status: Awaiting reviewer decision after resubmission.
World Spec drafting remains unauthorized.
Use the updated Korvin Merrow context package as source of truth. Ignore any historical references that imply:

James Carter is active
comorbidity approval is pending
medication approval is pending
SEND BACK remediation is incomplete Current operating mode: review-pending / preparation-only.
Show more
May 30
State acknowledged. Operating from the Korvin Merrow package as source of truth: synthetic identity (Korvin Merrow), Typical Clinical World, the 10+ comorbidity burden, and the specific dosed medication list are all locked and treated as approved. James Carter is retired. No remediation is outstanding. Mode is review-pending / preparation-only, and World Spec drafting stays unauthorized — I won't draft spec content, invent clinical detail, build file inventories, or redesign tasks.

The three earlier RED items that were patient-name and approval-status dependent are now closed by this update: identity is synthetic (2.2), the comorbidity burden is approved, and the medication list is approved. What that does is shift weight onto the risks that the medication list, now that it's concrete, activates — plus the structural surface that's independent of those approvals.

A few notes on what the now-concrete medication list changes for the eventual spec, since this is the substantive thing this update moves:

The dosed list (sacubitril/valsartan 24/26 BID, carvedilol 12.5 BID, furosemide 40 daily, spironolactone 25 daily, empagliflozin 10 daily, the prednisone-with-inconsistent-taper line, and the rest) is now the traceability spine for the spec's medication tasks. Once it's approved at the brainstorm layer, every one of those doses becomes a fact that the World File Plan must carry in a file (2.48 Blocker fact-to-file; 2.86 builder-ready descriptions) and that must read identically everywhere it appears (2.57 dose consistency; 2.59 no cross-task contradiction). The prednisone line is the one to watch: "inconsistent documented taper/dose" is deliberate and correct at the concept layer, but in the spec it has to be engineered inconsistency — each conflicting value locked to a named document and a Key Milestones date (2.90), labeled as an intentional trap in its substrate row, not left looking like a writing error. That's the difference between the steroid source-of-truth trap reading as designed versus reading as a defect.

Two interactions worth holding now, while it's still preparation:

Spironolactone + sacubitril/valsartan during AKI/hyperkalemia risk is a second, independent medication-hold reasoning thread alongside the ARNI/diuretic one. When the HF-AKI trap (Trap 2) is instantiated, the hold/restart logic has to be coherent across both the RAAS-acting agents and the diuretics against the same creatinine and potassium trends — otherwise the consultant-synthesis task (Task 5) and the med-rec task (Task 1) can end up implying different correct restart sequences, which is exactly the 2.59 cross-task contradiction failure.
Alendronate, calcium/vitamin D, and the steroid line form a quiet osteoporosis sub-thread that the brainstorm establishes (osteoporosis from chronic steroid exposure is in the comorbidity list). It carries no task today, which is fine — but under the supplementary litmus test (2.50) and builder-ready description rule (2.86), any file that mentions these has to be either load-bearing for a task (essential) or pure noise (supplementary), declared deliberately. The risk is a half-thread: documented richly enough to look like it should matter, but with no task that uses it, which invites a reviewer to ask whether a task is missing.
None of that is a new defect and none of it reopens the brainstorm — it's the medication-layer prep that becomes actionable specifically because the list is now approved rather than pending.

Everything else from my prior preparation report stands unchanged and unrepeated: the 2.101 Section-D/E Blocker, the 05/06-template-vs-v6.3 eight-column mismatch (Source/Tool), the Key Milestones superset rule (2.22/2.23/2.76), task-level file ID integrity (2.94), care-team/authority naming (2.97/2.26/2.27), confirmed-vs-presumed PMH split (2.11), file scope (2.96), and the multi-anchor world-file dating rule against the earliest post-snapshot anchor. The task-suite structural items I raised — six distinct workflows against the 3–5 ceiling (2.107) and the clinical-only suite needing one administrative deliverable (2.108) — are task-design questions, so I'm holding them as flagged-not-actioned per your instruction not to redesign tasks; they'll need a physician decision at spec time, but nothing is required now.

Holding here in preparation-only mode. When reviewer GO comes through, the first productive step will be locking the Key Milestones date skeleton, since under v6.3 it's the single timeline source of truth that the temporal gate, the file dates, and every trap anchor all reconcile against — getting it right first prevents the most expensive class of rework. Ready when you are.

State update.
Human reviewer Stacey S approved the Korvin Merrow Brainstorm.
Reviewer message:
"great job! I approved your brainstorm. Next steps are to move forward with world spec and file template development."
Current state:
- Brainstorm approved
- World Spec and file template development are now the next phase
- Use Korvin Merrow package as source of truth
- James Carter is retired and historical only
- Reviewer-requested fixes are complete and accepted
Operating boundary:
Do not draft World Spec content until Alexander explicitly starts the post-GO interview.
Do not invent clinical details, file inventory, task prompts, golden responses, or grader guidance.
Your next role:
Help prepare for the World Spec phase by reviewing proposed physician decisions against:
- World Spec template
- AutoQC v6.3
- source-of-truth guide
- prior reviewer feedback

Show more
May 30
GO is logged. Stacey S approved the Korvin Merrow Brainstorm; World Spec and file-template development is the authorized next phase. Source of truth is the Korvin Merrow package; James Carter is historical only; reviewer fixes are accepted.

I want to be precise about the one boundary that matters here, because the approval and the boundary point in slightly different directions. Stacey authorized the phase. Your standing instruction is that I don't draft World Spec content until you explicitly start the post-GO interview. Those are consistent: the phase is open, but the drafting trigger is yours to pull. So my role right now is the one you named — reviewing your proposed physician decisions against the template, AutoQC v6.3, the source-of-truth guide, and prior reviewer feedback — not producing spec content, clinical detail, file inventory, prompts, goldens, or grader guidance. I'll hold that line until you say the interview is starting.

To make this phase productive rather than reactive, here's how I'd suggest we use the gap between now and the interview, and what I'll need from you to review well.

The highest-leverage thing to settle first is the Key Milestones date skeleton, for the reason I flagged at the close of preparation: under v6.3 it's the single timeline source of truth that the Temporal Anchoring Gate, the file dates (2.44), every trap's date lock (2.90), and the every-date-appears rule (2.22) all reconcile against. If you bring me a proposed set of calendar dates — admission through the Day 6 18:00 snapshot, plus the post-snapshot task anchors at discharge, ~+7 days, and ~+30 days — I can check it for internal consistency, gate compliance, and the no-orphan-milestones rule (2.23) before any file or task is pinned to it. Getting this right first is what prevents the most expensive class of rework, because everything else hangs off these dates.

Beyond that, the decisions I'm positioned to review as you make them, each against a specific bar:

The synthetic identity block — DOB reconciled to age 62 (2.100), MRN in an obviously synthetic format (2.3), anthropometrics self-consistent (2.9/2.56). You propose, I check the arithmetic and format.
The confirmed-vs-presumed split of the comorbidity list (2.11) — which conditions are locked/carried-forward versus under active reasoning. This bounds what the tasks can treat as given.
The source-of-truth hierarchy content and its placement in the Data Hierarchy Note (2.65), plus the care-team roster with consistent provider names across inpatient and consulting roles (2.97/2.26/2.27).
The Decision Friction Table structure — your three frictions (Nephro/Cards, Family/Team, Endo) rendered as Friction / Options / Correct Pathway, with the Endo row tied to an actual advocacy artifact so it stays a friction and doesn't revert to the steroid trap (2.14/2.37).
The medication-layer mechanics I raised last turn — how the deliberate prednisone-dose inconsistency gets locked to named documents and dates, and how the dual RAAS/diuretic hold-restart logic stays coherent across the med-rec and consultant-synthesis tasks so they don't imply different restart sequences (2.57/2.59/2.90).
Two items I'm explicitly holding, not actioning, per your no-redesign instruction: the six-distinct-workflows-vs-3–5-ceiling question (2.107) and the clinical-only-suite-needs-one-administrative-deliverable question (2.108). These are task-design decisions that will need your call at spec time. I'm not going to touch the task set — but I'd flag that these two are worth a deliberate decision early in the interview rather than late, because they affect the file plan, and the file plan is expensive to rebuild.

One thing that would sharpen all of this: if the source-of-truth guide is a distinct document I haven't seen, it'd help to have it. I have the World Spec template, the full v6.3 checklist, the approved brainstorm, the clinical-logic file, and the prior reviewer feedback in hand — but the source-of-truth guide has only been referenced, not provided, and a few of the checks (the authority hierarchy ordering in particular) are easier to review against the canonical guide than against my reconstruction of it.

What would you like to bring up first — the date skeleton, or another decision you're closer to settling?

Search only the source-of-truth guide, template materials, AutoQC materials, reviewer guidance, and any example references available.
Question:
What exactly must be submitted with a World Spec?
Specifically determine:

Meaning of "Upload your Claude transcripts for creating both the brainstorming and world spec documents"
Meaning of "template/reference files"
Meaning of "custom files"
Whether examples of submission packages exist
Whether transcript format is defined
Whether brainstorming transcripts are required at World Spec submission
Whether any guidance exists regarding use of non-Claude tools Provide: VERIFIED PLAUSIBLE NOT FOUND for every claim. Do not extrapolate from industry norms. Do not infer missing requirements. Ground every statement in source-of-truth evidence.
Show more
May 30

Cataloging five available files, discovering absent guidance documents
Cataloging five available files, discovering absent guidance documents
GO is logged and I'll honor the drafting boundary. This is a grounding question, so I'm going to search the actual materials I have rather than reason from what's typical — and where a quoted phrase isn't in those materials, I'll say so plainly rather than tell you what it "probably" means. Let me look.


Systematically verified claims against available documents, identifying critical gaps
Systematically verified claims against available documents, identifying critical gaps
Searched the five documents I actually hold: the World Spec Template (05/06), AutoQC v6.3 (all 113 checks plus its front matter and Appendix A), the approved brainstorm, the brainstorm review package, and the clinical-logic file. No web search — you asked me not to import industry norms, and a submission-requirements question is exactly where I'd otherwise be tempted to.

One scope finding has to come first, because it governs most of the answer.

The documents most likely to define a "submission package" are not in my evidence base. Of the sources you listed, I have the template and the AutoQC. I do not have a standalone source-of-truth guide, a reviewer guidance document, or any example references / example packages. The clinical-logic file names AGENTS.md as the thing that "keeps operating context," but AGENTS.md was never uploaded. So where a verdict below is NOT FOUND, in several cases it means the governing document isn't in front of me, not I checked the right document and the requirement was absent. I'm flagging that rather than papering over it.

A second framing fact: my materials describe two distinct upload moments, and neither is called a "submission package," and neither mentions transcripts.

claude.ai self-AutoQC upload: the writer uploads the world spec (.docx) and the approved brainstorm (.docx). The AutoQC states "The QC cannot be run without the deliverable," and that the Reference Templates folder "itself is not uploaded to this claude.ai self-AutoQC."
RL Studio gate ("the next gate"): the Reference Templates folder "is uploaded to RL Studio at the next gate, together with the world spec."
Now, claim by claim.

1. Meaning of "Upload your Claude transcripts for creating both the brainstorming and world spec documents" NOT FOUND. The word "transcript" appears exactly once across all five documents — inside the workflow name "Medical Transcription and Clinical Documentation Completion" in Appendix A, which is unrelated. The quoted sentence, and the concept of uploading conversation transcripts at all, does not appear in the template, the AutoQC, or any file I hold. If this instruction is real, it originates in a document outside my evidence base (plausibly AGENTS.md or a submission portal/checklist I haven't been given). I won't tell you what it "means," because that would be invention.

2. Meaning of "template/reference files" PARTIALLY VERIFIED. The exact phrase "template/reference files" is not defined, but its components are:

VERIFIED: AutoQC 2.42 and the v6.3 change-log rename the file-origin column to "Template/Reference File Origin," identifying a file's source as Public Domain (with attribution), internal DataBank template (with template name), or Custom-made.
VERIFIED: There is a "Reference Templates folder" workflow. For engineering-converted rows, "the template you upload to the Reference Templates folder uses a generic descriptive filename WITHOUT a datestamp," while the spec's Filename column carries the datestamped engineering output name (the "two-track filename convention," audited by 2.113).
NOT FOUND: A definition of "template/reference files" as a named submission deliverable with its own packaging rules, beyond the folder-upload-at-RL-Studio statement above.
3. Meaning of "custom files" NOT FOUND as a category; VERIFIED only as a file-origin label. "Custom files" is not defined anywhere as a submission category. What exists:

VERIFIED: "Custom Made" (template) / "Custom Built by Writer" / "Custom-made with descriptive filename" (AutoQC 2.85) is one of four file-origin options in the File Plan, alongside Public Domain, DataBank Template, and Writer-Produced.
VERIFIED (adjacent): "Writer-produced media" is a distinct, explicitly listed row type (see claim 7) that engineering does not convert. Whether "custom files" in your source refers to this writer-produced category, to the "Custom Built by Writer" origin label, or to something else is NOT FOUND — I can't disambiguate it from my materials.
4. Whether examples of submission packages exist NOT FOUND. No example submission package, sample spec, or worked reference exists in my file set. The template ships illustrative placeholder text (e.g., "DischargeSummary_04262026.docx," example friction-table rows), and the AutoQC gives inline examples within check criteria (e.g., a sample filename "Joseph_World_Marcus_latest_5_12.docx"), but these are field-level illustrations, not example submission packages. The brainstorm review package is a brainstorm-stage review wrapper, not a spec submission example.

5. Whether transcript format is defined NOT FOUND. With no transcript requirement located at all (claim 1), there is correspondingly no format, file type, or structure for transcripts anywhere in my materials.

6. Whether brainstorming transcripts are required at World Spec submission NOT FOUND for transcripts specifically. What is VERIFIED is adjacent but different: the approved brainstorm document (.docx) must be uploaded with the spec to run the claude.ai self-AutoQC ("What the writer uploads with this file: the world spec (.docx), the approved brainstorm (.docx)"), and the AutoQC's prior-section sign-off block requires confirming the brainstorm passed its own AutoQC. That is a requirement to supply the approved brainstorm deliverable, not a brainstorming transcript. Whether a transcript is additionally required at submission is NOT FOUND in my evidence.

7. Whether any guidance exists regarding use of non-Claude tools PARTIALLY VERIFIED.

VERIFIED: Specific non-Claude tools are explicitly named as acceptable producers of certain file types. The "writer-produced media" category lists Nano Banana Pro, ElevenLabs, GarageBand, Photoshop, real-world photos, custom EKG/EEG/ventilation tracings, clinical imaging, and handwritten documents (AutoQC front matter, v6.3 change-log, and 2.113). For these rows, "engineering does not convert these," and the Filename column already names the final RL Studio upload.
VERIFIED: A separate "engineering-converted" path exists for most other files (templates → engineering output filename).
NOT FOUND: Any general policy on non-Claude tool use beyond this file-production context — e.g., rules about using other LLMs to draft the spec, or constraints on non-Claude tools in the reasoning/authoring process. The AutoQC's "What this QC does not verify → Authorship" note states the checklist "cannot confirm a deliverable was written by the writer rather than by an AI" and assigns that to the writer and Team Lead, but it sets no rule about which tools are permitted.
Summary of verdicts

Claim	Verdict
"Upload your Claude transcripts…" meaning	NOT FOUND
"template/reference files" meaning	PARTIALLY VERIFIED (column + Reference Templates folder; full definition NOT FOUND)
"custom files" meaning	NOT FOUND as category; VERIFIED only as a file-origin label
Example submission packages exist	NOT FOUND
Transcript format defined	NOT FOUND
Brainstorming transcripts required at spec submission	NOT FOUND (approved brainstorm document required: VERIFIED)
Guidance on non-Claude tools	PARTIALLY VERIFIED (named media tools; general policy NOT FOUND)
The single most consequential result: every question that turns on the word "transcript" is NOT FOUND, and the quoted transcript instruction does not exist in any document I have. Because you're quoting it verbatim, it almost certainly lives in a source I haven't been given — most likely AGENTS.md or a submission/portal checklist. If you upload that document, I can re-run this against it and convert the NOT FOUNDs to grounded verdicts. Until then, I'm not going to reconstruct those requirements from inference.

State Update Only.
Do not draft World Spec content.
Brainstorm Status:

Approved
Reviewer GO received
New physician decisions are now locked:
Temporal Architecture

6-day hospitalization
HD6 18:00 world close
discharge anchor
+7 day anchor
+30 day anchor
Underlying Story

Mixed physiology world
Infection + steroid issues + CKD/HF/polypharmacy
Not a single-cause admission
Presentation Trigger

Progressive weakness
Poor oral intake
Near-fall/lightheadedness
Family-noticed confusion
Possible urinary symptoms
Clinical Evolution

Approximately 3-week decline
World Tone

Medically improving
Operationally dangerous discharge
Primary Failure Target

Functional decline
Disposition safety
Discharge readiness reasoning
Complexity Direction

Exceed reviewer minimums
Target 12–15 comorbidities
Target 18–22 medications Current Phase: Preparation complete. World Spec drafting still not authorized. Next planned phase: Clinical Story Skeleton. Task: Acknowledge state update and identify any AutoQC, reviewer, or source-of-truth risks introduced by these newly locked decisions. Do not draft World Spec content. Do not redesign tasks. Do not create file inventories. Do not create prompts or golden responses.
Show more
May 31
State acknowledged. Locking the following as approved physician decisions for Korvin Merrow:

Temporal: 6-day hospitalization, HD6 18:00 world close, three post-close anchors (discharge, +7, +30).
Story: mixed physiology — infection + steroid + CKD/HF/polypharmacy, explicitly not single-cause.
Trigger: progressive weakness, poor oral intake, near-fall/lightheadedness, family-noticed confusion, possible urinary symptoms.
Evolution: ~3-week decline.
Tone: medically improving, operationally dangerous discharge.
Primary failure target: functional decline / disposition safety / discharge-readiness reasoning.
Complexity: 12–15 comorbidities, 18–22 medications.
Phase is preparation; spec drafting remains unauthorized; next planned phase is Clinical Story Skeleton. I'm not drafting spec content, redesigning tasks, building inventories, or writing prompts/goldens. Below are only the risks these newly locked decisions introduce, checked against AutoQC v6.3, the template, and reviewer/source-of-truth materials. I'm not re-raising anything from prior reports.

The one that genuinely shifts the risk profile: "near-fall/lightheadedness" + "primary failure target = disposition safety." This is now the load-bearing element of the world, and it's the element most exposed to the reveal-drift objection. Lightheadedness, near-fall, weakness, poor intake, and a steroid taper form a symptom cluster that points cleanly at adrenal insufficiency / orthostatic hypotension. Your guardrail already says adrenal risk stays one contributor among five — but with disposition safety now the primary target and these symptoms now the trigger, a hostile reviewer will look harder at whether the near-fall resolves to a single tidy cause. The risk isn't in the decision; it's that the spec instantiation must keep the near-fall multi-causal (orthostasis from volume/med changes, deconditioning, neuropathy, glucose, and steroid effect all live), or the "operationally dangerous discharge" reading collapses into "missed adrenal crisis." This is a judgment item AutoQC can't catch — it's exactly in the authorship/difficulty/clinical-validity blind spot the checklist names.

The internal-consistency tension that's now baked in: "medically improving" + "operationally dangerous." This is the right design tone, but it sets up a cross-section contradiction risk under 2.59 and the cross-cutting consistency checks (2.55–2.58). The physician notes must read as genuine improvement while nursing/PT/family signal danger — and those two truths have to coexist without one looking like a documentation error. If the improvement is overstated, the discharge-readiness target dies (too easy); if the danger is overstated, the "improving" frame becomes incoherent. The tone is approved; the calibration is a spec-time judgment call, and it's the thing that makes or breaks the primary failure target.

Complexity-count interactions — three concrete AutoQC pressures from the new targets:

The 12–15 comorbidity / 18–22 medication targets clear all the minimum bars comfortably (modality diversity 2.51, medication-list completeness 2.12), and "exceed reviewer minimums" is sound instinct. But scaling up multiplies obligations the every-check-passes rule treats as hard:

Traceability load (2.48 Blocker, 2.57, 2.86): every one of 18–22 medications that appears in any task's Expected Output or trap needs a file home and a consistent dose everywhere it appears. More meds = more surface for a single dose mismatch to force a SEND BACK. The count is approved; the discipline scales with it.
Supplementary-litmus exposure (2.50 Major): a 12–15 comorbidity burden invites "background" conditions (the osteoporosis/alendronate, OSA, neuropathy threads). Each must be either load-bearing-and-essential or pure-noise-and-supplementary. The risk is the half-thread — a comorbidity documented richly enough to look like it should drive a task but attached to none, which invites "is a task missing?"
Difficulty-distribution / "why hard for AI" (2.24, 2.99): more comorbidities is not the same as more synthesis difficulty. A reviewer can read 15 comorbidities as breadth-padding if the hardness still comes from the same discharge-safety synthesis. The spec's complexity section will need to show the burden creates reasoning difficulty, not just length.
Temporal: the locked architecture is gate-compliant, with one watch-item. HD6 18:00 close + three strictly-post-close anchors satisfies the Temporal Anchoring Gate's structure (2.41 Blocker) cleanly — good. The watch-item is unchanged from before but now fixed by the lock: the +7 and +30 anchors mean any artifact those tasks reason from (a post-discharge follow-up encounter, a 30-day readmission-window record) must be a task-level file dated at that anchor and scoped to that task — never a world-level file, because a world file dated after HD6 18:00 fails the gate, and a shared post-close file leaks across tasks (2.40 Blocker). The "~3-week decline" is pre-admission backstory; it needs to surface in Key Milestones (2.22) and the clinical history (2.17) as dated context, but it sits before admission, so it poses no gate problem — just a date-table completeness obligation.

Source-of-truth: nothing in this update introduces a new authority-hierarchy risk; the prior 2.65 obligation stands. One small note — "family-noticed confusion" and "family reports" now appear at both the trigger and the discharge-friction layers, which makes the family's position a recurring source. That strengthens the Family-vs-Team friction (good) but means "family report" needs its fixed rung in the documented hierarchy so a task can't be gamed by over-weighting it.

Two items I'm holding, not actioning (per no-redesign): the new "disposition safety" primary target leans on the discharge-cluster tasks, which keeps the 2.107 distinct-workflow-ceiling and 2.108 clinical-vs-administrative-mix questions live. These decisions sharpen the case toward the discharge cluster, which is the right clinical call — but they don't resolve those two task-design questions, and I'd flag that the complexity-scaling decision (more meds, more comorbidities) makes the file plan bigger, which raises the cost of deferring the task-mix decision. Both remain your calls at spec time.

Net: the locked decisions are coherent and clear the AutoQC minimums with room to spare. The risk they introduce is concentrated almost entirely in judgment surfaces AutoQC can't verify — keeping the near-fall multi-causal under a now-primary disposition-safety target, and calibrating "improving but dangerous" so both halves stay true — plus the mechanical traceability load that scales with the comorbidity and medication counts. Nothing here needs action in preparation-only mode; they're the things to hold as you build the Clinical Story Skeleton. Ready when you move to it.

Clinical Story Skeleton v1 Review
Role: Hostile reviewer.
You are not the author. You are not the designer. You are not drafting content.
Assume the Clinical Story Skeleton is locked and your job is to find weaknesses before World Spec construction begins.
Review against:

Approved Brainstorm
World Spec template
AutoQC v6.3
Reviewer feedback history
Locked physician decisions
Evaluate:

Clinical Validity

Is the hospitalization believable?
Are consultant behaviors realistic?
Is the discharge tension realistic?

Source-of-Truth Integrity

Any future source conflicts likely to fail?
Any hidden single-source assumptions?
Any hierarchy concerns?

Trap Integrity

Steroid trap support
HF/AKI trap support
Functional decline trap support
Sepsis anchoring trap support
Discharge hierarchy trap support

Friction Integrity

Cardiology vs Nephrology
Family vs Team
Endocrinology vs Documentation

Temporal Integrity

6-day admission
HD6 world close
discharge/+7/+30 structure
decline timeline

Disposition Safety Integrity

Does the world genuinely test discharge reasoning?
Does it remain medically improving but operationally dangerous?

Reviewer SEND BACK Risk What specifically could cause:

GO
MINOR REVISION
SEND BACK
Classify findings:
RED

likely blocker
YELLOW

notable concern
GREEN

strong
Do not redesign. Do not rewrite. Do not draft World Spec. Do not create files.
Provide:
Overall Verdict:

GO
MINOR REVISION
SEND BACK Explain reasoning. Focus on finding weaknesses, not validating strengths.
Clinical Story Skeleton v1 (Locked)
Patient:
Korvin Merrow, 62-year-old male.
Baseline:
- Lives with family.
- Independent but slowed by chronic illness.
- Occasional cane use.
- Mild age-related forgetfulness only.
- Chronic diseases generally stable before current decline.
PMR / Prednisone:
- Several-year PMR history.
- Chronic prednisone exposure.
- Multiple prior flares and taper attempts.
- Recent taper initiated because symptoms appeared controlled.
- Prednisone history contains reconstructable source-of-truth inconsistencies across documentation, medication history, family understanding, and patient recollection.
Three-Week Decline:
- Reduced stamina.
- Reduced activity.
- Poor appetite.
- Reduced fluid intake.
- Increasing weakness.
- Increasing family dependence.
- Possible urinary symptoms.
- Progressive unsteadiness.
- Progressive cognitive slowing.
Escalation:
- Medication-management mistakes.
- Increased dependence.
- Lightheadedness.
- Near-fall event.
- Family recognizes meaningful deviation from baseline and seeks care.
ED Presentation:
- Suspected urinary-source infection.
- Dehydration.
- AKI risk.
- Altered baseline mental status.
- Functional decline.
- Sepsis-oriented management is clinically reasonable.
- Infection is a contributor, not the entire explanation.
Hospital Course:
HD1:
- Admission and stabilization.
HD2:
- Partial improvement.
- Consultant involvement begins.
HD3:
- PT/OT identify functional concerns.
HD4:
- Consultant tensions emerge.
- Steroid-history inconsistencies recognized.
HD5:
- Medical improvement continues.
- Disposition questions become dominant.
HD6:
- Patient appears medically improved.
- Discharge remains debatable.
Discharge State:
- Infection improved.
- AKI improving.
- Hemodynamics stable.
- Mental status improved.
- Oral intake improved.
However:
- Functional reserve uncertain.
- Medication restart strategy not fully settled.
- Steroid interpretation imperfect.
- Family concern persists.
- Disposition risk remains meaningful.
Core Theme:
Medically improving.
Operationally dangerous.
Primary Failure Target:
Disposition safety.
Functional decline recognition.
Discharge-readiness reasoning.
Near-Fall Framework:
Multi-factorial.
Not attributable to a single cause.
Contributors include:
- poor intake
- volume depletion
- medication effects
- neuropathy
- deconditioning
- infection physiology
- steroid-related physiology

Clinical Story Skeleton v1 (Locked)
Patient:
Korvin Merrow, 62-year-old male.
Baseline:
- Lives with family.
- Independent but slowed by chronic illness.
- Occasional cane use.
- Mild age-related forgetfulness only.
- Chronic diseases generally stable before current decline.
PMR / Prednisone:
- Several-year PMR history.
- Chronic prednisone exposure.
- Multiple prior flares and taper attempts.
- Recent taper initiated because symptoms appeared controlled.
- Prednisone history contains reconstructable source-of-truth inconsistencies across documentation, medication history, family understanding, and patient recollection.
Three-Week Decline:
- Reduced stamina.
- Reduced activity.
- Poor appetite.
- Reduced fluid intake.
- Increasing weakness.
- Increasing family dependence.
- Possible urinary symptoms.
- Progressive unsteadiness.
- Progressive cognitive slowing.
Escalation:
- Medication-management mistakes.
- Increased dependence.
- Lightheadedness.
- Near-fall event.
- Family recognizes meaningful deviation from baseline and seeks care.
ED Presentation:
- Suspected urinary-source infection.
- Dehydration.
- AKI risk.
- Altered baseline mental status.
- Functional decline.
- Sepsis-oriented management is clinically reasonable.
- Infection is a contributor, not the entire explanation.
Hospital Course:
HD1:
- Admission and stabilization.
HD2:
- Partial improvement.
- Consultant involvement begins.
HD3:
- PT/OT identify functional concerns.
HD4:
- Consultant tensions emerge.
- Steroid-history inconsistencies recognized.
HD5:
- Medical improvement continues.
- Disposition questions become dominant.
HD6:
- Patient appears medically improved.
- Discharge remains debatable.
Discharge State:
- Infection improved.
- AKI improving.
- Hemodynamics stable.
- Mental status improved.
- Oral intake improved.
However:
- Functional reserve uncertain.
- Medication restart strategy not fully settled.
- Steroid interpretation imperfect.
- Family concern persists.
- Disposition risk remains meaningful.
Core Theme:
Medically improving.
Operationally dangerous.
Primary Failure Target:
Disposition safety.
Functional decline recognition.
Discharge-readiness reasoning.
Near-Fall Framework:
Multi-factorial.
Not attributable to a single cause.
Contributors include:
- poor intake
- volume depletion
- medication effects
- neuropathy
- deconditioning
- infection physiology
- steroid-related physiology

Show more
May 31
Hostile review of Clinical Story Skeleton v1, treated as locked. I'm hunting weaknesses, not validating. Checked against the approved brainstorm, the template, AutoQC v6.3, reviewer history, and the locked physician decisions. No redesign, no rewrite, no spec content, no files.

Two scope honesty notes up front. First, a skeleton is upstream of the spec, so many AutoQC checks (filenames, columns, ID conventions) can't yet pass or fail — I'm only flagging where the skeleton bakes in a future failure, not where it's silent on something it shouldn't yet contain. Second, the most dangerous weaknesses here are clinical-judgment ones that sit in AutoQC's stated blind spot (authorship, genuine difficulty, deep clinical validity) — so a clean future AutoQC will not catch them. That's where I'm concentrating.

1. Clinical Validity
YELLOW — Hospital course is under-determined in a way that hides risk. The HD1–HD6 arc is a list of labels ("partial improvement," "consultant tensions emerge"), not events with clinical content. As a skeleton that's expected, but it means the believability can't actually be tested yet — and two things it commits to are already in tension. The patient presents with altered mental status and functional decline severe enough to drive a near-fall and a care-seeking event, yet the entire course is six days to "medically improved." For a 62-year-old with this comorbidity load, AKI on CKD, and a confusion/weakness syndrome, a six-day turnaround to discharge-debatable is plausible but tight; if the spec makes the presentation as sick as the trigger implies, six days may read as rushed, and if it softens the presentation to fit six days, the "operationally dangerous" thesis weakens. This is the calibration risk I flagged at lock, now visible in the skeleton.

RED-adjacent (YELLOW for now): consultant behavior is asserted, not instantiated. "Consultant tensions emerge" (HD4) is the load-bearing clinical event for two of your three frictions, and the skeleton gives it no behavioral content. The believability of cardiology vs nephrology depends entirely on what each actually recommends and when — which doesn't exist yet. Not a defect in a skeleton, but it means the single most rejection-prone element (consultant friction realism, flagged repeatedly in reviewer history) is still entirely unproven. Watch-item, not blocker.

GREEN: discharge tension is realistic and well-constructed. "Medically improving / operationally dangerous" with uncertain functional reserve, unsettled med restart, imperfect steroid interpretation, and persistent family concern is a genuine, common, high-stakes hospitalist dilemma. This is the strongest part of the skeleton.

2. Source-of-Truth Integrity
RED: the central source-of-truth claim is asserted but structurally unsupported, and that's now a pattern. The prednisone line — "reconstructable source-of-truth inconsistencies across documentation, medication history, family understanding, and patient recollection" — is the same sentence in concept from the brainstorm forward, and it still names four conflicting sources without committing which one wins. Under AutoQC 2.65, an authority trap requires a documented hierarchy; "reconstructable" is the writer asserting a resolution exists without stating the rung order that produces it. This isn't a skeleton-stage excuse: the skeleton is where you decide that there is a hierarchy, even if the spec fills in the values. As written, four-way steroid disagreement with no stated precedence is a 2.65 failure waiting at spec time. This is the highest-severity finding in the review.

YELLOW: a new single-source dependency just entered via "patient recollection." The skeleton adds patient recollection as a fourth steroid source alongside documentation, med history, and family. But the patient presented with altered mental status and cognitive slowing — so his recollection is simultaneously a named source-of-truth input and explicitly unreliable. If any task's correct answer leans on reconciling patient recollection, the hierarchy must rank an impaired narrator, and a reviewer will ask how an AMS patient's recall is a usable source at all. Either it's deliberately low on the hierarchy (fine, but say so) or it's a contradiction.

YELLOW: "family understanding" is load-bearing at three layers now — trigger ("family recognizes deviation"), source-of-truth (steroid history), and friction (Family vs Team). Concentrating that much weight on one non-clinical source without a fixed hierarchy rung invites a task being gamed by over-weighting family. Needs its rung pinned.

3. Trap Integrity
Trap	Verdict	Weakness
Steroid source-of-truth	RED	Four sources, no hierarchy (see §2). Strongest concept, weakest structural support.
HF/AKI medication	YELLOW	Skeleton says "medication restart strategy not fully settled" — but a trap needs a correct answer. "Not fully settled" at discharge risks becoming "no determinable right answer," which fails the plausible-wrong-answer logic (2.36) and traceable-correct-answer expectation. The dual RAAS/diuretic hold-restart logic I flagged at lock is invisible here.
Functional decline	GREEN	Well-supported: HD3 PT/OT concerns + "functional reserve uncertain" + family signal across multiple document types. This is the trap the skeleton supports best — appropriate, since it's the primary target.
Sepsis anchoring	YELLOW	"Infection is a contributor, not the entire explanation" supports it conceptually, but the skeleton never says infection markers/cultures improve and partially clarify — the anchoring trap needs the early framing to look more complete than it is. The temporal contrast isn't yet in the arc.
Discharge hierarchy	YELLOW	Depends on a "reassuring discharge artifact read alone" vs. evidence elsewhere. The skeleton has the elsewhere (functional, family, meds) but no committed reassuring artifact to be misled by. Trap has no anchor yet.
Cross-trap RED-adjacent concern: four of five traps converge on the same discharge moment and the same evidence pool (functional + family + meds + steroid). The functional-decline and discharge-hierarchy traps in particular risk being the same trap twice — the brainstorm review already forced a Trap 3 vs Trap 7 distinction, and the skeleton hasn't re-established the boundary at the story level. Watch for collapse into one mechanism.

4. Friction Integrity
GREEN: Cardiology vs Nephrology. Genuine two-party clinical conflict, both positions reasonable, supported by the HF/AKI substrate. Strongest friction. (Realism still unproven per §1, but the structure is sound.)

YELLOW: Family vs Team. Valid, but at risk of being too obviously correct in the family's favor. The skeleton stacks every danger signal (functional, cognitive, med mistakes, near-fall) on the family's side and gives the team only "appears medically improved." A friction where one side is plainly right isn't a friction — it's a trap the model should catch. The team's position needs genuine merit (real improvement, legitimate reasons discharge could be appropriate) or this degrades into a single-answer disposition call.

RED: "Endocrinology vs Documentation" is mislabeled and reverts to a trap. This heading is the tell. The brainstorm explicitly fixed this: the friction is Endocrinology vs the inpatient team, and survives as a friction only because Endo leaves an explicit advocacy position — the conflicting steroid records are a trap, not the friction. "Endocrinology vs Documentation" relabels the friction as Endo-vs-records, which is precisely the trap wearing a friction label that you were sent back toward before. Per 2.37 (frictions vs traps distinguished), this is a classification failure carried into the skeleton. Either Endo advocates against a human counterparty, or this is not a friction.

5. Temporal Integrity
GREEN: 6-day admission + HD6 18:00 close + discharge/+7/+30 anchors. Structurally clean against the Temporal Anchoring Gate (2.41). All task anchors fall strictly after close.

YELLOW: the ~3-week decline needs date-anchoring it doesn't yet have. The decline is narrated as a sequence with no dates. Under 2.22, every date referenced anywhere must hit Key Milestones; a three-week prodrome with "recent taper initiated" implies datable events (taper start, symptom onset, near-fall) that must land on the timeline without contradicting the six-day admission. Not a gate problem (it's pre-admission), but a completeness obligation the skeleton is silent on.

YELLOW (latent): +7 and +30 artifacts. Reaffirming the lock-time watch-item — anything those tasks reason from must be task-level and dated at the anchor, never a world file (would fail 2.41) and never shared (would fail 2.40). The skeleton doesn't violate this, but it also doesn't acknowledge it, and it's the easiest spec-time mistake to make.

6. Disposition Safety Integrity
GREEN on intent, YELLOW on the knife-edge. The world genuinely targets discharge reasoning — that's its spine, and it's the right spine. The vulnerability is the same one from two angles: (a) if the danger signals are as loud as the skeleton stacks them (§4 Family vs Team), the "correct" disposition becomes obvious and the world gets too easy — failing the genuine-difficulty bar (which AutoQC can't test, but trajectory runs and reviewers will); (b) if they're muted to preserve difficulty, "operationally dangerous" weakens. The skeleton currently leans toward (a) — every arrow points at "not safe to discharge." A disposition-safety world is only hard if discharge is defensible, not just if it's wrong.

RED-adjacent: the near-fall framework is multi-causal in the list but the arc may not deliver it. The seven-contributor list is exactly right against the reveal-drift risk. But the escalation section presents the near-fall immediately after "lightheadedness" and "medication-management mistakes," which are the orthostatic/adrenal-flavored contributors — the most reveal-prone reading. The list says multi-factorial; the narrative sequencing nudges toward orthostasis/steroid. If the spec lets labs or the course resolve the near-fall to one cause, the primary failure target inverts into a missed-diagnosis puzzle. The brainstorm's own guardrail is satisfied on paper; the story sequencing quietly undercuts it. Hold this as the top clinical-judgment risk.

7. Reviewer Decision Risk
What earns GO: the temporal architecture, the functional-decline trap, the cardio/nephro friction, and the core disposition thesis are all strong enough to pass as-is.

What forces MINOR REVISION: the team's side of Family-vs-Team needing genuine merit; the sepsis-anchoring temporal contrast not yet in the arc; the discharge-hierarchy trap lacking a reassuring-artifact anchor; the 3-week decline needing date-anchoring; the patient-recollection-as-source contradiction.

What forces SEND BACK:

The "Endocrinology vs Documentation" mislabel — a frictions-vs-traps classification error (2.37) the project was already steered away from once. A reviewer who remembers the prior pass will treat re-emergence as a regression.
The steroid hierarchy still undocumented — four conflicting sources, no stated precedence (2.65). The skeleton was the place to commit that a hierarchy exists; it doesn't.
Near-fall reveal-drift if sequencing wins over the multi-causal list — converts a disposition-safety world into the adrenal-insufficiency puzzle the guardrail forbids.
Overall Verdict: MINOR REVISION
Reasoning: the skeleton's architecture is sound — temporal structure is gate-clean, the functional-decline trap and disposition thesis are genuinely strong, and the cardio/nephro friction holds. It does not rise to SEND BACK because nothing structural is broken; it's a skeleton doing a skeleton's job. But it does not earn a clean GO, because it carries two recurrences of issues the project was already corrected on — the Endo friction relabeled as "vs Documentation" (a trap masquerading as friction), and the steroid source-of-truth still asserting reconciliation without a documented hierarchy — plus a near-fall narrative whose sequencing fights its own multi-causal guardrail. Those three are the difference between a story that holds at spec time and one that gets sent back, and all three are judgment fixes AutoQC will never flag for you.

Two findings I'm explicitly not actioning, per no-redesign: the four-traps-converge-on-discharge clustering and the Family-vs-Team one-sidedness both touch task architecture, which is yours to resolve. I'm flagging them as concerns, not redesigning them.

The single thing I'd put at the top: decide, at the story level, whether discharge is defensible. Right now every signal says "don't discharge," and a disposition-safety world is only hard if a competent clinician could genuinely argue either way.

Identity Package v1 Hostile Review
Role: Hostile reviewer.
Do not draft. Do not redesign. Do not create World Spec content.
Review the following proposed Identity Package:

Name: Korvin Merrow
DOB: 1964-02-18
Age: 62
MRN: KM-6427819
Height: 178 cm (5'10")
Weight: 97 kg (214 lb)
BMI: 30.6
Allergy: Lisinopril (cough)
Code Status: Full Code
Evaluate:

Clinical realism
Internal consistency
Reviewer risk
AutoQC risk
Synthetic identity safety
Demographic plausibility
Comorbidity compatibility
Functional-decline compatibility
Disposition-world compatibility
Future World Spec risk
Attempt to break the package.
Ask:

Does anything feel artificial?
Does anything create unintended task difficulty?
Does anything create reviewer concern?
Does anything conflict with the ratified Clinical Story Skeleton?
Classify findings:
RED

blocker
YELLOW

concern
GREEN

strong
Provide:
Overall Verdict:

GO
MINOR REVISION
SEND BACK Do not rewrite the package unless a finding requires correction. Focus on identifying weaknesses, not validating strengths.
Show more
May 31
Hostile review of Identity Package v1. Trying to break it, not bless it. Checked against AutoQC v6.3 identity checks (2.2, 2.3, 2.9, 2.100, plus 2.10/2.15), the template's Patient Profile, and the ratified Clinical Story Skeleton. No drafting, no redesign, no spec content.

Let me start with the one thing that's actually verifiable as wrong, then work through the rest.

The arithmetic, checked rather than eyeballed. DOB 1964-02-18 against the world's HD6 18:00 close (the relevant "as-of"). The decline is ~3 weeks; admission is ~early-to-mid 2026 if the document date (May 29, 2026) is anywhere near the world's present. As of Feb 18 2026 he's turned 62; as of May 2026 he's still 62. So DOB↔age is consistent (GREEN, 2.100 passes) — provided the spec's Key Milestones place admission in 2026. If the world's calendar were set before Feb 18 of its year, he'd be 61 and 2.100 would fail. Flagging the dependency, not a defect.

BMI, recomputed. 97 / (1.78²) = 97 / 3.1684 = 30.61. The stated 30.6 is correct (GREEN, 2.9 passes). Height/weight unit conversions also check: 178 cm ≈ 5'10", 97 kg ≈ 214 lb. Internally consistent.

Now the findings.

1. Clinical realism — YELLOW. BMI 30.6 (class I obesity) is fine on its own and fits the metabolic cluster. But hold it against the skeleton's ~3-week decline with poor appetite, reduced intake, and weakness severe enough to drive a near-fall. A patient three weeks into that course often shows weight loss from baseline. 97 kg is presented as a static number with no baseline. At spec time, if the trajectory implies meaningful intake reduction, a single admission weight with no prior weight is a missed opportunity at best and a mild inconsistency at worst (a malnourished-presentation patient at a stable obese weight). Not wrong; under-specified in a way the disposition/functional story will pressure.

2. Internal consistency — GREEN. All computed fields reconcile (age, BMI, conversions). No internal contradiction in the package as written.

3. Reviewer risk — YELLOW, and this is the main one. Two items a hostile human reviewer will catch that AutoQC won't:

The lisinopril allergy is a latent contradiction with the medication list. The ratified clinical context (carried from clinical-logic and the brainstorm) puts Korvin on sacubitril/valsartan. Sacubitril/valsartan is contraindicated within 36 hours of an ACE inhibitor (angioedema risk) — but more to the point, a patient with a documented ACE-inhibitor intolerance who is on an ARNI is a coherent and realistic story (ACEi cough → switched to ARB-based therapy). So this is defensible. The risk is the opposite: it's defensible only if the spec tells that story. A lisinopril allergy sitting next to an ARNI with no documented switch rationale invites "why is an ACEi-intolerant patient on this regimen?" The allergy is realistic; it creates an explanation obligation the identity package doesn't carry alone.
"Lisinopril (cough)" is labeled an allergy, but ACEi cough is an intolerance/adverse effect, not an allergy. Clinically, cough is the textbook non-allergic ACEi side effect. AutoQC 2.10 only checks that allergies are populated, so this passes the check — but a domain reviewer reading "Allergy: Lisinopril (cough)" may flag the mislabel, since true allergy vs intolerance matters for whether the whole class is off-limits. Minor, but it's exactly the kind of clinical-precision nit a hostile reviewer raises.
4. AutoQC risk — GREEN on the hard checks, with one note. 2.2 (synthetic name), 2.3 (synthetic MRN), 2.9 (anthropometrics), 2.100 (DOB↔age), 2.10 (allergies populated), 2.15 (code status populated) all pass as written. No AutoQC blocker here. The only AutoQC-adjacent watch-item is downstream, not in this package (see §10).

5. Synthetic identity safety — YELLOW. "Korvin Merrow" is unmistakably invented — clears 2.2 cleanly, good. But the MRN format is the weak point. "KM-6427819" embeds the patient's initials (K.M.). Real MRNs are not initial-derived; an initial-prefixed identifier reads as constructed-for-a-test, which cuts against the realism the world depends on, and the v6.3 criterion for 2.3 is that the format "cannot be confused with any real institution's numbering pattern" — initial-prefixing is conspicuously synthetic in a way that's arguably too on-the-nose rather than realistically synthetic. It will pass the check (it's clearly not a real institution's pattern), so it's not a blocker, but it's the single most artificial-feeling element in the package. If realism is being graded by a human, an initials-based MRN is a tell.

6. Demographic plausibility — GREEN. 62-year-old male, the stated build, living with family — all coherent and unremarkable. No plausibility problem.

7. Comorbidity compatibility — YELLOW. The package is compatible with the comorbidity set but silent on the fields the comorbidities make load-bearing, and the skeleton/lock raised the targets to 12–15 comorbidities and 18–22 meds. With CKD3, HFrEF, T2DM, and anemia of CKD all ratified, a Patient Profile that carries no baseline labs (baseline creatinine/eGFR, baseline A1c, baseline hemoglobin, a dry weight for the HF patient) will force every task to treat admission values as baseline — which directly undermines the AKI-on-CKD trap and the "renal function improving toward baseline" reasoning. The template explicitly lists baseline labs and functional status as common Patient Profile additions. This package omits them. Not an identity error per se, but the identity package is where baseline anchors belong, and their absence is a future-traceability problem (§10).

8. Functional-decline compatibility — YELLOW. "Occasional cane use" and "mild age-related forgetfulness only" come from the skeleton's baseline, and the identity package doesn't contradict them — but it also doesn't encode a baseline functional status field, which is the primary failure target's anchor. The entire disposition-safety thesis rests on "deviation from baseline," and baseline function is currently a prose line in the skeleton, not a structured Profile field. The identity package is the natural home for it. Its absence here means the most important comparator in the world has no fixed value.

9. Disposition-world compatibility — YELLOW → RED-adjacent on one point. Code Status: Full Code is the finding to interrogate hardest. For a 62-year-old it's a perfectly reasonable default and passes 2.15. But in a disposition-safety world whose whole point is transition planning, goals-of-care and code status are part of the disposition conversation. Full Code stated flatly, with no advance-directive context, is defensible for this patient — but a hostile reviewer of a discharge-readiness world may ask whether code status / advance directives should be a richer element given the theme. This is a judgment call, not a defect; I'm flagging it because "disposition world + bare Full Code" is the kind of thing that draws a reviewer question even when the answer ("yes, Full Code, here's why") is fine. Not a blocker; a probable question.

10. Future World Spec risk — YELLOW. The package itself introduces no spec-time blocker, but it defers three things that become traceability obligations the moment the spec is built: baseline labs (§7), baseline functional status (§8), and the lisinopril→ARNI switch rationale (§3). Under 2.48 (fact-to-file Blocker) and 2.57 (dose/value consistency), every value a task's correct answer leans on needs a file home and a consistent source. A baseline creatinine that the AKI trap depends on must exist somewhere; if it's not in the identity package, it has to appear in a file, and the package is the cleanest place to anchor it. Deferring isn't wrong — but it's a debt, and this is the natural moment to decide whether these live in the Profile or in files.

Breakage attempt — direct answers
Does anything feel artificial? Yes — the MRN. Initial-derived (KM-) is the one element that reads as built-for-a-test rather than realistically synthetic.
Does anything create unintended task difficulty? Yes — the absence of baseline labs/weight/function will force admission values to stand in for baseline, which can either trivialize or muddy the AKI-on-CKD and functional-decline reasoning depending on how the spec resolves it.
Does anything create reviewer concern? Three: the lisinopril allergy↔ARNI pairing needing a stated switch rationale; "allergy" vs "intolerance" mislabel for ACEi cough; and bare Full Code in a disposition-themed world.
Does anything conflict with the ratified Clinical Story Skeleton? No hard conflict. One soft tension: a static 97 kg with no baseline against a 3-week reduced-intake decline. Nothing in the package contradicts the skeleton's baseline lines, but it leaves the skeleton's most important comparator (baseline function) un-encoded.
Overall Verdict: MINOR REVISION
Reasoning: nothing here is a blocker. Every hard AutoQC identity check passes — the name is synthetic, the MRN clears the (low) bar, the arithmetic on age and BMI is correct, code status and allergies are populated. So this is not SEND BACK. But it doesn't earn a clean GO either, because two clinical-precision items will draw hostile-reviewer fire (the ACEi-cough-as-"allergy" mislabel and the lisinopril↔ARNI pairing with no documented switch), the MRN is conspicuously test-shaped, and — most substantively — the package is silent on the baseline anchors (renal/A1c/hemoglobin, dry weight, baseline functional status) that this specific world's primary failure target and AKI-on-CKD trap will depend on. Those silences aren't errors in an identity block, but they're the difference between an identity package that supports the disposition world and one that merely doesn't contradict it.

The only item I'd treat as approaching a real correction rather than a judgment call is the allergy label: "Allergy: Lisinopril (cough)" states as allergy what is clinically an intolerance, and in a world where medication reasoning is central, that distinction is load-bearing. The rest are concerns to weigh, not defects to fix — and per your instruction I'm not rewriting the package, only flagging where a finding points at a correction.


WORLD_SPEC_KICKOFF.md
md


governance-package-v1.md
269 lines

md


identity-package-review-addendum.md
56 lines

md


identity-package-v1.md
126 lines

md

Governance Package v1 Hostile Review
Role: Hostile reviewer.
You are not the author. You are not the designer. You are not drafting content.
Assume Governance Package v1 is a candidate lock and your job is to find weaknesses before ratification.
Primary Artifact: governance-package-v1.md
Reference Materials:

Approved Brainstorm
Reviewer feedback history
Human Review GO from Stacey S
Ratified Clinical Story Skeleton v1
Identity Package v1
Identity Package review addendum
Clinical logic
World Spec AutoQC v6.3
WORLD_SPEC_KICKOFF.md
Mission: Attempt to break Governance Package v1.
Review the actual document, not summaries.
Evaluate:

Care Team Roster Integrity

Missing stakeholders?
Unsupported consultants?
Care team realism?
Scope creep?

Authority Hierarchy Integrity

Does hierarchy create contradictions?
Does hierarchy accidentally erase consultant disagreement?
Does hierarchy create reviewer risk?
Does hierarchy conflict with disposition logic?

Source-of-Truth Integrity

General hierarchy
Prednisone hierarchy
Conflict resolution logic
Authority-trap readiness
AutoQC 2.65 exposure

Confirmed vs Presumed Split

Anything misclassified?
Anything that should be confirmed but isn't?
Anything that should remain uncertain but doesn't?

Friction Integrity Review each friction independently:
A. Cardiology vs Nephrology
B. Family vs Primary Team
C. Endocrinology vs Primary Team
Determine:

Is it a real friction?
Are both sides defensible?
Is it actually a trap masquerading as friction?
Could a reviewer challenge it?

Consultant Disagreement Themes

Realistic?
Distinct?
Redundant?
Clinically believable?

Administrative Deliverable Decision

Does this support the world?
Does it create future task-design problems?
Does it satisfy likely reviewer expectations?

Workflow Consolidation

Compatible with approved workflow guidance?
Compatible with AutoQC expectations?
Risk of future workflow-count violations?

Governance-Level Reviewer Risk Attempt to identify:

SEND BACK risks
Major revision risks
Hidden contradictions
Governance decisions likely to fail during World Spec construction

Future World Spec Risk What governance decisions could become expensive later?
Classification:
RED

likely blocker
YELLOW

concern
GREEN

strong
Important:
Do NOT redesign. Do NOT rewrite. Do NOT draft World Spec. Do NOT create tasks. Do NOT create file inventory. Do NOT create milestones. Do NOT create templates. Do NOT create goldens. Do NOT create grader guidance.
Output:
Overall Verdict:

GO
MINOR REVISION
SEND BACK
For every finding:

explain why
cite the governance section involved
distinguish true defect vs implementation watch-item End with: Would you ratify Governance Package v1 today? YES or NO Explain.
Show more
May 31

Inventoried uploaded files and located missing reference document
Inventoried uploaded files and located missing reference document
Hostile review of Governance Package v1, candidate lock. Trying to break it. One uploaded file — WORLD_SPEC_KICKOFF.md — isn't in the documents block, so let me read it from disk before reviewing, since it's named as a reference material.


Read the WORLD_SPEC_KICKOFF.md file that's referenced but not in the documents block
Read the WORLD_SPEC_KICKOFF.md file that's referenced but not in the documents block
Read the kickoff. Useful — it independently records the same "Endocrinology vs Documentation" ban as a ratified guardrail, which lets me check the governance doc against an authority outside itself. Now the hostile review of Governance Package v1.

One framing note: this artifact is governance, not spec, so most AutoQC checks can't yet pass/fail. I'm distinguishing true defects (something the doc states that's wrong or self-contradictory now) from implementation watch-items (something downstream that the doc correctly defers). I'll only call a defect when the document, as written, contains the error.

1. Care Team Roster Integrity — §1
GREEN, with one YELLOW. Roster matches the brainstorm and skeleton; no unsupported consultants (every named specialty is justified by the clinical logic); no scope creep. It also satisfies AutoQC 2.97 (inpatient + consulting) and the roster-coverage checks.

YELLOW — defect-adjacent: the roster contains a stakeholder the source-of-truth hierarchies omit. The roster lists Primary Care Physician (§1, Stakeholders). Neither the Master Source-of-Truth Hierarchy nor the prednisone hierarchy (§3) places the PCP anywhere. In a world with +7 and +30 post-discharge anchors and a TCM/follow-up task concept, the PCP is a documentation source — outpatient notes, the pre-admission med list, prior steroid taper plans plausibly originate from PCP or rheumatology records. A PCP who is a named care-team member but has no rung in either hierarchy is a latent 2.65 gap: when an authority trap turns on an outpatient record, the hierarchy can't resolve it. True defect in the sense that the omission exists now in the governance doc, even though its consequence lands at spec time.

2. Authority Hierarchy Integrity — §2
YELLOW — the structural concern the doc half-anticipates but doesn't fully neutralize. §2 ranks "Attending Hospitalist > Consulting Attending Specialists." The PLAUSIBLE note in the consistency review and the implementation note both flag that this could "flatten" consultant disagreement, and instruct distinguishing documentation authority from clinical disagreement. Good — but here's the break: two of your three frictions are consultant-vs-consultant or consultant-vs-team, and a hierarchy that ranks the hospitalist above all specialists tells a resolver to defer to the hospitalist. That is exactly the move that kills Cardiology vs Nephrology, because the hospitalist's reconciliation becomes the "right" answer by authority rather than by reasoning. The doc's guardrail ("hierarchy resolves evidence conflicts, not recommendations") is the correct distinction in principle, but it's stated as prose intent, not as an operational rule a grader could apply. The risk: at spec time, the friction's "correct pathway" gets written as "defer to hospitalist," collapsing a genuine clinical dilemma into an authority lookup. Watch-item bordering on defect because the contradiction is latent in the ordering itself, and the mitigation is currently only a note.

Second YELLOW: two hierarchies, one ordering conflict. §2 (authority) ranks PT/OT above Case Management/SW above Family. §3 (source-of-truth) ranks Consultant Documentation at rung 4, Family at 5. These coexist, but they slice the same evidence pool differently — §2 is about disposition/functional evidence, §3 about "clinical facts." A spec author has to know which hierarchy governs which task, and the only guidance is two implementation notes. When the functional-decline trap (a clinical fact about cognition/ambulation) meets a disposition question, both hierarchies arguably apply and they rank the sources differently (PT/OT is rung 3 in §2 but absent from §3). That's a genuine ambiguity the doc creates and doesn't resolve.

3. Source-of-Truth Integrity — §3
GREEN on the core fix. This section is the single biggest improvement in the package: it converts the long-running RED finding (steroid hierarchy asserted but never documented) into two explicit ordered lists. The prednisone hierarchy (rheum attending > med rec > pharmacy/refill > family > patient recollection) is exactly what 2.65 requires, and it matches the kickoff's ratified guardrail verbatim. This directly retires the highest-severity item from the skeleton review.

YELLOW — the master hierarchy ranks consultant documentation below med rec and pharmacy history (§3, rungs 2–4). That's defensible for medication facts, but the label is "Clinical facts." A consultant's clinical assessment (e.g., nephrology's read on volume status) outranked by a pharmacy refill record is backwards for non-medication clinical facts. The hierarchy is medication-shaped but labeled general. At spec time this can produce a wrong "correct answer" when a clinical (non-med) fact conflicts between a consultant note and pharmacy data. True defect: the ordering as written is internally mismatched to its own "clinical facts" label.

YELLOW — patient recollection is bottom-ranked in both hierarchies (good) but the AMS contradiction from the skeleton review is unaddressed. Both lists keep patient recollection as a source. The patient presented with altered mental status; ranking his recollection last is the right call, but the doc never states why it's usable at all given the AMS. A reviewer will ask. Minor, but unretired.

4. Confirmed vs Presumed Split — §4 / §5
GREEN, with one RED-adjacent classification question. The split is clean and matches 2.11's intent: 11 confirmed chronic conditions, 6 genuinely-uncertain interpretive questions held open (preventing the reveal-drift). The implementation note explicitly forbids converting the presumed set into a single hidden diagnosis — directly responsive to reviewer history.

The break attempt: "Adrenal suppression contribution" is listed as a Presumed/Active Question (§5) while "Osteoporosis/osteopenia from chronic steroid exposure" is Confirmed (§4). These are in tension. If osteoporosis is confirmed as steroid-induced, the chart is asserting clinically significant cumulative corticosteroid exposure — which materially raises the prior probability of adrenal suppression and partially answers the very question §5 holds open. You can't simultaneously confirm "enough chronic steroid to cause osteoporosis" and treat "did the steroids matter physiologically" as fully open, without the spec carefully separating bone effects from HPA-axis effects. Not a fatal contradiction — they're different organ systems — but it's a seam a hostile reviewer will pull, and the doc doesn't acknowledge it. I'd call it a true defect of under-specification: the confirmed line leaks information into the presumed set.

5. Friction Integrity — §6
A. Cardiology vs Nephrology — GREEN as written, but inherits the §2 authority risk (the hierarchy could flatten it; see above). Both sides defensible, real two-party conflict. The reviewer challenge is not "is it a friction" but "does your own authority hierarchy let a grader shortcut it."

B. Family vs Primary Team — GREEN. The governance guardrail explicitly balances it ("should not make discharge obviously safe or obviously unsafe"), which retires the skeleton-review YELLOW that the family side was over-stacked. The kickoff reinforces this with the team's defensible-discharge rationale. Well-handled.

C. Endocrinology vs Primary Team — GREEN, and correctly relabeled. This retires the skeleton-review RED. The heading is now "vs Primary Team," the guardrail explicitly states "documentation is evidence, not a friction participant" (kickoff) and "steroid discrepancy remains a trap" (§6 guardrail). The frictions-vs-traps separation (2.37) is now correct at the governance layer. Good.

One cross-friction YELLOW: the Endo-vs-Team friction and the steroid trap now share the same clinical substrate and must be kept in separate spec locations (friction table vs Failure Design) per 2.37. The doc says this; the risk is purely at instantiation. Watch-item.

6. Consultant Disagreement Themes — §7
YELLOW — §7 is thin to the point of being non-load-bearing, and it duplicates §6. Three one-line positions ("Restart GDMT sooner," "Prioritize renal recovery," "Steroid contribution may be underappreciated") plus "Hospitalist must reconcile." This is a compressed restatement of §6 with no added content. It's not wrong, but it adds nothing §6 doesn't, and "Hospitalist must reconcile" quietly re-imports the §2 flattening risk (it frames the hospitalist as the synthesizer-of-record). Redundant section; minor. The themes are realistic and clinically believable — the concern is non-distinctness from §6, not plausibility.

7. Administrative Deliverable Decision — §8
YELLOW — the decision is correct but the doc leaves it dangerously under-determined against 2.108. §8 says "YES" and lists four candidate areas (transition of care, discharge planning, care coordination, follow-up). The break: all four of those are arguably still clinical disposition work, not clearly healthcare-administration work products in the 2.108 sense (the check's examples are prior auth, coding, utilization review, peer review). Transition-of-care and discharge planning notes are clinical-administrative hybrids; a hostile reviewer applying 2.108 strictly could find that the world still lacks a clean administrative deliverable (coding, prior auth, UR, peer review). The governance doc believes it has satisfied 2.108; it may have only satisfied it ambiguously. This is the item most likely to surprise you at spec time — the decision reads as closed but the check may not accept the candidates. True defect of reasoning: §8's implementation note asserts 2.108 support that the listed candidates don't unambiguously deliver.

8. Workflow Consolidation — §9
GREEN on self-awareness, YELLOW on a live tension it doesn't resolve. §9 wisely labels "Acute Hospital Management" a conceptual umbrella only and the PLAUSIBLE note confirms it's not a tracker label — good, this won't cause a 2.98 failure by itself. But the unresolved problem is 2.107, and the doc knows it: §9's note says final tasks "must satisfy the 3-5 distinct catalog workflow constraint," yet the six rough task concepts (carried in the kickoff) map to six distinct P0/P1 workflows. The governance package does not resolve the over-count; it defers it ("final task architecture must select… without exceeding 3-5"). That deferral is legitimate at governance stage — but it means the single most likely future SEND-BACK (six workflows vs the 3–5 ceiling) is still completely unresolved, and §9 gives no mechanism for collapsing six into 3–5. Watch-item by phase rules, but it's the expensive one.

9. Governance-Level Reviewer Risk
SEND BACK risks (governance layer): none that are fatal as governance. Nothing here is broken badly enough that the governance architecture itself should be rejected.

Major-revision risks:

The §2 authority hierarchy potentially flattening the consultant frictions (the contradiction is in the ordering; the mitigation is only a note).
The §3 master hierarchy being medication-shaped but labeled "clinical facts."
The §8 administrative-deliverable candidates possibly not satisfying 2.108 strictly.
Hidden contradictions found:

Osteoporosis-confirmed-as-steroid-induced (§4) vs adrenal-suppression-as-open-question (§5). [seam]
PCP in roster (§1) but absent from both hierarchies (§3). [gap]
§2 and §3 rank the same evidence pool differently with no governing rule for which applies when. [ambiguity]
Governance decisions likely to fail during World Spec construction: the 2.107 six-workflow over-count (unresolved), and the 2.108 administrative-deliverable ambiguity (asserted-but-not-secured).

10. Future World Spec Risk — what gets expensive
The expensive items, ranked: (1) the six-into-3–5 workflow collapse — deferring it past governance means task architecture may need rework after the file plan is partly built, and the file plan is the costliest thing to rebuild; (2) the authority-hierarchy/friction tension — if "correct pathway" gets written as "defer to hospitalist," every friction-touching task and its golden inherit the flaw, and goldens are human-authored and slow to redo; (3) the dual-hierarchy ambiguity — a wrong governing-hierarchy choice propagates into multiple traps' resolution logic. All three are cheap to decide now as governance rules and expensive to unwind after drafting.

Overall Verdict: MINOR REVISION
Reasoning: this package does the most important thing it needed to do — it retires the two recurring RED findings that have dogged the project (the steroid hierarchy is now documented per 2.65; the Endo friction is correctly relabeled and separated from the steroid trap per 2.37), and it correctly balances Family-vs-Team. As governance architecture it is sound and nothing in it is broken badly enough to reject. It does not earn a clean GO because it carries one genuine clinical seam (osteoporosis-confirmed vs adrenal-open), three structural ambiguities the document creates and doesn't resolve (PCP missing from hierarchies; §2/§3 dual-hierarchy governing-rule absent; master hierarchy mislabeled "clinical facts" while ordered for medications), and two checks it believes it satisfied but only ambiguously secured (2.108 administrative deliverable; 2.107 still-deferred six-workflow over-count). None of these is a governance blocker; all are correctable as governance rules before they get expensive at spec time — which is the entire point of fixing them at this layer.

The single highest-value correction: make the §2 authority hierarchy's "documentation authority ≠ clinical disagreement" distinction an operational rule, not a prose note — because as ordered, it points a future grader at "defer to the hospitalist," and that one move can quietly hollow out the two consultant frictions the world depends on.

Would you ratify Governance Package v1 today? NO.

Not because it's unsound — it's the strongest artifact in the chain so far — but because ratifying today locks three ambiguities (dual-hierarchy governing rule, PCP's hierarchy rung, the "clinical facts" mislabel) and one clinical seam (osteoporosis/adrenal) into the foundation that the World Spec will be built on, plus it carries forward the unresolved 2.107 over-count under the appearance of a closed workflow decision. Each is a five-minute governance clarification now versus a post-drafting rework later. I'd hold ratification, resolve those as governance-level notes (no redesign, no spec content — just tightening the rules the doc already contains), and then lock. The frictions, the roster, and the source-of-truth fix are all strong enough to keep as-is.


governance-package-clarification.md
74 lines

md


governance-package-v1.md
312 lines

md

Given:
- Governance Package v1
- Governance clarification addendum
- Previous hostile review findings
Have all accepted findings been resolved?
Are any governance-level blockers still present?
Would you ratify Governance Package v1 today?
Answer:
YES or NO
If NO:
List only unresolved governance blockers.
Do not perform a new hostile review.
Do not search for new concerns.
Do not redesign.
Do not revisit resolved findings.
Do not discuss task architecture unless a governance defect remains.
Classify each prior finding:
RESOLVED
PARTIALLY RESOLVED
UNRESOLVED
Provide final recommendation:
GO
MINOR REVISION
SEND BACK
If GO:
State explicitly that Governance Package v1 is ready for ratification and identify any remaining items as post-governance task-architecture watch items rather than governance defects.

Show more
May 31
Closeout check only — verifying my prior findings against the v2 document and the clarification, not running a new review. I'll classify each prior finding and nothing more.

Mapping each finding from my prior hostile review to its disposition in the updated Governance Package v1 and the clarification addendum:

PCP missing from source-of-truth hierarchies — RESOLVED. §3 now lists "Primary Care Documentation" at rung 5, placed after Consultant Documentation and before Family Report. The roster-to-hierarchy gap is closed.

Authority hierarchy could flatten the consultant frictions ("defer to the hospitalist") — RESOLVED. §2 now carries an explicit Operational rule: "authority hierarchy resolves factual/documentation conflicts… does not resolve clinical recommendation disagreements… not by automatically deferring to the highest-ranked authority." This converts my highest-value correction from a prose note into an operational rule, which is exactly what I asked for.

Dual-hierarchy ambiguity (no rule for which governs when both apply) — RESOLVED. §3 now states the governing-rule split directly: Authority Hierarchy for role-based governance/disposition/functional evidence/decision ownership; Source-of-Truth Hierarchy for factual conflict resolution; and "If both appear relevant, the World Spec must state which hierarchy governs the task or trap." The selection rule now exists.

Master hierarchy mislabeled "clinical facts" while ordered for medications — PARTIALLY RESOLVED. The clarification reframes the master hierarchy as governing "factual conflict resolution, especially medication history, outpatient records, consultant documentation, family reports, and patient recollection," and the §3 implementation note now emphasizes factual conflict resolution rather than general clinical assessment. The label "Clinical facts:" still heads the list, but the surrounding text now scopes it to factual/documentation conflicts and routes clinical-assessment disagreements to the Authority Hierarchy's operational rule instead. The original defect — a consultant's clinical assessment being outranked by pharmacy data — is now neutralized by routing, not by reordering. Functionally addressed; the residue is a labeling nicety, not a governance defect.

Osteoporosis-confirmed-as-steroid-induced vs adrenal-suppression-open (clinical seam) — RESOLVED. §5 now carries the explicit clarification: confirmed osteoporosis/osteopenia "reflects cumulative chronic steroid exposure… does not prove that current symptoms are primarily caused by adrenal suppression. Current adrenal/steroid contribution remains an active interpretive question." The bone-effect-vs-HPA-axis seam is separated, and the reveal-drift guardrail is preserved.

2.107 six-workflow over-count — DEFERRED (not a governance defect). The clarification explicitly defers this to task architecture, and §9 now adds a Task-architecture watch-items block recording it. I flagged at the time that deferral is legitimate at governance stage; the only change I'd note is that it is now documented as deferred rather than silently carried, which removes the "closed decision masking an open problem" concern. Correctly classified as a watch-item.

2.108 administrative-deliverable ambiguity — DEFERRED (not a governance defect). Same treatment: the clarification defers securing the administrative deliverable to task architecture, and §9 records it as a watch-item alongside 2.107. The governance-level decision ("YES, one is required") stands; whether the candidates strictly satisfy 2.108 is now openly an open task-architecture question rather than an asserted-but-unsecured claim.

No prior finding is UNRESOLVED. No governance-level blocker remains. The two items that are not "RESOLVED" are the two I classified at the time as legitimately deferrable (2.107, 2.108), and they are now explicitly recorded as deferred task-architecture watch-items rather than governance defects — which is the correct home for them.

Would you ratify Governance Package v1 today? YES.

Governance Package v1 is ready for ratification. Every accepted finding from the prior hostile review that was a governance-level concern has been resolved: the PCP hierarchy placement, the authority-flattening operational rule, the dual-hierarchy governing-rule split, the master-hierarchy scoping, and the osteoporosis/adrenal clinical seam. The package also retains the two structural wins that mattered most across the project — the documented prednisone source-of-truth hierarchy (2.65) and the correctly relabeled, trap-separated Endocrinology-vs-Primary-Team friction (2.37).

Remaining items are post-governance task-architecture watch-items, not governance defects:

2.107 — collapsing the six rough task concepts into 3–5 distinct catalog workflows. To be resolved during task architecture.
2.108 — securing an unambiguous administrative deliverable (i.e., confirming the chosen workflow satisfies the clinical-plus-administrative expectation, not only disposition-clinical work). To be resolved during task architecture.
Both are correctly scoped out of governance and recorded as such in §9 and the clarification. They become live again at the task-architecture phase, not before.

Final recommendation: GO.

World Spec Construction Readiness Review
Role:
Independent reviewer.
Not hostile review. Not architecture review.
Goal:
Determine whether the project is ready to begin World Spec Construction Preparation.
Current State:

Brainstorm approved
Temporal Architecture locked
Clinical Story Skeleton ratified
Identity Package locked
Governance Package ratified
Physician Architecture complete
Review:

Is any critical physician decision still missing?
Is any governance decision still unresolved?
Is any source-of-truth rule still undefined?
Is any reviewer-risk item still open?
Are any previously deferred items actually blockers?
Are AutoQC 2.107 and 2.108 correctly classified as future task-architecture concerns?
Does the project possess sufficient information to begin World Spec construction? Important: Do NOT draft. Do NOT redesign. Do NOT reopen architecture. Do NOT invent new requirements. Classify: RESOLVED OPEN BLOCKER Output: Construction Readiness Assessment GO CAUTION NO-GO If CAUTION: Explain why. If NO-GO: List only actual blockers. If GO: State: The project is ready to begin World Spec Construction Preparation. Remaining concerns belong to later construction phases. Would you authorize beginning World Spec Construction Preparation today? YES or NO
Show more
May 31
Construction readiness review — independent, not hostile. The architecture is ratified, so I'm not reopening it; I'm checking whether the inputs needed to begin World Spec Construction Preparation are in place, and classifying each gate.

A framing note that determines the verdict: there's a real distinction between "ready to begin preparation" and "has everything the finished spec needs." A World Spec construction phase legitimately produces values that don't exist yet — that's what the phase is for. So an item only counts as a BLOCKER here if its absence prevents starting, not if it's something construction will generate. I'm applying that line deliberately.

1. Is any critical physician decision still missing? — RESOLVED for starting; OPEN items are construction inputs, not prerequisites. The decisions required to begin are all locked: patient identity, temporal architecture, the clinical story arc, confirmed-vs-presumed split, frictions, care team, and both source-of-truth hierarchies. What's still pending — the calendar date skeleton, medication expansion from the compact 14 toward the 18–22 target, comorbidity refinement toward 12–15, and the baseline anchors (baseline creatinine/eGFR, A1c, hemoglobin, dry weight, baseline functional status) — are the first work-products of construction, not missing decisions that gate it. The kickoff explicitly stages these as construction-phase tasks. The one I'd watch most: the baseline anchors are required for the AKI-on-CKD and functional-decline reasoning to be interpretable, so they must be produced early in construction — but their absence now doesn't prevent starting.

2. Is any governance decision still unresolved? — RESOLVED. Governance Package v1 ratified; every accepted hostile-review finding closed (PCP hierarchy rung, authority-flattening operational rule, dual-hierarchy governing-rule split, master-hierarchy scoping, osteoporosis/adrenal seam). No governance item is open.

3. Is any source-of-truth rule still undefined? — RESOLVED. Both hierarchies are documented and ordered: the master clinical-facts hierarchy (now including Primary Care Documentation) and the prednisone-specific hierarchy. The governing-rule for which applies when both are relevant is stated. This was the project's longest-running risk; it's closed at the governance layer. (Per-task hierarchy selection is a construction step, correctly so.)

4. Is any reviewer-risk item still open? — RESOLVED at the governance/architecture layer; the remaining ones are construction-quality risks that cannot be retired before construction. The structural reviewer risks that could be closed pre-construction are closed (synthetic identity, friction/trap separation, documented hierarchy). The risks that remain — keeping the near-fall multi-causal, calibrating "improving but dangerous," keeping the steroid evidence scattered rather than a reveal — are instantiation risks that live in AutoQC's stated blind spot and can only be managed during construction, not before it. They're open in the sense that they're not yet executed, but they are not pre-construction blockers; they're the things construction must get right.

5. Are any previously deferred items actually blockers? — No. RESOLVED as correctly-deferred. The two deferred items (2.107, 2.108) were classified at ratification as legitimately task-architecture-stage, and nothing has changed that. Neither prevents beginning construction; both come due before spec upload.

6. Are AutoQC 2.107 and 2.108 correctly classified as future task-architecture concerns? — Yes. RESOLVED (classification correct). 2.107 (collapse six rough task concepts into 3–5 distinct catalog workflows) and 2.108 (secure an unambiguous administrative deliverable, not only disposition-clinical work) are both genuinely task-architecture decisions. They are recorded as such in §9's watch-items block and the clarification. They are real and must be resolved before upload — but they are correctly not governance defects and not start-of-construction blockers. Classification stands.

7. Does the project possess sufficient information to begin World Spec construction? — Yes. The approved Brainstorm is the authoritative source for locked frictions/traps; the template and AutoQC v6.3 define the target structure; identity, temporal architecture, story skeleton, and governance supply the spine. The post-GO interview sequence (date skeleton first) is defined. That is sufficient to begin.

Classification summary

Gate	Status
Critical physician decisions (to start)	RESOLVED
Governance decisions	RESOLVED
Source-of-truth rules	RESOLVED
Reviewer-risk (architecture layer)	RESOLVED
Deferred items as blockers	RESOLVED (not blockers)
2.107 / 2.108 classification	RESOLVED (correctly future)
Sufficient info to begin	RESOLVED
Calendar skeleton, med expansion, comorbidity refinement, baseline anchors	OPEN — construction inputs, not blockers
Near-fall multi-causality, tone calibration, steroid non-reveal	OPEN — construction-quality items, not blockers
No gate is classified BLOCKER.

Construction Readiness Assessment: GO
The project is ready to begin World Spec Construction Preparation. Remaining concerns belong to later construction phases.

Specifically: every item that could be resolved before construction is resolved — identity, temporal architecture, story skeleton, governance, and both source-of-truth hierarchies are locked, and the two deferred AutoQC items (2.107, 2.108) are correctly scoped to task architecture, not to the start of construction. The OPEN items fall into two clean buckets, neither of which gates starting: construction inputs the phase exists to produce (the calendar date skeleton, medication expansion to 18–22, comorbidity refinement to 12–15, baseline anchors) and construction quality obligations that can only be executed during construction (keeping the near-fall multi-causal, calibrating medically-improving-but-operationally-dangerous, keeping the steroid evidence non-revealing).

One sequencing flag carried forward, not as a blocker but as the thing to do first: begin with the Key Milestones calendar skeleton, because under v6.3 it's the single timeline source of truth that the temporal gate, file dates, and every trap's date-lock reconcile against — and place the baseline anchors early, since the AKI-on-CKD and functional-decline reasoning depend on them. Getting those two first prevents the most expensive rework.

Would you authorize beginning World Spec Construction Preparation today? YES.


key-milestones-calendar-skeleton-v1.md
137 lines

md

Key Milestones Calendar Skeleton v1 Ratification Review
Role: Independent reviewer.
Not hostile review.
Purpose: Determine whether Key Milestones Calendar Skeleton v1 is ready for lock.
Review only:

Temporal consistency
HD1-HD6 structure
World snapshot placement
Discharge anchor
+7 anchor
+30 anchor
Pre-admission decline timing
AutoQC 2.22 readiness
AutoQC 2.23 readiness
AutoQC 2.41 readiness Do NOT redesign. Do NOT draft World Spec. Do NOT add clinical content. Do NOT create milestones. Do NOT create files. Classify: RESOLVED OPEN BLOCKER Output: Would you lock Key Milestones Calendar Skeleton v1 today? YES or NO If NO: List only actual blockers. If YES: State: Key Milestones Calendar Skeleton v1 Status: LOCK READY Final Recommendation: GO MINOR REVISION SEND BACK
Show more
May 31
Ratification review of the calendar skeleton. Independent, not hostile. I verified the date arithmetic by hand rather than trusting the document's own VERIFIED rows — a calendar skeleton's entire job is the arithmetic, so checking it is the review.

Let me walk the math against each gate.

HD1–HD6 structure — RESOLVED. HD1 05/18 through HD6 05/23 is six consecutive calendar days (18, 19, 20, 21, 22, 23). Six days, no gaps, no doubled dates. Matches the ratified 6-day hospitalization exactly.

World snapshot placement — RESOLVED. Snapshot fixed at 05/23/2026 18:00, landing on HD6, with the explicit rule that no world file may post-date it. A single, definite, timestamped close is precisely what 2.41 Step 1 requires.

Discharge anchor — RESOLVED. 05/24/2026 falls strictly after 05/23 18:00. Confirmed after the snapshot.

+7 anchor — RESOLVED, with the label-vs-arithmetic note worth stating explicitly. 05/31/2026 is 7 days after the discharge anchor (05/24 → 05/31 = 7 days). It is 13 days after the HD6 snapshot. The document is internally honest about this — the column header reads "7 days after discharge anchor," not after snapshot — so this is consistent, not an error. I'm flagging it only so it's on record: the "+7" is measured from discharge, not from close. Any future file or task reasoning that says "+7 from the snapshot" would be wrong; "+7 from discharge" is right. Correctly defined as written.

+30 anchor — RESOLVED, same basis. 05/24 + 30 days: May has 31 days, so 05/24 → 05/31 is 7 days, + 23 more lands on 06/23/2026. Confirmed 06/23 is exactly 30 days after the discharge anchor (and 30 days after discharge is the standard readmission window, which fits the safety/readmission-review use). Measured from discharge, consistent with the +7 convention.

Pre-admission decline timing — RESOLVED. 04/27/2026 → 05/18/2026 (HD1) = 21 days. The document claims "21 days / about 3 weeks"; verified. The intermediate pre-admission anchors also check: 05/11 is 7 days before HD1, 05/17 is 1 day before HD1. All sit before admission, so they pose no temporal-gate issue — they're backstory dates, correctly scoped.

DOB/age across the span — RESOLVED (confirming the skeleton's own claim). Born 1964-02-18; as of every date in the skeleton (04/27/2026 through 06/23/2026) he has already had his 2026 birthday, so he is 62 throughout. No date in the framework pushes him outside the age-62 window. 2.100 readiness holds.

AutoQC 2.41 readiness — RESOLVED. All three gate steps are satisfiable from this skeleton: a definite snapshot exists (Step 1); the post-snapshot anchors give every future task an explicit anchor (Step 2); and all three anchors (05/24, 05/31, 06/23) fall strictly after 05/23 18:00 (Step 3). The skeleton also correctly carries forward the standing rule that any +7/+30 artifact must be a task-level file dated at its anchor, never a world file — which is what keeps the gate clean once construction adds files.

AutoQC 2.22 readiness — RESOLVED as readiness. 2.22 (every spec date appears in Key Milestones) is a superset rule that can only be satisfied once the spec has dates; at skeleton stage what's required is that the canonical date source exists and is designated as the inheritance point. It does, and the document states the rule that all future dates must be added here first. That's the correct readiness posture — 2.22 itself remains a construction-completion check, not something lockable now.

AutoQC 2.23 readiness — RESOLVED. No orphan milestones: every date in the skeleton carries an explicit framework role, and no surplus dates are introduced. Clean against 2.23 at this stage.

Classification summary

Gate	Status
Temporal consistency	RESOLVED
HD1–HD6 structure	RESOLVED
World snapshot placement	RESOLVED
Discharge anchor	RESOLVED
+7 anchor	RESOLVED
+30 anchor	RESOLVED
Pre-admission decline timing	RESOLVED
2.22 readiness	RESOLVED
2.23 readiness	RESOLVED
2.41 readiness	RESOLVED
No gate is OPEN or BLOCKER. Every date arithmetic claim in the document independently checks out, and the one item that could be misread — the "+7/+30 measured from discharge, not snapshot" — is labeled correctly in the source, so it's a consistency note for downstream use, not a defect.

Would you lock Key Milestones Calendar Skeleton v1 today? YES.

Key Milestones Calendar Skeleton v1 Status: LOCK READY

Final Recommendation: GO.

One thing to carry into construction, not a revision: when files and tasks start attaching to these anchors, hold the line that "+7" and "+30" mean from discharge (05/24) — 05/31 and 06/23 respectively — since the natural slip is to re-measure them from the HD6 snapshot. The skeleton has it right; downstream just needs to inherit it as written.

good job so far

May 31
Thanks. Quick orientation on where things stand before the next ask comes in.

Locked and behind us: Brainstorm (Stacey's GO), temporal architecture, Clinical Story Skeleton, Identity Package, Governance Package, and now the Key Milestones Calendar Skeleton. Construction readiness was GO.

Still preparation-only — I haven't drafted any World Spec content, and per the kickoff the next substantive move is the physician decision interview, which only starts when you explicitly start it.

The natural next steps from here, roughly in dependency order: the baseline anchors (baseline creatinine/eGFR, A1c, hemoglobin, dry weight, baseline functional status), then medication expansion toward 18–22 and comorbidity refinement toward 12–15, then task architecture — which is where the two deferred items (2.107 six-into-3–5 workflows, 2.108 administrative deliverable) come due. I'd suggest baseline anchors first, since the AKI-on-CKD and functional-decline reasoning both hang on them.

What would you like to do next?


baseline-anchor-package-v1.md
132 lines

md


clinical-story-skeleton-ratification.md
150 lines

md


governance-package-ratification.md
73 lines

md


identity-package-v1.md
126 lines

md

Baseline Anchor Package v1 Ratification Review
Role: Independent reviewer.
Not hostile review.
Purpose: Determine whether Baseline Anchor Package v1 is ready for lock.
Review only:

Baseline functional status
Baseline creatinine
Baseline eGFR
Baseline hemoglobin
Baseline A1c
Dry weight
Baseline mobility
Baseline cognition
Baseline medication-management ability
Baseline home support
Reference Materials:

Baseline Anchor Package v1
Ratified Clinical Story Skeleton v1
Locked Identity Package v1
Ratified Governance Package v1
Locked Key Milestones Calendar Skeleton v1
Current clinical logic
Approved Brainstorm
Evaluate:

Clinical Plausibility

Do baseline values fit the ratified comorbidity profile?
Do values support CKD3, HFrEF, DM2, CAD, HTN, PMR, anemia of CKD?
Any unrealistic baseline?

Internal Consistency

Do baseline anchors agree with one another?
Any contradiction between dry weight and baseline function?
Any contradiction between cognition and medication management?

Story Compatibility

Do anchors support:
 
AKI on CKD reasoning
Functional decline reasoning
Disposition safety reasoning
Mixed physiology model
Family concern
Medication reconciliation trap

Reviewer Risk

Any baseline value likely to trigger reviewer challenge?
Any baseline value too neat, too severe, or too mild?

Construction Readiness

Are these sufficient baseline comparators for future construction?
Is anything important missing?
Important:
Do NOT redesign the world. Do NOT draft World Spec. Do NOT create hospital-course labs. Do NOT create admission values. Do NOT create file inventory. Do NOT create task architecture. Do NOT create templates. Do NOT create prompts. Do NOT create goldens. Do NOT create grader guidance.
Classify each finding:
RESOLVED OPEN BLOCKER
Output:
Would you lock Baseline Anchor Package v1 today?
YES or NO
If NO: List only actual blockers.
If YES: State:
Baseline Anchor Package v1 Status: LOCK READY
Final Recommendation:
GO MINOR REVISION SEND BACK
Distinguish:

true defect
physician preference
future construction item Do not reopen previously ratified architecture.
Show more
May 31

Verified clinical consistency and identified physician-preference decisions requiring ratification
Verified clinical consistency and identified physician-preference decisions requiring ratification
Ratification review of Baseline Anchor Package v1. Independent, not hostile. This is the first artifact in the chain carrying actual clinical numbers, so the review has to be substantive — I checked the two values that can be checked against each other (creatinine↔eGFR) by hand, and worked the dry-weight logic against the dehydration story, rather than trusting the package's own PLAUSIBLE rows.

Two pieces of real verification first, because they're where the value is.

Creatinine↔eGFR internal consistency — confirmed. Running the candidate creatinine range through CKD-EPI 2021 (race-free) for a 62-year-old male: creatinine 1.6 → eGFR ≈ 48, creatinine 1.8 → eGFR ≈ 42. So the stated creatinine range maps to eGFR ≈ 42–48, which sits inside the package's stated 40–50 mL/min/1.73m² and lands squarely in CKD stage 3 (straddling 3a/3b). The two ranges are mutually consistent — they weren't just plausible-sounding numbers chosen independently. Good.

Dry weight vs the dehydration story — the one item with downstream consequence. The package sets dry weight = locked weight = 97 kg. That's coherent only under one reading of the locked Identity weight. The patient is HFrEF (so "dry weight" is a meaningful concept) and presents volume-depleted from a 3-week poor-intake decline → prerenal AKI on CKD. If the locked 97 kg is his baseline/euvolemic dry weight, then his admission weight (a future construction value) must be somewhat below 97, and everything is consistent. If the locked 97 kg was instead meant as an admission weight, then dry weight = 97 = admission weight fights the dehydration narrative. The package surfaces exactly this in its review question ("should 97 kg serve as dry weight or should they differ"), so it's correctly deferred to Alexander — but his answer also implicitly settles whether the locked 97 was baseline or admission, which sets the future admission weight. This is a physician decision, not a defect, but it's the one to nail down because it propagates into volume-status and HF-medication reasoning.

Per-anchor verdicts

Anchor	Verdict	Note
Baseline functional status	RESOLVED	Matches ratified skeleton verbatim in substance.
Baseline creatinine 1.6–1.8	RESOLVED (range)	Plausible CKD3; consistent with eGFR (above).
Baseline eGFR ~40–50	RESOLVED (range)	Inside CKD stage 3; consistent with creatinine.
Baseline hemoglobin 10.5–11.5	RESOLVED (range)	Mild-moderate anemia; slightly anemic for early stage 3 on its own, but defensible given diabetic nephropathy.
Baseline A1c 7.6–8.2	RESOLVED (range)	Realistically imperfect; correctly avoids a too-neat or extreme value.
Dry weight ~97	OPEN (physician)	See dry-weight reconciliation above — the elevated decision.
Baseline mobility	RESOLVED	Consistent with story; cane-scope wording is a physician-preference confirmation.
Baseline cognition	RESOLVED	"Mild forgetfulness only" + family oversight is coherent.
Baseline med-management	RESOLVED	Mild forgetfulness + partial self-management + complex regimen = the vulnerability the med-rec trap needs. No contradiction with cognition.
Baseline home support	RESOLVED	Matches the family/team friction.
1. Clinical plausibility — RESOLVED. Every value fits the ratified comorbidity profile; no unrealistic baseline. The deliberate choice to avoid perfect/extreme values (A1c, Hgb) is sound design.

2. Internal consistency — RESOLVED, with the single dry-weight clarification (OPEN, physician). Cognition↔medication-management is consistent, not contradictory. Creatinine↔eGFR is consistent (verified). No other internal conflict.

3. Story compatibility — RESOLVED. The anchors support all six target reasoning lines: AKI-on-CKD (baseline creatinine/eGFR give the comparator), functional decline (function/mobility/cognition), disposition safety (function + home support), mixed physiology (no single anchor over-determines a cause), family concern (home support + baseline cognition), and the med-rec trap (med-management vulnerability).

4. Reviewer risk — RESOLVED at this stage. No value is too severe or too mild. Presenting candidates as ranges is appropriate for a baseline-anchor package and won't draw a reviewer challenge now. The one forward risk: when ranges narrow to single locked values during construction, creatinine and eGFR must be locked as a consistent pair (creatinine 1.7 → eGFR ~45, not independently chosen) or a later consistency check bites. Future-construction discipline, not a current defect.

5. Construction readiness — sufficient to proceed. Answering the review's "anything important missing" honestly: the package covers the comparators this world's reasoning needs. The one anchor Alexander may want to add, given how central hemodynamics are to the cardio/nephro friction and the medication-restart reasoning, is a baseline blood pressure (so admission borderline-hypotension reads as a deviation from a normally-controlled-hypertensive baseline). I raise it only because the review asks — it's an optional physician call, not a required addition, and I'm not inventing it as a requirement. Baseline potassium, by contrast, belongs to hospital-course/admission values (which this package correctly excludes), not to baseline anchors.

Finding classification

True defects: none.
Physician-preference items: the six review questions — most importantly dry-weight = 97 vs differ; plus cane-use scope, and the eventual narrowing of each range to a single value.
Future-construction items: preserving the creatinine↔eGFR pairing when ranges become single values; setting the future admission weight consistently with the dry-weight decision; optionally adding a baseline BP anchor if Alexander wants it.
Would you lock Baseline Anchor Package v1 today? YES — from a review standpoint. I find no clinical defect, no internal inconsistency, and no blocker; the package is clinically sound and the values are verified-consistent where they can be cross-checked.

Baseline Anchor Package v1 Status: LOCK READY

The one honest caveat on the word "lock": the numeric values are the physician's to ratify, and the package itself routes them to Alexander via six explicit confirmation questions. I can certify there's nothing standing in the way clinically — but the actual lock action is Alexander confirming those six (especially dry weight), because numeric clinical values originate from him, not from me. Once he confirms, this is locked with no reservations.

Final Recommendation: GO.


clinical-story-timeline-package-v1.md
md


clinical-logic.md
md

Clinical Story Timeline Package v1 Ratification Review
Role: Independent reviewer.
Not hostile review.
Purpose:
Determine whether Clinical Story Timeline Package v1 is ready for lock.
This is a ratification review, not a redesign review.
Review only the submitted timeline package against:

Approved Brainstorm
Ratified Clinical Story Skeleton v1
Locked Identity Package v1
Ratified Governance Package v1
Locked Key Milestones Calendar Skeleton v1
Locked Baseline Anchor Package v1
Current Clinical Logic
Do NOT:

Draft World Spec content
Create files
Create labs
Create vitals
Create medication lists
Create task architecture
Create file inventory
Create prompts
Create goldens
Create grader guidance
Redesign the world
Evaluate:

Story Progression Integrity
Review:

Pre-admission decline
HD1
HD2
HD3
HD4
HD5
HD6
Discharge
+7
+30
Questions:

Does progression feel clinically realistic?
Does each stage naturally follow the previous stage?
Are any transitions forced or artificial?

Timeline Logic
Review:

HD1–HD6 progression
World close placement
Discharge placement
+7 anchor
+30 anchor
Confirm:

Temporal continuity
No timeline contradictions
No drift from locked calendar doctrine

Friction Integrity
Review:

Cardiology vs Nephrology
Family vs Primary Team
Endocrinology vs Primary Team
Questions:

Do frictions activate at the correct point?
Do they remain believable?
Does any friction become one-sided?
Does any friction collapse into another?

Trap Integrity
Review:

Steroid source-of-truth trap
HF-AKI medication trap
Functional/cognitive trap
Sepsis anchoring trap
Discharge source-hierarchy trap
Questions:

Are traps distinct?
Are any traps collapsing together?
Does any trap become too obvious?
Does any trap lose relevance?

Mixed Physiology Preservation
Confirm:

Infection
Dehydration
Medication effects
CKD/HF physiology
Neuropathy
Deconditioning
Steroid-related physiology
Questions:

Is the world still multi-factorial?
Has any hidden single diagnosis emerged?

Disposition-Safety Preservation
Confirm:

Functional decline remains primary failure target.
Medically improving / operationally dangerous tension remains intact.
Discharge remains defensible.
Discharge remains debatable.

Source-of-Truth Preservation
Confirm:

Prednisone history remains reconstructable.
Prednisone history remains unresolved.
No hidden-answer reveal emerges.
Governance hierarchy remains respected.

Future Construction Readiness
Review whether the timeline remains compatible with:

18–22 medication target
12–15 comorbidity target
Named-provider requirements
Surgical-history requirements
AutoQC 2.107
AutoQC 2.108
Do not require resolution.
Only determine whether compatibility is preserved.
Classify findings as:

RESOLVED
OPEN
BLOCKER
Output:
Clinical Story Timeline Ratification Review
Would you lock Clinical Story Timeline Package v1 today?
YES or NO
If NO: List only actual blockers.
If YES: State:
Clinical Story Timeline Package v1 Status: LOCK READY
Final Recommendation:
GO MINOR REVISION SEND BACK
Distinguish:

true defects
physician preference items
future construction items Do not reopen previously ratified architecture.
Show more
May 31
Ratification review of the Clinical Story Timeline Package v1. Independent, not hostile. Let me read the package and the current clinical-logic file before reviewing — the timeline package itself wasn't in the documents block, only its path.


Viewed 2 files, ran a command
Viewed 2 files, ran a command
Read in full, including the truncated consistency rows. This is the first artifact that sequences when each friction and trap activates across the timeline, so the substantive review is about activation logic and the one structural risk a stage-by-stage table introduces. Checked against all seven ratified inputs.

The date spine first, since it's mechanical: every date in the table (04/27 decline start, 05/18 HD1, 05/23 18:00 close, 05/24 discharge, 05/31 +7, 06/23 +30) matches the locked calendar skeleton exactly, and the package explicitly restates "+7 and +30 measured from discharge, not world close" — the exact carry-forward note I flagged at calendar lock. No drift from calendar doctrine. RESOLVED.

1. Story progression integrity — RESOLVED. The arc is clinically realistic and each stage follows from the last: home decline → ED stabilization (HD1) → partial improvement + consultants begin (HD2) → PT/OT reveal function lags medical improvement (HD3) → consultant tensions explicit + steroid inconsistencies surface (HD4) → disposition becomes dominant (HD5) → improved-but-risky close (HD6). The HD3 placement of functional concerns before the HD5 disposition pivot is the right ordering — function becomes visible as an issue before it becomes the decision. No transition is forced. The one stage I'd note as physician-preference, not defect: HD2 has consultants arriving the day after admission, which is realistic for a complex AKI/HF patient but slightly fast; the package itself flags consultant timing as refinable. Acceptable.

2. Timeline logic — RESOLVED. Temporal continuity holds, no contradictions, no calendar drift (above). World close correctly terminates the inpatient world; the three post-close anchors sit strictly after 05/23 18:00.

3. Friction integrity — RESOLVED, and the activation staging is the package's real contribution. The frictions activate at clinically correct points and — importantly — at different points, which is what keeps them from collapsing into one another:

Cardiology vs Nephrology emerges HD2 (medication-safety-vs-cardioprotection once acute illness forces med holds), active by HD4. Correct — this friction needs the AKI/hypotension to be real first.
Endocrinology vs Primary Team emerges HD2–HD4 as steroid history is recognized as unclear, active HD4. Correctly gated on recognition of the inconsistency.
Family vs Primary Team is deliberately latent early (family supplies baseline context HD1–HD3) and becomes active HD5 when disposition dominates. This is the right call and directly preserves the ratified balance — it doesn't activate until there's an actual discharge decision to disagree about.
No friction becomes one-sided (the HD6 row keeps both sides of each live), and none collapses into another because they're separated by both topic and activation timing. The Family/Team balance ratified earlier is intact.

4. Trap integrity — RESOLVED, with one watch-item carried forward (OPEN, not a defect). The five traps are seeded and reinforced at sensible points: steroid source-of-truth established pre-admission and reinforced through HD4–HD6; HF-AKI seeded by polypharmacy, activated as inpatient med-hold logic HD1→HD4; functional/cognitive seeded pre-admission, reinforced HD3+; sepsis anchoring established HD1, reinforced HD2–HD4 ("improvement can distract"); discharge source-hierarchy forming HD3, established HD5. The HD6 row explicitly states "no trap is resolved by a single document or single diagnosis" — good, that's the self-containment-meets-difficulty discipline.

The watch-item, unchanged from the brainstorm/skeleton reviews: functional/cognitive trap (#3) vs discharge source-hierarchy trap (#5) still share the discharge-safety substrate, and the timeline reinforces both through HD5–discharge. The package keeps them nominally distinct (#3 = finding buried evidence; #5 = recognizing a reassuring discharge artifact isn't the whole truth), which is the correct distinction — but they remain the pair most at risk of reading as one trap when instantiated into actual files. Not a defect in the timeline; a flag for file construction. OPEN (future construction).

5. Mixed physiology preservation — RESOLVED. All seven contributors (infection, dehydration, medication effects, CKD/HF, neuropathy, deconditioning, steroid physiology) remain live and interacting at every stage; the "what remains unresolved" column repeatedly refuses to collapse them. No hidden single diagnosis emerges — the near-fall is explicitly multi-factorial at the pre-admission row, honoring the ratified guardrail.

6. Disposition-safety preservation — RESOLVED. Functional decline stays the primary failure target (HD3→discharge spine), "medically improving / operationally dangerous" is stated at HD6 in nearly those words, and the discharge anchor row holds both "clinically defensible" and "debatable" simultaneously — the exact dual-truth the world depends on. This is the cleanest preservation in the package.

7. Source-of-truth preservation — RESOLVED. Prednisone history stays reconstructable-but-unresolved through HD4–HD6, no hidden-answer reveal, and the friction/trap separation (steroid record = trap; Endo disagreement = friction) is respected per governance. Hierarchy doctrine intact.

8. Future construction readiness — compatibility preserved, nothing resolved (correctly). The timeline leaves room for 18–22 meds, 12–15 comorbidities, named providers, surgical history, and doesn't foreclose the 2.107/2.108 task-architecture decisions. Two honest notes: (a) named providers — the timeline references roles (PT/OT, consultants, "primary team") but no provider names, which is correct at this stage and consistent with the roster awaiting construction; (b) surgical history — the package lists it as a future-compatibility item, and nothing in the timeline contradicts adding one, but I'll flag that surgical history is referenced as a requirement here without appearing in any ratified upstream artifact — it's the one forward item that hasn't been seen before, so it's worth confirming where that requirement originates before construction treats it as binding. OPEN (future construction). Not a timeline defect.

Finding classification

True defects: none.
Physician-preference items: HD2 consultant-arrival timing (refinable per the package's own note); any later tightening of which friction is "dominant" vs merely "active" at HD4–HD5.
Future-construction items: keeping traps #3 and #5 distinct when they become actual files; confirming the origin/scope of the "surgical-history requirement"; the standing 2.107/2.108 task-architecture decisions.
Would you lock Clinical Story Timeline Package v1 today? YES. No true defect, no internal contradiction, no calendar drift, and every ratified guardrail (friction labels, Family/Team balance, near-fall multi-causality, steroid non-reveal, mixed physiology, disposition-safety target) is preserved. The activation staging is clinically sound and actively protects the frictions from collapse.

Clinical Story Timeline Package v1 Status: LOCK READY

The same honest caveat I gave on the baseline package applies to the word "lock": this artifact sequences physician-originated clinical logic, and the DISPUTED row correctly routes it to Alexander for physician review before locking. From a review standpoint there's nothing blocking it — but the lock action is Alexander's confirmation, since the clinical story is his. Once he confirms, it's locked without reservation.

Final Recommendation: GO.

One thing to carry into construction, not a revision: when the #3/#5 traps become real documents, build in a deliberate distinction — #3 as a genuinely buried finding (present but easy to miss) and #5 as a reassuring-but-incomplete artifact (visible but misleading if trusted alone) — so they don't render as the same "discharge looks fine but isn't" trap twice. The timeline keeps them separate conceptually; the files will need to keep them separate concretely.


task-architecture-package-v1.md
md

Task Architecture Package v1 is complete and currently in CANDIDATE REVIEW.
Please perform an independent ratification review.
Review scope:

Workflow Architecture Integrity
Are the four workflows distinct?
Are any workflows redundant?
Does any workflow appear overloaded?
AutoQC 2.107 Review
Verify the architecture genuinely resolves the workflow-count issue.
Verify no hidden fifth workflow still exists.
Verify TCM and readmission-risk reasoning are correctly embedded rather than becoming separate workflows.
AutoQC 2.108 Review
Determine whether Discharge Planning Documentation legitimately satisfies the administrative-deliverable requirement.
Identify any reviewer-risk if this interpretation is challenged.
Trap Distribution Review
Verify all major traps have architectural representation.
Verify Trap #3 and Trap #5 remain distinct.
Identify any trap that appears overrepresented or underrepresented.
Friction Distribution Review
Verify representation of:
Cardiology vs Nephrology
Family vs Primary Team
Endocrinology vs Primary Team
Verify no friction dominates excessively.
Verify no friction becomes architecturally invisible.
Consistency Review Check consistency against:
Approved Brainstorm
Governance Package
Clinical Story Timeline Package
Baseline Anchor Package
Reviewer Risk Assessment Identify:
SEND BACK risks
Major Revision risks
Minor Revision risks Classify findings as:

VERIFIED
PLAUSIBLE
DISPUTED
NO ISSUE End with: Would you ratify Task Architecture Package v1 today? Answer: YES or NO and provide reasoning. Do not redesign tasks. Do not create prompts. Do not create goldens. Do not create grader guidance. Do not create file inventories. Review only.
Show more
May 31
Independent ratification review of Task Architecture Package v1. This is the artifact where the two longest-deferred items — 2.107 and 2.108 — finally come due, so this review carries more weight than the recent ones. Let me read it before judging.


Viewed 2 files, ran a command
Viewed 2 files, ran a command
Read in full, including the truncated trap-distinction and friction rows. This is the artifact that finally resolves 2.107 and 2.108, so I checked the workflow names against the AutoQC's Appendix A catalog and worked the consolidation arithmetic rather than accepting the package's own "VERIFIED" rows.

The most important verification: do the four named workflows actually exist in the approved catalog, verbatim? From the AutoQC Appendix A list I read earlier: "Discharge Medication Reconciliation" ✓, "Hospital Discharge Summary Generation" ✓, "Discharge Planning Documentation" ✓, and "Interdisciplinary Care Plan Development and Documentation" — this last one I can confirm appears in the catalog as a P1 workflow (it was the Task 5 mapping in the brainstorm). All four are exact catalog labels, not invented umbrellas. The "Acute Hospital Management" umbrella from the governance package has been correctly dropped — it does not appear as a workflow here, which is right, since it was never a real catalog label. This is the check that mattered most, and it passes.

1. Workflow architecture integrity — VERIFIED. The four workflows are genuinely distinct: medication reconciliation (action reasoning), discharge summary (narrative synthesis), discharge planning (disposition/coordination), and interdisciplinary care plan (consultant synthesis). No two are redundant — each tests a different competency, which was the standing requirement. The one to scrutinize for overload is Discharge Planning Documentation, which absorbs three of six task concepts (transition plan, follow-up note, readmission review). I'll treat that under 2.107 and the PLAUSIBLE finding below rather than calling it redundant — the workflow is single and distinct; the question is whether three tasks under it stay differentiated.

2. AutoQC 2.107 — VERIFIED, count resolved. Six task concepts → four distinct catalog workflows, inside the 3–5 range with one slot of margin. The consolidation math is sound and traceable: the two genuinely-distinct competencies (med rec, discharge summary) stay solo; consultant synthesis stays solo (correctly — merging it would weaken the specialist-conflict design); and the three disposition-flavored tasks (transition, TCM follow-up, readmission) collapse into the single Discharge Planning Documentation workflow.

No hidden fifth workflow: confirmed. The prior mapping's fifth and sixth distinct catalog workflows — "Transitional Care Management Documentation (TCM)" and "Patient Risk Stratification Assessment" — are explicitly demoted from workflow status to reasoning components inside Discharge Planning Documentation. Two DISPUTED findings in the package nail this down by name. That's exactly the consolidation that retires the count problem.
TCM and readmission correctly embedded: confirmed. Both are preserved as reasoning (the +7 and +30 anchors still drive them) without being separate catalog workflows. This is the right move and it's documented.
One honest note, not a defect: the brainstorm originally mapped six tasks to six distinct P0/P1 labels (I flagged that as the live 2.107 risk several reviews ago). This package resolves it by re-assigning three of those tasks to the Discharge Planning Documentation workflow. That's legitimate — multiple tasks under one workflow is explicitly allowed — but it does mean the task-to-workflow mapping has changed from the brainstorm, and at spec time each task's workflow line must read the new assignment, not the brainstorm's original label. Worth carrying forward so the spec doesn't accidentally re-cite the old six-way mapping.

3. AutoQC 2.108 — PLAUSIBLE, not VERIFIED — and this is the one finding I'd elevate. The package locates the administrative deliverable in Discharge Planning Documentation and argues it carries care-coordination/transition/readmission work. That is a defensible reading, and the package's DISPUTED finding correctly resists forcing in billing/coding/prior-auth. But I flagged this exact risk at governance review and it has not fully closed: 2.108's intent distinguishes clinical work products from healthcare-administration work products, and the check's own examples lean toward coding, prior auth, utilization review, and similar operations-facing artifacts. Discharge planning and care coordination are clinical-administrative hybrids — they're more administrative than a progress note, but a strict reviewer applying 2.108 could find they're still disposition-clinical rather than a clean operations deliverable.

So the residual reviewer-risk is real and specific: if a reviewer challenges whether Discharge Planning Documentation counts as the administrative work product, the architecture has no second administrative deliverable to fall back on. The package made a deliberate, reasonable bet (hybrid counts; don't distort the world with billing); I'm not second-guessing the clinical judgment. I'm flagging that it remains a bet, not a settled pass, and it's the single most likely place this architecture draws a revision request. The package's mitigation (utilization review listed as "plausible but not selected") is the natural fallback if challenged. PLAUSIBLE — adequate to ratify, but eyes open.

4. Trap distribution — VERIFIED, with #3/#5 distinctness explicitly preserved. All five traps have architectural representation across the workflows. The Trap #3 vs #5 distinction — the watch-item I've carried since the brainstorm — is now stated cleanly: #3 is failure to find buried evidence; #5 is failure to distrust a visible-but-incomplete artifact. That's the exact distinction I asked for at timeline lock, now written into the architecture. Distribution assessment: steroid and HF-AKI traps are flagged by the package itself as at-risk-of-overuse (appropriately — both touch three+ workflows), with explicit guidance to vary whether each is central or secondary per task. No trap is underrepresented; sepsis-anchoring is the lightest-touch (three workflows) but adequately covered. The overload risk is correctly identified and bounded as a drafting-discipline item.

5. Friction distribution — VERIFIED. All three frictions are represented; none is invisible; none dominates architecturally. Cardiology vs Nephrology and Family vs Primary Team are correctly noted as naturally strongest (medication + disposition are central), and Endocrinology vs Primary Team is preserved through the care-plan and med-rec workflows with the standing guardrail that it must stay a risk-interpretation friction, not a missed-diagnosis reveal. The distribution matches the ratified governance balance — no friction has been flattened by the consolidation, which was a genuine risk when three tasks merged into one workflow (the Family/Team friction could have swallowed the others under Discharge Planning Documentation; it didn't, because consultant synthesis stayed a separate workflow carrying the specialist conflicts).

6. Consistency review — VERIFIED against all five inputs. Brainstorm (all six concepts preserved, reserve task still excluded); Governance (consultant synthesis kept distinct, admin-deliverable decision implemented, umbrella correctly dropped); Timeline (anchors preserved post-close, TCM/readmission folded in); Baseline Anchor (baseline comparators remain relevant to all workflows). No upstream artifact is contradicted, and nothing reopens ratified architecture.

7. Reviewer risk assessment

SEND BACK risks: none at the architecture layer. The count is resolved, the workflows are real catalog labels, nothing structural is broken.
Major revision risks: one, conditional — the 2.108 administrative-deliverable challenge. If a reviewer rules that discharge planning is clinical-administrative rather than a clean administrative work product, the architecture needs a second admin deliverable (utilization review is the pre-identified fallback). This is the only finding that could escalate beyond minor.
Minor revision risks: the three-tasks-under-one-workflow differentiation (PLAUSIBLE) — the transition plan, TCM follow-up, and readmission review must be made distinct by requester, time anchor, reasoning emphasis, and deliverable surface, or they'll read as duplicative; and the task-to-workflow re-assignment carry-forward (don't re-cite the brainstorm's old six-way mapping at spec time).
Finding classification summary: VERIFIED — workflow distinctness, 2.107 count resolution, no hidden fifth workflow, TCM/readmission embedding, trap representation, #3/#5 distinction, friction balance, all five consistency checks. PLAUSIBLE — 2.108 administrative-deliverable interpretation; three-tasks-one-workflow differentiation; four-vs-five margin. DISPUTED — (correctly, by the package) that billing/coding must be added; that readmission needs a standalone workflow. NO ISSUE — boundary discipline intact.

Would you ratify Task Architecture Package v1 today? YES.

Reasoning: the package does the one hard thing this phase existed to do — it resolves the 2.107 workflow-count problem that has been deferred since the brainstorm, and it does so cleanly: four real catalog workflows, verifiable consolidation arithmetic, the two would-be fifth/sixth workflows explicitly demoted to reasoning components by name, and the bogus "Acute Hospital Management" umbrella correctly dropped. It also closes my longest-standing trap watch-item by writing the #3/#5 distinction into the architecture, and it preserves the friction balance through the consolidation rather than letting Discharge Planning Documentation swallow the specialist conflicts.

It earns ratification rather than a hold because the one genuinely unresolved item — 2.108 — is a reasonable, documented bet with a named fallback, not a defect: the world supports discharge planning/care coordination as its administrative deliverable far more naturally than it would support bolted-on billing, and forcing coding work would damage the clinical design the whole project has protected. The honest caveat is that 2.108 is a bet, not a settled pass, and it's the most likely place a hostile reviewer pushes back at spec time — so I'd ratify with that flag explicit: if 2.108 is challenged, utilization review is the pre-identified second administrative deliverable, and adding it would not require reopening the clinical architecture.

Same standing note on "ratify": this package records physician decisions from the Task Architecture Interview, and the clinical/workflow choices are Alexander's; from an independent-review standpoint there's nothing blocking ratification, and the DISPUTED rows correctly reserve the judgment calls to him. The minor items (differentiating the three discharge-planning tasks; citing the new workflow assignments rather than the brainstorm's old mapping) are drafting-discipline carry-forwards, not ratification blockers.


medication-expansion-package-v1.md
md


clinical-story-timeline-package-v1.md
md


task-architecture-package-v1.md
md


clinical-story-skeleton-ratification.md
150 lines

md


governance-package-ratification.md
73 lines

md


baseline-anchor-package-v1.md
137 lines

md


identity-package-v1.md
126 lines

md


key-milestones-calendar-skeleton-v1.md
139 lines

md

Medication Expansion Package v1 is complete and currently in CANDIDATE REVIEW.
Please perform an independent ratification review.
This is a ratification review, not a hostile review and not a redesign exercise.
Review only the submitted Medication Expansion Package v1 against:

Approved Brainstorm
Ratified Clinical Story Skeleton v1
Locked Identity Package v1
Ratified Governance Package v1
Locked Key Milestones Calendar Skeleton v1
Locked Baseline Anchor Package v1
Locked Clinical Story Timeline Package v1
Locked Task Architecture Package v1
Current Clinical Logic
Do NOT:

redesign the medication list
create new medications
create medication doses
create medication schedules
create medication timelines
create medication reconciliation outputs
create admission medication lists
create discharge medication lists
create tasks
create prompts
create expected outputs
create goldens
create grader guidance
create file inventory
draft World Spec content
Review Scope

Medication Architecture Integrity
Review the complete candidate medication architecture.
Questions:

Is the overall medication burden clinically realistic?
Is approximately 21 medications plausible for this patient?
Does any medication feel artificial or unsupported?
Does any medication create an unintended disease arc?

Polypharmacy Realism
Evaluate:

HFrEF
CAD
CKD Stage 3
Type 2 Diabetes
Diabetic Neuropathy
PMR with chronic prednisone exposure
Anemia of CKD
Osteoporosis/Osteopenia
Questions:

Does the medication burden fit the approved comorbidity profile?
Is the complexity realistic rather than inflated?
Is the burden sufficient to support medication-reconciliation reasoning?

Trap Support Review
Review support for:

Steroid source-of-truth trap
HF/AKI medication trap
Functional/cognitive decline trap
Discharge-safety trap
Polypharmacy-related reasoning
Questions:

Are the traps strengthened?
Is any trap weakened?
Does any medication accidentally reveal a hidden answer?
Is mixed physiology preserved?

Friction Support Review
Review support for:

Cardiology vs Nephrology
Family vs Primary Team
Endocrinology vs Primary Team
Questions:

Does the medication architecture naturally support these frictions?
Does any friction become one-sided?
Does any medication create a new unintended friction?

Source-of-Truth Preservation
Review:

Prednisone hierarchy
Chronic steroid exposure evidence
Medication reconciliation complexity
Questions:

Is prednisone still reconstructable rather than obvious?
Is steroid exposure supported without creating reveal-drift?
Is the governance hierarchy still respected?

Future Construction Compatibility
Determine compatibility with:

Future comorbidity expansion package
Named-provider roster package
Surgical-history package
Daily hospital-course framework
Medication reconciliation construction
File inventory architecture
Do not require resolution.
Only determine whether compatibility is preserved.

Physician Review Questions
Provide explicit answers to:

Keep candidate baseline medication count at 21?
Keep insulin lispro in baseline architecture?
Keep nitroglycerin rescue medication?
Keep both polyethylene glycol and senna?
Keep separate cholecalciferol?
For each answer provide:

YES or NO
reasoning
Classification
Classify findings as:

RESOLVED
OPEN
BLOCKER
Distinguish:

true defects
physician preference items
future construction items End with: Medication Expansion Package v1 Status: LOCK READY or NOT LOCK READY Would you ratify Medication Expansion Package v1 today? YES or NO Final Recommendation: GO MINOR REVISION SEND BACK Do not redesign the package. Review only.
Show more
May 31
Independent ratification review of Medication Expansion Package v1. This is the first artifact that scales the regimen from the locked 14 to the ~21 target, so the review is substantive: I checked the renal-dosing safety of each agent against the CKD3/AKI story, the cross-package consistency against the locked 14, and watched specifically for any medication that quietly answers an open clinical question. Let me read it.


Viewed 2 files, ran a command
Viewed 2 files, ran a command
Read in full. This is the most clinically dense artifact yet — 21 medications — so the review verifies three things the package can't self-certify: that the expansion preserves the locked 14 without altering them, that every added agent is renally and clinically defensible for this patient, and that nothing in the additions quietly answers an open question (the reveal-drift risk, which is sharpest in medication choices).

Cross-package consistency check first — does the expansion preserve the locked 14? Comparing against the Identity/kickoff locked compact list (sacubitril-valsartan, carvedilol, furosemide, spironolactone, empagliflozin, aspirin, atorvastatin, metformin ER, insulin glargine, prednisone, alendronate, calcium/vit D, ferrous sulfate, gabapentin): all 14 are present and unchanged in role. The 7 additions are nitroglycerin (rescue), insulin lispro, acetaminophen, pantoprazole, polyethylene glycol, senna, and cholecalciferol. 14 + 7 = 21. The locked core is preserved exactly; the package adds, it does not alter. This was the most important consistency risk and it passes.

Renal/clinical safety scan of the additions, against CKD3 + AKI:

Nitroglycerin (PRN), acetaminophen, pantoprazole, PEG, senna, cholecalciferol — all renally benign, all common in this exact patient archetype, none introduces a new disease arc. Clinically clean.
Insulin lispro — the one addition I scrutinized hardest, and it's the one with a real consistency question (handled in Physician Q2 below). Not unsafe; the question is where it belongs, not whether it's plausible.
No added medication is renally contraindicated, and none implies a comorbidity not already approved. Good.

The reveal-drift scan — does any medication answer an open question? This is where a medication list can silently break a disposition-safety world. The package handles it correctly and explicitly: the bone-health cluster (alendronate, calcium/vit D, cholecalciferol) plus pantoprazole corroborate chronic steroid exposure without proving current adrenal suppression — exactly the osteoporosis-vs-adrenal distinction ratified in governance. The package states this guardrail in three places (lines 156, 164, 251). No medication points unambiguously at adrenal insufficiency, sepsis, or any single near-fall cause. Mixed physiology preserved. This is the subtlest risk in the artifact and it's correctly defended.

Now the scoped review.

1. Medication architecture integrity — RESOLVED. 21 is clinically realistic for this comorbidity stack — arguably on the higher-but-plausible side, which is appropriate given the "exceed reviewer minimums" lock. No medication is artificial or unsupported; each maps to an approved condition. No unintended disease arc — the package explicitly declines to add BPH, COPD, anticoagulation, opioids, or psych meds (line 105), which is the right discipline (any of those would have created a new arc).

2. Polypharmacy realism — RESOLVED. Every one of the eight named comorbidities is represented by appropriate therapy; the burden fits the profile rather than being inflated. Complexity is realistic (it comes from class diversity, supplements-vs-meds ambiguity, chronic-vs-temporary status) rather than from exotic agents. Sufficient to support medication-reconciliation reasoning — the mix of GDMT, insulin, steroid-with-uncertain-taper, supplements, a PRN rescue, and a bowel regimen is precisely what generates copy-forward and omission errors.

3. Trap support — RESOLVED, all five strengthened or held. Steroid source-of-truth: strengthened (prednisone central; bone/GI corroborate exposure) with reveal guardrail intact. HF/AKI: strongly supported (six agents create genuine restart tension) with an explicit anti-overload guardrail. Functional/cognitive: supported (gabapentin sedation, insulin complexity, diuretics as plausible contributors) without letting any single med explain the near-fall. Discharge-safety: strengthened (regimen breadth makes safe discharge instructions genuinely hard). Polypharmacy reasoning: supported without a rare interaction. No trap weakened; no medication reveals a hidden answer.

4. Friction support — RESOLVED. Cardiology vs Nephrology strongly supported by the HF/renal-sensitive agents; Family vs Primary Team strongly supported by total regimen burden (with the team's defensible side preserved); Endocrinology vs Primary Team adequately supported via prednisone with the reveal guardrail. No friction becomes one-sided, and critically no medication creates a new unintended friction — I checked specifically for an anticoagulation or antiplatelet-intensity conflict (none added beyond the already-approved aspirin) and a psych-med sedation conflict (none added). Clean.

5. Source-of-truth preservation — RESOLVED. Prednisone stays reconstructable-not-obvious; chronic steroid exposure is corroborated by the bone/GI cluster without proving adrenal suppression; the prednisone hierarchy and governance master hierarchy are respected (the package defers actual reconciliation to authorized construction and flags preserving the hierarchy). The supplement-vs-medication classification ambiguity (calcium/vit D vs separate cholecalciferol; OTC acetaminophen/PEG/senna) is a designed source-of-truth complexity, not a defect — it's exactly the "is this a charted med or a patient-reported supplement" reconciliation challenge.

6. Future construction compatibility — preserved across all six. No medication forecloses the comorbidity-refinement package, the provider roster (it explicitly leaves outpatient PCP/rheum/cards/nephro/endo/pharmacy sourcing open), the surgical-history package (no med requires a surgical history — verified: none of the 21 implies a prior procedure), the daily hospital-course framework (no timing/orders created), med-rec construction, or the file inventory (no filenames/dates). Compatibility intact; nothing resolved prematurely.

7. Physician review questions — explicit answers

Q1 — Keep the count at 21? YES. 21 sits inside the 18–22 target with margin on both sides, and the "exceed reviewer minimums" lock favors the upper-middle of the range. The burden is realistic, not padded. If Alexander wanted to trim, the only candidates are the redundant-by-design bowel pair (Q4) — but trimming isn't necessary for compliance or realism. Recommend keeping 21.

Q2 — Keep insulin lispro in baseline architecture? NO (lean), physician's call. This is the one genuine consistency tension in the package. The locked baseline shows imperfect-but-not-brittle control (A1c 7.6–8.2 on basal glargine + metformin), and the kickoff/Identity locked list carries glargine but not lispro. A patient controlled on basal + oral at that A1c often does not have prandial lispro as a chronic outpatient med — prandial insulin more typically appears as inpatient correction/sliding-scale or steroid-induced hyperglycemia coverage. Adding lispro to baseline mildly inflates the home regimen's complexity beyond what the A1c implies, and it slightly muddies a future trap (steroid-induced hyperglycemia requiring prandial coverage is more powerful if lispro is introduced inpatient, not pre-existing). My lean: reserve lispro for the inpatient hospital-course phase rather than baseline. But this is a physician-preference / clinical-judgment call, not a defect — baseline lispro is defensible (long-standing diabetes + steroid exposure), and if Alexander wants the higher baseline complexity it's legitimate. Flagging because it's the single item where the addition has a downstream-trap consequence worth a deliberate choice. Also note: lispro is the one addition not on the locked 14, so keeping it means the baseline list now formally exceeds the previously-locked compact list by this agent — worth an explicit acknowledgment.

Q3 — Keep nitroglycerin rescue? YES. PRN nitroglycerin is standard for a documented-CAD patient, renally benign, and serves a real reconciliation purpose (PRN/rescue meds are classically omitted or copied-forward without indication). It does not create a new disease arc (no active ACS implied). Keep.

Q4 — Keep both PEG and senna? YES, with a note. A dual bowel regimen (osmotic + stimulant) is realistic for a patient on iron + reduced mobility + opioid-free chronic constipation risk, and the package's stated intent is that the pair creates a duplicate-supportive-medication reconciliation challenge — a deliberate, low-stakes trap substrate. That's a legitimate design choice. If Alexander prefers a leaner list, dropping to one is harmless. Either is defensible; keeping both is the more reconciliation-rich choice. Physician preference.

Q5 — Keep cholecalciferol separate from the calcium/vit D combo? YES, with the same caveat. A separate cholecalciferol alongside a calcium/vitamin-D combination is a real-world redundancy (patients accumulate both a prescribed combo and an OTC D3), and it's explicitly intended here as a supplement-vs-medication source-classification challenge. That's a designed complexity, not an error. The only watch-item: at construction, the combined vitamin D load (combo + standalone D3) should stay within a clinically sensible total so it doesn't read as an accidental over-supplementation flag. Defensible to keep; physician preference whether the added complexity is worth it.

Classification summary

True defects: none.
Physician-preference items: insulin lispro baseline-vs-inpatient placement (Q2 — the one with a downstream-trap consequence); the count (Q1); the PEG/senna pair (Q4); separate cholecalciferol (Q5); nitroglycerin (Q3, low-stakes).
Future-construction items: keep HF/AKI medication reasoning from dominating all tasks (package's own guardrail); preserve the prednisone hierarchy at med-rec construction; keep total vitamin D sensible if cholecalciferol stays separate; if lispro stays baseline, ensure the steroid-induced-hyperglycemia inpatient trap is still constructed so it isn't pre-empted.
Every gate classifies RESOLVED. No OPEN blocker. The two would-be concerns (lispro placement; the deliberate redundancies) are clinical-judgment calls the package correctly routes to Alexander via its five review questions.

Medication Expansion Package v1 Status: LOCK READY.

Would you ratify Medication Expansion Package v1 today? YES. The expansion preserves the locked 14 exactly, adds 7 clinically defensible agents to reach a realistic 21, strengthens all five traps and all three frictions without one-sidedness, and — the subtlest and most important check — defends the reveal-drift boundary by corroborating chronic steroid exposure through the bone/GI cluster without letting any medication prove adrenal suppression. There is no true defect and no internal inconsistency.

Same standing caveat on the word "lock/ratify": medication selection is physician-originated clinical content, and the package correctly presents all 21 as candidate architecture with five explicit confirmation questions. From an independent-review standpoint nothing blocks ratification — but the actual lock is Alexander answering those five, with insulin lispro (Q2) being the one I'd genuinely want his decision on rather than a rubber stamp, because baseline-vs-inpatient placement changes what a later glycemic trap can do. Once he confirms the five, this is locked without reservation.

Final Recommendation: GO.

good review so far

May 31
Thanks. Where the build stands:

The full physician-architecture and construction-prep chain is now reviewed and locked or lock-ready: Brainstorm, Temporal/Calendar, Clinical Story Skeleton, Identity, Governance, Baseline Anchors, Clinical Story Timeline, Task Architecture (2.107 resolved, 2.108 a documented bet), and now Medication Expansion (lock-ready pending Alexander's five answers, with insulin lispro the one real decision).

Two genuine carry-forwards still open, neither blocking:

Insulin lispro placement (baseline vs inpatient) — the one medication decision with a downstream-trap consequence.
2.108 administrative deliverable — defensible as Discharge Planning Documentation, but a bet; utilization review is the named fallback if a reviewer challenges it.
By the kickoff's own sequence, the remaining construction-prep pieces before actual World Spec drafting are roughly: comorbidity refinement toward 12–15, the named-provider roster, and surgical history (the one requirement I flagged as not yet traced to an upstream source — worth confirming where it originates before it's treated as binding). After those, the spec itself: Patient Profile, Clinical Complexity Overview, Key Milestones table, Failure Design tables, the file plan (the 8-column Source/Tool issue from v6.3 lands here), and the tasks.

Still preparation-only — I haven't drafted any spec content, and the next substantive step waits on your explicit go.

What's next?


comorbidity-expansion-package-v1.md
md

Independent ratification review of Comorbidity Expansion Package v1.
Review-only role. Do not redesign the package and do not create new conditions.
Review objectives:

Verify preservation of all previously approved conditions.
Verify consistency with:
Approved Brainstorm
Governance Package
Baseline Anchor Package
Clinical Story Timeline
Medication Expansion Package
Current Clinical Logic
Evaluate whether the three added secondary conditions:
Class I obesity
Chronic GERD / acid-suppression indication
Chronic constipation tendency are clinically justified and architecturally appropriate. Specifically assess:

Clinical plausibility
Internal consistency
Mixed-physiology preservation
Friction preservation
Trap preservation
Source-of-truth preservation
Medication architecture compatibility
Disposition-safety compatibility
Future construction compatibility
Determine whether any condition:

Creates a new dominant disease arc
Answers an open clinical question
Collapses mixed physiology
Weakens existing traps
Weakens existing frictions
Conflicts with locked medication architecture
Classify findings as:

RESOLVED
OPEN
BLOCKER
Distinguish:

True defects
Physician-preference items
Future-construction items Conclude with: Would you ratify Comorbidity Expansion Package v1 today? Provide a final verdict: Comorbidity Expansion Package v1 Status: LOCK READY or NOT LOCK READY Final Recommendation: GO or NO GO.
Show more
May 31
Independent ratification review of Comorbidity Expansion Package v1. Review-only — I won't redesign or add conditions. This package scales the comorbidity list toward the 12–15 target, and since the three additions are secondary conditions, the central question is whether any of them quietly does something a secondary condition shouldn't: create a dominant arc, answer an open question, or contradict the locked medication list. Let me read it.


Viewed 2 files, ran a command
Viewed 2 files, ran a command
Read in full. The substantive checks for a comorbidity expansion are different from the medication one: I verified the eleven carried-forward conditions are preserved exactly, that each of the three additions is genuinely derivative of something already locked (rather than a new arc), and — the sharpest risk — that none of the three answers an open question or contradicts the locked medication list. One cross-package number needs flagging, which I'll take first.

The medication-count consistency note. This package's body says 21 baseline medications in the Medication Expansion Package; line 183 of this comorbidity package refers to "the 20-medication baseline architecture." That's an internal cross-reference discrepancy — 21 vs 20 — between two artifacts that are supposed to be mutually consistent. It does not change any clinical content here (no medication is added or removed by this package), and it may simply reflect counting the calcium/vitamin-D combination as one item vs two. But it's a true defect of the small, traceability kind: under the eventual 2.57/2.59 consistency discipline, two locked packages citing different baseline medication counts is exactly the sort of mismatch a reviewer catches. It needs reconciling to a single agreed number before both are treated as jointly locked. Not a blocker to the clinical content of this package; a documentation-consistency fix. OPEN (true defect, minor).

Now the scoped review.

Objective 1 — Preservation of approved conditions — RESOLVED. All eleven previously-approved/ratified conditions are present and unchanged: HFrEF, CAD, HTN, hyperlipidemia, CKD3, T2DM, diabetic neuropathy, OSA, PMR, anemia of CKD, osteoporosis/osteopenia. Nothing removed, no role altered. 11 + 3 = 14, inside the 12–15 target.

Objective 2 — Consistency across all source packages — RESOLVED, except the 20/21 cross-reference (above). Brainstorm: comorbidity burden matches the reviewer-approved expansion. Governance: confirmed conditions preserved; presumed/active questions left open. Baseline Anchor: every numeric anchor (creatinine/eGFR, Hgb, A1c, dry weight, mobility, cognition) now has a condition-level home — good, this actually closes a small gap (anchors were slightly free-floating before; now each is motivated by a named condition). Timeline: no hospital-course event added. Medication Expansion: the three additions map cleanly to already-locked drugs (obesity↔no new drug; GERD↔pantoprazole; constipation↔PEG/senna). Clinical Logic: consistent.

Objective 3 — The three added secondary conditions

Class I obesity by BMI — clinically justified, architecturally clean. This is the strongest of the three because it's not really a new condition — it's the named clinical entity already implied by the locked BMI 30.6. Adding it makes explicit what the Identity Package already fixed. It introduces no new medication, supports OSA/diabetes/HTN/HFrEF coherence and rehab/mobility planning, and creates no arc. The only discipline note (which the package states): obesity must stay background, not become a bariatric/weight-management arc. RESOLVED.

Chronic GERD / chronic acid-suppression indication — justified, with the one nuance worth stating. This exists to give pantoprazole a charted indication rather than letting a PPI float unexplained — legitimate, and it adds real source-of-truth complexity (is the PPI for a true GERD diagnosis or just aspirin/steroid gastroprotection?). That ambiguity is designed, not a defect. The nuance: the package frames it as "GERD / chronic acid-suppression indication," and those aren't quite the same thing — a formal GERD diagnosis vs. prophylactic acid suppression for an aspirin+steroid patient. For a secondary background condition this dual framing is acceptable (it's arguably more realistic, since charts are often vague here), but at construction the team should pick which the chart asserts so it doesn't read as two different things in two files. Physician-preference refinement, not a defect. RESOLVED.

Chronic constipation tendency — justified. Derivative of iron + gabapentin + reduced mobility + polypharmacy, and it gives the PEG/senna pair a charted basis. "Tendency" is appropriately soft — it's a risk state, not a hard diagnosis, which keeps it background. Supports discharge-instruction realism without a GI arc. RESOLVED.

Specific risk assessments requested:

New dominant disease arc? No. All three are explicitly secondary and derivative; none introduces a new specialty, a new acute problem, or a new task. Verified against the "no new arc" bar.
Answers an open clinical question? No — and this is the check that matters most. None of the three touches infection source, steroid/adrenal contribution, dehydration degree, medication contribution, or discharge readiness. Critically, the GERD and constipation additions sit near the steroid story (acid suppression and bone health both corroborate chronic steroid exposure) but the package correctly holds the line: corroborating cumulative exposure ≠ proving current adrenal suppression. The osteoporosis-vs-adrenal governance distinction is preserved verbatim (line 102). No reveal-drift.
Collapses mixed physiology? No. The additions reinforce multi-causality (more plausible contributors to reduced reserve) rather than concentrating explanation in one cause.
Weakens existing traps? No. Each trap is supported or held; the buried-functional trap gains plausible contributors (neuropathy/OSA/anemia/obesity) without any single one explaining the near-fall.
Weakens existing frictions? No. All three frictions stay strongly/adequately supported; the additions feed Family-vs-Team (functional burden) without unbalancing it, and don't create a new friction (I checked specifically — no condition introduces a new specialist conflict).
Conflicts with locked medication architecture? No clinical conflict — every addition matches an existing drug. The only medication-related issue is the 20/21 count cross-reference, which is documentation, not clinical conflict.
Future construction compatibility — preserved. Surgical history can remain independent (none of the 14 requires a prior procedure — verified); provider roster stays flexible; no labs/vitals/events/files created.

Classification summary

True defects: one — the 20-vs-21 baseline-medication-count cross-reference between this package (line 183) and the locked Medication Expansion Package. Minor, documentation-consistency, must reconcile before joint lock.
Physician-preference items: whether the GERD addition is charted as a formal diagnosis vs prophylactic acid-suppression indication; whether all three secondary conditions are kept or any trimmed (the package itself asks this); whether constipation stays "tendency" vs a firmer diagnosis.
Future-construction items: keep all three as background (don't elevate); make the functional-reserve evidence discoverable across multiple files at construction; preserve the steroid non-reveal guardrail when these conditions appear in documents.
Gates: all RESOLVED except the medication-count cross-reference, which I classify OPEN (minor true defect). No BLOCKER.

Would you ratify Comorbidity Expansion Package v1 today? Not quite as-is — I'd ratify after one trivial reconciliation. The clinical architecture is sound: all eleven approved conditions preserved, three genuinely-secondary derivative additions that create no arc, answer no open question, and preserve mixed physiology, frictions, traps, and the steroid non-reveal. There is no clinical defect and no blocker. The single thing standing between this and a clean ratification is the 20-vs-21 medication-count cross-reference — reconcile that one number against the locked Medication Expansion Package (decide whether the calcium/vitamin-D combo counts as one item or two, and state the agreed total identically in both), and this locks without reservation.

Comorbidity Expansion Package v1 Status: LOCK READY — conditional on reconciling the 20/21 medication-count reference. On clinical content alone it is lock-ready; I'm holding the unconditional stamp only for that one-line consistency fix, because letting two locked packages cite different baseline counts is precisely the traceability mismatch this whole review chain exists to prevent.

Same standing note: condition selection is physician-originated, and the package correctly presents the three additions as candidates with explicit "confirm these don't feel like padding" questions for Alexander. From a review standpoint nothing clinical blocks ratification.

Final Recommendation: GO — with the one documentation reconciliation (medication count) completed as part of locking, and Alexander's confirmation of the three secondary conditions.


provider-roster-package-v1.md
md

Independent ratification review of Provider Roster Package v1.
Review-only.
Do not redesign the package. Do not create providers. Do not create notes. Do not create files. Do not create tasks. Do not create prompts. Do not create goldens. Do not create grader guidance. Do not create World Spec content.
Review the package exactly as written.
Review goals:

Provider architecture integrity
Governance compatibility
Authority hierarchy compatibility
Master source-of-truth compatibility
Prednisone source-of-truth compatibility
Friction support
Trap support
Future construction compatibility
Evaluate specifically:

Are all required authority sources represented?
Is any required provider missing?
Is any provider unsupported by the approved architecture?
Does any provider create a new disease arc?
Does any provider create a new friction?
Does any provider collapse an existing friction?
Does any provider weaken an existing trap?
Does any provider weaken the source-of-truth hierarchy?
Does any provider introduce real-person-name risk?
Does the naming strategy over-name minor contributors?
Does the roster preserve the distinction between:
 
authority hierarchy
source-of-truth hierarchy
friction participants
trap participants Special attention:

Cardiology vs Nephrology
Family vs Primary Team
Endocrinology vs Primary Team
Prednisone source-of-truth trap
HF/AKI medication trap
Buried functional/cognitive trap
Discharge source-hierarchy trap
Trap #3 vs Trap #5 distinction
Required classifications:

RESOLVED
OPEN
BLOCKER
Also distinguish:

True defects
Physician-preference items
Future-construction items Conclude with: Would you ratify Provider Roster Package v1 today? Answer: YES or NO Then provide: Provider Roster Package v1 Status: LOCK READY or NOT LOCK READY Final Recommendation: GO or HOLD Do not propose redesign unless a true defect exists.
Show more
Jun 1
Independent ratification review of Provider Roster Package v1. Review-only — no providers, notes, files, or spec content created. For a roster, the highest-severity checks are synthetic-name safety (real-person risk), whether every authority-hierarchy and source-of-truth rung has a provider to embody it, and whether naming a provider accidentally turns a documentation trap into a person-driven friction. Let me read it.


Viewed 2 files, ran a command
Viewed 2 files, ran a command
Read in full. For a roster the make-or-break checks are name safety, hierarchy coverage, and friction/trap role integrity — I worked each of those rather than accepting the package's own VERIFIED rows, and I checked one thing the review questions specifically asked about: whether any named provider collapses a friction by becoming a single authoritative voice.

Synthetic-name safety — the highest-severity check for a roster — RESOLVED, with one item to confirm. The seven names (Elian Vossmere, Maris Caldrane, Iven Solthar, Nerea Veylorn, Talia Quenor, Soren Halvek, Mara Merrow) are deliberately uncommon constructed names; none reads as a real public figure or a real institution's known clinician, which clears the real-person-name risk that 2.2-class checks exist to catch. The one item worth flagging, not as a defect but as a deliberate choice to confirm: the family caregiver is "Mara Merrow" — same surname as the patient, Korvin Merrow. That's realistic (spouse/family sharing a surname) and not an error, but it's worth an explicit confirmation that the shared surname is intended, because at file-construction a shared surname can create minor disambiguation friction in note headers ("Merrow" alone becomes ambiguous). Physician-preference confirmation, not a defect.

1. Provider architecture integrity — RESOLVED. The roster cleanly separates named recurring high-authority roles from service-role placeholders, which is the correct strategy: provenance where source-of-truth reasoning needs a stable author, role-based where naming would only add cast burden. Every clinical service the world needs is represented.

2/3/4/5. Governance, authority-hierarchy, master and prednisone source-of-truth compatibility — RESOLVED. This is the strongest part of the package. Every rung of all three ratified hierarchies now has a provider mapped to it:

Authority hierarchy: hospitalist (Vossmere) → three named consultants → PT/OT → CM/SW → family (Mara) → patient (Korvin). Complete, in order.
Master source-of-truth: attending → pharmacy (med rec) → pharmacy (history) → consultants → PCP (Quenor) → family → patient. The PCP rung — the gap I flagged at governance review and that the clarification added — now has a named embodiment. Complete.
Prednisone-specific: rheumatology (Halvek) at rung 1 → pharmacy → pharmacy/refill → family → patient. The top prednisone-authority rung is correctly held by outpatient rheumatology, not endocrinology — which is exactly right and is the distinction the whole steroid-trap design depends on.
The package explicitly notes Veylorn (endo) interprets steroid risk inpatient but Halvek (rheum) remains the highest-authority history source. That's the precise separation that keeps the steroid trap reconstructable.

6. Friction support — RESOLVED, and the anti-collapse check passes. This was the review's special-attention concern, and it's handled correctly:

Cardiology vs Nephrology: Caldrane vs Solthar as distinct named voices, with the explicit rule that Vossmere reconciles rather than auto-defers (line 134). This directly honors the governance operational rule that the authority hierarchy resolves documentation conflicts, not clinical-recommendation disagreements. The friction is NOT collapsed by naming the hospitalist above the consultants — the package states the non-deferral guardrail in three places.
Family vs Primary Team: Mara (baseline/home-safety) vs Vossmere/team (medically-improving), with PT/OT/nursing/CM/SW supplying evidence that can cut either way (line 144) — preserving the ratified two-sided balance.
Endocrinology vs Primary Team: Veylorn vs Vossmere as the human conflict, with Halvek/pharmacy as evidence substrate explicitly "without becoming inpatient friction participants" (line 154). This is the correctly-relabeled friction, and naming Halvek does NOT recreate the banned "Endocrinology vs Documentation" framing — he's a source, not a friction party.
No provider creates a new friction, and none collapses an existing one. Verified specifically.

7. Trap support — RESOLVED, including the #3/#5 distinction. Each trap has distinct provider/source channels: prednisone trap (six distinct-authority roles, explicitly avoiding the "vs Documentation" collapse); HF/AKI trap (consultants for recommendations, pharmacy for history, hospitalist for integration, with the "latest note isn't automatically correct" guardrail); buried functional/cognitive trap (nursing/PT/OT/family/CM/SW as channels beyond physician notes). The Trap #3 vs Trap #5 distinction — the watch-item I've carried since the brainstorm — is restated cleanly at lines 204–209: #3 is buried-but-present evidence, #5 is a visible-but-incomplete artifact over-trusted if read alone. The roster supports both as different problems, which is what construction will need.

No provider weakens any trap, and no provider weakens the source-of-truth hierarchy — naming actually strengthens it by giving each rung a stable author.

Disease-arc and over-naming checks: No provider introduces a new disease arc (every role maps to an already-approved condition/service — verified against the locked comorbidity list). No over-naming of minor contributors — resident, nursing, PT, OT, CM, SW, and pharmacy are all correctly left role-based, with the package flagging that resident and pharmacist can be named later only if file construction needs recurring provenance. That's the right restraint.

The four-way distinction the review asked about — authority hierarchy vs source-of-truth hierarchy vs friction participants vs trap participants — is preserved and, notably, the roster makes it legible: the same provider can occupy different roles in different structures (e.g., Vossmere is top of the authority hierarchy, the attending-documentation source, AND a friction participant), and the package keeps those roles distinct rather than conflating them. Pharmacy and Halvek are sources/trap-substrate but explicitly not friction participants — the cleanest expression of the trap-vs-friction line the project has produced.

Classification summary

True defects: none.
Physician-preference items: confirm the intended shared "Merrow" surname for patient and caregiver; decide later whether the resident/covering clinician is used; decide later whether pharmacy gets a named pharmacist.
Future-construction items: apply the same synthetic-name standard to any later additions; at file construction, use the role-based channels to keep Trap #3 (buried) and Trap #5 (visible-but-incomplete) instantiated as genuinely different document behaviors; ensure shared-surname note headers disambiguate.
Every gate classifies RESOLVED. No OPEN item, no BLOCKER. This is the cleanest package in the chain — and unlike the comorbidity package, it carries no cross-reference discrepancy (I checked the medication/comorbidity counts aren't restated here, so the 20/21 issue doesn't propagate into this artifact).

Would you ratify Provider Roster Package v1 today? YES. The roster covers every authority and source-of-truth rung with a named or role-based source, keeps all three frictions two-sided (with the explicit non-deferral guardrail that prevents the hospitalist from collapsing the consultant conflicts), preserves every trap including the #3/#5 distinction, introduces no new disease arc or friction, avoids over-naming, and uses clearly synthetic names with no real-person risk. There is no true defect and no blocker.

Provider Roster Package v1 Status: LOCK READY.

Same standing note: the provider cast and the naming choices are physician-owned, and the package correctly presents the roster as candidate architecture with the two optional-naming decisions (resident, pharmacist) and the implicit surname confirmation reserved for Alexander. From a review standpoint nothing blocks ratification — the only thing I'd want a yes/no on rather than a rubber stamp is the intended shared "Merrow" surname, purely so it's a deliberate choice on record before it reaches note headers.

Final Recommendation: GO.


surgical-history-package-v1.md
md

Independent ratification review of Surgical History Package v1.
Review-only.
Do not redesign the package. Do not create procedures. Do not create operative reports. Do not create procedure notes. Do not create files. Do not create tasks. Do not create prompts. Do not create expected outputs. Do not create goldens. Do not create grader guidance. Do not create World Spec content.
Review the package exactly as written.
Review goals:

Surgical-history architecture integrity
Compatibility with approved Brainstorm
Compatibility with Governance Package
Compatibility with Baseline Anchor Package
Compatibility with Clinical Story Timeline Package
Compatibility with Medication Expansion Package
Compatibility with Comorbidity Expansion Package
Compatibility with Provider Roster Package
Evaluate specifically:

Are all included procedures justified by approved architecture?
Is any included procedure unsupported?
Is any required procedure missing?
Does any procedure create a new disease arc?
Does any procedure answer an open clinical question?
Does any procedure weaken mixed physiology?
Does any procedure weaken the functional-decline story?
Does any procedure weaken the discharge-safety story?
Does any procedure weaken a friction?
Does any procedure weaken a trap?
Does any procedure create source-of-truth problems?
Does any procedure contradict the 20-medication architecture?
Does any procedure contradict the 14-condition architecture?
Special attention:

Remote PCI with coronary stent placement
Diagnostic sleep study confirming OSA
Exclusion of CABG
Exclusion of dialysis access
Exclusion of major orthopedic repair
Exclusion of amputation/major diabetic foot surgery
Exclusion of temporal artery biopsy
Exclusion of screening colonoscopy for v1
Review:

CAD compatibility
HFrEF compatibility
CKD3 compatibility
T2DM compatibility
PMR compatibility
Osteoporosis compatibility
OSA compatibility
Functional decline compatibility
Review trap compatibility:

Trap #1 Steroid Timeline / Source-of-Truth
Trap #2 HF/AKI Medication Reconciliation
Trap #3 Buried Functional / Cognitive Status
Trap #5 Discharge Source-Hierarchy
Mixed-physiology preservation
Reveal-drift prevention
Review friction compatibility:

Cardiology vs Nephrology
Family vs Primary Team
Endocrinology vs Primary Team
Review future-construction compatibility:

Daily Hospital Course Framework
File Inventory Architecture
World Spec Construction
Task Construction
Goldens
Grader Guidance
Required classifications:

RESOLVED
OPEN
BLOCKER
Also distinguish:

True defects
Physician-preference items
Future-construction items Conclude with: Would you ratify Surgical History Package v1 today? Answer: YES or NO Then provide: Surgical History Package v1 Status: LOCK READY or NOT LOCK READY Final Recommendation: GO or HOLD Do not propose redesign unless a true defect exists.
Show more
Jun 1
Independent ratification review of Surgical History Package v1. Review-only — no procedures, op-notes, files, or spec content created. For a surgical-history layer the distinctive checks are: does any included procedure contradict the locked condition/medication architecture, and — more subtly — does any procedure answer an open question (a surgical history is a sneaky place to accidentally resolve the steroid or cardiac story). The package also makes a set of exclusions, so the review has to check the exclusions are justified too, not just the inclusions. Let me read it.


Viewed 2 files, ran a command
Viewed 2 files, ran a command
Read in full. A surgical-history layer is the lowest-intrinsic-risk package in the chain — it adds two quiet procedures and excludes six — so the review is mostly confirming restraint rather than hunting for arcs. But two checks matter regardless of how quiet the package looks: whether either included procedure answers an open question, and whether the package's own cross-references to the locked counts are correct. I'll lead with the count issue since it's the one carry-forward.

The medication-count cross-reference — the propagated issue, now confirmed across three packages. This package repeatedly references "the 20-medication baseline architecture" (section 4 header, line 165; line 339; the review question). The Medication Expansion Package itself states 21. The Comorbidity Package said 20 (line 183 there). So we now have a 20-vs-21 discrepancy appearing in two downstream packages (comorbidity and surgical) against the source package's 21. This does not affect any clinical content in the surgical package — no medication is touched — but it confirms the discrepancy is propagating rather than isolated, which raises its priority slightly: every new package is inheriting "20" while the locked source says "21." OPEN (true defect, minor, now propagating) — reconcile the canonical count once, in the Medication Expansion Package, and correct the references in both the comorbidity and surgical packages so all three agree before any are treated as jointly locked. The likely root is whether the calcium/vitamin-D combination counts as one line or two; pick one and state it identically everywhere.

That is the only finding. Everything else is clean.

1. Surgical-history architecture integrity — RESOLVED. Two confirmed procedures (remote PCI with stent; diagnostic sleep study confirming OSA), zero presumed, six explicitly excluded with rationale. The "Presumed: None" stance is exactly right — the package states that no procedure should be invented merely for realism, which is the correct discipline for a layer that could easily accumulate low-yield chart noise.

2–8. Compatibility across all source packages — RESOLVED. Both procedures map to already-locked conditions: PCI ↔ CAD (and supports aspirin/atorvastatin/nitroglycerin and the cardiology-protective-therapy stance), sleep study ↔ OSA. Neither contradicts the 14-condition list, and neither requires a medication not already present. Governance, baseline anchors, timeline, and provider roster are all preserved (the package even maps provenance to roster sources — cardiology/PCP for PCI, sleep medicine/PCP for the study — without creating documents). No contradiction anywhere except the count reference noted above.

The specific included/excluded items:

Remote PCI with stent — justified. Gives CAD a concrete origin and reinforces why cardiology cares about not losing protective therapy at discharge. The guardrail (don't convert the admission into ACS or a post-procedural complication) is stated and correct.
Diagnostic sleep study confirming OSA — justified. Confirms a locked diagnosis without an acute procedural burden; correctly held as background functional-reserve context, explicitly not the cause of the AMS.
CABG excluded — correct. Would over-intensify the cardiac history; PCI is sufficient for the CAD/HFrEF stakes.
Dialysis access excluded — correct, and clinically important. This is the exclusion that most protects the world: dialysis-access history would imply ESRD/advanced CKD, contradicting the CKD3 baseline and inflating the nephrology stakes the AKI-on-CKD reasoning depends on. Right call.
Major orthopedic repair excluded — correct. Would create a competing single-cause mobility explanation and undercut the multi-factorial near-fall.
Amputation / major diabetic foot surgery excluded — correct. Would create a dominant functional-disability arc, contradicting the "independent but slowed" baseline.
Temporal artery biopsy excluded — correct, and subtle. This is the exclusion that protects the steroid design: a TAB would drag PMR toward giant-cell arteritis — a different, more specific rheumatologic arc not in the brainstorm — and could shift the steroid story away from the intended source-of-truth ambiguity. Excluding it keeps the steroid history document-driven, not procedure-driven. Good catch by the package.
Screening colonoscopy excluded for v1 — reasonable. Common for age 62 but supports none of the frictions/traps/medication logic; excluding it avoids low-yield noise. The package leaves it available as optional preventive-history texture later, which is the right disposition. Minor physician-preference item (some reviewers like a colonoscopy for age-realism; its absence is defensible and its presence would be harmless).
Required-procedure-missing check: No required procedure is missing. The one I checked specifically — given the locked anemia of CKD and ferrous sulfate — is whether any GI/endoscopic workup for anemia "should" exist; the answer is no, because anemia of CKD is adequately explained by the renal disease and doesn't require a procedural workup in this baseline. Nothing else in the architecture demands a procedure.

Trap compatibility — RESOLVED, all preserved, one strengthened. Trap #1 (steroid): no procedure reveals or reframes the steroid answer (TAB correctly excluded). Trap #2 (HF/AKI): PCI strengthens the credibility of chronic cardiac medication stakes without determining restart timing — strengthened-without-collapse, the ideal outcome. Trap #3 (buried functional): no mobility-limiting procedure added, so functional risk must still be found in nursing/PT/OT/family docs. Trap #5 (discharge source-hierarchy): no discharge artifact or shortcut created. The #3/#5 distinction is untouched and intact.

Reveal-drift — RESOLVED. This is the check that matters most for a surgical layer, and it passes cleanly: no procedure explains the near-fall, weakness, hypotension, AMS, AKI, steroid concern, or discharge risk by itself. The PCI is the only procedure with any pull toward a single cause (it could have tempted an "ischemic event" reading of the admission), and the package explicitly fences that off. Mixed physiology preserved.

Friction compatibility — RESOLVED. Cardiology vs Nephrology: PCI supports cardiology's perspective without making cardiology automatically correct or erasing nephrology's concerns (line 199) — the non-collapse guardrail again. Family vs Team and Endo vs Team: surgical history creates no new baseline explanation and doesn't touch the steroid friction. No friction weakened; none created.

Future-construction compatibility — preserved. No hospital-course events, no filenames/dates/Section-3 rows, no task concept, no goldens. The package correctly notes that file construction will later decide where the PCI and sleep-study histories are evidenced (admission history vs cardiology background vs PCP records) — which is the right deferral.

Classification summary

True defects: one — the 20-vs-21 medication-count cross-reference, now confirmed propagating into a second downstream package. Minor, documentation-consistency, fix at the source and correct both references.
Physician-preference items: confirm PCI and the sleep study should remain the only confirmed procedures; decide whether a screening colonoscopy is wanted for age-realism (harmless either way).
Future-construction items: decide at file construction where each procedural history is evidenced; preserve the reveal-drift restraint into the Daily Hospital Course Framework.
Gates: all RESOLVED except the medication-count cross-reference, OPEN (minor true defect, propagating). No BLOCKER.

Would you ratify Surgical History Package v1 today? On clinical content, yes — but I'd reconcile the count first, and this time I'd treat it as a chain-level fix rather than a one-package note, because the discrepancy has now appeared in two downstream packages (comorbidity and surgical) while the source package says 21. The surgical architecture itself is excellent: two well-justified quiet procedures, six correctly-reasoned exclusions (with the dialysis-access and temporal-artery-biopsy exclusions doing real protective work for the CKD3 baseline and the steroid design), every trap and friction preserved, reveal-drift cleanly controlled, and no new disease arc. There is no clinical defect and no blocker.

Surgical History Package v1 Status: LOCK READY — conditional on reconciling the propagating 20/21 medication-count reference at its source (Medication Expansion Package) and correcting the references here and in the Comorbidity Package so all three state the identical number. On clinical content alone it is lock-ready; I'm holding the unconditional stamp for that one cross-package number, and flagging that it's now a two-package propagation rather than an isolated typo — worth fixing once, canonically, before the count reaches the file plan where 2.57/2.59 consistency is enforced hard.

Same standing note: procedure selection is physician-owned, and the package correctly presents PCI and the sleep study as candidates with the exclusions reserved for Alexander's confirmation. From a review standpoint nothing clinical blocks ratification.

Final Recommendation: GO — with the medication-count reconciliation completed as a chain-level consistency fix (not just a surgical-package edit) and Alexander's confirmation of the two procedures.


medication-expansion-package-v1.md
md

medication already fixed , 20 baseline medications

Jun 1

Check the updated medication count and how the calcium/vitamin D and cholecalciferol items are now reconciled
Check the updated medication count and how the calcium/vitamin D and cholecalciferol items are now reconciled
Confirmed — the count is reconciled, and the fix is cleaner than a renumber. Line 364 shows how you got to 20: insulin lispro was removed from baseline and reserved as a future inpatient-only candidate. That's exactly the Q2 call I flagged as the one real decision in that package, and you took the lean I recommended — which also means the cross-package discrepancy and the lispro question are both closed by the same edit.

So the chain now reads consistently: Medication Expansion says 20 baseline (line 40, line 114, line 402), and the comorbidity and surgical packages' "20-medication" references are now correct rather than ahead of the source.

Two small things worth noting, both already handled in the file but worth saying for the record:

The clinical rationale is sound. With insulin lispro out of baseline, the home regimen now matches the locked A1c (7.6–8.2 on basal glargine + metformin, no chronic prandial insulin) — which is the more realistic baseline. And reserving lispro for inpatient leaves the steroid-induced-hyperglycemia thread available to be constructed during the hospital course rather than pre-empted, which is the stronger design.

The calcium/vitamin-D items are unchanged (line 101 combo + line 102 separate cholecalciferol both still present), so the route to 20 was the lispro removal, not collapsing the vitamin-D lines. That's worth keeping straight, because it means the supplement-vs-medication reconciliation complexity you deliberately built (combo + standalone D3) is intact — the count came down by dropping a prandial insulin, not by simplifying the bone-health supplements.

With that, the conditional holds on the comorbidity and surgical packages are released:

Medication Expansion Package v1 — 20 baseline, lispro reserved inpatient. LOCK READY, count reconciled.
Comorbidity Expansion Package v1 — its "20-medication" reference is now correct against the source. The conditional I placed (reconcile 20/21) is satisfied; clears to LOCK READY on clinical content, pending only Alexander's confirmation of the three secondary conditions.
Surgical History Package v1 — same: its "20-medication" references now match. Conditional satisfied; LOCK READY on clinical content, pending Alexander's confirmation of the two procedures.
No defects remain open across the medication/comorbidity/surgical layer. The only carry-forward from this stretch that isn't a documentation item is the construction-time note: since lispro is now reserved for inpatient, make sure the hospital-course phase actually builds the steroid-hyperglycemia / inpatient-insulin thread, so that reservation gets used rather than forgotten.

Where that leaves the overall build: the full construction-prep chain — identity, temporal/calendar, story skeleton, governance, baseline anchors, timeline, task architecture, medication, comorbidity, provider roster, surgical history — is now reviewed and lock-ready, with the physician confirmations (the secondary conditions, the two procedures, the roster surname) being the remaining human sign-offs rather than anything blocking.

Still preparation-only — no World Spec prose drafted. By the kickoff sequence, the next phase after these locks is the Daily Hospital Course Framework, and then the World Spec proper (Patient Profile, Clinical Complexity Overview, the Key Milestones table, Failure Design tables, the file plan with the 8-column Source/Tool structure, and the tasks). Ready for whichever you want to take next.


daily-hospital-course-framework-v1.md
md

Independent ratification review of Daily Hospital Course Framework v1.
Review-only.
Do not redesign the framework.
Do not create labs, vitals, notes, files, tasks, prompts, expected outputs, goldens, grader guidance, synthetic documents, or World Spec prose.
Focus on whether the framework is architecturally sound and ready to become the canonical HD1-HD6 evolution model.
Review objectives:

Daily progression realism
Is HD1→HD6 believable for this type of hospitalization?
Does anything activate too early or too late?
Does the progression preserve "improving but not safely solved"?
Timeline consistency
Verify consistency with:
Locked Calendar Skeleton
Locked Clinical Story Timeline Package
Locked Baseline Anchor Package
Locked Medication Expansion Package
Locked Comorbidity Expansion Package
Locked Provider Roster Package
Locked Surgical History Package
Friction architecture
Cardiology vs Nephrology
Family vs Primary Team
Endocrinology vs Primary Team Verify:

activation timing
peak timing
world-close status

Trap architecture
Review:

Trap #1 Prednisone Source-of-Truth
Trap #2 HF/AKI Medication Reconciliation
Trap #3 Buried Functional/Cognitive Status
Trap #4 Sepsis Anchoring After Partial Improvement
Trap #5 Discharge Source-Hierarchy
Verify:

establishment phase
reinforcement phase
world-close status
Special attention:

Trap #3 vs Trap #5 distinction
mixed-physiology preservation
no hidden single answer
no reveal-drift

Provider involvement timeline
Verify:

Hospitalist
Cardiology
Nephrology
Endocrinology
PCP
Rheumatology
Nursing
PT/OT
Case Management
Social Work
Pharmacy
Family
Confirm:

appropriate timing
appropriate role scope
PCP and Rheumatology remain provenance sources rather than inpatient actors

Disposition-safety architecture
Verify:

discharge becomes reasonable
discharge remains risky
family remains defensible
primary team remains defensible
Neither side should become obviously correct.

Future task compatibility
Verify support for:

Discharge Medication Reconciliation
Hospital Discharge Summary Generation
Discharge Planning Documentation
Interdisciplinary Care Plan Development and Documentation
Without requiring redesign.

Preparation-layer completion review
Assuming ratification:
Would this complete the preparation layer and authorize transition into World Spec construction?
Classify findings:

RESOLVED
OPEN
BLOCKER
Distinguish:

true defects
physician-preference items
future-construction items End with: Daily Hospital Course Framework v1 Status: LOCK READY or NOT LOCK READY Would you ratify today? YES or NO Final Recommendation: GO or NO GO
Show more
Jun 1
Independent ratification review of Daily Hospital Course Framework v1. Review-only — no labs, vitals, notes, files, or spec prose created. This is the capstone of the preparation layer: it's where the locked story timeline becomes the canonical day-by-day evolution model that the file plan and tasks will hang off. The substantive checks are whether the day-by-day clinical trajectory is realistic (not just labeled), whether activation/peak timing of frictions and traps matches the locked timeline package, and — the one that matters most at this stage — whether the framework holds the line on "improving but not safely solved" without any single day resolving the case. Let me read it.


Viewed 2 files, ran a command
Viewed 2 files, ran a command
Read in full. This is the most consequential preparation artifact because every synthetic file and every task will inherit its day-by-day logic, so I checked three things hard: clinical realism of the trajectory (not just the labels), exact alignment of friction/trap activation against the locked Clinical Story Timeline Package, and — the capstone-specific risk — whether the framework holds "improving but not safely solved" on every single day without one day quietly resolving the case.

Trajectory realism — RESOLVED. The HD1→HD6 arc is clinically believable for this hospitalization type, and critically each day's clinical state (not just its label) follows from the prior. HD1 stabilization → HD2 early treatment response with consultants justified → HD3 functional/cognitive concerns surfacing as acuity drops → HD4 consultant tensions and steroid-source problems explicit → HD5 disposition dominant → HD6 improved-but-dangerous close. The pacing is right: nothing activates too early (consultants don't appear day 1; PT/OT functional concerns wait for HD3 when acuity has dropped enough to make function visible; case management/social work correctly wait for HD5 when disposition is live) and nothing too late (steroid-source recognition by HD2–HD4, not deferred to discharge). The one item the package itself flags as refinable — HD4 as the consultant-conflict peak — I'd affirm as correct, not just plausible: HD4 sits after stabilization and before disposition dominates, which is exactly when competing reasonable recommendations collide in a real hospital course. Physician may refine, but it needs no change.

The "improving but not safely solved" check — RESOLVED, and this is the framework's strongest property. Every single day's "Disposition readiness status" column holds the tension: HD1–HD4 "not discharge ready," HD5 "possibly approaching but not safely solved," HD6 "may be defensible but safe discharge is not automatic." No day flips to "ready." The Improvement Trajectory section (the "genuinely improves" vs "remains concerning" split) reinforces this — real improvement is conceded (so the case isn't rigged toward obvious non-discharge) while residual concern persists (so it isn't rigged toward obvious discharge). That dual concession is what keeps the disposition friction live, and it's maintained cleanly across all six days.

Timeline consistency against the locked packages — RESOLVED across all seven. The HD-by-HD beats match the locked Clinical Story Timeline Package exactly (HD2 consultants begin, HD3 PT/OT, HD4 tensions + steroid inconsistency, HD5 disposition pivot, HD6 close) — this framework is a faithful expansion of the locked timeline, not a divergence. The Locked Temporal Frame (lines 65–74) reproduces the calendar skeleton's dates and the discharge-anchored +7/+30 convention correctly. Baseline anchors stay comparators (not converted to hospital-day values). And the medication consistency is now clean: line 423 explicitly reserves "inpatient glycemic-management" construction for later — which is precisely the home for the insulin lispro you just moved out of baseline. That reservation confirms the lispro decision propagated correctly into this framework: lispro-as-inpatient now has an explicit construction hook here, so it won't be forgotten. The 20-medication architecture is referenced consistently (no recurrence of the 20/21 discrepancy — I checked; this package doesn't restate a count, it references the architecture). Comorbidity, provider roster, and surgical history all map without contradiction (PCI and sleep study stay remote background; no new arc).

Friction architecture — RESOLVED. Activation, peak, and world-close status are all specified and clinically sensible:

Cardiology vs Nephrology: seeded HD1, active HD2 onward, runs through the final medication plan; world-close = still active. Correct.
Family vs Primary Team: latent HD1–HD3 (family supplies baseline), activates HD5 when disposition dominates, peaks HD5–HD6; world-close = active, both sides defensible. This is the right staging — it doesn't activate before there's a discharge decision to disagree about.
Endocrinology vs Primary Team: seeded by PMR/steroid history, active HD2–HD4, peaks at the steroid-risk decision; world-close = "relevant but not dominant," with the explicit guardrail that the world must not become a hidden adrenal-insufficiency case.
All three carry both-sides-defensible language at close. No friction collapses to an obvious correct side, and none activates as a documentation conflict (Endo stays a risk-interpretation friction, not "vs documentation").

Trap architecture — RESOLVED, with the #3/#5 distinction explicitly preserved. Establishment and reinforcement phases are specified per trap and align with the activation logic: Trap #1 (pre-admission→HD1 establish, HD2–HD4 reinforce), Trap #2 (HD1–HD2 establish, HD3–HD5 reinforce), Trap #3 (pre-admission→HD3 establish, HD3–HD6 reinforce), Trap #4 (HD1 establish, HD2–HD5 reinforce), Trap #5 (HD5 establish, HD5–HD6 reinforce). The Trap #3 vs Trap #5 distinction — the watch-item I've tracked since the brainstorm — is stated cleanly twice (lines 272–277 and the HD5/HD6 rows): #3 = did the clinician find the buried evidence; #5 = did the clinician recognize a reassuring discharge artifact is incomplete and reconcile it. The framework also correctly establishes #5 at HD5 (when a discharge-facing artifact first exists) rather than earlier, which is what keeps it from merging into #3. This is the cleanest the distinction has been rendered in the chain.

Reveal-drift and mixed physiology — RESOLVED. The capstone risk for a day-by-day model is that some day quietly names the answer; it doesn't. Every day's "what remains concerning" keeps multiple contributors live, the HD6 row states "no trap is resolved by one document or one diagnosis," and the steroid thread carries its non-reveal guardrail at world-close. No single day resolves the near-fall, the weakness, the hypotension, or the AMS to one cause. Mixed physiology intact across all six days.

Provider involvement timeline — RESOLVED. Timing and role scope are appropriate: hospitalist HD1–HD6 (synthesis/ownership), cardiology/nephrology HD2–HD6, endocrinology HD2–HD6 strongest HD4–HD6, nursing HD1–HD6, PT/OT HD3–HD6, case management/social work HD5–HD6, pharmacy HD1–HD6 strongest HD4–HD6. Critically, the requested check passes: PCP and rheumatology are explicitly held as provenance sources, not inpatient actors (lines 287–288, "not an inpatient decision-maker" / "not an inpatient friction participant unless later explicitly created"). This preserves the prednisone hierarchy (rheumatology as top history source) without letting rheumatology become a live inpatient friction party — exactly right.

Disposition-safety architecture — RESOLVED. The framework dedicates a full section to why discharge becomes reasonable AND why it remains risky, and separately why family is defensible AND why the primary team is defensible, closing with "neither side should be obviously correct." This is the ratified balance instantiated at the day level, and it's symmetric — the team's defensibility (improvement is real; continued hospitalization has its own risks) is given as much weight as the family's (longitudinal baseline knowledge; numbers ≠ home safety). Neither side is stacked.

Future task compatibility — RESOLVED. All four locked workflows are supported by the framework's reasoning channels (med rec, discharge summary, discharge planning, interdisciplinary care plan), and the framework correctly creates no prompts/inputs/outputs/goldens. Post-world task anchoring is preserved (tasks occur after the HD6 18:00 close).

Classification summary

True defects: none. (And notably, no recurrence of the medication-count issue — the lispro fix propagated correctly, with an explicit inpatient-glycemic construction hook at line 423.)
Physician-preference items: HD4 consultant-conflict peak timing and HD5 Trap #5 establishment (both flagged by the package as refinable; both are correct as written, so refinement is optional).
Future-construction items: at file construction, instantiate Trap #3 (buried-but-present) and Trap #5 (visible-but-incomplete) as genuinely different document behaviors; build the inpatient insulin/steroid-hyperglycemia thread so the reserved lispro is actually used; keep both sides of each friction defensible when notes are authored.
Every gate classifies RESOLVED. No OPEN item, no BLOCKER.

Preparation-layer completion review. This is the last architecture/preparation artifact in the kickoff sequence. With it ratified, the full preparation layer is complete: identity, temporal/calendar, story skeleton, governance, baseline anchors, story timeline, task architecture, medication, comorbidity, provider roster, surgical history, and now the daily hospital course framework. There is no remaining preparation artifact between this and World Spec construction. So yes — assuming ratification (and the physician confirmations still pending on the secondary conditions, the two procedures, and the roster surname), this completes the preparation layer and authorizes transition into World Spec construction. The next phase would be the spec proper: Patient Profile, Clinical Complexity Overview, the Key Milestones table, Failure Design tables, the Section 3 file plan (where the 8-column Source/Tool structure and the fact-to-file traceability discipline land), and the tasks.

Daily Hospital Course Framework v1 Status: LOCK READY. No defect, no internal inconsistency, faithful expansion of the locked timeline, all frictions and traps correctly staged with the #3/#5 distinction preserved, mixed physiology and reveal-drift controlled across every day, and the disposition balance symmetric. The lispro decision is confirmed propagated with a construction hook.

Would you ratify today? YES — from a review standpoint. Same standing note: the day-by-day clinical evolution is physician-originated, and the package correctly presents itself as candidate with the two timing refinements reserved for Alexander. From an independent-review standpoint nothing blocks ratification; the HD4/HD5 timing items are affirm-or-refine choices, not defects.

Final Recommendation: GO — into World Spec construction, with the standing physician confirmations (secondary conditions, two procedures, roster surname) carried forward as sign-offs and the construction-time note that the reserved inpatient insulin/steroid-hyperglycemia thread must actually be built so the lispro reservation is used.


world-spec-skeleton-v1.md
md


Independent ratification review of World Spec Skeleton v1. Review-only. Do not redesign the skeleton. Do not create World Spec prose. Do not create file inventory rows. Do not create synthetic files. Do not create tasks. Do not create prompts. Do not create expected outputs.

pasted

Independent ratification review of World Spec Skeleton v1. as pasted.

Jun 1
Independent ratification review of World Spec Skeleton v1. Review-only — no prose, file rows, tasks, or downstream artifacts created. This is the bridge artifact: it maps the locked preparation layer onto the official template structure. The substantive checks are whether it aligns to the actual template I have on disk (Sections 1–4), whether every locked package has a non-duplicated home, and whether it stays inside the skeleton phase. Let me read it, then re-confirm the template structure rather than trusting memory.


Viewed 2 files, ran a command
Viewed 2 files, ran a command
Read in full, including the truncated mapping and boundary tables. The substantive check for a skeleton is template fidelity and package coverage, and I verified the section structure against the actual template on disk rather than memory.

Template fidelity — verified against the on-disk template, RESOLVED with one note. The skeleton's four canonical sections (Clinical Scenario, Task Specifications, World File Plan, World Summary) match the World_Spec_Template_05_06.docx structure I read earlier. The Section 1 subsection anchors (1.1 Big Picture, 1.2 Patient Profile, 1.3 Clinical History and Context, 1.4 Key Milestones, 1.5 Clinical Complexity Overview) and the Section 3 split (3.1 world-level essential, 3.2 task-level essential, 3.3 supplementary, total count) align with the template. No section is missing, none conflicts, and the skeleton explicitly subordinates itself to the official template ("a construction skeleton for mapping... not a replacement template," line 26) — which correctly heads off the 2.101 Section-D/E risk and the "no extra top-level sections" check (line 244 addresses this directly).

The one note I'll carry, not a defect: the skeleton references the template at World_Spec_Template_05_06.docx. That's the 05/06 revision — the same one whose file-plan table is 7 columns where AutoQC v6.3 (revised 05/23) requires 8 (the Source/Tool split I flagged at the very start of this engagement). The skeleton's Section 3 boundary correctly defers actual file rows, so nothing is wrong here — but when Section 3 is built, it must follow the v6.3 8-column structure, not the 05/06 template's 7-column layout. The skeleton's line 119 boundary doesn't yet name the column count, and line 304's "use official DOCX template" instruction is the exact place that could propagate the 7-column error. OPEN (future-construction watch-item, not a skeleton defect) — confirm Section 3 inherits the v6.3 column set, and confirm with the Team Lead which template revision is canonical.

Objective 1 — Template compatibility — RESOLVED (with the 8-column watch-item above carried to construction). Maps cleanly onto the four-section template; final spec will fit.

Objective 2 — Locked package coverage — RESOLVED. I checked each of the thirteen locked artifacts for a home: every one is sourced to at least one section in the §1/§2 mapping tables and the §2 section-to-source table. None is orphaned. The cross-check that matters — does any section source from the wrong package — passes: identity/baseline/comorbidity feed Patient Profile; calendar/timeline feed Key Milestones; daily framework feeds HD1–HD6 course; governance feeds frictions + hierarchies; brainstorm feeds traps; task architecture feeds Section 2. No package is duplicated unnecessarily — where a package appears in multiple rows (governance, daily framework), it's because that package legitimately feeds multiple sections, which is correct, not redundant. And the medication reference now reads "20-medication baseline architecture" (line 147), consistent with the reconciled count — the lispro fix propagated here too.

Objective 3 — Traceability architecture — RESOLVED. Every major world fact traces to a locked package via the §2 mapping. Source-of-truth, governance hierarchy, prednisone hierarchy, timeline, frictions, and traps each have an explicit source assignment and a "preserve" construction note. Critically, nothing reopens a locked decision — the construction notes are uniformly "use," "do not reopen," "do not create new," which protects provenance discipline rather than re-deriving. The prednisone hierarchy is correctly sourced to Governance + Clinical Story Skeleton Ratification and assigned to both Section 1 (stated) and later Section 3 (enforced) — the two-touch placement that makes authority traps usable.

Objective 4 — Boundary discipline — RESOLVED, and this is the skeleton's strongest feature. The phase gate holds cleanly. Section 2 maps task architecture but creates no prompts/outputs/failure tables/grader content (line 98). Section 3 maps structure but creates no file rows/filenames/dates/IDs/source-tool entries (line 119). Section 4 creates no final summary (line 135). The Boundary Classification table (§3) is genuinely useful discipline — it pre-assigns, for each element, what belongs in the spec vs. file inventory vs. synthetic files vs. tasks vs. prompts vs. goldens, which is exactly the separation that prevents downstream leakage. On the specific question — the deferred file inventory decision is correct. The DISPUTED row (lines 346–354) explicitly resists starting file rows now, on the playbook ground that file planning follows task design; starting files now would risk reverse-engineering them before task requirements stabilize. That's the right call and it aligns with the AutoQC's file-after-task discipline.

Objective 5 — Studio alignment — RESOLVED, with one honest flag. The skeleton supports all six task concepts across four workflows, reserves Section 2 for them, keeps reference/template files separate for later upload handling, and preserves the AutoQC-validation-comes-later sequence. The flag is the transcript item (lines 212–220): the skeleton lists "Claude transcript requirements" as later submission work and points to internal guideline files (11_transcript_requirements.md, 13_claude_workflow_audit.md). Those are documents I haven't seen — and recall that when you asked me to ground the transcript question against source-of-truth earlier, the transcript requirement was NOT FOUND in any material I hold. So this row is internally consistent (it correctly defers transcripts and doesn't fabricate them) but it references a requirement whose definition still lives outside my evidence base. Not a skeleton defect — the deferral is the right posture — but the transcript requirement itself remains unverified against canonical source, and that's a submission-packaging item to pin down before upload, exactly as the row says.

Objective 6 — AutoQC readiness — RESOLVED at the structural level. The skeleton's §5 readiness table honestly distinguishes what's locked (VERIFIED: temporal, source-of-truth, workflow-count, administrative deliverable, no-section-drift, no-premature-artifacts) from what can't be confirmed until later (PLAUSIBLE: task solvability, file traceability, no-orphan-dates, no-post-world-files — all correctly flagged as un-verifiable until Sections 2/3 exist). This is the right calibration: it claims no premature AutoQC pass (line 224–230 explicitly states it does not run or simulate AutoQC). The administrative-deliverable row still carries the 2.108 bet (Discharge Planning Documentation / Care Coordination), which remains the documented-bet-with-fallback from task-architecture review — unchanged, correctly preserved, not newly resolved.

Objective 7 — Construction readiness — RESOLVED. If ratified, World Spec prose construction can begin. No additional preparation-layer artifact is required — the daily framework was the last one, and this skeleton confirms the full chain (thirteen locked packages) has a structural home. There is no missing architectural package. The recommended construction plan (§6: skeleton → spec prose → review → lock → file inventory → synthetic files → tasks → prompts → outputs → goldens → grader → AutoQC/packaging) is sound phase discipline and correctly orders file-inventory after spec lock and task design.

Classification summary

True defects: none.
Physician-preference items: several mapping rows offer "1.2 or 1.3" / "1.2 or 1.5" placement choices (e.g., Baseline Clinical State, Comorbidity Profile, Medication Architecture) — these are legitimate drafting-time placement decisions, not defects; the skeleton appropriately leaves them open rather than forcing them.
Future-construction items: (1) Section 3 must use the v6.3 8-column file-plan structure (Source + Tool split), not the 05/06 template's 7 columns — the single most important carry-forward, since it's a guaranteed-return AutoQC item if missed; (2) confirm the canonical template revision with the Team Lead; (3) pin down the transcript requirement against canonical source before submission packaging; (4) the standing 2.108 administrative-deliverable bet, with utilization review as the named fallback if challenged; (5) the standing physician confirmations (secondary conditions, two procedures, roster surname).
Every objective classifies RESOLVED, with the 8-column file-plan structure as the one OPEN future-construction watch-item that I'd make sure is written into the construction plan now so it isn't discovered at AutoQC.

Would you ratify World Spec Skeleton v1 today? YES. It maps cleanly onto the official four-section template, gives every one of the thirteen locked packages a non-duplicated home, preserves traceability/hierarchy/timeline/friction/trap discipline without reopening any locked decision, holds the phase boundary rigorously (file inventory correctly deferred), and honestly calibrates what AutoQC can and can't yet verify. There is no true defect and no blocker.

World Spec Skeleton v1 Status: LOCK READY.

Final Recommendation: GO.

Does ratifying World Spec Skeleton v1 authorize immediate World Spec prose construction? NO — not automatically. Two reasons, and the distinction matters. First, procedurally: throughout this engagement the standing rule has been that ratifying an artifact confirms readiness, but the next phase begins only when you explicitly start it — and the skeleton itself encodes this (line 262: "does not authorize downstream artifacts before Alexander explicitly starts each step"). Ratification clears the path; it doesn't step onto it. Second, substantively: World Spec prose is the first phase that produces actual spec content — Patient Profile prose, the Key Milestones table, the Clinical Complexity Overview — and that's authored content, not review output. So ratifying the skeleton means "the structure is correct and construction may begin"; the prose construction itself is a separate, explicitly-authorized step, and when it starts, the one thing to carry in from this review is that Section 3's file plan must follow the v6.3 8-column structure rather than the 05/06 template's 7 columns.


world-spec-v1.md
md


Independent ratification review of World Spec v1. Review-only. Do not redesign the World Spec. Do not create file inventory rows. Do not create synthetic files. Do not create tasks. Do not create task prompts. Do not create expected outputs. Do not create goldens. Do not c

pasted

Independent ratification review of World Spec v1. as pasted

Jun 1
Independent ratification review of World Spec v1. Review-only — no file rows, synthetic files, tasks, prompts, outputs, goldens, grader content, or new architecture created. This is the first artifact that is actual spec content rather than preparation, so the review is the most demanding yet: I'm checking faithful implementation of all thirteen locked packages plus the skeleton, and — most importantly — that the act of writing prose didn't silently alter, omit, or reintroduce anything the locks settled. Let me read it.


Viewed 2 files, ran a command
Viewed 2 files, ran a command
Read in full, both passes. I cross-checked every locked value against the source packages — identity fields, the 14 conditions, the 20 medications by name, the provider roster, the three hierarchies verbatim, and all eleven calendar dates — rather than trusting the spec's own VERIFIED rows. This is the densest fidelity check in the chain, so I'll report what I verified, then the findings.

Verbatim fidelity spot-checks (the ones that catch silent drift):

Identity block (lines 44–53) matches Identity Package v1 field-for-field, including MRN KM-6427819, BMI 30.6, and "Lisinopril (cough)" relabeled as "Allergy / intolerance" — which correctly implements the addendum's ACE-intolerance carry-forward.
20 medications (lines 88–95): I counted by name against the reconciled Medication Expansion list — aspirin, atorvastatin, nitroglycerin, sacubitril/valsartan, carvedilol, furosemide, spironolactone, empagliflozin, ferrous sulfate, metformin ER, insulin glargine, gabapentin, acetaminophen, prednisone, pantoprazole, PEG, senna, alendronate, calcium/vit-D combo, cholecalciferol = 20. Insulin lispro is explicitly excluded from baseline and reserved as inpatient-only (line 97) — the lispro decision propagated correctly and is stated in the exact form the fix specified.
14 conditions (lines 65–78) match the comorbidity package, including the three secondary additions, with osteoporosis carrying "does not prove current adrenal suppression" (line 75) — the governance osteoporosis/adrenal distinction preserved verbatim.
Three hierarchies (lines 146–171) reproduce the Governance Package's authority hierarchy, master source-of-truth hierarchy (with PCP at rung 5), and prednisone-specific hierarchy (rheumatology at rung 1) exactly, with the non-deferral governance rule (line 173).
Eleven calendar dates (lines 181–193) match the locked calendar skeleton, including the "+7/+30 from discharge, not world close" annotations on the correct rows.
Provider roster (lines 128–144) matches, including the seven synthetic names and Mara Merrow's intended shared surname.
Now the objectives.

Objective 1 — Locked-artifact fidelity — RESOLVED. No locked decision altered, no locked fact omitted that the spec scope requires, no new architecture introduced, and — the reintroduction check — nothing previously excluded is back: insulin lispro stays out of baseline, the six excluded procedures stay excluded (the spec keeps only the remote PCI and sleep study), and no rare-disease element appears. Every section maps to a locked source.

Objective 2 — Timeline integrity — RESOLVED. All six required anchors are exact; no drift, no contradiction, no post-world leakage (the spec explicitly states the +30 anchor "without creating a new post-discharge event inside this World Spec candidate," line 243), and the Key Milestones table is internally consistent. The discharge-anchored +7/+30 convention is preserved with the annotations.

Objective 3 — Clinical architecture integrity — RESOLVED. 14 conditions (no unsupported, none missing), 20 medications (consistent, lispro correctly excluded), procedural history quiet and correct, baseline anchors carried as ranges with the explicit "baseline only, not admission values" guard (line 57), functional and cognitive baselines intact. No drift on any anchor.

Objective 4 — Governance & source-of-truth integrity — RESOLVED. All three hierarchies reproduced exactly; no source authority changed (rheumatology remains top prednisone-history source, endocrinology remains an interpreter not a history source); the governance non-deferral rule is stated, preserving provenance discipline. This is faithful to the letter.

Objective 5 — Friction architecture — RESOLVED. All three frictions render with both sides explicitly defensible (the spec gives each a "defensible because…" pair and a "the judgment is not who's right" close). None one-sided, none collapsed, none new. Endo-vs-Primary-Team correctly states "the steroid-record discrepancy is a trap, not a friction participant" (line 269) — the relabel that the project was sent back toward earlier is held.

Objective 6 — Trap architecture — RESOLVED. All five traps stated; the #3 vs #5 distinction is explicit and correct (lines 285–301): #3 = did the clinician find buried evidence; #5 = after seeing a reassuring artifact, did the clinician recognize it's incomplete. No reveal-drift — Trap #1 explicitly says "avoids making adrenal insufficiency the hidden answer" (line 277) and Trap #4 names premature closure as the failure. No hidden-answer drift, no collapse.

Objective 7 — Mixed physiology preservation — RESOLVED. All eight requested contributors remain active (lines 80, 197, 407); the near-fall is stated multi-factorial with all seven contributors (line 197). The spec explicitly resists each single-answer drift: not sepsis-only (line 36, 295), not adrenal (line 277, 329), not medication-error-only (the HF/AKI trap frames opposite failure modes, line 283). The world has not drifted toward any single answer.

Objective 8 — Task support readiness — RESOLVED. All four locked workflows are supported, with the six rough concepts mapped (line 307–314) and the four authoritative workflows listed (line 318–321). TCM and readmission stay embedded in Discharge Planning Documentation (line 323), preserving the 2.107 resolution. The administrative deliverable is carried by Discharge Planning Documentation (line 323) — the documented 2.108 bet, unchanged. No workflow under-supported or over-constrained.

Objective 9 — Future file-construction readiness — RESOLVED. There is enough world detail (daily course, hierarchies, provider sources, trap substrates, baseline anchors) to begin file inventory after lock, and I see no gap that would force major restructuring. The spec correctly defers file rows. One forward note carried below (the 8-column structure), but that's a Section-3 construction concern, not a spec-content gap.

Objective 10 — Studio readiness — RESOLVED structurally, with the standing carry-forwards. The spec follows the four-section template, supports future task construction, and claims no premature AutoQC pass. The carry-forwards from prior reviews are unchanged and remain future items: the v6.3 8-column file-plan structure for Section 3, the 2.108 bet with utilization-review fallback, and the transcript requirement still unverified against canonical source.

One observation worth stating precisely — not a defect, a scope note on the word "complete." The review prompt asks whether this is a "complete" implementation. It's a complete and faithful implementation of Sections 1, 2-mapping, and 4 at the spec-architecture level — but by design it does not yet contain the Section 2 task specifications (prompts, expected outputs, Failure Design tables) or the Section 3 file inventory rows. The spec is explicit and correct about this (lines 305, the Section-3 deferral). So "World Spec v1" here is faithfully the narrative/architecture spec that precedes task-spec drafting and file planning — which matches the skeleton's construction plan (spec prose → lock → file inventory → tasks). I'm flagging it only so "LOCK READY" isn't misread as "the entire World Spec including tasks and files is done." It's the correct artifact for this phase; it's just important that the lock is understood as locking the world architecture, with task specs and file plan as the explicitly-sequenced next phases.

Classification summary

True defects: none. Every locked value I cross-checked matches its source package; no drift, no omission, no reintroduction.
Physician-preference items: the few "1.2 or 1.3" placement choices the skeleton left open are now resolved into specific placements in the prose — all clinically sensible; none is a defect. The standing physician sign-offs (secondary conditions, two procedures, roster surname) remain confirmations, and the spec correctly routes itself to "physician and reviewer-style audit before lock" (line 441).
Future-construction items: (1) Section 3 file plan must use the v6.3 8-column structure (Source/Tool split), not the 05/06 template's 7 columns — the single most important carry-forward; (2) the 2.108 administrative-deliverable bet, utilization review as fallback; (3) transcript requirement to be pinned against canonical source before submission; (4) at file construction, instantiate Trap #3 (buried-but-present) and Trap #5 (visible-but-incomplete) as genuinely different document behaviors; (5) build the reserved inpatient insulin/steroid-hyperglycemia thread so lispro is used.
Every objective classifies RESOLVED. No OPEN item internal to the spec; no BLOCKER.

Would you ratify World Spec v1 today? YES. It is a faithful, traceable implementation of all thirteen locked packages and the skeleton: every identity value, all 14 conditions, all 20 medications, the three hierarchies, all eleven dates, the provider roster, both procedures, all three frictions, and all five traps are reproduced consistent with their locked sources, with mixed physiology and the disposition-safety target preserved and no reveal-drift. There is no true defect and no internal inconsistency.

World Spec v1 Status: LOCK READY — understood as locking the world architecture/narrative spec, with Section 2 task specifications and the Section 3 file inventory as the explicitly-sequenced next phases (not omissions).

Final Recommendation: GO.

If ratified, does World Spec v1 authorize File Inventory Architecture construction? NO — not as the immediate next step, and not automatically. Two reasons. First, the standing procedural rule holds: ratification confirms readiness, but each downstream phase begins only when you explicitly start it. Second, and more specific to this artifact: both the skeleton's construction plan (§6) and the official playbook sequence task design before file inventory — file planning follows stable task specifications so files aren't reverse-engineered before task requirements exist. World Spec v1 deliberately defers Section 2 task specs. So the correct next phase after locking this spec is Section 2 task specification construction, and File Inventory Architecture comes after that. Ratifying World Spec v1 authorizes neither automatically — it clears the path to the task-specification phase, which is itself a separate, explicitly-authorized step, and when Section 3 is eventually built it must follow the v6.3 8-column file-plan structure.


file-inventory-architecture-v1.md
md


Independent ratification review of File Inventory Architecture v1. Review-only. Do not redesign the file architecture. Do not create file inventory rows. Do not create filenames. Do not create synthetic files. Do not create notes. Do not create labs. Do not create vitals.

pasted

Independent ratification review of File Inventory Architecture v1.
as pasted

Jun 1
Independent ratification review of File Inventory Architecture v1. Review-only — no file rows, filenames, synthetic files, or downstream content created. This is the artifact that plans the document ecosystem the whole world hangs on, so the substantive checks are: does every world fact and trap have a plausible document home, does the world-level boundary hold against the 05/23 18:00 close, and is the architecture compatible with the v6.3 file-plan checks (the 8-column Source/Tool structure, the ~90/10 essential/supplementary split, the ≥20 / ≥4-modality bars). Let me read it.


Viewed 3 files, ran a command
Viewed 3 files, ran a command
Read in full. For a file-ecosystem plan the decisive checks are: does every trap and friction have a distinct document substrate, does the world-level boundary hold against the close, and is the plan compatible with the v6.3 file-plan checks. I worked each against the matrices rather than the summary rows, and I built a quick trap→file and hierarchy→file coverage check by hand.

Trap-to-file coverage — built and verified, RESOLVED. I checked each trap against the world-level architecture (§2) and the coverage matrix (§4) to confirm multi-document substrate and no single-file resolution:

Trap #1 (prednisone): rheumatology provenance + verified med-rec + pharmacy/refill + endo consult + admission/progress — five distinct sources, hierarchy-resolvable. Multi-doc. ✓
Trap #2 (HF/AKI): med-rec + MAR/action source + nephrology + cardiology + hospitalist progress + trend source — multi-doc, time-sensitive. ✓
Trap #3 (buried functional): nursing + PT + OT + family + SW/CM, explicitly outside prominent physician summaries. Multi-doc. ✓
Trap #4 (sepsis anchoring): ED assessment + admission H&P + progress + trend source + consults — early-vs-late contrast across docs. ✓
Trap #5 (discharge hierarchy): a visible discharge-facing artifact reconciled against nursing/PT/OT/family/pharmacy. ✓
No trap is single-file-solvable (the 2.48/multi-doc synthesis discipline), none is over-exposed, and the #3 vs #5 distinction is explicitly protected at the architecture level (lines 132–136): #3 lives in non-prominent sources (buried-but-present), #5 lives in a visible artifact (present-but-incomplete). The package even instructs that later construction "must make these two traps live in different source patterns" — exactly the carry-forward I've tracked since the brainstorm, now written into the file plan.

Hierarchy-to-file coverage — verified, RESOLVED. Every rung of all three hierarchies (§6) maps to a planned file support: authority hierarchy (hospitalist docs → consult docs → PT/OT → CM/SW → family communication → documented patient report), master source-of-truth (attending → med-rec → pharmacy → consult → PCP → family → patient), and prednisone-specific (rheumatology provenance → med-rec → pharmacy/refill → family → patient). No rung is left without a document home, and the critical relationships hold: rheumatology provenance is the highest prednisone source while endocrinology "interprets but does not outrank rheumatology for prednisone history" (line 89). Provenance discipline preserved.

Now the objectives.

Objective 1 — World Spec fidelity — RESOLVED. Every major world fact has a plausible document home; no locked world element lacks support; no proposed file type contradicts the spec; no new architecture introduced. The named providers map to the right document types (Vossmere→hospitalist progress, Caldrane→cardiology, Solthar→nephrology, Veylorn→endo, Halvek→rheumatology provenance, Quenor→PCP provenance, Mara→family communication). The remote PCI/sleep-study stay quiet provenance (line 97, "should stay quiet"). No reintroduction of excluded items.

Objective 2 — File-ecosystem integrity — RESOLVED. World/task/supplementary tiers are correctly separated and defined. No required type missing (ED, admission, progress, three consults, pharmacy, med-rec, nursing, PT, OT, family, CM, SW, discharge artifact, outpatient provenance, trend source — the full chart). None unnecessary. Realistic for a 6-day stay, and the package actively guards against clutter ("do not create daily notes for every service unless needed," line 229; supplementary "used sparingly," line 64).

Objective 3 — Workflow coverage — RESOLVED. All four workflows are solvable from the planned ecosystem (the "Supported workflows" column maps each file to its workflows). None under- or over-supported; none requires a missing source. TCM and readmission stay embedded in Discharge Planning Documentation (lines 112, 119) — 2.107 resolution preserved at the file layer.

Objective 4 — Trap coverage — RESOLVED (detail above). No reveal-drift — Trap #1 file note preserves "avoid hidden-adrenal-insufficiency drift," endo consult explicitly interprets-not-reveals. No hidden-answer drift. #3/#5 distinct.

Objective 5 — Friction coverage — RESOLVED. Each friction has distinct source channels (§5) with both sides defensible, and the matrix explicitly instructs files must "avoid making either service obviously correct" / "preserve gray-zone discharge judgment" / "prevent hidden-adrenal-insufficiency drift." No friction collapsed; no new friction created by the file plan.

Objective 6 — Source-of-truth coverage — RESOLVED (detail above). All three hierarchies fully mapped; none weakened; provenance preserved.

Objective 7 — Temporal integrity — RESOLVED. World-level boundary correctly stated and enforced (all world files ≤ 05/23 18:00; the discharge-facing artifact is explicitly dated "no later than 05/23/2026 18:00," line 96). The three post-world anchors are classified task-level/post-world. No post-world leakage, no contradiction. The package correctly flags that the discharge summary is a post-world task deliverable, not a world-level file — which is the subtle temporal trap (a discharge summary dated after close would fail the gate as a world file); handled correctly (line 197).

Objective 8 — AutoQC readiness — RESOLVED, and this is where the package is notably strong. §8 explicitly names the 8-column file-plan structure and Source/Tool separation as a requirement (line 203) — the single most important carry-forward I've flagged repeatedly, now captured in the architecture rather than left to be discovered. The AutoQC watch-items list (lines 214–221) names 2.42 (column mismatch/Source+Tool), 2.48 (fact-to-file), 2.65 (hierarchy), 2.107, 2.108, and 2.113 (Source/Tool + origin convention) — the exact checks this layer is exposed to. This is the first artifact to internalize the 8-column issue, which closes the watch-item I've carried since the start.

Objective 9 — File-count strategy — RESOLVED, with one note worth stating. The ranges (18–24 world-level, 6–10 task-level, 3–6 supplementary) are realistic for this hospitalization and clear the v6.3 minimums (≥20 total essential, ≥4 modalities — the world-level set spans notes, consults, nursing, PT/OT, MAR, labs/vitals, pharmacy, family communication, which is well over 4). The note, not a defect: the supplementary count (3–6) against an essential count of ~24–34 puts the supplementary share well under the ~10% the v6.3 supplementary-mix check (2.52) looks for — which is the safe direction (too little noise never fails; too much load-bearing noise does), and the package's "use sparingly" discipline is correct. But at construction, confirm the essential/supplementary ratio sits where 2.52 expects; if 2.52 wants a firmer ~90/10 split, the supplementary band may need to scale with the essential count. Minor future-construction calibration, not a flaw in the architecture.

Objective 10 — Construction readiness — RESOLVED. If ratified, File Inventory v1 table construction can begin; no further architecture package is required first; I see no gap that would force restructuring (the ecosystem is complete across services, traps, frictions, hierarchies, and time). The construction order (§10: table → review → lock → synthetic world files → task files → task specs → prompts → outputs → goldens → grader → AutoQC) is sound.

Classification summary

True defects: none. The architecture is faithful, complete, and internally consistent; every trap and hierarchy rung has a distinct document home.
Physician-preference items: the Social Work file is marked "optional-to-essential depending on final tasks" (line 95) — a legitimate deferral, his call at task time; whether the remote-procedure provenance file is needed at all (line 97, "optional") — also a reasonable defer.
Future-construction items: (1) Section 3 table must implement the v6.3 8-column Source/Tool structure (now captured in §8 — carry it through); (2) confirm the essential/supplementary ratio against 2.52's ~90/10 expectation when counts are finalized; (3) the standing 2.108 bet (Discharge Planning Documentation as administrative deliverable, utilization-review fallback); (4) at synthetic-file construction, instantiate Trap #3 (buried) and Trap #5 (visible-but-incomplete) as genuinely different source patterns; (5) decide how objective trends are represented (the package correctly defers values); (6) transcript requirement still to be pinned against canonical source before submission.
Every objective classifies RESOLVED. No OPEN item internal to the architecture; no BLOCKER.

Would you ratify File Inventory Architecture v1 today? YES. It gives every locked world element a document home, provides distinct multi-document substrate for all five traps (with the #3/#5 distinction protected at the source-pattern level), maps every rung of all three hierarchies to file support, holds the world-level temporal boundary cleanly, keeps all three frictions two-sided, supports all four workflows, and — notably — is the first artifact to internalize the v6.3 8-column Source/Tool requirement rather than leaving it as a downstream surprise. There is no true defect and no internal inconsistency.

File Inventory Architecture v1 Status: LOCK READY.

Final Recommendation: GO.

If ratified, does File Inventory Architecture v1 authorize File Inventory v1 table construction? YES — this is the one ratification in the chain where the answer is yes. The reason the prior artifacts' answers were "no, next phase first" was that a downstream phase always sat between them and the thing being asked about. Here, File Inventory v1 table construction is the immediate, direct next step that this architecture exists to enable (§10 step 1), and there is no intervening architecture package required. So ratifying this package does authorize beginning the File Inventory v1 table — with three conditions carried in: the table must use the v6.3 8-column Source/Tool structure (not the 05/06 template's 7 columns), each row must carry the fact-to-file traceability the world facts require, and the world-level boundary (≤ 05/23 18:00) must be enforced row by row. The standing procedural rule still applies — the table phase begins when you explicitly start it — but unlike the earlier artifacts, the very next construction step is correctly the one the question names, so the authorization is direct rather than deferred.

One orientation note, since this ratification flips the gate to "build": everything from here produces actual synthetic chart content — real note text, lab values, medication lists, dates on files. That's a meaningful shift from the architecture-and-review work the chain has been doing, and it's the first point where the physician-authored vs assistant-drafted boundary on task prompts/goldens (which has been protected all along) starts to matter concretely. Worth confirming, when you start the table, which rows are Claude-draftable architecture vs which must originate from Alexander.


file-inventory-v1.md
md


Independent ratification review of File Inventory v1. Review-only. Do not redesign the inventory. Do not create new file rows. Do not add file IDs. Do not remove file IDs. Do not create filenames. Do not create synthetic files. Do not create note contents. Do not create la

pasted

Independent ratification review of File Inventory v1. as pasted

Jun 1
Independent ratification review of File Inventory v1. Review-only — no new rows, IDs, filenames, synthetic files, or downstream content created. This is the first artifact with concrete file rows (IDs, filenames, dates, Source/Tool entries), so it's the one where the v6.3 mechanical checks finally bite: 8-column structure, every world-file date ≤ close, every date in milestones, ID uniqueness/sequence, and the ~90/10 split. I'll verify those by hand against the actual rows rather than trusting the summary. Let me read it.


Viewed 3 files, ran a command
Viewed 3 files, ran a command
Read in full, all 33 rows plus every matrix. This is the artifact where mechanical AutoQC checks finally apply to concrete rows, so I ran the verifiable ones by hand rather than trusting the summary: ID uniqueness/sequence, the world-file temporal boundary row by row, date-to-milestones membership, the count math, and the trap/hierarchy coverage cross-references.

Mechanical checks I ran against the actual rows:

ID integrity: FI-W01→W22 (22, contiguous, unique), FI-T01→T07 (7, contiguous, unique), FI-S01→S04 (4, contiguous, unique). No gaps, no duplicates, monotonic within each tier (2.82/2.95 class). ✓
Count math: 22 + 7 + 4 = 33. World-level 22 inside 18–24; task 7 inside 6–10; supplementary 4 inside 3–6. Essential total (world + task = 29) clears the ≥20 essential bar. ✓
World-file temporal boundary — checked every world row: W01–W11 carry HD1–HD6 dates (05/18–05/23); W08 spans HD1–HD2, W11 spans HD5–HD6 "before 18:00"; W12/W13/W17/W18/W19/W20 are HD-range "through 05/23 18:00"; W22 is "05/23 before 18:00"; W05/W06/W07 are pre-admission provenance. No world row uses 05/24, 05/31, or 06/23. The discharge-facing artifact (W22) is explicitly pre-18:00. The 2.41 world-file boundary holds row by row. ✓
Post-world anchors are task-only: FI-T01/T02/T03/T04/T07 = 05/24, T05 = 05/31, T06 = 06/23. All classified Task-Level. ✓
Date-to-milestones membership: every date used (04/27 implied via pre-admission, 05/18–05/23, 05/24, 05/31, 06/23) exists in the locked Key Milestones table. No orphan dates (2.22/2.23). ✓
Modality spread: ED docs, H&P, progress notes, med-rec, pharmacy report, three consults, MAR, lab/vital trend source, nursing flowsheet, PT, OT, family communication, CM/SW, discharge artifact, outpatient provenance, problem list — well over the ≥4 modality bar (2.51). ✓
Now the objectives.

Objective 1 — World Spec fidelity — RESOLVED. Every major world fact has a file home (I cross-checked the provider roster, the three hierarchies, both procedures, and the trap substrates against specific rows). No row contradicts the spec; no new architecture introduced. The named providers map to the correct authoring rows (Vossmere→W03/W08/W11/W22, Caldrane→W15, Solthar→W14, Veylorn→W16, Halvek→W06, Quenor→W07, Mara→W20). Procedures sit in supplementary provenance (S01/S02), correctly quiet.

Objective 2 — File-inventory integrity, with the requested FI-W08–W11 granularity scrutiny — RESOLVED. The special-attention question is whether progress-note granularity is inflated. It isn't, and the design is deliberate: W08 consolidates HD1–HD2, then W09 (HD3), W10 (HD4), W11 (HD5–HD6) are single rows per phase. So six hospital days are covered by four progress rows, not six — the consolidation the architecture promised (line 199 confirms "daily notes are consolidated where possible"). Critically, the four are not redundant — each carries a distinct clinical function tied to the daily framework: W08 = early response/stabilization, W09 = the acute→functional transition (Trap #3/#4 pivot), W10 = consultant tensions + steroid inconsistency surfacing (all three frictions + Traps #1/#2/#4), W11 = improvement-with-residual-uncertainty (Trap #5 + frictions). That maps exactly to the ratified HD-by-HD activation logic. No row exists from inflation; none is a trim candidate. Ecosystem realistic for a 6-day stay.

Objective 3 — Workflow coverage — RESOLVED. Each of the four workflows has a substantial supporting set (matrix §2), spanning world + task + supplementary. None under-supported; none over-constrained; none depends on a missing source. TCM/readmission stay inside Discharge Planning Documentation (T05/T06), preserving the 2.107 resolution at the row level.

Objective 4 — Trap coverage, with the #3/#5 distinction — RESOLVED. Every trap has multi-row primary substrate (matrix §3): #1 across W04/W05/W06/W16/W20 (five distinct source channels — rheumatology, med-rec, pharmacy, endo, family), #2 across the medication/consultant/trend rows, #3 in the nursing/PT/OT/family cluster (W17–W20), #4 across the ED/admission/progress/trend rows, #5 anchored on the visible discharge artifact (W22) reconciled against the broader chart. No single "answer file" exists — I checked specifically that no one row resolves a trap alone; each trap requires ≥2 rows, and the matrix's primary/secondary split enforces synthesis. The #3/#5 distinction is explicit and now instantiated as different file behaviors (lines 116–119): #3 lives in non-prominent sources (buried), #5 lives in a visible artifact W22 (present-but-incomplete). This is the cleanest the distinction has been — it's now a concrete file (W22) vs a source-cluster (W17–W20), not just a conceptual note. No reveal-drift (endo W16 interprets, doesn't reveal; Trap #1 keeps rheumatology as separate authority), no hidden-answer drift.

Objective 5 — Friction coverage — RESOLVED. All three frictions have two-sided row support (matrix §4): Cardiology (W15) vs Nephrology (W14) with hospitalist/trend context preventing auto-deference; Family (W20) vs Primary Team (W11) with both grounded; Endo (W16) vs Primary Team with the steroid records as trap-substrate, not friction participant. No file collapses a friction; none creates a new one.

Objective 6 — Source-of-truth coverage — RESOLVED. Every rung of all three hierarchies maps to explicit file IDs (matrix §5), and the critical relationships hold: rheumatology (W06) is the sole highest prednisone-history source while endo (W16) interprets; attending docs top the master hierarchy; patient recollection sits lowest (W03/W04). Provenance discipline preserved, and Source vs Tool/Origin are kept as separate columns.

Objective 7 — Temporal integrity — RESOLVED (verified row by row above). No leakage, no improper post-world world-file, no contradiction. The §6 temporal validation is accurate — I confirmed its claims against the rows rather than taking them on faith.

Objective 8 — AutoQC readiness — RESOLVED, notably strong. The table implements the 8-column structure with Source (col 5) and Tool/Origin (col 6) as separate columns (lines 32–41) — the single most-flagged carry-forward from the very start of this engagement, now concretely realized rather than promised. Fact-to-file traceability is supported (every workflow/trap/hierarchy maps to rows). The verifiable mechanical checks (IDs, dates, boundary, count, modality) all pass. This inventory would clear the structural file-plan checks.

One honest AutoQC-adjacent note, not a defect at this stage: the Tool/Origin column currently reads "Planned synthetic … file in future phase" on every row. That's correct for a planning inventory — the actual tool (e.g., the engineering converter, or a writer-produced-media tool for any tracing/imaging) gets specified at synthetic-file construction. But 2.113 and the Source/Tool convention will eventually want the specific origin per row (engineering-converted vs writer-produced-media, with the two-track filename implication). So the column structure is right and present; the values are appropriately deferred. Carry-forward, not a flaw.

Objective 9 — File-count strategy — RESOLVED. 22/7/4 all within target; 33 total is proportionate, not padded. The world-level count sits middle-high deliberately (justified by the workflow/trap/friction/hierarchy load), with daily-note consolidation preventing inflation. No obvious trim candidate (I looked — even FI-S04 problem-list and FI-S03 home-support earn their place as texture without sole evidence). No obvious missing row.

One calibration note carried from the architecture review, still the safe direction: supplementary share is 4/33 ≈ 12%, close to the ~10% the 2.52 supplementary-mix check looks for — fine, and erring toward less noise is never the failing direction. Worth a final confirmation against 2.52's exact expectation at lock, but not an issue.

Objective 10 — Construction readiness — RESOLVED. If ratified, synthetic world-level file construction can begin; no further inventory pass is required (the table is complete, traceable, and boundary-clean); I see no gap that would force restructuring. The rows give synthetic-file construction everything it needs: per-file type, level, date, author, and the traps/frictions/workflows each must serve.

Classification summary

True defects: none. IDs, dates, boundary, counts, coverage, and the 8-column structure all check out against the actual rows.
Physician-preference items: none newly introduced here; the standing sign-offs (secondary conditions, two procedures, roster surname) remain, and a reviewer may trim/merge rows if any feels redundant (the package invites this, line 283) — but I found none that must be.
Future-construction items: (1) specify the per-row Tool/Origin values (engineering-converted vs writer-produced-media) at synthetic-file construction, with the 2.113 two-track filename convention; (2) confirm the 4/33 supplementary ratio against 2.52 at lock; (3) at synthetic-file construction, build Trap #3 (buried in W17–W20) and Trap #5 (visible-but-incomplete in W22) as genuinely different document behaviors; (4) FI-W12 trend-source and FI-W13 MAR-source must get their value representation decided when authorized (correctly deferred here); (5) the standing 2.108 bet and transcript-requirement items.
Every objective classifies RESOLVED. No OPEN item internal to the inventory; no BLOCKER.

Would you ratify File Inventory v1 today? YES. It is a complete, internally consistent, traceable, boundary-clean 33-row file plan: 22/7/4 within target, contiguous unique IDs, every world file dated ≤ close with no post-world leakage, every date in milestones, all four workflows and five traps and three frictions and three hierarchies mapped to specific rows with no single-file "answer," the #3/#5 distinction now instantiated as a concrete artifact-vs-cluster split, and — the long-tracked item — the v6.3 8-column Source/Tool structure concretely implemented rather than promised. There is no true defect and no internal inconsistency.

File Inventory v1 Status: LOCK READY.

Final Recommendation: GO.

If ratified, does File Inventory v1 authorize synthetic world-level file construction? YES — with the boundary distinction that matters most from here. Like the architecture-package ratification, this is one where the next step the question names is the direct next step (the architecture's construction order put synthetic world-level file construction immediately after inventory lock), so ratifying authorizes beginning it — when you explicitly start it. But this is the threshold where the work changes character more than at any prior gate: synthetic world-level files are the first artifacts containing actual clinical content — real note prose, lab and vital values, consultant recommendation text, medication administration entries, dates inside documents. Three things should travel into that phase: every world file stays dated ≤ 05/23 18:00 (enforced at the content level, not just the row); each file's content must carry the facts its tasks' eventual correct answers depend on (the fact-to-file traceability that 2.48 enforces); and Trap #3 vs Trap #5 must be written as genuinely different behaviors (buried-but-present vs visible-but-incomplete).

And the one boundary I'd flag explicitly now, because it's about to become live rather than theoretical: synthetic world files are chart content and are within scope for this construction phase — but task prompts, expected outputs, and golden responses remain physician-authored and are a separate, later, explicitly-gated step. The inventory cleanly separates world/task-context files (which describe requests) from the task deliverables themselves (which it correctly does not create). When synthetic-file construction begins, world-level chart files are the work; the task goldens are not, and that line — which has been protected all the way down this chain — is the one to hold most carefully as the project moves from planning into content.


synthetic-world-file-construction-plan-v1.md
md


Independent ratification review of Synthetic World-Level File Construction Plan v1. Review-only. Do not redesign the plan. Do not create synthetic files. Do not create filenames. Do not create note contents. Do not create chart notes. Do not create discharge summaries. Do not

pasted

Independent ratification review of Synthetic World-Level File Construction Plan v1. as pasted

Jun 1
Independent ratification review of Synthetic World-Level File Construction Plan v1. Review-only — no synthetic files, filenames, note contents, labs, vitals, medication lists, consultant text, or downstream artifacts created. This is a governance plan for the construction step, not content, so the substantive checks are: does the batching respect dependency order, are the anti-drift checkpoints strong enough for the phase where actual clinical content gets written, and does the plan carry forward the boundaries (temporal, no-answer-file, #3/#5) that the prior layers established. Let me read it.


Viewed 2 files, ran a command
Viewed 2 files, ran a command
Read in full. This is a governance plan, so the review verifies process integrity, not clinical content: does the batching respect dependency order, do the checkpoints actually catch the failure modes this phase introduces, and does the plan carry the established boundaries forward intact. I cross-checked the batch file lists against the locked File Inventory v1 IDs and tested the dependency logic for ordering errors.

Batch-to-inventory ID coverage — verified, RESOLVED. I checked the five batches against the locked FI-W set: Batch 1 = W01–W07 (7), Batch 2 = W08–W13 (6), Batch 3 = W14–W16 (3), Batch 4 = W17–W21 (5), Batch 5 = W22 (1). Total = 22, matching File Inventory v1's world-level count exactly, with no ID omitted, none duplicated, and none invented. Every world-level row has exactly one batch home.

Dependency-order logic — verified sound, RESOLVED. I tested the ordering for the kind of error that causes construction rework — a file that must react to another being built before it. The order is correct:

Batch 1 (presentation + provenance + baseline) first — nothing depends on later files; it's the substrate everything inherits. ✓
Batch 2 (hospitalist course + trend/MAR sources) second — inherits Batch 1 baseline so daily evolution references the right starting point. ✓
Batch 3 (consultants) after the spine — consultants must "respond to the same clinical spine" (line 105), which requires Batch 2 to exist first. This is the key dependency: a cardiology note that references a creatinine trend can't be written before the trend source (W12) exists. Correctly ordered. ✓
Batch 4 (nursing/PT/OT/family/CM-SW) after baseline+spine — functional decline must be "interpreted against baseline and hospital course." ✓
Batch 5 (W22 discharge artifact) strictly last — it synthesizes incompletely from all prior sources, so it cannot precede them. ✓
The FI-W22-last strategy is correct and is the plan's strongest single decision. W22 is the visible discharge-facing artifact that Trap #5 hinges on; it carries the highest answer-file-drift risk because it's reassuring-by-design. Building it last, against already-constructed sources, lets the author make it credibly incomplete — reassuring enough to tempt over-trust, but missing the caveats that live in W14–W21. If built early, it would have nothing concrete to be incomplete relative to. The plan correctly flags it as highest-risk (lines 109, 280–286) and gates it with an over-completeness checkpoint.

On the one open question the plan itself poses (Batch 3/4 parallel vs sequential): the plan asks reviewers to confirm. My read — they can be built in parallel after Batch 2, because Batch 3 (consultants) and Batch 4 (functional/family) draw on the same Batch 1+2 substrate but not on each other. There's no hard dependency between a nephrology note and a PT assessment. The only caution: Trap #5's substrate spans both batches (W14–W16 consultant caveats + W17–W21 functional/family evidence both feed the "what W22 is missing" set), so if built in parallel, the W22 checkpoint must verify it's incomplete against the union of both. Parallel is fine; the W22 review just has to come after both land. This is a physician/process-preference confirmation, not a defect — the plan correctly leaves it to ratification.

Now the objectives.

Objective 1 — Fidelity to locked architecture — RESOLVED. The plan implements the locked artifacts without introducing new architecture, diagnoses, workflows, traps, frictions, providers, or medications. It explicitly names File Inventory v1 as authoritative and forbids new world facts (line 25). Every trap/friction/hierarchy reference traces to a locked source.

Objective 2 — Construction philosophy — RESOLVED, and notably complete. The six principles (closed-world, source-of-truth, trap preservation, friction preservation, no-answer-file, temporal integrity) cover the failure modes this phase introduces. The No-Answer-File Doctrine (§1) is the most valuable addition — it enumerates the specific files that could become answer keys (final med plan, steroid document, discharge artifact, functional note, consultant note) and forbids each. Nothing material is missing. No principle creates future risk; they're constraints, not generative instructions.

Objective 3 — Batching strategy — RESOLVED (detail above). Dependency order sound, no file mis-batched, W22-last correct, the one parallel-vs-sequential question correctly surfaced for confirmation.

Objective 4 — Trap preservation — RESOLVED. Each trap has a preservation plan (§3) with four columns that are exactly the right four: where evidence lives, what stays diffuse, what stays visible, and what must never become an answer file. This "visible enough to find, diffuse enough to miss" framing (line 65) is the correct calibration against both failure directions (too obvious / too buried). The #3 vs #5 distinction is preserved as different construction behaviors (lines 121–124): #3 = is buried evidence found, #5 = is a visible artifact over-trusted. No trap becomes too obvious or too weak under these rules; no reveal-drift (Trap #1 forbids proving adrenal suppression as the reveal; Trap #4 forbids "sepsis was wrong" / "adrenal explains everything").

Objective 5 — Friction preservation — RESOLVED. The friction plan (§4) gives each friction an evidence-distribution strategy, balancing requirements, and anti-collapse guardrails. The guardrails directly prevent the known failure modes: "do not make either consultant outdated/careless/obviously wrong," "do not let latest-note-wins solve it," "do not turn documentation into a friction participant," "do not make adrenal insufficiency the hidden reveal." Both sides preserved; one-sided construction is explicitly blocked.

Objective 6 — Source-of-truth preservation — RESOLVED. All three hierarchies have construction rules mapping rungs to files (§5), with the operational rule (line 169) that hierarchy resolves factual conflicts, not recommendation disagreements — the governance distinction that keeps the consultant frictions alive. Provenance protected; the "do not collapse into one omniscient summary" rule (line 43) prevents hierarchy collapse.

Objective 7 — Temporal integrity — RESOLVED. The temporal preservation plan (§6) constrains each file group to ≤ 05/23 18:00 and — importantly — adds a subtler control: it forbids hindsight contamination (line 177, "post-HD1 hindsight that would make early reasoning look obviously right or wrong"). That's a sophisticated catch: a world file can be correctly dated pre-close yet still leak future knowledge by being written with hindsight. The plan blocks both the date leak and the knowledge leak. No post-world anchor permitted in world files.

Objective 8 — Construction governance — RESOLVED, strong. The eight per-batch review checkpoints (§7) are comprehensive and map to every risk: row fidelity, no-new-architecture, source/tool separation, no-answer-file, distributed-but-discoverable evidence, friction balance, temporal boundary, and — checkpoint 8 — "future file content does not pre-write task prompts, expected outputs, goldens, or grader guidance." That last one is the critical boundary control for this exact phase: it's the safeguard that keeps synthetic chart construction from bleeding into the physician-authored task deliverables. Its presence is what makes this governance adequate rather than merely sequential. No major safeguard missing.

Objective 9 — Construction readiness — RESOLVED. If ratified, Batch 1 can begin; no further planning layer is required (the plan is complete across philosophy, batching, trap/friction/hierarchy/temporal preservation, and checkpoints); I see no gap that would force reconstruction. The dependency order ensures later batches inherit earlier substrate correctly.

Classification summary

True defects: none. Batch IDs match the inventory exactly, dependency order is sound, and every established boundary is carried forward.
Physician-preference / process items: confirm whether Batch 3 and Batch 4 are built in parallel or strictly sequential (the plan surfaces this; my read is parallel-after-Batch-2 is fine, with W22 review gated after both).
Future-construction items: at actual construction, specify per-file Tool/Origin values (engineering-converted vs writer-produced-media, 2.113) — the plan keeps Source/Tool conceptually separated but the concrete origin is set when files are built; enforce fact-to-file traceability (2.48) as content is written; apply the over-completeness test to W22; and hold checkpoint 8 (no pre-writing of task goldens) rigorously, since this is the phase where that line is most easily crossed.
Every objective classifies RESOLVED. No OPEN item; no BLOCKER.

Would you ratify Synthetic World-Level File Construction Plan v1 today? YES. It is sound construction governance: the five batches cover all 22 locked world files with no ID error, the dependency order correctly ensures each batch inherits the substrate it must react to, the FI-W22-last strategy correctly protects the highest answer-file-drift risk, and the philosophy, trap/friction/hierarchy/temporal preservation plans, and eight per-batch checkpoints carry every established boundary forward — including the critical checkpoint-8 control that synthetic chart files must not pre-write the physician-authored task deliverables. There is no true defect and no internal inconsistency.

Synthetic World-Level File Construction Plan v1 Status: LOCK READY.

Final Recommendation: GO.

If ratified, does this authorize Batch 1 synthetic world-level file construction? YES — directly, with the boundary I'd flag most firmly at this threshold. As with the inventory ratification, the next step the question names is the direct next step (Batch 1 is the first construction action this plan governs), so ratifying authorizes beginning it when you explicitly start. But this is the gate where the project crosses from planning about content into creating content — Batch 1 produces real ED notes, an H&P, medication-reconciliation prose, pharmacy and outpatient provenance with actual history. Three controls travel into Batch 1: every file dated ≤ 05/23 18:00 with no hindsight contamination; the prednisone provenance (W06) constructed so rheumatology is the highest source and the steroid sources do not all align cleanly (Trap #1's diffuseness); and no Batch-1 file functioning as an answer key.

And the boundary that becomes load-bearing exactly here, which I want to state plainly: this authorizes constructing world-level synthetic chart files — patient-chart content. It does not authorize task prompts, expected outputs, golden responses, or grader guidance, which remain physician-authored and sit behind a later, separate gate (checkpoint 8 exists precisely to enforce this during construction). Throughout this entire chain that line has held — I've reviewed architecture and governance, and the clinical/authored content has stayed with Alexander. Batch 1 is the first time I'd be reviewing actual generated chart content rather than plans, so when it comes, the review will shift to verifying the content honors these constraints — and the one thing I'll watch hardest is that chart files stay chart files and don't drift into pre-writing the task answers.


batch-1-validation-review.md
295 lines

md


FI-W01_ed-triage-initial-intake.md
82 lines

md


FI-W02_ed-provider-assessment.md
75 lines

md


FI-W03_admission-history-and-physical.md
119 lines

md


FI-W04_initial-medication-reconciliation-note.md
131 lines

md


FI-W05_pharmacy-refill-history-report.md
99 lines

md


FI-W06_outpatient-rheumatology-prednisone-provenance.md
76 lines

md


FI-W07_primary-care-outpatient-baseline-summary.md
96 lines

md

Independent ratification review of Batch 1 Synthetic World-Level File Construction.
Review-only.
Do not rewrite files.
Do not create new files.
Do not create Batch 2 files.
Do not create task prompts.
Do not create expected outputs.
Do not create goldens.
Do not create grader guidance.
Do not create AutoQC responses.
Do not create submission artifacts.
Subject:
Batch 1 Synthetic World-Level File Construction
Files:

FI-W01
FI-W02
FI-W03
FI-W04
FI-W05
FI-W06
FI-W07
Validation artifact:

batch-1-validation-review.md
Purpose:
Determine whether Batch 1 faithfully implements the locked World Spec, File Inventory, Governance architecture, source-of-truth hierarchies, trap architecture, friction architecture, temporal boundaries, and closed-world constraints.
Review Objective 1 — Inventory Fidelity
Verify each file against its locked File Inventory row.
Questions:

Does each file fulfill its intended row purpose?
Any missing row purpose?
Any invented purpose?
Any row drift?
Classify:

RESOLVED
OPEN
BLOCKER
Review Objective 2 — Temporal Integrity
Verify:

HD1 anchoring
Pre-admission provenance
No post-world information
No discharge outcomes
No +7 information
No +30 information
Questions:

Any temporal leakage?
Any timeline contradiction?
Classify:

RESOLVED
OPEN
BLOCKER
Review Objective 3 — Trap Preservation
Review:

Trap #1 Prednisone Source-of-Truth
Trap #2 HF/AKI Medication Reconciliation
Trap #3 Buried Functional/Cognitive Status
Trap #4 Sepsis Anchoring After Partial Improvement
Trap #5 Discharge Source-Hierarchy
Questions:

Is any trap weakened?
Is any trap over-exposed?
Does any file become an answer file?
Any reveal drift?
Special attention:
Prednisone hierarchy reconstruction.
Classify:

RESOLVED
OPEN
BLOCKER
Review Objective 4 — Friction Preservation
Review:

Cardiology vs Nephrology
Family vs Primary Team
Endocrinology vs Primary Team
Questions:

Are both sides preserved?
Any friction collapse?
Any new friction introduced?
Classify:

RESOLVED
OPEN
BLOCKER
Review Objective 5 — Source-of-Truth Preservation
Review:

Authority hierarchy
Master hierarchy
Prednisone hierarchy
Questions:

Are hierarchy levels represented correctly?
Any provenance collapse?
Any source improperly elevated?
Classify:

RESOLVED
OPEN
BLOCKER
Review Objective 6 — Construction Quality
Questions:

Clinical realism?
Internal consistency?
Naming consistency?
No-answer-file compliance?
Readiness for lock?
Classify:

RESOLVED
OPEN
BLOCKER
Required Distinction
Separate findings into:

True defects
Physician-preference items
Future-construction items Conclude with: Would you ratify Batch 1 Synthetic World-Level File Construction today? YES or NO Then provide: Batch 1 Synthetic World-Level File Construction Status: LOCK READY or NOT LOCK READY Final Recommendation: GO or HOLD Additionally answer: If ratified, does this authorize Batch 2 Synthetic World-Level File Construction? YES or NO Review only.
Show more
Jun 1
Independent ratification review of Batch 1 — the first artifacts containing actual synthetic chart content. This review is qualitatively different from every prior one: I'm no longer checking a plan, I'm checking generated clinical prose against the locked architecture and against itself for internal consistency. So I read all seven files closely and cross-checked the clinical facts (medications, conditions, baseline values, dates, the prednisone evidence chain) for agreement across files — that cross-file consistency is exactly what the eventual 2.57/2.59 checks enforce, and it's where generated content most often drifts.

I'll lead with the cross-file consistency verification, then the objectives.

Cross-file clinical consistency — checked fact by fact, RESOLVED.

Identity: MRN KM-6427819 appears identically in W01, W02, W03, W04 (the files that state it); age 62 consistent throughout. ✓
Conditions: the 14-condition list in W03 (H&P) and W07 (PCP) match each other and the locked comorbidity package, including the three secondary additions (class I obesity, GERD/acid-suppression, constipation tendency). W02's HPI condition list is consistent (it's a prose subset, not a contradiction). ✓
Medications: the regimen in W03, W04, and W05 is mutually consistent and matches the locked 20 — and critically, insulin lispro does not appear in any baseline file (W04 lists insulin glargine only; no prandial insulin). The lispro-reserved-for-inpatient decision propagated correctly into the actual chart content. ✓
Baseline anchors: W07 carries creatinine 1.6–1.8, eGFR 40–50, Hgb 10.5–11.5, A1c 7.6–8.2, dry weight ~97 kg — matching the locked Baseline Anchor Package exactly, and explicitly labeled "baseline anchors… not admission values" (the distinction the baseline review insisted on). No admission lab values appear anywhere in Batch 1 — correct, since labs belong to Batch 2's trend source. ✓
ACE-intolerance→ARNI: W07 states sacubitril/valsartan "appears consistent with prior ACE-inhibitor intolerance due to lisinopril cough" — implementing the addendum's carry-forward that the ARNI needs a coherent switch rationale, and treating the lisinopril entry as intolerance. ✓
Provider names: Vossmere (W03), Halvek (W06), Quenor (W07), Mara Merrow (W01/W04) match the locked roster. ✓
No clinical contradiction across the seven files. This is the check most likely to surface drift in generated content, and it's clean.

Objective 1 — Inventory fidelity — RESOLVED. Each file's header reproduces its locked FI-W row (ID, type, level, date, author, purpose, supported workflows/traps/frictions) and the body fulfills that purpose. No missing purpose, no invented purpose, no row drift. The header metadata matches File Inventory v1 row-for-row.

Objective 2 — Temporal integrity — RESOLVED, with one wording nuance worth noting (not a defect). All seven files anchor to 05/18/HD1 or pre-admission provenance; none contains discharge outcomes, +7, or +30 information; every file carries an explicit closed-world disclaimer. I checked specifically for hindsight contamination (the subtle leak the construction plan warned about) — the ED and admission notes reason forward from presentation without knowing the outcome, and W06's rheumatology provenance describes intended taper without stating what happened inpatient. Clean.

The nuance: W06's header anchor reads "Pre-admission provenance available by HD4." That's faithfully copied from the locked inventory row, so it's correct as written — but it encodes a content constraint Batch 1 can't fully self-enforce: W06's information is pre-admission, but its availability to the inpatient team is HD4. Since W06 is built in Batch 1 (before the HD4 hospitalist note exists), later construction must ensure nothing in the HD1–HD3 notes (W08, W09) references rheumatology provenance the team didn't have until HD4. Not a Batch 1 defect — W06 itself contains no post-world or post-HD4 content — but it's a future-construction sequencing note: the "available by HD4" timing must be honored when Batch 2/3 reference this record. Worth flagging because it's the one place where a provenance file's build order (Batch 1) and its in-world availability (HD4) diverge.

Objective 3 — Trap preservation, with special attention to prednisone reconstruction — RESOLVED. This is the heart of Batch 1, and it's well executed. The prednisone evidence is deliberately distributed and non-aligning across the five source channels exactly as the hierarchy requires:

W06 (rheumatology, highest authority): intended cautious taper, explicitly "does not prove actual adherence."
W05 (pharmacy): fills support chronic + recent exposure with changing directions, explicitly "cannot confirm whether Korvin followed the latest taper… or misunderstood instructions."
W04 (med-rec): patient says still-on vs maybe-tapering vs maybe-skipped; family saw "more than one prednisone instruction"; bottle present but "does not confirm actual recent use."
W01 (triage/family + patient): patient "still on a little" then "might have been tapering"; family says bottle directions and actual use "may not match."
W03 (admission): marks the admission interview as unreliable for steroid details.
No single file resolves the prednisone question — reconstruction genuinely requires synthesizing rheumatology intent + pharmacy availability + reconciliation uncertainty + collateral, ranked by the hierarchy. And the reveal-drift guardrail holds: W06 explicitly states it "does not prove that current weakness, lightheadedness, or altered mentation is primarily caused by adrenal suppression," and "does not erase the clinically reasonable early sepsis frame." Adrenal insufficiency is not being set up as the hidden answer.

The other traps: Trap #4 (sepsis anchoring) — W02 frames urinary sepsis as reasonable while explicitly preserving the broader differential and stating it "should not be treated as the only possible contributor"; W03 echoes "explains part… does not yet explain the entire decline." Established correctly without invalidating the early frame. Trap #2 (HF/AKI) — W03/W04/W05 establish the cardiorenal medication tension and flag holds/reassessment without deciding restart timing or creating a final med plan. Trap #3 (buried functional, seed) — W01/W07 seed baseline-deviation and functional concern (the full buried evidence comes in Batch 4's nursing/PT/OT). Trap #5 (discharge hierarchy, seed) — W07 seeds the "don't dismiss family concern just because he looks improved" logic. No trap is over-exposed, and no file functions as an answer file — I verified each ends in unresolved status rather than resolution.

Objective 4 — Friction preservation — RESOLVED. All three frictions have balanced substrate and neither side is made careless: Cardiology vs Nephrology (W03/W04/W05 establish both HFrEF/CAD protective rationale and CKD/AKI/hemodynamic risk without deciding); Family vs Primary Team (W01/W07 give family's baseline-deviation concern real weight while W02/W03 preserve the reasonable acute medical frame — the ratified two-sided balance); Endocrinology vs Primary Team (steroid uncertainty established as substrate without premature activation, and the records are kept as trap, not as a friction participant). No friction collapses; none is newly introduced.

Objective 5 — Source-of-truth preservation — RESOLVED. The master and prednisone hierarchies are instantiated as separate source channels rather than collapsed into one summary: attending (W03), med-rec (W04), pharmacy (W05), PCP (W07), family (W01/W04), patient (W01/W03/W04), rheumatology-as-top-prednisone-source (W06). Critically, the files state their relative authority correctly — W05 says pharmacy is "stronger than patient recollection… weaker than rheumatology documentation for intended taper"; W07 says the PCP list "should not be treated as superior to verified medication reconciliation or rheumatology prednisone guidance." No source is improperly elevated; provenance is preserved, not flattened.

Objective 6 — Construction quality — RESOLVED. Clinical realism is high — these read as genuine ED/admission/provenance documents, with appropriate register per author (triage nursing voice in W01, EM provider reasoning in W02, hospitalist synthesis in W03, pharmacist source-reliability framing in W04). Internal consistency verified (above). Naming consistent. No-answer-file compliance verified per file. Ready for lock.

The boundary I said I'd watch hardest — did chart content drift into pre-writing task answers? — RESOLVED, clean. Every file ends with an explicit disclaimer that it contains no task prompts, expected outputs, goldens, or grader guidance, and — more importantly than the disclaimer — the content honors it: no file states what a future task should ask, what the correct discharge decision is, or what the model should conclude. The closest any file comes is W04/W05 listing "highest-yield follow-up sources," which is realistic clinical documentation (a pharmacist would note what to verify), not a task answer. The chart-files-stay-chart-files line held.

Classification summary

True defects: none. No clinical contradiction across files, no inventory drift, no temporal leakage, no answer-file, no reveal-drift, and the lispro-reserved decision correctly absent from baseline content.
Physician-preference items: none requiring action in Batch 1; the standing sign-offs (the clinical content here is consistent with the locked packages Alexander approved) carry forward.
Future-construction items: (1) honor W06's "available by HD4" timing when Batch 2/3 reference rheumatology provenance — don't let HD1–HD3 notes cite it early; (2) Batch 2 must not over-resolve the prednisone/medication/infection questions Batch 1 deliberately left open (the validation artifact flags this correctly); (3) the per-file Tool/Origin currently reads "Synthetic chart file / provenance file" — at packaging, the 2.113 engineering-converted vs writer-produced-media origin and two-track filename convention still need specifying; (4) Batch 2's objective trend source (W12) and MAR (W13) will introduce the first admission values — the baseline-vs-admission distinction W07 established must be preserved there.
Every objective classifies RESOLVED. No OPEN item; no BLOCKER. The validation artifact's own findings are accurate — I independently reached the same conclusions rather than relying on it.

Would you ratify Batch 1 Synthetic World-Level File Construction today? YES. The seven files faithfully implement their locked inventory rows, are internally consistent across every clinical fact I cross-checked (identity, 14 conditions, 20 medications with lispro correctly absent, baseline anchors, provider names, ACE→ARNI rationale), preserve all five traps with the prednisone source-hierarchy genuinely distributed across five non-aligning channels, hold the adrenal-reveal guardrail, keep all three frictions two-sided, instantiate the source hierarchies as separate channels rather than a collapsed summary, and — the boundary that became live at this phase — contain real chart content without drifting into pre-writing any task answer. Clinical realism is high and there is no true defect.

Batch 1 Synthetic World-Level File Construction Status: LOCK READY.

Final Recommendation: GO.

If ratified, does this authorize Batch 2 Synthetic World-Level File Construction? YES — directly, per the locked construction plan's dependency order. Batch 2 (FI-W08–W13: the hospitalist course spine plus the objective trend and MAR source files) is the defined next step, and it correctly depends on Batch 1 existing so the daily evolution inherits the baseline and provenance just constructed. So ratifying Batch 1 authorizes beginning Batch 2 when you explicitly start it. Three things travel into Batch 2, and the second is the one I'd watch most: every W08–W13 file stays dated within HD1–HD6 ≤ 05/23 18:00; Batch 2 must continue the evolution without retro-resolving what Batch 1 left open — the prednisone adherence question, the medication restart timing, and the infection-vs-mixed-physiology balance all stay unresolved through the hospital course (over-resolving them is the single most likely way Batch 2 could weaken Traps #1, #2, and #4); and W12/W13 will introduce the first admission lab/vital values and MAR entries, so the baseline-vs-admission distinction that W07 carefully drew must be preserved, with values consistent against those baseline anchors (a Batch 2 creatinine trend must reconcile with the 1.6–1.8 baseline, or the AKI-on-CKD reasoning breaks). When Batch 2 arrives, the review will again focus on cross-file consistency and on holding the chart-content-not-task-answers line.


Independent ratification review of Batch 2 Synthetic World-Level File Construction. Review-only. Do not rewrite files. Do not create new files. Do not create Batch 3 files. Do not create task prompts. Do not create expected outputs. Do not create goldens. Do not create grader

pasted


batch-2-validation-review.md
322 lines

md


FI-W08_hd1-hd2-hospitalist-progress-documentation.md
78 lines

md


FI-W09_hd3-hospitalist-progress-documentation.md
81 lines

md


FI-W10_hd4-hospitalist-progress-documentation.md
86 lines

md


FI-W11_hd5-hd6-hospitalist-discharge-planning-progress-documentation.md
86 lines

md


FI-W12_objective-renal-infection-hemodynamic-trend-summary-source.md
79 lines

md


FI-W13_medication-administration-inpatient-medication-action-source.md
94 lines

md

Independent ratification review of Batch 2 Synthetic World-Level File Construction as pasted

Jun 1
Independent ratification review of Batch 2 — six files containing the hospital-course spine plus the first objective values (FI-W12 labs/vitals, FI-W13 MAR). This is the highest-stakes content review so far: Batch 2 introduces actual numbers, which means the consistency checks become quantitative. The single most important thing I can do is verify the FI-W12 lab trends against the locked baseline anchors and against the clinical narrative — because a creatinine trend that doesn't reconcile with the 1.6–1.8 baseline would break the AKI-on-CKD reasoning the whole world depends on. Let me work the numbers.

The FI-W12 trend table — verified arithmetic and clinical coherence, RESOLVED and notably strong.

The creatinine trend: HD1 2.62 → HD2 2.38 → HD3 2.12 → HD4 1.98 → HD5 1.86 → HD6 1.80, against a stated baseline of 1.6–1.8. I checked this against the AKI-on-CKD story it has to tell:

It lands at, not below, baseline. HD6 1.80 is the top of the 1.6–1.8 baseline band — so renal function has "improved toward baseline" without fully returning to it (the narrative says exactly this). This is the clinically correct endpoint: a patient mid-recovery from prerenal AKI on CKD3 should be approaching but not necessarily at his best baseline at discharge. If it had dropped to 1.4 it would contradict the baseline; if it stayed at 2.4 the "improving" frame would fail. 1.80 is the right number.
The peak is plausible. HD1 2.62 against a 1.6–1.8 baseline is roughly a 1.5× elevation — consistent with prerenal AKI from a 3-week poor-intake/volume-depletion decline, not so high as to imply intrinsic renal failure or need for dialysis (which the surgical package correctly excluded). Coherent.
The trajectory is monotonic and smooth — each day improves, consistent with treated prerenal AKI resolving with volume repletion, no implausible jumps.
The supporting labs track coherently: BUN 48→29 (falls with creatinine, consistent prerenal pattern), WBC 15.6→9.4 (leukocytosis resolving with infection treatment — supports Trap #4's "infection was real and improved" without erasing it), potassium 5.1→4.4 (mildly elevated at AKI peak, normalizing — and critically, the 5.1 peak is exactly why spironolactone/sacubitril-valsartan holds are justified, which the MAR reflects), glucose 140–260 (poorly controlled, consistent with the 7.6–8.2 baseline A1c plus acute illness plus steroid effect — and notably elevated enough to justify the inpatient lispro). Temperature febrile→afebrile, BP borderline→stable-but-not-robust.

Every number reconciles with the locked baseline anchors and tells the intended "improving but not resolved" story. This is the check Batch 2 most had to pass, and the arithmetic is clean.

The potassium↔medication-hold coherence — the cross-file check I flagged at lock, verified. I specifically checked whether FI-W12's potassium trend reconciles with FI-W13's medication actions, because the dual RAAS/diuretic hold logic was a concern I raised back at the medication-expansion review. It coheres: K+ 5.1 at HD1 → spironolactone held "during AKI/hyperkalemia-risk period" (W13) and sacubitril/valsartan held — both correct given the K+ and the AKI. As K+ normalizes to 4.4, W13 frames restart as "discussed/reassessed" but explicitly not finalized. The labs justify the holds and the holds match the labs. No contradiction, and the restart question stays open (preserving Trap #2).

Cross-file consistency against Batch 1 — verified, RESOLVED.

Insulin lispro: W13 lists it explicitly as "inpatient-only glycemic-management action… not a baseline outpatient medication," reinforced in the daily spine and the validation artifact. The lispro decision holds at the content level — it appears only as inpatient correction, never retroactively added to baseline, and the glucose trend (140–260) provides the clinical justification for why inpatient correction was needed. This is the cleanest possible handling of that decision.
Baseline anchors: W12 reproduces the W07 baseline values (creatinine 1.6–1.8, eGFR 40–50, Hgb 10.5–11.5, dry weight ~97) identically and re-labels them "baseline, not admission values" — the distinction preserved.
Provider/identity/conditions/medications: consistent with Batch 1; no drift.
Objective 1 — Inventory fidelity — RESOLVED. Each file fulfills its locked row purpose; no missing/invented purpose, no row drift. No duplication with Batch 1 — these are the hospital-course files Batch 1 explicitly deferred. One positive note: the Tool/Origin fields now read "Writer-created synthetic chart file / data source" (more specific than Batch 1's generic label), moving toward the 2.113 origin specification.

Objective 2 — Temporal integrity — RESOLVED, and the W06/HD4 sequencing concern I raised at Batch 1 is now resolved correctly. This was my single carry-forward from Batch 1: would the early hospitalist notes leak rheumatology provenance before its HD4 availability? They don't. W08 (HD1–HD2) explicitly states "Outpatient rheumatology provenance is not yet available in the active inpatient chart" and closes with "FI-W06… is not used here because its locked availability is by HD4." W09 (HD3) keeps prednisone "unresolved by active inpatient sources." W10 (HD4) introduces it: "Outpatient rheumatology provenance has become available in the chart by HD4." The timing constraint is honored precisely — the exact thing I asked Batch 2 to watch. No post-world info, no discharge outcome, no +7/+30, every file dated ≤ 05/23 18:00 (W11 explicitly "before 18:00").

Objective 3 — Trap preservation, with special attention to W12/W13 behavior and #3/#5 — RESOLVED.

Trap #1 (prednisone): W10 lays out the five-source hierarchy and reaches a working interpretation ("clinically relevant, requires reconstruction… does not by itself prove adrenal suppression") without resolving adherence; W13 administers prednisone "under interim inpatient plan while source reconstruction continued… home taper truth remains unresolved by MAR alone." The trap stays a synthesis problem; reveal-drift guardrail holds.
Trap #2 (HF/AKI): strengthened across W08/W10/W11/W12/W13 — holds established, trends improving, restart explicitly not finalized. The MAR records "what happened, not what should happen next" (W13) — exactly the right framing to keep restart reasoning open.
W12 does not become an answer/interpretation file: verified. It states repeatedly that a near-baseline creatinine "does not by itself determine readiness for HFrEF medication restart," that potassium/BP "must be reconciled with actual medication actions and consultant timing," and that it "does not decide final infection source, medication plan, steroid contribution, or discharge readiness." It supplies trends, not conclusions. This was the key risk for the trend source and it's correctly bounded.
W13 does not become a final medication source: verified. It explicitly is "not a discharge medication reconciliation, final medication list, final restart plan, or answer file" and routes interpretation to W04/W05/W06/W12/consultants. Correct.
#3 vs #5 distinct: W09 makes functional/cognitive concerns visible in the physician frame but explicitly under-elaborated ("does not replace future nursing, PT, OT… records that the concern is emerging") — Trap #3 seed preserved as buried-elsewhere. W11 is the visible-but-incomplete discharge-facing physician source ("a superficial reader could view discharge planning as straightforward. That interpretation is incomplete") — Trap #5. The two are instantiated as genuinely different behaviors, and W11 explicitly flags it must not duplicate the later W22. Distinction holds.
Trap #4 (sepsis anchoring): WBC resolving + infection "reasonable part of the presentation" + "avoiding premature closure" across W08–W12, with no file saying "sepsis was wrong." Correct.
Objective 4 — Friction preservation — RESOLVED. W10 and W11 give the cleanest two-sided rendering yet of all three frictions: Cardiology vs Nephrology (both "defensible pressures" named, neither made correct, hospitalist synthesizes rather than defers); Family vs Primary Team (both positions explicitly "defensible," "medically improving but operationally dangerous"); Endocrinology vs Primary Team (endo concern "reasonable" AND primary-team caution against over-attribution "defensible," steroid "important but not dominant"). No collapse, no specialty made obviously correct, no new friction. The hospitalist-reconciles-not-defers framing directly honors the governance non-deferral rule.

Objective 5 — Source-of-truth preservation — RESOLVED. Batch 2 adds three source channels (attending progress, trend source, MAR) without collapsing provenance or elevating any source improperly. W12 and W13 both explicitly rank themselves below the synthesis they feed (trends/actions don't override consultant/reconciliation/rheumatology sources). The prednisone hierarchy is correctly applied in W10 with rheumatology as top authority introduced at HD4.

Objective 6 — Cross-batch consistency — RESOLVED (verified in detail above): identity, providers, medications, comorbidities, baseline anchors all consistent; lispro inpatient-only; baseline count 20 preserved.

Objective 7 — Construction quality — RESOLVED. Clinical realism is high — the progress notes read as authentic daily hospitalist documentation with a believable trajectory, and the trend table is clinically coherent (verified numerically). Internal consistency verified. Naming consistent. No-answer-file compliance verified per file. Ready for lock and ready to serve as Batch 3 dependency (consultants will respond to this spine).

The boundary I watch hardest — chart content vs pre-written task answers — RESOLVED, clean. No file states what a task should ask or what the correct discharge/medication/steroid answer is. W11 comes closest to the discharge question but deliberately ends in unresolved ("operationally dangerous if the discharge plan over-trusts a visible source") rather than supplying the answer. W13's "competing interpretations" lists what each specialty could reasonably worry — clinical documentation, not a grader key. The line held.

Classification summary

True defects: none. The trend arithmetic reconciles with baseline anchors, the K+/medication-hold logic coheres across W12/W13, the W06/HD4 timing is honored, lispro stays inpatient-only, and no file is an answer file.
Physician-preference items: none requiring action; the clinical values (creatinine trajectory, K+, WBC, glucose ranges) are the first hard numbers in the world and are Alexander's to confirm as physician-authored content — but they are clinically sound and internally consistent, so I find nothing to challenge.
Future-construction items: (1) Batch 3 consultants (W14 nephrology, W15 cardiology, W16 endocrinology) must respond to this trend/MAR spine and stay defensible/time-sensitive without making one specialty correct; (2) preserve the prednisone hierarchy in W16/W20; (3) W22 must remain useful-but-incomplete and not duplicate W11; (4) the per-file Tool/Origin will still need final engineering-converted vs writer-produced-media specification (W12/W13 as data sources may have specific origin implications) at packaging; (5) keep the FI-W12 values from being overused by later files as if they settled restart/disposition (the validation artifact flags this correctly).
Every objective classifies RESOLVED. No OPEN item; no BLOCKER. The validation artifact's findings are accurate — I independently verified the quantitative claims rather than relying on it.

Would you ratify Batch 2 Synthetic World-Level File Construction today? YES. The six files faithfully implement their locked rows; the hospital-course spine evolves believably from stabilization through plausible-but-unsettled discharge planning; the first objective values are clinically coherent and — verified numerically — reconcile with the locked baseline anchors (creatinine landing at the top of the 1.6–1.8 band, K+/WBC/glucose all tracking the intended story), with the potassium trend correctly justifying the medication holds in the MAR; the W06/HD4 timing constraint I flagged at Batch 1 is honored precisely; insulin lispro stays inpatient-only in the content; all five traps are preserved with W12/W13 correctly bounded as trend/action sources rather than answer files; all three frictions stay two-sided with hospitalist-synthesizes-not-defers framing; and the chart-content-not-task-answers line held. There is no true defect and no internal inconsistency.

Batch 2 Synthetic World-Level File Construction Status: LOCK READY.

Final Recommendation: GO.

If ratified, does this authorize Batch 3 Synthetic World-Level File Construction? YES — directly, per the construction plan's dependency order. Batch 3 (FI-W14 nephrology, FI-W15 cardiology, FI-W16 endocrinology) is the defined next step, and it correctly depends on Batches 1–2 existing so the consultants "respond to the same clinical spine" — which now includes the trend source and MAR the consultants must reason from. So ratifying Batch 2 authorizes beginning Batch 3 when you explicitly start it. The controls that travel into Batch 3 are specific and important: each consultant note stays dated within HD2–HD6 (strongest HD4–HD6 per the inventory) ≤ 05/23 18:00; neither nephrology nor cardiology may be made obviously correct — both must remain defensible and time-sensitive, reconciling against the same W12 trends and W13 actions without one specialty's note functioning as the restart answer (this is the core of Trap #2 and the Cardiology-vs-Nephrology friction, and it's the single most likely place Batch 3 could slip); endocrinology (W16) must stay interpretive — raising steroid/adrenal risk as one consideration, explicitly not the hidden single diagnosis, preserving the reveal guardrail; and the prednisone hierarchy must hold with rheumatology (W06) above endocrinology's inpatient interpretation. When Batch 3 arrives, the review will focus on consultant defensibility, the no-specialty-is-correct balance, and continued cross-file numerical consistency with the W12 trends.


batch-3-validation-review.md
330 lines

md


FI-W14_nephrology-consultation-documentation.md
123 lines

md


FI-W15_cardiology-consultation-documentation.md
116 lines

md


FI-W16_endocrinology-consultation-documentation.md
132 lines

md

Independent ratification review of Batch 3 Synthetic World-Level File Construction.
Review only.
Do not rewrite files.
Do not create files.
Do not create Batch 4.
Subject:
Batch 3 Synthetic World-Level File Construction
Files:

FI-W14 Nephrology Consultation Documentation
FI-W15 Cardiology Consultation Documentation
FI-W16 Endocrinology Consultation Documentation
Validation Artifact:

Batch 3 Validation Review
Primary Review Focus:

Consultant defensibility
Cardiology vs Nephrology balance
Endocrinology hidden-answer risk
Trap preservation
Source-of-truth preservation
Anti-answer-file compliance
Temporal integrity
Batch 1 and Batch 2 consistency
Review Questions:
Consultant Integrity

Is nephrology clinically defensible?
Is cardiology clinically defensible?
Is endocrinology clinically defensible?
Does any consultant become obviously correct?
Does any consultant become obviously wrong?
Classify: RESOLVED / OPEN / BLOCKER
Cardiology vs Nephrology
Verify:

timing disagreement preserved
sequencing disagreement preserved
neither consultant becomes final medication authority
neither consultant collapses Trap #2
Classify: RESOLVED / OPEN / BLOCKER
Endocrinology
Verify:

adrenal insufficiency not proven
steroid risk remains meaningful
prednisone hierarchy preserved
rheumatology remains highest-authority taper source
no hidden diagnosis reveal
Classify: RESOLVED / OPEN / BLOCKER
Source-of-Truth Preservation
Verify:

consultants remain interpretation sources
consultants do not become source overrides
attending synthesis remains necessary
Classify: RESOLVED / OPEN / BLOCKER
Anti-Answer-File Review
Verify:

no final discharge medication plan
no final prednisone taper
no final disposition decision
no final diagnosis resolution
Classify: RESOLVED / OPEN / BLOCKER
Batch Consistency
Review consistency against:

FI-W01 through FI-W07
FI-W08 through FI-W13
Verify:

no identity drift
no medication drift
no baseline drift
no source hierarchy drift Classify: RESOLVED / OPEN / BLOCKER Conclude: Would you ratify Batch 3 today? Answer: YES or NO Then provide: Batch 3 Synthetic World-Level File Construction Status: LOCK READY or NOT LOCK READY Final Recommendation: GO or HOLD Additionally answer: If ratified, does this authorize Batch 4 Synthetic World-Level File Construction? YES or NO Explain briefly. Review only.
Show more
Jun 1
Independent ratification review of Batch 3 — the three consultant notes. This is the batch where the Cardiology vs Nephrology friction either holds as a genuine two-sided disagreement or collapses, and where the endocrinology note either stays interpretive or drifts into the adrenal reveal the whole world is built to avoid. So I read W14 and W15 side by side specifically to test symmetry (the validation artifact correctly flags they must be reviewed as a pair), and I read W16 hardest of all three for hidden-diagnosis drift. I also re-checked the lab values the consultants cite against the locked FI-W12 trend.

Numerical consistency with FI-W12 — verified, RESOLVED. Both W14 and W15 cite "creatinine 2.62 → 1.98 on HD4, potassium 5.1 → 4.6," and "creatinine near 1.80 by HD6, potassium 4.4." These match the locked FI-W12 trend table exactly (HD1 2.62/5.1, HD4 1.98/4.6, HD6 1.80/4.4). The consultants are reasoning from the actual numbers in the trend source, not invented ones — so the cross-file quantitative chain holds. W16 cites the same glucose-elevated pattern from W12. No numerical drift.

Cardiology vs Nephrology — read as a pair for symmetry — RESOLVED, and this is the strongest friction execution in the build. I tested the specific failure mode: does either consultant become the obviously-correct one? They don't, and the symmetry is deliberate and clean:

Nephrology (W14): cautious on sequencing — "avoid restarting all renal/hemodynamic-sensitive medications at once," potassium risk for spironolactone/RAAS, floor BP "does not fully demonstrate orthostatic reserve." But it explicitly concedes the other side: "Nephrology agrees the chronic HFrEF/CAD regimen should not be lost indefinitely. The concern is sequencing and monitoring, not permanent abandonment."
Cardiology (W15): proactive on protection — "temporary acute-illness holds can become unintended long-term omissions," "held during AKI should not remain the only medication logic once the AKI trend improves." But it equally concedes: "Cardiology recognizes nephrology's concern that renal recovery, potassium, blood pressure, and intake remain relevant. The disagreement is about timing and sequencing, not whether renal safety matters."
Both notes name the same synthesis variables (renal trend, potassium, BP, intake, HFrEF/CAD risk, monitoring feasibility, functional/family concern) and both explicitly state neither specialty is the final authority — "Neither cardiology nor nephrology should be treated as the automatic final answer" (W15), "Neither perspective resolves the final medication plan alone" (W14). The disagreement is genuinely about timing and sequencing, which is exactly the locked friction ("medication restart timing"). Neither is careless; neither is obstructionist. The mirror-image concession structure is the right construction — each note is the strongest reasonable version of its specialty's position while granting the other's legitimacy.

Timing/sequencing disagreement preserved: yes — the entire friction is now explicitly a timing question, not a whether question.
Neither becomes final medication authority: yes — both defer to hospitalist synthesis.
Neither collapses Trap #2: yes — restart is reassessed but explicitly not finalized in either note; the MAR-shows-what-happened-not-what-should-happen-next logic holds.
Endocrinology — read hardest for hidden-answer drift — RESOLVED, guardrail held firmly. This is the file most at risk in the entire build, and it's handled with discipline. I checked the specific drift: does W16 quietly make adrenal insufficiency the answer? It does the opposite, repeatedly and structurally:

Adrenal insufficiency explicitly not proven: "Endocrinology does not interpret the case as proven adrenal insufficiency"; "avoid documenting adrenal insufficiency as proven unless objective clinical evaluation supports it"; "Adrenal insufficiency is not proven by this note, and steroid physiology does not explain the entire admission."
Steroid risk remains meaningful (the other half of the guardrail): "chronic steroid exposure should be incorporated into risk assessment… rather than treated as irrelevant once infection markers improve." So it doesn't over-correct into dismissing steroids either — it holds the genuine middle, which is what keeps it a friction rather than a non-issue.
The symptom-overlap framing is exactly right: W16 lists weakness/lightheadedness/low-reserve as overlapping with adrenal physiology AND with infection-recovery, dehydration/AKI, HF/CKD med effects, neuropathy/deconditioning, poor intake. By keeping the near-fall multi-attributable, it honors the ratified near-fall multi-causality guardrail at the consultant level — the steroid is one candidate among many, never the reveal.
Prednisone hierarchy preserved and rheumatology stays highest: W16 lists the five-source hierarchy with "Outpatient rheumatology attending documentation is the highest-authority source" at rung 1, and explicitly states endocrinology interprets but does not replace rheumatology. The validation artifact's carry-forward ("later files must not let endocrinology replace rheumatology as the prednisone-history source of truth") is honored here.
Endo vs Primary Team stays a two-sided risk-interpretation friction: both the team's caution against over-attribution and endo's caution against dismissal are called "reasonable," with the disagreement framed as "about risk interpretation and safe handling of uncertainty, not about one source proving a hidden diagnosis." Correct relabel preserved.
The endocrinology note is interpretive, not an answer key. The reveal-drift risk that has shadowed this world since the brainstorm is, at the consultant layer, cleanly avoided.

Now the structured objectives.

Consultant integrity — RESOLVED. All three defensible: nephrology cautious-not-obstructionist, cardiology proactive-not-careless, endocrinology interpretive-not-definitive. No consultant obviously correct; none obviously wrong. Each reads as authentic specialty documentation with appropriate domain focus.

Cardiology vs Nephrology — RESOLVED (detail above): timing/sequencing disagreement preserved, neither is final medication authority, neither collapses Trap #2.

Endocrinology — RESOLVED (detail above): adrenal insufficiency not proven, steroid risk remains meaningful, prednisone hierarchy preserved, rheumatology highest-authority, no hidden-diagnosis reveal.

Source-of-truth preservation — RESOLVED. All three consultants are presented as interpretation sources, not overrides — each explicitly states it does not override attending synthesis, the other consultants, MAR, trends, functional evidence, family, or future discharge sources. Attending synthesis is repeatedly affirmed as necessary ("the primary team should synthesize…"). The hospitalist-synthesizes-not-defers governance rule is honored in all three notes. No source improperly elevated.

Anti-answer-file — RESOLVED. Verified per file: W14 no final medication restart plan, W15 no final GDMT plan, W16 no final taper/no proven adrenal insufficiency/no final diabetes plan. None makes a disposition decision. Each ends in explicit deferral to synthesis. Multi-document reconciliation remains required.

Temporal integrity — RESOLVED. All three anchored HD2–HD6 (strongest HD4–HD6), every dated entry ≤ 05/23 18:00 (HD5–HD6 addenda explicitly "before 18:00"). W16 correctly notes endocrinology engaged after rheumatology provenance "became available by HD4" — honoring the W06/HD4 timing that has held since Batch 2. No post-world info, no discharge outcome, no +7/+30.

Batch 1 & 2 consistency — RESOLVED. Identity, comorbidities, medication architecture, baseline anchors, prednisone uncertainty, and the rheumatology hierarchy all inherited without contradiction. Lab citations match FI-W12 exactly (verified). Insulin lispro: W16 explicitly affirms it "should remain inpatient-only unless separately established as an outpatient medication" — the decision holds at the consultant layer too. No identity/medication/baseline/hierarchy drift.

The boundary I watch hardest — chart content vs pre-written task answers — RESOLVED, clean. The consultant notes come closest of any batch to the medication-reconciliation and care-coordination tasks, since that's literally what consultants opine on. But they stay clinical recommendations, not grader keys: none states what a task should ask, what the correct restart sequence is, or what the model should conclude. W14/W15's "the primary team should synthesize [list]" is authentic consultant documentation (consultants do defer final synthesis to the primary team), not a task answer. The line held even at the batch most exposed to crossing it.

Classification summary

True defects: none. Lab citations match the locked trend source, the Cardiology/Nephrology symmetry is clean, the endocrinology reveal-guardrail holds firmly, and no file is an answer file.
Physician-preference items: none requiring action; the consultant clinical reasoning is sound and is Alexander's physician-authored content to confirm, but I find nothing to challenge.
Future-construction items: (1) FI-W20 (family communication) and FI-W22 (discharge artifact) must not collapse the prednisone uncertainty these notes preserved; (2) Batch 4's nursing/PT/OT/family files carry the buried functional evidence — the consultants correctly only gesture at functional concerns without supplying that substrate, so Batch 4 remains necessary and must keep Trap #3 (buried) distinct from Trap #5 (visible-but-incomplete in W22); (3) W22 must remain useful-but-incomplete and reconcile against these consultant caveats rather than resolving them; (4) per-file Tool/Origin (writer-created synthetic consultant file) will still need final 2.113 origin specification at packaging.
Every objective classifies RESOLVED. No OPEN item; no BLOCKER. I independently verified the quantitative and symmetry claims rather than relying on the validation artifact, and reached the same conclusions.

Would you ratify Batch 3 Synthetic World-Level File Construction today? YES. The three consultant notes are each clinically defensible; the Cardiology vs Nephrology friction is preserved as a genuine, symmetric timing-and-sequencing disagreement in which neither specialty is made correct, careless, or the final medication authority; the endocrinology note holds the reveal-guardrail firmly — adrenal insufficiency explicitly not proven while steroid risk stays meaningful, with rheumatology preserved as the highest-authority prednisone source; all three remain interpretation sources that defer to hospitalist synthesis; none functions as an answer file; lab citations match the locked FI-W12 trend exactly; and consistency with Batches 1–2 (including insulin-lispro inpatient-only) holds. There is no true defect and no internal inconsistency. This is the batch that most tested whether the frictions and the anti-reveal discipline could survive contact with actual specialty documentation, and they did.

Batch 3 Synthetic World-Level File Construction Status: LOCK READY.

Final Recommendation: GO.

If ratified, does this authorize Batch 4 Synthetic World-Level File Construction? YES — directly, per the construction plan's dependency order. Batch 4 (FI-W17 nursing, FI-W18 PT, FI-W19 OT, FI-W20 family communication, FI-W21 case management/social work) is the defined next step, and it depends on Batches 1–3 existing so functional decline is interpreted against the established baseline and hospital course. So ratifying Batch 3 authorizes beginning Batch 4 when you explicitly start it. The controls that travel into Batch 4 are specific, and the first is the one I'd watch hardest because it's this batch's whole reason for existing: Batch 4 carries the buried functional/cognitive substrate (Trap #3) — the nursing/PT/OT/family observations of weakness, intake, ambulation tolerance, cognition, ADL and medication-management concerns that the physician notes (W09/W11) only gestured at. Those must be present and discoverable but in less-prominent sources, so that a reader who only reads physician summaries can plausibly miss them — that's the buried-evidence mechanism. Second: Trap #3 (buried, in W17–W21) must stay distinct from Trap #5 (visible-but-incomplete, in the not-yet-built W22) — Batch 4 is buried evidence, W22 is the reassuring-but-incomplete artifact; don't let a Batch 4 nursing note become a second "discharge looks fine" artifact. Third: Family vs Primary Team must stay balanced — Mara Merrow's baseline-deviation concern (W20) must be clinically meaningful without making discharge obviously unsafe, preserving the ratified two-sided balance. Fourth: every file dated within its HD range ≤ 05/23 18:00, and no file an answer key. When Batch 4 arrives, the review will focus on whether the functional evidence is genuinely buried-yet-discoverable, the #3/#5 distinction, and the family-balance.


batch-4-validation-review.md
282 lines

md


FI-W17_bedside-nursing-observation-notes-flowsheet-summary.md
121 lines

md


FI-W18_physical-therapy-assessment.md
114 lines

md


FI-W19_occupational-therapy-assessment.md
106 lines

md


FI-W20_family-communication-care-conference-documentation.md
116 lines

md


FI-W21_case-management-social-work-discharge-planning-note.md
109 lines

md


Independent ratification review of Batch 4 Synthetic World-Level File Construction. Review only. Do not rewrite files. Do not create files. Do not create Batch 5. Do not create task files. Do not create prompts. Do not create expected outputs. Do not create goldens. Do not

pasted

Independent ratification review of Batch 4 Synthetic World-Level File Construction. as pasted

Jun 1
Independent ratification review of Batch 4 — the five files carrying the buried functional/cognitive substrate (nursing, PT, OT, family, case management). This is the batch whose entire reason for existing is Trap #3, so the central question is subtle and specific: is the functional evidence present and discoverable but buried enough that a reader skimming only physician summaries would plausibly miss it — without tipping into a dramatic "obviously unsafe discharge" note that would collapse the trap into an answer key. I read all five files against that calibration, and checked the family-balance and #3/#5 separation hardest.

The Trap #3 calibration — the make-or-break judgment for this batch — RESOLVED. This is the hardest thing to get right in the whole world, and it's tuned correctly. The test is a two-sided knife-edge: too loud and it becomes an answer file; too quiet and the trap doesn't exist. Batch 4 sits in the genuine middle, and each file repeatedly signals it:

FI-W17 (nursing): "No acute nursing event established that discharge was unsafe. The concern was cumulative: Korvin looked better medically but still needed more practical support than his baseline description suggested." That's the exact buried-evidence mechanism — no single dramatic flag, a pattern that accumulates across shifts (cueing for call-light use, unsure whether he'd taken a med, fatigue after clustered care).
FI-W18 (PT): "No single PT finding established that home discharge would fail." Mobility is "deliberately mixed" — improving, not impossible, not back to baseline, safety-dependent on endurance/cueing/support.
FI-W19 (OT): "This does not prove he cannot manage medications after discharge. It does show that a complex changed regimen would require clear instructions and support." Medication-management concern is real but framed as conditional risk, not incapacity.
The recurring phrasing across all three — "subtle rather than dramatic," "improving but not clean baseline," "easy to overlook because the physician-facing problems appear to be improving" — is precisely the buried-but-discoverable register.
And critically: the functional evidence is distributed across five files such that no one file solves discharge readiness. Nursing has cueing/intake, PT has mobility/endurance, OT has ADL/medication-sequencing, family has baseline-deviation, CM/SW has support-capacity. A reader must synthesize all five against the FI-W07 baseline to see the disposition risk — which is exactly Trap #3's design. No file is the answer key.

The "easy to overlook" mechanism — verified against the physician layer. The buried-evidence trap only works if the physician notes (W09/W11) underweight what the nursing/therapy notes contain — otherwise nothing is buried. I checked the seam: W09 (HD3 hospitalist) said functional concerns were "emerging" and "easy to underweight because the physician-facing medical problems appear to be improving," explicitly deferring detail to "future nursing, PT, OT… sources." Batch 4 now supplies that deferred detail in the lower-visibility sources. So the buried mechanism is real: the physician summaries gesture, the therapy/nursing notes carry the substance, and a reader who stops at the physician notes misses it. The two layers interlock correctly.

Family vs Primary Team — read hardest for one-sidedness — RESOLVED. The specific failure mode is making family obviously right (which would collapse the friction into "listen to family = correct"). It's avoided with care. FI-W20's most important line: Mara "wants Korvin home when safe and understands he has improved. Her concern is that 'better than Monday' is not the same as ready to manage the next steps without support" — and explicitly "Mara is not simply objecting to discharge" and "does not establish refusal or a decisive unsafe-discharge fact." So family concern is meaningful and specific without being dispositive. Symmetrically, every Batch 4 file repeatedly affirms the team's defensible side — "medical improvement," "objective trends better," "discharge planning can reasonably be explored," "Neither position is documented as obviously correct." The friction stays genuinely two-sided. Neither family is overpowered nor made correct; the team is not made careless.

Trap #3 vs Trap #5 separation — verified, the distinction holds concretely — RESOLVED. The risk at this batch is that a CM/SW or nursing note becomes a second "discharge looks fine" artifact, pre-empting W22. It doesn't. FI-W21 (the most at-risk file, since it's discharge-planning-flavored) explicitly "does not become a discharge plan snapshot, discharge summary, or final interdisciplinary plan" and lists open items rather than a reassuring synthesis. Every Batch 4 file is buried evidence (Trap #3); none is the visible-but-incomplete artifact (Trap #5, reserved for W22). The validation artifact's framing is correct and I verified it against the files: Batch 4 = distributed buried substrate; W22 = the not-yet-built reassuring artifact. No early W22, no discharge-summary surrogate, no collapse.

Now the structured objectives.

Objective 1 — Inventory fidelity — RESOLVED. Each file fulfills its locked row purpose (nursing observations, PT mobility/endurance, OT ADL/medication-management, family baseline/communication, CM/SW logistics); no missing/invented purpose; no row drift; no duplication with Batches 1–3 (these are the functional/family/transition files those batches deferred). FI-W20's authorship is correctly noted as documentation of Mara's report by hospitalist/nursing/CM-SW — keeping it a charted collateral source, not a direct family document.

Objective 2 — Temporal integrity — RESOLVED. All five anchored within HD1–HD6 / HD3–HD6 / HD5–HD6 ≤ 05/23 18:00 (HD6 entries explicitly "before 18:00"). No post-world info, no discharge outcome, no +7/+30, no use-before-available. The nursing note spanning HD1–HD6 correctly contains only progressively-available observations.

Objective 3 — Trap #3 preservation — RESOLVED (detail above): present, clinically meaningful, distributed across all five files, discoverable-but-overlookable, no answer key, no hidden discharge answer. All five specific substrates verified — nursing cueing, PT mobility/endurance, OT medication-sequencing, family baseline-deviation, CM/SW support-capacity.

Objective 4 — Trap #3 vs #5 separation — RESOLVED (detail above): no early W22, no discharge-summary surrogate, no #5 collapse into #3.

Objective 5 — Family vs Primary Team — RESOLVED (detail above): family concern meaningful, not overpowered, not made obviously correct; team not careless; no file independently decides the friction.

Objective 6 — Source-of-truth preservation — RESOLVED. The specific risks all checked clean: family communication explicitly "does not outrank attending synthesis, verified medication reconciliation, pharmacy history, rheumatology prednisone provenance, consultant documentation, objective trends, or MAR" (W20); OT does not become a medication authority (it observes management ability, defers to reconciliation); nursing does not become a medication authority (documents collateral, "not verified medication history"); CM/SW does not become a disposition authority ("does not decide whether discharge should occur"). Rheumatology remains highest outpatient prednisone authority — W20 reproduces the five-rung prednisone hierarchy with rheumatology at the top and explicitly preserves it against family report. Governance intact.

Objective 7 — Batch consistency — RESOLVED. No identity/provider/medication/baseline/consultant drift across Batches 1–3. Insulin lispro remains inpatient-only (W21: "inpatient-only correctional insulin lispro should not be assumed to be a home medication without a final authorized medication plan"). Prednisone uncertainty preserved (W20 family uncertainty + rheumatology-highest). Medication-restart uncertainty preserved (W21 flags renal/HF timing requires synthesis, no final list). Functional evidence builds on W09's emerging concern and W11's "improving but operationally dangerous" frame without contradiction.

Objective 8 — Anti-answer-file — RESOLVED. Verified per file: none makes discharge obviously safe or unsafe; none resolves medication restart timing, prednisone history, or consultant disagreement; none is a hidden answer file. Each ends in explicit deferral to synthesis. The "operationally dangerous if over-trusted" logic stays in W11 (physician) and will live in W22 (artifact) — Batch 4 supplies the evidence that should be synthesized, not the synthesis.

The boundary I watch hardest — chart content vs pre-written task answers — RESOLVED, clean. Batch 4 is close to the discharge-planning and transition-of-care tasks, but the files stay clinical documentation, not grader keys. FI-W21's "open items" list and FI-W20's "specific family questions" are authentic care-conference documentation (these are the questions a real family asks and a real CM note tracks), not task prompts or expected answers. No file states what a task should ask or what the correct disposition is. The line held.

Classification summary

True defects: none. The Trap #3 calibration is correct (buried-but-discoverable, distributed, no answer key), the family-balance holds, the #3/#5 separation is concrete, source hierarchies are preserved, and consistency with Batches 1–3 holds including lispro inpatient-only.
Physician-preference items: none requiring action; the functional/cognitive clinical judgments are sound and are Alexander's physician-authored content to confirm, but I find nothing to challenge. (One subjective note the validation artifact itself raises and I agree with: candidate review should confirm the evidence is "subtle enough" — my read is it is, sitting correctly below dramatic disability; a physician may calibrate the exact subtlety, but it's within the right band.)
Future-construction items: (1) FI-W22 (Batch 5) must remain visible-but-incomplete and must NOT duplicate or resolve all the Batch 4 functional evidence — it should be the reassuring artifact that a reader could over-trust precisely because it underweights what these five files contain; this is the single most important carry-forward and the whole point of building W22 last; (2) W22 must not resolve final disposition, medication restart, prednisone taper, or consultant caveats; (3) preserve the distributed functional substrate as substrate (don't let any later file flatten it into one conclusion); (4) per-file Tool/Origin still needs final 2.113 specification at packaging.
Every objective classifies RESOLVED. No OPEN item; no BLOCKER. I independently verified the Trap #3 calibration, family-balance, and #3/#5 separation rather than relying on the validation artifact, and reached the same conclusions.

Would you ratify Batch 4 Synthetic World-Level File Construction today? YES. The five files carry the buried functional/cognitive substrate at exactly the right calibration — present, clinically meaningful, distributed across nursing/PT/OT/family/CM-SW, discoverable through synthesis but easy to overlook if a reader stops at the improving physician summaries, and with no single file functioning as an answer key. The Family vs Primary Team friction stays genuinely two-sided (Mara meaningful and specific but not dispositive; team defensible but not careless). Trap #3 (buried, here) stays distinct from Trap #5 (visible-but-incomplete, reserved for W22), with no early discharge artifact created. Source hierarchies hold (family below rheumatology/reconciliation; OT/nursing not medication authorities; CM/SW not disposition authority). Consistency with Batches 1–3 holds including insulin-lispro inpatient-only and preserved prednisone/restart uncertainty. There is no true defect and no internal inconsistency. This batch carried the subtlest judgment in the build — buried-but-discoverable without drama — and it's tuned correctly.

Batch 4 Synthetic World-Level File Construction Status: LOCK READY.

Final Recommendation: GO.

If ratified, does this authorize Batch 5 Synthetic World-Level File Construction? YES — directly, and it is the final world-level batch. Batch 5 is FI-W22 (the discharge-facing artifact), the single file the construction plan deliberately sequenced last because it carries the highest answer-file-drift risk, and it depends on all of Batches 1–4 existing so it can synthesize incompletely against them. So ratifying Batch 4 authorizes beginning Batch 5 when you explicitly start it. The controls travelling into Batch 5 are the most important of any batch, because W22 is Trap #5 and getting it wrong undoes the trap: W22 must be visible and reassuring enough that a reader could plausibly over-trust it, yet genuinely incomplete — it must NOT contain all the caveats that live in W14–W21, must NOT resolve final disposition, final medication restart, final prednisone taper, or the full consultant synthesis, and must NOT duplicate the Batch 4 functional evidence (if it did, there'd be nothing for the reader to miss, and Trap #5 would collapse). It must be dated 05/23 before 18:00, stay an artifact rather than becoming the actual discharge summary (that's a post-world task deliverable), and remain not-an-answer-file. When Batch 5 arrives, the review will focus almost entirely on that calibration — is W22 credibly reassuring and genuinely incomplete — plus the temporal boundary and the chart-content-not-task-answers line. After W22 locks, the 22-file world-level set is complete, and the project moves toward task-level files and then the physician-authored task layer, where the boundary I've watched all along becomes the central one.


batch-5-validation-review.md
271 lines

md


FI-W22_discharge-facing-plan-snapshot-before-world-close.md
159 lines

md


Independent Ratification Review of Batch 5 Synthetic World-Level File Construction Review only. Do not rewrite files. Do not create files. Do not lock Batch 5. Do not create task files. Do not create prompts. Do not create expected outputs. Do not create goldens. Do not cr

pasted

Independent Ratification Review of Batch 5 Synthetic World-Level File Construction
Review only. As pasted

Jun 2
Independent ratification review of Batch 5 — FI-W22, the single discharge-facing artifact built last by deliberate design. This is the most consequential single-file review in the build, because FI-W22 is Trap #5: its entire job is to be visible, organized, and reassuring enough that a reader could over-trust it, while remaining genuinely incomplete so that full case understanding still requires the rest of the world. Get it too complete and Trap #5 collapses (and arguably Trap #3 with it); get it too caveated and it stops being a credible discharge artifact. The review centers on that calibration and on the World Necessity Test the prompt correctly flags as the most important question.

The Trap #5 calibration — the make-or-break judgment — RESOLVED, and tuned correctly. I read W22 specifically asking: does it look authoritative while being incomplete? Both halves hold.

The "reassuring and visible" half: W22 reads as a genuine interdisciplinary discharge-planning snapshot — organized problem-by-problem (infection, AKI/CKD, HFrEF/CAD, diabetes, PMR/prednisone, functional/support), names the attending, lists all consultant and functional services involved, and leads with a clean "discharge-planning positives" summary (afebrile, creatinine improved toward baseline, K+ improved, BP stable, intake/alertness improved). A reviewer skimming this would plausibly think "improving patient, coordinated plan, reasonable discharge." That's exactly the over-trust surface Trap #5 needs.

The "genuinely incomplete" half — the critical test: W22 systematically converts every resolvable question into a deferred item rather than an answer. The "Items To Complete Before Final Discharge Order" section and the per-problem "Plan" entries all point forward — "final medication reconciliation," "document which HFrEF medications are continued/restarted/held/deferred," "include a clear prednisone instruction aligned with rheumatology intent," "finalize therapy recommendations," "confirm assistive-device plan and supervision expectations." It states plainly: "No final discharge order has been entered in this snapshot." So the artifact is reassuring in tone and organization while being empty of resolution — which is the precise mechanism. A reader who trusts the reassuring frame and stops here misses that none of the hard questions is actually answered.

The World Necessity Test — answered explicitly, PASS. This is the prompt's most important question, so I worked it directly: assume a task performer reads only FI-W22 — what do they still miss, and do Batches 1–4 remain necessary?

Critical information still missing: the actual lab trend values (W22 says "creatinine improved toward baseline" but gives no numbers — those live only in FI-W12); the specific medication hold/action history (FI-W13); the content of the consultant disagreement (W22 names that Cardiology and Nephrology were "reviewed" but not what each actually argued — that's FI-W14/W15); the buried functional evidence (W22 says "improved and participating in mobility/ADL work" but omits the cueing needs, endurance limits, medication-sequencing difficulty, and baseline-deviation that live in FI-W17–W21); the prednisone source conflict (W22 says "reviewed with available sources" without exposing that the sources don't align — that's FI-W04/W05/W06/W20).
Which traps still function reading only W22: all five. Trap #1 (prednisone) — W22 gives an instruction-to-be-written, not the resolved history. Trap #2 (HF/AKI restart) — W22 explicitly defers restart sequencing. Trap #3 (buried functional) — W22 omits the distributed functional substrate entirely, so the buried evidence is still buried. Trap #4 (sepsis anchoring) — W22 keeps infection "reasonable" without resolving the mixed-physiology question. Trap #5 (over-trust) — W22 is the trap, and a reader who stops here falls into it.
Which frictions still function: all three — W22 names the participants and the tensions but resolves none ("preserve cardioprotective therapy while respecting renal recovery," without choosing; steroid "without proving adrenal insufficiency"; family "participating" without making their concern dispositive).
Which hierarchies still matter: all — W22 explicitly says rheumatology provenance "remains important for intended outpatient taper context" and does not elevate family/endo/itself above it, so the source hierarchy still must be applied using the underlying files.
Verdict: Batches 1–4 are unambiguously still necessary. FI-W22 cannot substitute for the world — it is a pointer to unfinished work, not a synthesis of it. PASS.
This is the cleanest possible result: the artifact is genuinely useful and genuinely insufficient at the same time.

Now the structured objectives.

Objective 1 — Inventory fidelity — RESOLVED. Fulfills its locked row purpose (visible, reassuring-but-incomplete discharge-facing artifact before world close); no row drift; no missing/invented role; and it remains a planning snapshot explicitly ("No final discharge order has been entered"), not a completed discharge summary. The distinction between this artifact and the actual discharge-summary task deliverable is preserved — W22 is the chart artifact a task would be performed against, not the task output.

Objective 2 — Temporal integrity — RESOLVED. Anchored 05/23 before 18:00; no final discharge order; no completed disposition; no +7/+30; and — the subtle check — no retrospective/future knowledge (it reasons forward from "late afternoon before final orders," not from knowing the outcome). Clean.

Objective 3 — Trap #5 validation — RESOLVED (detail above): easy to find, easy to read, appears authoritative/helpful/reassuring, yet remains incomplete; full understanding still requires the world; it creates exactly the intended false sense of sufficiency for a superficial reader.

Objective 4 — Trap #3 vs #5 separation — RESOLVED, and this is the specific risk I checked hardest. The danger was that W22, in summarizing the functional plan, would expose the Batch 4 buried evidence and thereby collapse Trap #3 into Trap #5. It doesn't. W22 summarizes function at the planning level — "improved and participating in mobility and ADL work," "confirm assistive-device plan and supervision expectations" — without reproducing the detail that constitutes Trap #3: no cueing-need specifics, no endurance/transfer findings, no OT medication-sequencing difficulty, no baseline-deviation evidence, no caregiver-capacity specifics. So the buried evidence stays buried in W17–W21; W22 is the visible surface that underweights it. The two traps remain distinct and, importantly, interlock: W22 is over-trustable precisely because it doesn't expose what Batch 4 contains. Verified per-source — PT, OT, nursing, family, CM/SW are each referenced but none is summarized completely.

Objective 5 — Consultant friction preservation — RESOLVED. Cardiology vs Nephrology: W22 preserves timing uncertainty ("cardioprotective therapy remains important, while renal recovery and hemodynamic reserve remain relevant to timing"), chooses no winner, and converts neither consultant into final authority (defers to "final medication reconciliation"). Endocrinology vs Primary Team: steroid uncertainty preserved, adrenal insufficiency not proven, endo not made the answer, rheumatology not displaced. Both frictions stay active.

Objective 6 — Prednisone hierarchy preservation — RESOLVED. Rheumatology remains highest outpatient authority ("Rheumatology provenance remains important for intended outpatient taper context"); W22 does not elevate family report, does not elevate endocrinology, and does not itself become a prednisone source-of-truth file (it calls for an instruction to be written aligned to rheumatology intent, not a resolved taper). Hierarchy intact.

Objective 7 — Family and functional ambiguity — RESOLVED. Family concerns acknowledged ("Mara has been updated and is participating") and preserved without being over-exposed (the specific worries from W20 aren't reproduced) or under-exposed (family involvement is clearly part of the plan), and W22 does not decide the friction. Functional status: doesn't over-expose Trap #3 (above), and makes discharge neither obviously safe ("final disposition depends on…") nor obviously unsafe (it's "reasonable to continue"). The "plausible but not safely solved" balance holds.

Objective 8 — Anti-answer-file — RESOLVED. Verified: resolves none of final disposition, medication restart timing, consultant disagreement, prednisone history, or discharge readiness; is not a hidden answer file. Every resolvable question is a deferred item.

Objective 9 — World Necessity Test — PASS (answered explicitly above).

The boundary I've watched the whole build — chart content vs pre-written task answers — RESOLVED, clean, and especially important here. FI-W22 is the file closest to being a task answer, since the discharge-summary and discharge-planning tasks produce something that looks like it. The construction correctly keeps W22 as the input artifact (the reassuring-but-incomplete chart snapshot a task is performed against) rather than the output (the completed synthesis a task would produce). W22 states what remains to be done; it does not do it. No task prompt, expected output, golden, or grader content appears. The line held at the single file most able to cross it.

Classification summary

True defects: none. The Trap #5 calibration is correct (reassuring-and-visible yet genuinely incomplete), the World Necessity Test passes decisively, the #3/#5 separation holds (W22 underexposes rather than reproduces Batch 4), all three frictions and the prednisone hierarchy are preserved, and it is not an answer file.
Physician-preference items: the validation artifact's own carry-forward — candidate review should confirm W22 is neither "too complete" nor "too explicitly caveated." My read: it sits correctly in the band. If anything, a physician might judge the closing "Guardrails" paragraph (which lists everything W22 is not) as slightly meta for an in-world chart artifact — but that's a stylistic note, not a defect, and it doesn't leak future knowledge or resolve anything. Alexander's call whether to trim in-chart meta-language at final packaging.
Future-task-layer observations: (1) task files must NOT turn W22 into the source-of-truth answer (the whole point is that trusting W22 alone is the trap); (2) the discharge-summary task will produce the synthesis W22 deliberately withholds — that output is physician-authored task-layer content, still blocked until explicitly authorized; (3) per-file Tool/Origin still needs final 2.113 specification at packaging; (4) at task construction, the "items to complete" in W22 are good raw material for what a task might ask — but the prompts/goldens that operationalize that remain physician-authored.
Every objective classifies RESOLVED; Objective 9 is PASS. No OPEN item; no BLOCKER. I independently worked the World Necessity Test and the #3/#5 separation rather than relying on the validation artifact, and reached the same conclusions.

Would you ratify Batch 5 Synthetic World-Level File Construction today? YES. FI-W22 operationalizes Trap #5 correctly: it is visible, organized, and reassuring enough to be over-trusted, while remaining genuinely incomplete — every hard question is deferred rather than answered. The World Necessity Test passes decisively: a reader of W22 alone still misses the lab values (W12), the medication action history (W13), the actual consultant arguments (W14/W15), the buried functional substrate (W17–W21), and the prednisone source conflict (W04/W05/W06/W20), and all five traps and three frictions still function — so Batches 1–4 remain necessary and W22 cannot substitute for the world. The #3/#5 distinction holds because W22 underexposes the Batch 4 evidence rather than reproducing it. Frictions, prednisone hierarchy, insulin-lispro inpatient-only, and consistency with Batches 1–4 are all preserved, and the file is not an answer file. There is no true defect and no internal inconsistency. This was the highest-risk single file in the build, and the calibration is right.

Batch 5 Synthetic World-Level File Construction Status: LOCK READY.

Final Recommendation: GO.

If ratified, does this complete the World-Level Synthetic File Layer? YES. FI-W22 was the final world-level file (FI-W01–W22), and with it ratified, all 22 locked world-level rows from File Inventory v1 are constructed and reviewed: Batch 1 (W01–W07 presentation/provenance), Batch 2 (W08–W13 hospital-course spine + trend/MAR sources), Batch 3 (W14–W16 consultants), Batch 4 (W17–W21 buried functional/family/transition substrate), and Batch 5 (W22 discharge-facing artifact). The world-level layer is complete — the closed chart at the 05/23 18:00 snapshot now exists in full, internally consistent across every cross-file check I've run batch to batch (identity, 14 conditions, 20 medications with lispro inpatient-only, baseline anchors reconciling with the lab trends, provider roster, all three hierarchies, all five traps, all three frictions, and the temporal boundary).

What remains before the world is submission-ready is not world-level files: it's the task-level context files (FI-T01–T07, the post-world request framers at the discharge/+7/+30 anchors) and the supplementary files (FI-S01–S04), then the physician-authored task layer — task prompts, expected outputs, golden responses, and grader guidance — plus final Section 3 packaging (the 8-column file plan with 2.113 Tool/Origin specification) and the self-AutoQC run. The task layer is the one where the boundary I've tracked through every batch becomes the central event rather than a guardrail: those prompts and goldens are physician-authored and have been blocked all along, and when that phase opens it should be on Alexander's explicit authorization, with my role staying QC against the checklist rather than authorship. The world they'll be built on is now complete and sound.


task-level-context-file-architecture-v1.md
md

Independent Ratification Review of Task-Level Context File Architecture v1
Review only.
Do not modify files.
Do not create files.
Do not create FI-T files.
Do not create supplementary files.
Do not create prompts.
Do not create expected outputs.
Do not create goldens.
Do not create grader guidance.
Do not create AutoQC responses.
Do not create submission artifacts.
Artifact Under Review:
Task-Level Context File Architecture v1
Purpose:
Determine whether the task-layer architecture is structurally sound and ready for ratification before any FI-T construction begins.
Review Objective 1 — Architecture Completeness
Verify:

FI-T01 through FI-T07 architecture exists.
Each FI-T role is distinct.
No missing task-layer responsibilities.
No unnecessary overlap.
No architecture gaps.
Classify:

RESOLVED
OPEN
BLOCKER
Review Objective 2 — World Necessity Preservation
Verify:

FI-T files cannot replace the world.
FI-W22 remains incomplete.
World review remains necessary.
No FI-T architecture creates an answer file.
Questions:

Can a future performer complete tasks using only FI-T files?
Does architecture force interaction with world-level files?
Classify:

RESOLVED
OPEN
BLOCKER
Review Objective 3 — Trap Coverage
Verify coverage and preservation of:

Trap #1
Trap #2
Trap #3
Trap #4
Trap #5
Questions:

Are all traps exercised?
Does any FI-T architecture collapse a trap?
Does any trap become irrelevant?
Classify:

RESOLVED
OPEN
BLOCKER
Review Objective 4 — Friction Preservation
Verify preservation of:

Cardiology vs Nephrology
Endocrinology vs Primary Team
Family vs Primary Team
Questions:

Does any FI-T architecture resolve a friction?
Does architecture preserve ambiguity where required?
Classify:

RESOLVED
OPEN
BLOCKER
Review Objective 5 — Physician Workflow Compliance
Verify alignment with Medicine Team guidance.
Questions:

Are future deliverables physician-owned?
Are workflows reviewer-safe?
Any non-physician ownership risk?
Any workflow likely to be rejected?
Classify:

RESOLVED
OPEN
BLOCKER
Review Objective 6 — Source-of-Truth Preservation
Verify protection of:

master hierarchy
authority hierarchy
prednisone hierarchy
medication-restart uncertainty
Questions:

Can FI-T architecture accidentally elevate lower-authority sources?
Can FI-T architecture bypass hierarchy reasoning?
Classify:

RESOLVED
OPEN
BLOCKER
Review Objective 7 — P0/P1/P2 Coverage
Verify:

at least one P0 workflow exists
workflow distribution is sensible
workflow mapping is internally consistent
Classify:

RESOLVED
OPEN
BLOCKER
Review Objective 8 — Boundary Compliance
Verify:

no prompts created
no expected outputs created
no goldens created
no grader guidance created
no AutoQC responses created
no submission artifacts created
Classify:

RESOLVED
OPEN
BLOCKER
Review Objective 9 — Construction Readiness
Question:
If ratified today, can FI-T01 through FI-T07 be constructed without further architecture work?
Answer:
YES or NO
Explain.
Required Distinction
Separate findings into:

True Defects
Physician Preference Items
Future-Layer Observations Do not redesign unless a true defect exists. Conclusion Would you ratify Task-Level Context File Architecture v1 today? Answer: YES or NO Then provide: Task-Level Context File Architecture v1 Status: LOCK READY or NOT LOCK READY Final Recommendation: GO or HOLD Additionally answer: If ratified, is the repository ready to begin FI-T construction immediately? YES or NO Explain briefly. Review only. Do not create artifacts. Do not modify files.
Show more
Jun 2
Independent ratification review of Task-Level Context File Architecture v1 — the plan for the seven post-world request-framing files (FI-T01–T07). This is the architecture immediately preceding the physician-authored task layer, so the central checks are: does it preserve the World Necessity result Batch 5 just established (task-context files frame requests, they don't backfill world evidence), and does it keep deliverable ownership physician-side. Let me read it.


Viewed 2 files, ran a command
Viewed 2 files, ran a command
Read in full, including the truncated workflow mapping. This is an architecture/governance artifact for the task-context layer, so the review verifies structural soundness and — most importantly — that it preserves the World Necessity result Batch 5 just established and keeps deliverable ownership physician-side. I cross-checked the FI-T workflow mappings against the locked Task Architecture Package and the four approved workflows.

The World Necessity preservation — the single most important check at this layer — RESOLVED. The whole risk of a task-context layer is that a "context" file quietly becomes an answer key by backfilling world evidence or duplicating FI-W22 into a complete synthesis. The architecture forecloses this structurally and repeatedly, and it does so in the prohibited columns of the inventory rather than just in prose principles:

Every FI-T row's "Relationship to world files" column says "Must force synthesis across [specific FI-W files]" — the files are required, not optional.
Every row's "Prohibited content classes" column bans the answer (FI-T01: no final medication list/restart algorithm/prednisone answer; FI-T02: no actual discharge summary/hidden diagnosis; FI-T03: no final disposition; FI-T04: no completed care plan; etc.).
Global guardrails §2 state it four ways: "Do not make any FI-T file necessary because the world files are incomplete," "Do not hide a critical world fact only in an FI-T file," "Do not make an FI-T file the answer source for its task."
§6 explicitly preserves the Batch 5 result: "FI-W22 must remain visible, useful, and incomplete… Batch 1 through Batch 4 must remain necessary… No single task context file can replace the world."
Answering the prompt's two direct questions: Can a future performer complete tasks using only FI-T files? No — every FI-T is architected as a pointer to world files, banned from carrying the evidence needed to solve its task. Does the architecture force interaction with world-level files? Yes — explicitly, per-file, via the "must force synthesis across…" requirement. The World Necessity result holds at the task-context layer.

Now the objectives.

Objective 1 — Architecture completeness — RESOLVED. FI-T01–T07 architecture exists with distinct roles: T01 med-rec request, T02 discharge-summary request, T03 discharge-readiness/coordination request, T04 consultant-synthesis request, T05 +7 follow-up request, T06 +30 safety-review request, T07 med-safety handoff addendum. The one pair to scrutinize for unnecessary overlap is T01 vs T07 (both medication-safety): they're differentiated — T01 is the full reconciliation request, T07 is a focused handoff addendum narrowing to holds/restarts/taper ambiguity, explicitly "FI-T01-style medication reasoning without adding missing medication facts." That's a defensible distinction (a reconciliation request plus a focused safety handoff is realistic), though it's the lightest differentiation in the set — I'd flag it as the one a reviewer might question, not as a defect. No missing task-layer responsibility (all four workflows + the +7/+30 reasoning are covered); no architecture gap.

Objective 2 — World Necessity preservation — RESOLVED (detail above): FI-T files cannot replace the world, FI-W22 remains incomplete, world review remains necessary, no FI-T architecture creates an answer file.

Objective 3 — Trap coverage — RESOLVED. The trap matrix (§3) maps each trap to primary and secondary FI-T coverage with explicit "forbidden trap collapse patterns." All five are exercised; no FI-T collapses a trap; none becomes irrelevant. The #3/#5 distinction is preserved at this layer too ("Do not summarize all functional evidence inside task context… Preserve the need to read nursing, PT, OT, family, and care coordination sources" for #3; "Do not let FI-W22 or an FI-T file become the visible source that replaces chart review… Do not merge Trap #5 with Trap #3"). The "vary trap centrality so no single trap dominates" principle is sound design.

Objective 4 — Friction preservation — RESOLVED. The friction matrix (§4) specifies where each friction should appear and "where it must not be resolved." No FI-T file may declare a consultant winner, prove adrenal insufficiency, or make family dispositive. The hospitalist-synthesizes-not-defers governance rule is restated. Ambiguity is preserved where required.

Objective 5 — Physician workflow compliance — RESOLVED, and this is the layer-specific strength. The physician-perspective mapping (§5, rows 134–142) is explicit that final deliverables remain physician-authored, physician-reviewed, or physician-supervised — even for the administrative/care-coordination deliverable (T03: "physician-facing or physician-supervised, even when case management, social work, PT/OT, nursing, and family evidence support it"). The crucial distinction is stated cleanly (§5): "Source-of-truth hierarchy answers which evidence source is authoritative; task-design guidance answers who authors, reviews, supervises, or communicates the final deliverable." That correctly separates evidence-authority from deliverable-ownership. No non-physician ownership risk; the workflows are reviewer-safe. One note carried below on the 2.108 administrative-deliverable framing.

Objective 6 — Source-of-truth preservation — RESOLVED. §7 protects all three hierarchies with the key safeguard that "FI-T files may identify which channels require review but may not reorder them" — this directly answers the prompt's risk (can FI-T architecture elevate lower-authority sources or bypass hierarchy reasoning?). No: rheumatology stays highest for prednisone, consultants don't become final authorities by virtue of task context, family/patient stay collateral, and medication-restart uncertainty stays a time-sensitive synthesis problem FI-T files "must not select." Hierarchy reasoning is required, not bypassable.

Objective 7 — P0/P1/P2 coverage — RESOLVED. Three P0 workflows represented (Discharge Medication Reconciliation, Hospital Discharge Summary Generation, Discharge Planning Documentation) and one P1 (Interdisciplinary Care Plan), matching the locked Task Architecture Package's four-workflow set exactly. Distribution is sensible (T01/T07 → med rec, T02 → summary, T03/T05/T06 → planning, T04 → care plan). P2 correctly handled as "secondary reasoning texture only," never promoted to a primary workflow — preserving the 2.107 count. Workflow mapping is internally consistent: I verified each FI-T's assigned workflow against the locked four, and the consolidation (T05/T06 folded into Discharge Planning Documentation rather than spun into TCM/Risk-Stratification standalone workflows) holds the 2.107 resolution.

Objective 8 — Boundary compliance — RESOLVED. §8 explicitly prohibits, until separate authorization: FI-T construction, FI-S construction, prompts, expected outputs, goldens, grader guidance, AutoQC responses, DOCX/submission artifacts, new synthetic files, and final task specs/answers. The verification record (§ Verification) confirms none were created. The artifact is architecture only.

The boundary I've tracked the whole build — chart/context vs physician-authored task answers — RESOLVED, and notably this artifact is the one that makes the boundary explicit as its central subject. §1's "Relationship to future prompts/expected outputs" sections, the §8 prohibitions, and the §9 roadmap (which sequences prompt/expected-output/golden/grader architecture as separate later phases) all reinforce that FI-T files frame requests but the task deliverables remain blocked and physician-owned. This is exactly the line I flagged at Batch 5 as becoming central — and the architecture treats it as central.

Classification summary

True defects: none. World Necessity preserved, hierarchies non-reorderable, all traps/frictions preserved with anti-collapse guardrails, workflow mapping consistent with the locked four and the 2.107 resolution, physician ownership explicit, boundaries intact.
Physician-preference items: (1) the T01/T07 differentiation is the lightest in the set — a reviewer might ask whether a separate med-safety handoff addendum is needed or whether it folds into T01; defensible as-is, Alexander's call; (2) the validation watch-item that FI-T files must preserve uncertainty "without making FI-W22 useless" is a calibration the physician will confirm at construction.
Future-layer observations: (1) the 2.108 administrative-deliverable question still rides on Discharge Planning Documentation (T03/T05/T06) — this architecture correctly keeps it physician-supervised, but the standing bet (with utilization-review as fallback if a reviewer challenges whether discharge planning counts as the administrative deliverable) remains a packaging-time item; (2) the physician-authored task layer (prompts, expected outputs, goldens, grader) is correctly sequenced as separate phases in §9 and remains blocked — when it opens, it should be on explicit authorization with my role staying QC, not authorship; (3) per-file Tool/Origin and the FI-S supplementary files are downstream; (4) Section 3 packaging still needs the v6.3 8-column structure.
Every objective classifies RESOLVED. No OPEN item; no BLOCKER.

Objective 9 — Construction readiness: YES. If ratified today, FI-T01–T07 can be constructed without further architecture work. The architecture specifies, per file: intended role, information scope, the exact world files each must force synthesis across, permitted content classes, prohibited content classes, workflow mapping, priority family, physician-ownership frame, trap coverage, and friction coverage. That is a complete construction specification — a builder has everything needed to write each FI-T context file correctly, and the guardrails define what must not appear. No gap would force a return to architecture.

Would you ratify Task-Level Context File Architecture v1 today? YES. It is structurally complete (seven distinct FI-T roles covering all four workflows plus +7/+30 reasoning), preserves the World Necessity result decisively (every FI-T architected as a pointer that forces world-file synthesis and is banned from carrying its task's answer), keeps FI-W22 incomplete and Batches 1–4 necessary, preserves all five traps and three frictions with explicit anti-collapse and anti-resolution guardrails, protects all three source hierarchies with the non-reorderable safeguard, maps workflows consistently with the locked four and the 2.107 resolution, makes deliverable ownership explicitly physician-side while correctly separating evidence-authority from deliverable-authorship, and holds every downstream boundary. There is no true defect and no internal inconsistency.

Task-Level Context File Architecture v1 Status: LOCK READY.

Final Recommendation: GO.

If ratified, is the repository ready to begin FI-T construction immediately? YES — directly, per the roadmap. FI-T construction is §9 step 3, the defined next step, and it depends only on this architecture being ratified (which depends in turn on the now-complete world-level layer). So ratifying authorizes beginning FI-T01–T07 construction when you explicitly start it. The controls travelling into construction are: each FI-T stays a compact request-framing file dated at its locked anchor (05/24, 05/31, or 06/23), forces synthesis across its specified world files rather than backfilling evidence, carries none of its prohibited content classes, preserves uncertainty without making FI-W22 useless, and keeps the #3/#5 distinction. The standing procedural rule still applies — construction begins on your explicit authorization. And the larger boundary remains: FI-T construction produces context files; the physician-authored task layer (prompts, expected outputs, goldens, grader guidance) is still blocked behind its own later authorization, and when it opens, that's the phase where I stay strictly in QC against the checklist rather than authoring — the line this whole chain has protected, now one step from the layer where it matters most.


Independent Clinical Architecture Review Review only. Do not modify files. Do not create files. Do not ratify or lock. Do not create FI-S files. Do not create task prompts. Do not create expected outputs. Do not create goldens. Do not create grader guidance. Do not crea

pasted


FI-T01_discharge-medication-reconciliation-request-context.md
103 lines

md


FI-T02_discharge-summary-drafting-request-context.md
98 lines

md


FI-T03_discharge-readiness-care-coordination-request-context.md
98 lines

md


FI-T04_consultant-synthesis-interdisciplinary-care-plan-request-context.md
98 lines

md


FI-T05_early-post-discharge-follow-up-assessment-request-context.md
100 lines

md


FI-T06_patient-safety-readmission-risk-review-request-context.md
101 lines

md


FI-T07_medication-safety-handoff-task-context-addendum.md
99 lines

md


task-context-files-validation-review.md
171 lines

md

Independent Verification Requirement: as pasted in prompts
Assume no prior review exists.
Do not defer to validation artifacts.
Do not defer to ratifications.
Verify every claim yourself.
If you disagree with the architecture, inventory, validation review, or another reviewer, say so explicitly.

Jun 2
Independent clinical-architecture review of FI-T01–T07. I'm taking the independent-verification instruction seriously: I read all seven context files and the validation artifact, but I'm verifying the claims against the actual world files I reviewed across Batches 1–5 rather than trusting any prior sign-off. Where I disagree, I'll say so plainly. This is a physician-level and task-design review, not a row-wording audit.

Let me start with the one thing the independent-verification framing demands I check hardest, because it's the failure mode most likely to be papered over by a confident validation artifact: do these files actually require world synthesis, or do they only claim to? A context file can list "FI-W14, FI-W15, FI-W16" in a required-synthesis table and still leak the answer in its prose. So I read the Review Focus and Trap Preservation sections of each, not just the file tables.

The result of that check — RESOLVED, but with one real disagreement I'll register. Six of the seven files genuinely require synthesis: they orient the future reviewer to domains ("medications held during AKI," "timing and sequencing uncertainty," "prednisone exposure and taper history") without stating the resolution of any of them. The orientation is the kind a real requester gives ("here's what to look at"), not the kind that pre-decides ("here's the answer"). That's the correct line and it holds.

My disagreement is with FI-T07, and I disagree with the validation artifact's clean pass on it. Not a defect — but the validation review and the architecture both treat FI-T07 as cleanly distinct from FI-T01, and on close reading it is the weakest-justified file in the set. Look at what FI-T07 actually contains: its required-synthesis table (FI-W03, W04, W05, W06, W11, W12, W13, W14, W15, W16, W19, W22) is nearly identical to FI-T01's (FI-W03, W04, W05, W06, W11, W12, W13, W14, W15, W16, W19, W22) — they are the same twelve files minus none. Its Handoff Focus list overlaps FI-T01's Review Focus almost line for line (holds vs reintroduction, renal/potassium safety, BP/volume, diabetes safety, inpatient-only insulin, prednisone ambiguity, home medication-management, follow-up). Its traps (#1, #2) are a subset of FI-T01's (#1, #2, #5). Its frictions are identical. The stated difference — FI-T07 "narrows attention" as a focused pharmacy handoff "addendum" — is real in framing but thin in substance: it's the same task with a pharmacy-voiced wrapper and Trap #5 demoted to "background."

I flagged this exact risk at the architecture-review stage as "the lightest differentiation in the set," and now that the file is built, the concern is confirmed, not resolved. This is a Physician Preference Item, not a True Defect — a real hospital does generate both a discharge med-rec request and a separate pharmacy medication-safety handoff, so it's clinically plausible, and FI-T07 doesn't leak any answer. But two task-context files that point to the same twelve files with the same focus invite a downstream question: when prompts are built from these, will FI-T01's task and FI-T07's task be meaningfully different, or will they produce near-duplicate medication-reconciliation work? I disagree with the validation artifact's implication that FI-T07's distinctness is settled. It should be flagged for the prompt-architecture phase: either FI-T07's eventual prompt must test a genuinely different competency (e.g., a focused hold/restart communication handoff rather than a full reconciliation), or FI-T07 risks redundancy with FI-T01. Worth a physician decision before prompts are written.

Now the structured review areas.

Review Area 1 — World Necessity (could a reviewer complete the task using only the FI-T; does it over-summarize or reveal the answer):

FI-T01 — STRONG. Forces synthesis across 12 world files; orients to domains without resolving restart timing or prednisone; explicitly "should not be usable as a standalone medication answer."
FI-T02 — STRONG. Requires ED→discharge reconstruction; the Trap #4 framing ("not as if sepsis was either the entire answer or a false lead") orients without revealing; cannot substitute for the course.
FI-T03 — STRONG. Requires the distributed functional substrate (W17–W21) plus W22; explicitly "intentionally does not summarize all of that evidence" — correctly keeps Trap #3 buried.
FI-T04 — STRONG. Requires consultant + trend + MAR + family + functional synthesis; "no consultant winner," hospitalist-synthesizes-not-defers preserved.
FI-T05 — STRONG, and notably well-guarded. The +7 anchor is the file most at risk of inventing a solved follow-up story; it explicitly forbids new labs/vitals/symptoms/outcomes and requires reconstruction from FI-W01–W22. The "+7 anchor is a task date, not permission to invent" line is exactly right.
FI-T06 — STRONG, same +30 guard. Forbids adverse event/readmission outcome/RCA; keeps the safety review inside Discharge Planning Documentation.
FI-T07 — ACCEPTABLE (downgraded from STRONG specifically for the redundancy-with-T01 concern above; it requires world synthesis and reveals nothing, so it clears the bar, but its independent necessity is the weakest).
No FI-T over-summarizes or reveals its answer. No FI-T collapses world exploration.

Review Area 2 — Physician Realism (would this exist in practice; is it physician-owned):

FI-T01 (discharge med rec) — STRONG, core hospitalist/pharmacist workflow.
FI-T02 (discharge summary) — STRONG, attending-owned by definition.
FI-T03 (discharge readiness/coordination) — STRONG; the file correctly keeps it physician-supervised even though CM/SW/PT/OT supply evidence — this is the realistic ownership structure.
FI-T04 (interdisciplinary care plan) — STRONG, hospitalist-led synthesis is exactly real.
FI-T05 (+7 follow-up) — STRONG, PCP/transition-team follow-up is standard.
FI-T06 (+30 safety review) — STRONG, quality/safety retrospective is a real workflow.
FI-T07 (med-safety handoff) — ACCEPTABLE; a pharmacy handoff is real, but see the redundancy note; physician review responsibility is preserved.
All seven are physician-owned or physician-supervised; none drifts to non-physician final ownership.

Review Area 3 — Clinical Reasoning Depth (reasoning vs transcription): The set forces reasoning, not extraction, because the core questions are irreducibly synthesis problems: the medication restart can't be transcribed (no file states it — it must be reconstructed from the K+/creatinine trend in W12 + the holds in W13 + the competing consultant logic in W14/W15 + discharge context); the prednisone history can't be extracted (the five sources don't align — it must be adjudicated by hierarchy); the disposition can't be looked up (the functional evidence is distributed across five files and must be weighed against the reassuring W22).

The one file I'd watch for transcription risk is FI-T02 (discharge summary) — discharge summaries can degrade into chart-summarization. But this context correctly defends against it by demanding the course be written "by evolution, not merely by copied problem list" and by foregrounding the Trap #4 anchoring judgment (sepsis was reasonable-then-incomplete), which requires interpretation, not transcription. No FI-T risks becoming checklist completion. FI-T07 is the one whose reasoning most overlaps another file's (T01), which is the redundancy point, not a transcription point.

Review Area 4 — Friction Integrity (both sides defensible; any subtle bias): I checked each file for one-sided framing. None biases:

Cardiology vs Nephrology — every file that carries it (T01, T04, T06, T07) frames it as "timing and sequencing," names both rationales, and explicitly forbids declaring a winner. No drift. (I verified against W14/W15 themselves, which I found symmetric at Batch 3 — the context files preserve that symmetry.)
Endocrinology vs Primary Team — every carrying file (T01, T02, T04, T05, T07) holds "steroid risk meaningful AND not the hidden diagnosis," with rheumatology kept above endocrinology. No drift toward the adrenal reveal.
Family vs Primary Team — every carrying file (T02, T03, T04, T05, T06) holds "family meaningful but not dispositive; team defensible but not careless." No drift toward family-obviously-right.
No FI-T makes a stakeholder obviously correct. Friction integrity is clean across all seven.

Review Area 5 — Trap Integrity (any neutralized trap; any revealed reasoning; any trap turned into a visible instruction): All five preserved; none neutralized. The check that matters most — does any context file turn a buried trap into a visible instruction? — passes: FI-T03 and FI-T06 (which carry Trap #3) explicitly refuse to summarize the functional evidence ("intentionally does not summarize all of that evidence"), which is the correct move — if they listed the cueing/endurance/medication-management findings, they'd convert buried Trap #3 into a visible checklist and destroy it. They don't. The #3 vs #5 distinction is preserved in every file that touches both (T03, T06): #3 = find the buried evidence; #5 = don't over-trust W22. No FI-T reveals hidden reasoning or transforms a trap into an instruction.

Review Area 6 — Anti-Answer-File (true leakage only): I checked for the five specific leaks. None present. No file implies a correct diagnosis (mixed physiology preserved, no adrenal reveal), a correct medication plan (restart explicitly deferred everywhere), a correct discharge decision (every file: "does not decide safe/unsafe"), a correct consultant winner (explicitly forbidden), or a correct steroid interpretation (rheumatology-hierarchy reconstruction required, adrenal insufficiency unproven). The "Prohibited Content" sections are not just disclaimers — I verified the body prose of each file honors them. No true answer-file leakage.

Review Area 7 — Submission Readiness (strong physician tasks; reviewer survival; future rework risk): These contexts would generate strong physician-level tasks that should survive reviewer scrutiny, because each forces multi-document synthesis, preserves uncertainty, and keeps deliverables physician-owned. The architectural weakness most likely to generate future rework is the FI-T01/FI-T07 overlap (above) — if both spawn full medication-reconciliation prompts, a reviewer may flag redundancy, and the fix would mean reworking one prompt's scope. Getting that differentiation decided before prompt construction avoids the rework.

Findings

True Defects: none. No answer-file leakage, no trap neutralization, no friction bias, no world-necessity failure, no broken physician ownership.
Physician Preference Items: (1) FI-T01/FI-T07 differentiation — the most important item; decide before prompts whether FI-T07's task is genuinely distinct (e.g., a focused hold/restart communication handoff) or folds into FI-T01, since as written they point to the same twelve files with the same focus; (2) whether FI-T02's discharge-summary task needs an explicit anti-transcription instruction at the prompt layer (the context defends against it, but the prompt should reinforce it).
Future-Layer Observations: (1) the standing 2.108 administrative-deliverable question still rides on FI-T03/T05/T06 under Discharge Planning Documentation — physician-supervised here, but the bet (utilization-review fallback) remains for packaging; (2) the physician-authored prompt/expected-output/golden/grader layer remains blocked and must stay physician-authored — my role there is QC, not authorship; (3) per-file Tool/Origin and Section 3's v6.3 8-column structure remain packaging items; (4) FI-S supplementary files are still to come.
Where I explicitly disagree with the validation artifact: it lists FI-T07's distinctness as cleanly VERIFIED. I do not fully agree — FI-T07 clears the world-necessity and anti-answer-file bars, but its independent justification relative to FI-T01 is thin, and I'd flag that as an open prompt-architecture decision rather than a settled point. This is a disagreement about task-design redundancy risk, not about clinical safety or answer leakage, where the artifact and I agree.

Would you approve these FI-T files as the foundation for future task construction? YES. All seven create physician-owned task contexts that require deep world synthesis, preserve clinical uncertainty, preserve consultant defensibility (both Cardiology/Nephrology and Endo/Primary-Team symmetric, Family/Team balanced), preserve physician reasoning burden (irreducible synthesis, not transcription), and avoid becoming answer files (no leakage on any of the five axes, verified in the prose not just the disclaimers). The world-necessity result from Batch 5 holds: every FI-T points back to FI-W01–W22 and none can substitute for the world. My one substantive reservation — the FI-T01/FI-T07 redundancy — is a task-design refinement to settle before prompts, not a barrier to approving the foundation.

Task-Level Context File Construction Clinical Architecture Status: STRONG. (Six STRONG, one ACCEPTABLE; no WEAK; no defect.)

Final Recommendation: GO WITH MINOR NOTES. The minor notes are: resolve the FI-T01/FI-T07 differentiation before prompt construction, and carry the anti-transcription emphasis into the FI-T02 prompt. Both are prompt-layer refinements. The standing boundary remains the one to hold most carefully from here: the next phase (task prompts, expected outputs, goldens, grader guidance) is physician-authored and still gated — when it opens on your explicit authorization, I stay in QC against the checklist, not authorship.


supplementary-file-architecture-v1.md
235 lines

md


supplementary-file-architecture-validation-review.md
192 lines

md


Independent Review — Supplementary File Architecture v1 Review only. Do not modify files. Do not create files. Do not ratify or lock. Do not create FI-S files. Do not create task prompts. Do not create expected outputs. Do not create goldens. Do not create grader guidance.

pasted

Independent Review — Supplementary File Architecture v1
 as pasted

Jun 2
Independent review of Supplementary File Architecture v1. Per the verification requirement, I'm assuming no prior review exists and verifying every claim against the locked inventory and the world files I reviewed across Batches 1–5, not deferring to the validation artifact or any ratification. The defining property of a supplementary layer is that it must add texture without carrying sole critical evidence — so the central check is the inverse of every prior batch: instead of "does this evidence reconcile," it's "does this architecture prevent these files from mattering too much." Where I disagree with the validation artifact, I'll say so.

The one thing the independent-verification framing demands I check first, because it's where a supplementary layer most often goes wrong and where a confident validation artifact would gloss it: the count claim. The architecture and validation both assert "exactly 4, fixed by File Inventory v1." I verified this against the File Inventory v1 I reviewed earlier — it specified 4 supplementary files (FI-S01–S04) within the 3–6 band, and the four roles here (PCI provenance, sleep-study provenance, home-support logistics, problem-list snapshot) match the inventory's supplementary rows exactly. The count is correct and the IDs align. No FI-S05 invented. Confirmed independently.

Now the substantive supplementary-specific check, which the prompt frames well: does this architecture prevent the files from becoming answer files / shortcuts? This is the whole risk of a supplementary layer, and it's where I focused hardest. The architecture handles it correctly and, notably, structurally — the "Prohibited content classes" column of each row bans that file's most dangerous over-reach, and §12 (Anti-Answer-File) adds the key principle most supplementary layers miss: "make the world easier by collecting dispersed evidence into one file" is explicitly forbidden. That's the precise supplementary failure mode — not that any one file lies, but that a "background" file quietly aggregates what should require synthesis. The architecture names and bans it. I'll verify each file against that bar below.

Review Objective 1 — Authorized artifact validation — RESOLVED. Only the two architecture documents exist; no FI-S files, prompts, expected outputs, goldens, grader guidance, AutoQC responses, DOCX, or submission artifacts. The §14 roadmap and §11/§13 boundaries hold the phase line. Verified against the file set provided.

Review Objective 2 — Inventory fidelity — RESOLVED for all four rows. I checked each FI-S role against the locked inventory and against the world files it claims to support:

FI-S01 (remote PCI/stent provenance) — RESOLVED. Supports the CAD/HFrEF background; the world already establishes "remote PCI/stent" in W03/W07/W15, so this adds provenance texture for an already-locked fact, not a new one. Prohibited column correctly bans an acute coronary event / new PCI / GDMT-restart answer / Trap-#2 key.
FI-S02 (remote sleep-study/OSA provenance) — RESOLVED. OSA is locked in the comorbidity set; this is background reserve context. The critical prohibition is right: "new hypoxemia arc, acute respiratory failure, hidden cause of altered mental status." That last one matters — OSA could be misused as a sneaky single-cause explanation for the AMS, which would puncture the mixed-physiology design. The architecture explicitly forbids it. Good catch by the architecture.
FI-S03 (home-support/equipment logistics) — RESOLVED. HD5–HD6 logistics texture supporting W20/W21; prohibited from becoming a final services authorization or discharge conclusion. This is the one FI-S file inside the world timeline (not pre-admission provenance), so its temporal boundary (≤ 05/23 18:00) is load-bearing — and §10 sets it correctly.
FI-S04 (problem-list/past-history snapshot) — RESOLVED, and this is the row I scrutinized hardest. A problem-list snapshot is the single most dangerous supplementary file in any clinical world, because a problem list is exactly the kind of artifact that can become a one-click answer ("here's everything in one place"). The architecture defends against it precisely: prohibited from being a "final diagnosis list, final discharge problem list, medication-reconciliation answer, prednisone source-of-truth answer, copy-forward answer file," and explicitly framed as "low-authority background" that "must not outrank stronger sources or become the discharge summary substrate." The "stale or copied-forward problem-list features if clearly non-authoritative" permission is actually a nice touch — it lets FI-S04 be realistically unreliable (a stale problem list is a real chart artifact), which adds texture without authority. Correct handling.
Review Objective 3 — Architecture fidelity — RESOLVED. No silent broadening or narrowing: §2 explicitly limits FI-S coverage to "coverage already recorded in locked File Inventory v1," and I verified the workflow/trap/friction/authority mappings match the locked matrices (no new workflow, no new trap, no new friction, no hierarchy change). The four locked workflows are referenced unchanged; the 2.107 count is untouched (supplementary files carry no workflow of their own).

Review Objective 4 — World necessity preservation — RESOLVED. This is the supplementary version of the Batch 5 test, and it passes. Each FI-S row's "Relationship to world files" column says "may support [files] as background/texture" and "must not replace" the substantive sources; the workflow matrix (§6) reaffirms that final reasoning "still requires" the full FI-W and FI-T sets per workflow; §12 bans the aggregation shortcut. Answering the prompt directly: no FI-S file creates a shortcut through the world or becomes a one-file solution — they are architected as texture that points to the world, and the workflows remain solvable only via the FI-W/FI-T sets. FI-W22 stays incomplete (no FI-S completes it). Verified.

Review Objective 5 — Trap preservation — RESOLVED, and the restraint here is the right call. The trap matrix (§7) assigns FI-S files to no primary trap coverage — Trap #1 none, Trap #2 FI-S01 indirect secondary only, Trap #3 none primary, Trap #4 none, Trap #5 FI-S03 secondary only. This is correct: supplementary files should not carry trap weight, because a trap whose evidence lives in a "supplementary" file is either mislabeled (it's actually essential) or the trap is solvable from background texture (too easy). By keeping all five traps' primary substrate in the world-level files and letting FI-S files only add indirect texture, the architecture preserves every trap without exposing hidden reasoning. The #3 vs #5 distinction is explicitly preserved (§7), and critically FI-S02 is forbidden from "explaining functional decline" (which would collapse Trap #3) and FI-S03 from becoming "a final discharge plan / visible answer file" (which would collapse Trap #5). No trap collapsed, weakened, or turned into an answer key.

Review Objective 6 — Friction preservation — RESOLVED. The friction matrix (§8) keeps FI-S coverage to indirect/secondary support only (FI-S01 indirect for Cardiology vs Nephrology, FI-S03 secondary for Family vs Primary Team, none for Endo vs Primary Team), with explicit anti-bias boundaries: FI-S01 "must not make Cardiology correct by default" nor "Nephrology overly cautious by default"; FI-S03 "must not make family concerns independently dispositive." No FI-S file resolves a friction, biases a side, or removes uncertainty. The Endo/Primary-Team friction correctly gets zero FI-S coverage — right, since any supplementary steroid content would risk the prednisone hierarchy and the adrenal-reveal guardrail.

Review Objective 7 — Source-hierarchy preservation — RESOLVED. §9 reproduces all three hierarchies verbatim and states FI-S files "do not outrank locked world-level sources, task-context files, or source-of-truth hierarchies." The specific risk for FI-S04 (a problem-list file elevating itself) is foreclosed — it's pinned as "low-authority background" that "must not outrank stronger sources." No FI-S file elevates a lower-authority source, overrides a higher one, or becomes a hierarchy shortcut. Rheumatology stays highest for prednisone; FI-S files carry no prednisone authority.

Review Objective 8 — Anti-answer-file — RESOLVED (detail above): the architecture would not permit future FI-S files to become answer files of any of the five named types. §11 + §12 + per-row prohibited columns are mutually reinforcing, and the aggregation-shortcut ban (§12) closes the supplementary-specific loophole.

Review Objective 9 — Validation review accuracy — RESOLVED, with one disagreement of emphasis I'll register. The validation artifact accurately reflects the architecture's boundaries, inventory alignment, trap/friction coverage, and hierarchy protections — I cross-checked each claim and found no misstatement. Where I'd push back: the validation artifact lists everything as flatly "VERIFIED" with no residual watch-items, which understates one real future-construction risk (below). That's not an inaccuracy in what it asserts; it's an omission of what it should flag. I disagree with the implication that FI-S construction is risk-free — it isn't quite, even though the architecture is sound.

Review Objective 10 — Future construction safety — RESOLVED, with the one watch-item. FI-S01–S04 can be safely constructed from this architecture without governance/inventory/hierarchy drift. The residual risk — and the thing the validation artifact should have flagged — is the ~90/10 essential/supplementary calibration against AutoQC 2.52, which I raised back at the File Inventory Architecture review and which lands here, at the file layer. With 29 essential files (22 world + 7 task) and 4 supplementary, the supplementary share is ~12%. That's the safe direction (too little noise never fails 2.52; too much load-bearing noise does), and these four are genuinely non-load-bearing, so I expect it passes — but it's the one quantitative check the supplementary layer is exposed to, and it should be confirmed at packaging rather than assumed. Not a defect; a watch-item the validation artifact omitted.

Findings

True Defects: none. Count correct (4, matching inventory), all four roles aligned, no silent scope change, world necessity preserved, all five traps and three frictions preserved with correct supplementary restraint, all three hierarchies intact, anti-answer-file protections complete including the aggregation-shortcut ban.
Governance / Metadata Inconsistencies: none material. One micro-note: FI-S03's "Priority Family" isn't labeled the way FI-T files were (it's logistics texture with no workflow of its own), which is correct — supplementary files shouldn't carry priority labels — but worth confirming the eventual Section 3 row leaves that field appropriately empty rather than copying a P-label.
Physician Preference Items: (1) at construction, FI-S04's "realistic staleness" should be calibrated by the physician — a stale problem list is good texture, but the staleness must be recognizably non-authoritative (e.g., visibly old or internally inconsistent with newer notes) so a reader doesn't mistake it for current truth; this is a content-calibration judgment for Alexander; (2) FI-S02's OSA/CPAP background should stay clearly historical so it can't be read as contributing to the acute AMS.
Future Construction Watch Items: (1) confirm the ~12% supplementary/88% essential split against AutoQC 2.52 at packaging — the one quantitative check this layer touches, omitted by the validation artifact; (2) at FI-S construction, each file must honor the aggregation ban — no FI-S file may collect dispersed world evidence into one place (the subtle way a "background" file becomes a shortcut); (3) the standing 2.108 administrative-deliverable bet (utilization-review fallback) remains for packaging; (4) per-file Tool/Origin and the v6.3 8-column Section 3 structure remain packaging items; (5) the physician-authored prompt/expected-output/golden/grader layer remains blocked behind §14's later phases.
Where I explicitly disagree with the validation artifact: it presents FI-S construction as fully de-risked ("VERIFIED" across the board with no watch-items). I disagree on emphasis — the architecture is sound and lock-ready, but the validation artifact omits the 2.52 essential/supplementary calibration, which is the one real (if low) future-construction risk this layer carries. This is a disagreement about completeness of flagging, not about any clinical-safety or answer-leakage claim, where the artifact and I agree.

Would you approve Supplementary File Architecture v1 for ratification and lock? YES. It correctly defines the FI-S layer: exactly four files matching the locked inventory, each architected as genuine background/provenance/logistics texture that supports without carrying sole critical evidence; world necessity preserved (no FI-S replaces FI-W01–W22 or FI-T01–T07, none completes FI-W22, and the aggregation shortcut is explicitly banned); all five traps preserved with correct supplementary restraint (no primary trap coverage, #3/#5 distinction intact, OSA barred from explaining the AMS, problem-list barred from becoming a copy-forward answer); all three frictions preserved without bias; all three hierarchies intact with FI-S files pinned as non-authoritative. There is no true defect and no internal inconsistency. The defining supplementary risk — a "background" file mattering too much — is foreclosed structurally.

Supplementary File Architecture v1 Status: LOCK READY.

Final Recommendation: GO — with the one watch-item I'd attach that the validation artifact omitted: confirm the essential/supplementary ratio against AutoQC 2.52 at packaging, and at construction hold the aggregation ban and FI-S04's recognizable-staleness calibration.

If ratified, can Supplementary File Architecture v1 proceed directly to FI-S01 through FI-S04 construction? YES — per the §14 roadmap, with the standing procedural rule. FI-S construction is the defined next step (§14 step 3) and depends only on this architecture being ratified and locked; there's no intervening architecture layer. So ratifying authorizes beginning FI-S01–S04 construction when you explicitly start it. The controls travelling into construction: each file stays genuinely supplementary (texture, never sole critical evidence), honors its temporal anchor (FI-S03 ≤ 05/23 18:00; the rest pre-admission/HD1), carries none of its prohibited content classes, and — the supplementary-specific one — does not aggregate dispersed world evidence into a shortcut. FI-S04 in particular must be recognizably non-authoritative.

And the larger boundary is now very close: after the FI-S files are built and locked, the next phase (§14 steps 6–10) is the physician-authored task layer — task prompts, expected outputs, goldens, grader guidance. That has been blocked through this entire chain and remains so. When it opens on your explicit authorization, it's the phase where I stay strictly in QC against the AutoQC checklist rather than authoring any prompt, expected output, golden, or grader rubric — the line this whole build has protected, now one locked layer away from the work where it's the central constraint.


FI-S01_remote-pci-coronary-stent-provenance-summary.md
92 lines

md


FI-S02_remote-sleep-study-osa-provenance-summary.md
89 lines

md


FI-S03_home-support-equipment-logistics-reference.md
98 lines

md


FI-S04_problem-list-past-history-snapshot.md
105 lines

md


supplementary-file-construction-validation-review.md
321 lines

md


Independent Review — Supplementary File Construction Review only. Do not modify files. Do not create files. Do not ratify or lock. Do not create new FI-S files. Do not create prompts. Do not create expected outputs. Do not create goldens. Do not create grader guidance.

pasted

Independent Review — Supplementary File Construction as pasted

Jun 2
I don't see the Supplementary File Construction artifacts in this message — no FI-S01–S04 files and no construction validation review came through, and nothing new was uploaded. The "as pasted" seems to point at content that didn't actually attach.

Before I flag that, let me make sure they're not sitting on disk from the session.


Check whether the FI-S construction files or their validation review are on disk
Check whether the FI-S construction files or their validation review are on disk
They are on disk — the four FI-S files and the construction validation review made it into the workspace even though they didn't render in the message. Good. I'll read them from disk and run the review. Same independent-verification posture as the architecture review: I verify every claim against the locked architecture and the world files, and I do not defer to the construction validation artifact.

Let me read all five.


Viewed 5 files
Viewed 5 files
All five read in full. Note for the record: the four FI-S files and the construction validation review reached the workspace but did not render in your message — I read them from disk. Now the review, with the independent-verification posture: I verified each file against the locked Supplementary File Architecture v1, against the world files it claims to support, and against itself, and I do not defer to the construction validation artifact. This is the last constructed content layer before the physician-authored task layer.

The supplementary-specific check is the inverse of the world-level batches: instead of "does this evidence reconcile and carry its weight," it's "does this file correctly fail to carry weight — texture without sole critical evidence, and crucially no aggregation shortcut." That's where I focused, and I'll lead with the check the independent-verification framing most demands, because it's where a problem-list file most often goes wrong and where a confident validation artifact would gloss it.

FI-S04 — the highest-risk supplementary file — verified hardest, RESOLVED. A problem-list snapshot is the single most dangerous supplementary artifact in any clinical world, because a problem list is exactly the shape of a one-click answer ("everything in one place"). Two specific failure modes, both checked:

Does it become an aggregation shortcut? The architecture's §12 explicitly banned "collecting dispersed evidence into one file," so I checked whether FI-S04 violates that. It lists the 14 conditions — but it lists only the comorbidities, which are already openly stated in W03 and W07 and were never the buried/dispersed evidence. The genuinely dispersed evidence (the functional/cognitive substrate across W17–W21, the prednisone source-conflict across W04/W05/W06/W20, the lab trend in W12) is not aggregated here. So FI-S04 restates already-visible background, not the synthesis-requiring evidence. It does not shortcut the world. That's the right line, and it's the one I most expected a problem-list file to cross.

Does it become a prednisone source? This is the subtle one. A problem list naturally contains "PMR / chronic steroid exposure" — and if FI-S04 stated a dose or taper, it would puncture Trap #1. It doesn't: line 73 explicitly says if PMR/prednisone "appears in problem-list language, that wording is background only. It does not outrank the locked prednisone source-of-truth hierarchy," and reproduces the five-rung hierarchy with rheumatology at top. It contains no medication list (line 62) and no dose. Verified — FI-S04 carries the condition label without carrying the steroid answer.

And the architecture's "recognizable staleness" calibration (my physician-preference note from the architecture review) is honored: line 29 frames it as "a low-authority orientation source [that] may include carried-forward or non-final problem-list phrasing," explicitly non-authoritative. Good.

FI-S02 — the second-highest risk — RESOLVED. OSA is the comorbidity most temptingly misusable as a hidden single-cause for the AMS (sleep apnea → hypercapnia → confusion). The architecture barred this, and the file honors it firmly: line 44 forbids "a hidden cause of altered mental status," line 81 forbids "explain the near-fall," line 84 forbids "create hidden hypoxemia or respiratory failure." It explicitly keeps the world "mixed-physiology" (line 37) and states it "does not explain the acute presentation" (line 35). The adrenal-reveal guardrail's cousin — the OSA-reveal — is closed. Verified against the mixed-physiology design I confirmed across Batches 1–5.

FI-S01 — RESOLVED. Remote PCI/stent provenance for the already-locked CAD history; explicitly not an acute coronary event, not a GDMT-restart decision, not a Cardiology-vs-Nephrology resolver (lines 42, 48, 79–89). It adds the "why CAD prevention matters" texture without carrying Trap #2 weight. Verified — it supports the already-established CAD background (W03/W07/W15) without adding a new arc.

FI-S03 — RESOLVED, and the one inside-the-world-timeline FI-S file, so temporal-checked. It's the only supplementary file dated HD5–HD6 (the rest are pre-admission/HD1), so its boundary is load-bearing: line 9 anchors it "through 05/23/2026 18:00," line 19 confirms no completed discharge outcome or post-discharge follow-up. Verified within the close. It preserves Trap #5 secondarily without becoming the visible artifact — line 77: "FI-W22 remains the visible, reassuring but incomplete discharge-facing source. FI-S03 must not complete FI-W22" — and keeps Family vs Primary Team balanced (lines 63–69). It explicitly carries no sole critical evidence (line 94). Verified — it adds logistics texture (DME, services feasibility, supervision questions) that points back to W21/W22 rather than replacing them.

Now the structured objectives.

Objective 1 — Authorized artifact validation — RESOLVED. Exactly four FI-S files, no FI-S05+, plus the construction review. No prompts, expected outputs, goldens, grader guidance, AutoQC responses, DOCX, or submission artifacts. Verified against the workspace listing.

Objective 2 — Inventory fidelity — RESOLVED for all four. Each file's header metadata (File ID, Type, Level=Supplementary, Anchor, Author/Source, Tool/Origin, Purpose, Supported Workflow/Trap/Friction) matches the locked Supplementary File Architecture v1 row and File Inventory v1. Roles, scopes, workflow/trap/friction mappings, authority mappings, temporal boundaries, and prohibited-content classes all align — I checked each file's row against the architecture's §5 table and found no drift.

Objective 3 — Architecture fidelity — RESOLVED. No silent broadening or narrowing: each file stays inside its architected role; no new workflow, hierarchy, source-of-truth rule, trap assignment, or friction assignment introduced. The trap/friction coverage levels match the architecture exactly (FI-S01 Trap #2 indirect; FI-S02 no primary trap; FI-S03 Trap #5 secondary + Family/Team secondary; FI-S04 source-hierarchy texture). Verified file-by-file against §7/§8.

Objective 4 — World necessity preservation — RESOLVED. This is the supplementary version of the Batch 5 test and it passes. Each file states it does not replace the world files (FI-S01 line 59/67; FI-S02 line 63; FI-S03 line 59; FI-S04 line 87), none completes FI-W22 (FI-S03 line 77 explicitly), and none aggregates dispersed evidence (verified above, especially FI-S04). The medication and discharge reasoning still require the full FI-W/FI-T sets. No FI-S file is a one-file solution or a shortcut.

Objective 5 — Trap preservation — RESOLVED. All five preserved. FI-S files carry no primary trap coverage (correct supplementary restraint), only indirect/secondary texture. The #3/#5 distinction holds (FI-S02 barred from explaining functional decline → Trap #3 stays buried in W17–W21; FI-S03 barred from being the visible artifact → Trap #5 stays on W22). No trap collapsed, weakened, exposed, or turned into an answer key. Trap #4 correctly gets zero FI-S coverage (no file reframes the admission).

Objective 6 — Friction preservation — RESOLVED. Cardiology vs Nephrology (FI-S01 refuses to resolve restart timing or favor a specialty), Family vs Primary Team (FI-S03 keeps both defensible), Endo vs Primary Team (zero FI-S coverage — correct, since any supplementary steroid content would risk the hierarchy and reveal guardrail). No friction resolved, biased, or made one-sided.

Objective 7 — Source-hierarchy preservation — RESOLVED. All three hierarchies preserved and FI-S files pinned as non-authoritative. FI-S04 is the critical test (a problem-list file self-elevating) and it explicitly subordinates itself (lines 73, 87). FI-S01 lists itself below all seven master-hierarchy rungs (lines 67–75). No FI-S file elevates a lower source, overrides a higher one, or becomes a hierarchy shortcut. Rheumatology stays highest for prednisone; no FI-S file carries prednisone authority.

Objective 8 — Anti-answer-file — RESOLVED. Verified per file: none decides medication restart (FI-S01), explains functional decline/AMS (FI-S02), determines discharge or completes W22 (FI-S03), or creates final diagnoses/med-rec/prednisone truth (FI-S04). The architecture's aggregation ban is honored. No critical evidence lives exclusively in any FI-S file — each restates low-authority background or points to stronger sources.

Objective 9 — Validation review accuracy — RESOLVED, with the same disagreement of emphasis I registered at the architecture stage. The construction validation artifact accurately reflects the files' content, boundaries, inventory alignment, trap/friction coverage, and hierarchy protections — I cross-checked each "VERIFIED" against the actual file text and found no misstatement. Where I push back, consistent with last review: the artifact again marks everything flatly "VERIFIED" with no residual watch-items, omitting the AutoQC 2.52 essential/supplementary ratio confirmation. That's an omission of flagging, not an inaccuracy in what it asserts — but I disagree with the implication that the supplementary layer is now fully de-risked through packaging.

Objective 10 — Future construction safety — RESOLVED (this layer being the construction). The files introduce no governance, inventory, answer-file, world-collapse, or hierarchy drift. The one residual item is the 2.52 ratio (below), low-risk and in the safe direction.

Required findings structure:

True Defects: none. Four files matching the locked architecture and inventory; FI-S04 carries the condition labels without becoming a prednisone source or aggregation shortcut; FI-S02 barred from explaining the AMS; FI-S03 within the close and not completing W22; all hierarchies, traps, and frictions preserved; no answer-file, no aggregation shortcut.
Governance / Metadata Inconsistencies: none material. FI-S03's metadata correctly carries no priority-family label (supplementary files shouldn't) — worth confirming the eventual Section 3 row leaves that field empty rather than inheriting a P-label, the same micro-note from the architecture review, now confirmed clean in the files.
Physician Preference Items: (1) FI-S04's "recognizable staleness" is honored in framing ("carried-forward or non-final phrasing") but is currently told, not shown — at packaging, the physician may want it to look visibly stale (e.g., an older date stamp or a minor inconsistency with newer notes) so a reader recognizes its low authority from the artifact itself rather than from a disclaimer; minor, Alexander's call. (2) FI-S02's OSA/CPAP content stays appropriately historical — confirmed kept historical, as the architecture intended.
Future Construction Watch Items: (1) confirm the essential/supplementary ratio against AutoQC 2.52 at packaging — now concrete: 22 world + 7 task = 29 essential vs 4 supplementary ≈ 12% supplementary; safe direction, these four are genuinely non-load-bearing, but it's the one quantitative check this layer touches and the validation artifact omits it; (2) per-file Tool/Origin: the FI-S files read "Writer-created supplementary [provenance/administrative/chart] file" — at packaging this still needs the 2.113 engineering-converted vs writer-produced-media origin and two-track filename specification; (3) the standing 2.108 administrative-deliverable bet (FI-S03 is administrative texture under Discharge Planning Documentation; utilization-review fallback) remains for packaging; (4) the v6.3 8-column Section 3 structure remains the packaging carry-forward.
Where I explicitly disagree with the validation artifact: consistent with my architecture-stage review, it presents the supplementary layer as fully de-risked through packaging, omitting the 2.52 ratio confirmation. The files are sound and lock-ready; the omission is in the validation artifact's flagging completeness, not in any clinical-safety or answer-leakage claim, where we agree.

Would you approve Supplementary File Construction for ratification and lock? YES. The four FI-S files faithfully implement the locked architecture: each is genuine background/provenance/logistics texture that carries no sole critical evidence; world necessity is preserved (none replaces the FI-W/FI-T sets, none completes FI-W22, and — verified hardest — FI-S04 does not aggregate the dispersed evidence into a shortcut); all five traps are preserved with correct supplementary restraint (no primary coverage, #3/#5 distinct, OSA barred from explaining the AMS, problem-list barred from being a prednisone source or copy-forward answer); all three frictions preserved without bias; all three hierarchies intact with every FI-S file pinned non-authoritative; FI-S03 sits within the world close. There is no true defect and no internal inconsistency. The defining supplementary risk — a "background" file mattering too much — is foreclosed in the actual content, not just asserted.

Supplementary File Construction Status: LOCK READY.

Final Recommendation: GO — with the one watch-item the validation artifact omitted (confirm the ~12% supplementary ratio against AutoQC 2.52 at packaging) and the minor physician-preference item (show FI-S04's staleness, don't just state it).

If ratified, what comes next? With the FI-S files locked, the entire file ecosystem is complete and reviewed: 22 world-level (FI-W01–W22) + 7 task-context (FI-T01–T07) + 4 supplementary (FI-S01–S04) = 33 files, every one independently verified, internally consistent across the full chain (identity, 14 conditions, 20 medications with lispro inpatient-only, baseline anchors reconciling with the lab trends, all three hierarchies, all five traps, all three frictions, the temporal boundary, and now the supplementary texture).

Per the architecture's §14 roadmap, the next phases (steps 6–11) are the physician-authored task layer — Task Prompt Architecture, Task Prompt Construction, Expected Output Architecture, Golden Architecture, Grader Guidance Architecture — then Packaging. This is the threshold the whole build has been moving toward, and it's where the boundary I've tracked through every single review becomes the central constraint rather than a guardrail: task prompts, expected outputs, golden responses, and grader guidance are physician-authored. They have been blocked through all 33 files, and they stay blocked until you explicitly authorize that phase. When it opens, my role is QC against the AutoQC checklist — verifying the physician-authored prompts/goldens/rubrics for consistency, solvability, trap preservation, and checklist compliance — not authoring any of them. The world they'll be built on is now complete, internally consistent, and sound.


task-prompt-architecture-v1.md
224 lines

md


task-prompt-architecture-validation-review.md
100 lines

md


Independent Review — Task Prompt Architecture v1 Review only. Do not modify files. Do not create files. Do not ratify. Do not lock. Do not create prompts. Do not create expected outputs. Do not create goldens. Do not create grader guidance. Do not create AutoQC response

pasted

Independent Review — Task Prompt Architecture v1
 as pasted

Jun 2
Independent review of Task Prompt Architecture v1. This is the threshold artifact I've been flagging through the entire build: it's the first piece of the physician-authored task layer. So before the objective-by-objective review, I need to be precise about my role here, because it determines what kind of review this can be.

A boundary clarification I have to state up front. Throughout this chain the standing rule has been that task prompts, expected outputs, goldens, and grader guidance are physician-authored, and my role is QC, not authorship. This artifact sits right on that line, and the distinction that matters is: this is task-prompt architecture, not task-prompt text. It defines how many prompts, which workflow each maps to, which files each must require, and what guardrails each must preserve — it explicitly writes no prompt wording (§ and the validation both confirm this, and I verified it: there is no clinician-facing request text anywhere in the file). Reviewing the architecture for structural soundness, count discipline, file-dependency correctness, and boundary preservation is squarely within QC. What I will not do — now or when prompt construction opens — is author or rewrite the prompts themselves, draft expected outputs, or write goldens/rubrics. So this review is legitimate as a structural/QC review; it is not me stepping into authorship. I'll flag where the architecture correctly reserves authorship to the physician.

With that clear, and taking the independent-verification instruction seriously (verifying against the locked artifacts, not deferring to the validation review), here's the review. I cross-checked the file-dependency matrix against the FI-T architecture and the world files most closely, since that's where a prompt architecture most easily drifts.

The count decision — the first thing to verify independently, and the one carrying my own prior disagreement — RESOLVED, and it resolves my FI-T01/FI-T07 concern correctly. The architecture sets 6 prompt families from 7 FI-T files, folding FI-T07 into TP-KM01 as an addendum rather than spawning a seventh prompt. This is exactly the resolution I argued for when I reviewed the FI-T files: I flagged then that FI-T07 was a near-duplicate of FI-T01 (same twelve world files, same medication focus) and said it "should be flagged for the prompt-architecture phase: either FI-T07's eventual prompt must test a genuinely different competency… or FI-T07 risks redundancy with FI-T01." The architecture takes the second path — FI-T07 does not become a standalone prompt; it sharpens TP-KM01's medication-safety focus (§1, §4 differentiation guardrail, §8 dependency matrix lists FI-T01 and FI-T07 as TP-KM01's required FI-T). This is the correct call and it closes the disagreement I registered. The validation artifact's watch-item to "confirm TP-KM01 vs FI-T07 differentiation remains explicit" is right to carry it forward to construction, but at the architecture level the redundancy risk is resolved: there is no second medication-reconciliation prompt.

Verified independently: 6 prompts map to the 4 locked workflows and the 6 task concepts from the Task Architecture Package; the 2.107 ≤5-distinct-workflow ceiling is honored because the 6 prompts collapse onto 4 workflows (Discharge Planning Documentation carries three of them — TP-KM03/05/06 — differentiated by anchor). No seventh prompt is required.

Objective 1 — Authorized artifact validation — RESOLVED. Architecture and validation artifacts exist; no prompts, expected outputs, goldens, grader guidance, AutoQC responses, DOCX, or submission artifacts. I verified the file contains no prompt text — §9 and §10 describe packaging/classification rules, not request wording. The §11 boundary conditions and §12 roadmap hold the phase line.

Objective 2 — Task count architecture — RESOLVED (detail above): six-family decision sound, FI-T07 correctly an addendum, no seventh prompt required, duplication risk resolved at the architecture level.

Objective 3 — Workflow fidelity — RESOLVED. All four locked workflows represented (§5): Discharge Medication Reconciliation (TP-KM01), Hospital Discharge Summary Generation (TP-KM02), Discharge Planning Documentation (TP-KM03/05/06), Interdisciplinary Care Plan (TP-KM04). None missing, none silently introduced, none narrowed. The one to scrutinize — three prompts under Discharge Planning Documentation — is correctly handled: §5 requires they "be differentiated by anchor, requester, and deliverable surface" (TP-KM03 = discharge-day readiness, TP-KM05 = +7 follow-up, TP-KM06 = +30 safety review), which is genuine differentiation by time-anchor and purpose, not three copies of one task. P0/P1/P2 stay tracker-metadata only. 2.107 preserved.

Objective 4 — Trap coverage fidelity — RESOLVED. I checked the trap matrix (§6) against the locked canon. All five mapped with primary/secondary families and explicit forbidden-collapse patterns. Trap mappings align (Trap #1 → TP-KM01/04; Trap #2 → TP-KM01/04; Trap #3 → TP-KM03/06; Trap #4 → TP-KM02/05; Trap #5 → TP-KM03/04/06) and match where the corresponding FI-T files carry those traps. No drift, no broadening/narrowing. The #3 vs #5 distinction is explicitly preserved (§6 Trap #5 row: "Preserve Trap #3 vs Trap #5 distinction"; Trap #3 row: "Do not summarize all functional evidence in the prompt"). The anti-reveal guardrails are carried (Trap #1: rheumatology highest, no adrenal authority; Trap #4: no "sepsis was false" / "steroids explain everything").

Objective 5 — Friction coverage fidelity — RESOLVED. All three frictions mapped (§7) with "must not be resolved by architecture" boundaries. Cardiology vs Nephrology (may require synthesis, may not choose a restart authority), Endo vs Primary Team (may require steroid-risk interpretation, may not prove adrenal insufficiency or replace rheumatology), Family vs Primary Team (may require synthesis, may not make family dispositive or team careless). No premature resolution, no bias, no hidden answer path. Consistent with the symmetric friction construction I verified in Batches 3–4.

Objective 6 — Source-hierarchy preservation — RESOLVED. §10's physician-perspective rule and the trap/friction boundaries preserve all three hierarchies. The architecture does not elevate lower-authority sources, weaken rheumatology (explicitly "highest outpatient prednisone-history source," §6), or create shortcut authority. The key conceptual line is restated correctly (§10): "Source-of-truth hierarchy governs factual conflicts; physician-perspective framing governs the final deliverable voice and responsibility" — the same evidence-authority vs deliverable-ownership distinction from the FI-T architecture.

Objective 7 — File dependency matrix — RESOLVED, and I verified this hardest. I cross-checked each prompt's required FI-W set against the corresponding FI-T file's required-synthesis table and against what each task actually needs:

TP-KM01 requires the same 12 world files FI-T01 specified (W03, W04, W05, W06, W11, W12, W13, W14, W15, W16, W19, W22) — exact match. FI-S01/S04 optional. Correct.
TP-KM02 requires the discharge-summary set (ED→course→trends→consultants→functional/family→W22, 17 files) — matches FI-T02's scope. Correct.
TP-KM03 requires the readiness set (W01, W07, W09, W11, W12, W17–W21, W22) — matches FI-T03. Correct.
TP-KM04 requires the consultant-synthesis set (16 files) — matches FI-T04. Correct.
TP-KM05/06 require FI-W01–W22 (full reconstruction) — matches FI-T05/06's "reconstruct from the whole world" framing for the +7/+30 tasks. Correct.
No critical file omitted; no unnecessary file promoted to required; FI-S files are uniformly "optional/supporting… must not carry sole critical evidence" (§8 safeguards). FI-W22 remains visible-but-incomplete — listed as required in the medication/summary/readiness/synthesis prompts but with the standing safeguard that it stays incomplete (§8). Verified.

Objective 8 — Prompt packaging architecture — RESOLVED. §9/§10 follow the Source-of-Truth principles: realistic clinician-facing requests, workflow framing ("read like a real clinical work request, not an exam question"), chart-review style required for all tasks, and explicit "no answer key, rubric, or grading hint" in prompts. Critically for the boundary I care about: §9 forbids including expected outputs/goldens/grader/scoring language in prompt packages "unless a future phase explicitly authorizes those artifacts," and forbids copying full evidence syntheses into prompt text. The architecture does not leak traps (it says preserve them, not state them), grading logic (explicitly excluded), answer paths, or governance into prompt design. The reference-world clutter-avoidance note (no duplicate/old folders, no ambiguous labels) is good packaging hygiene.

Objective 9 — Anti-answer-file — RESOLVED. No prompt family risks becoming an answer file of any named type. The architecture's per-family differentiation guardrails (§4) and trap/friction "must not resolve" boundaries (§6/§7) keep every prompt a request for synthesis rather than a container for the answer. TP-KM06 is correctly fenced from becoming an RCA or standalone risk-stratification workflow; TP-KM03 from becoming "final safe/unsafe discharge answer text"; TP-KM01 from a restart algorithm. The "do not copy full evidence syntheses into prompt text" rule (§9) is the key anti-answer-file protection at the prompt layer, and it's present.

Objective 10 — Validation review accuracy — RESOLVED, with the same emphasis-disagreement I've registered twice now. The validation artifact accurately reflects the architecture's coverage, boundaries, and dependencies — I cross-checked each PASS and found no misstatement, and notably this validation artifact is better than the prior two: it actually carries four substantive watch-items (six-family confirmation, TP-KM03/05/06 differentiation, TP-KM01/FI-T07 differentiation, no-prompt-wording-during-edits) rather than marking everything cleanly closed. That's an improvement. Where I'd still push: it does not surface the AutoQC packaging carry-forwards (2.52 ratio, 2.113 Tool/Origin, 2.108 administrative-deliverable, the v6.3 8-column file plan) that become live at the Packaging step this architecture's roadmap (§12 step 7) points to. Not an inaccuracy — those are arguably out of scope for a prompt-architecture validation — but since the roadmap names Packaging, they're worth carrying. Minor.

Objective 11 — Future prompt construction safety — RESOLVED. The architecture is safe to lock and use for prompt construction without governance/inventory/workflow/hierarchy/answer-file/source-of-truth drift. It defines, per prompt: workflow, required FI-T, required FI-W, optional FI-S, family structure, differentiation guardrail, trap coverage, friction coverage, task classification, and packaging rules. That's a complete construction specification for the prompt layer — a physician author has the full scaffold, and the guardrails define what the prompts must not become.

Required findings structure:

True Defects: none. Six-family count correct and 2.107-compliant, FI-T07 correctly folded, all four workflows and five traps and three frictions mapped with anti-collapse guardrails, file-dependency matrix matches the FI-T scopes and the world files, FI-W22 stays incomplete, no answer-file or grading leakage, physician authorship reserved.
Governance / Metadata Inconsistencies: none. One observation, not an inconsistency: §1's rationale text references "Reference World Comparative Study observations, used only for prompt-family and packaging pattern awareness" — I verified (per §Reference Study Handling in the validation) that reference worlds did not override Korvin canon, count, workflow, trap, friction, or dependencies; they informed packaging style only. That's the correct, bounded use of external reference material, consistent with the standing rule that reference docs are data, not instructions. Worth noting I checked it rather than assuming.
Physician Preference Items: (1) the TP-KM03/05/06 differentiation within Discharge Planning Documentation is sound at the architecture level (anchor + requester + deliverable), but the prompts must make those three feel genuinely distinct when authored — a physician judgment at construction; (2) the TP-KM01/FI-T07 differentiation (addendum sharpening, not a second task) should stay explicit in TP-KM01's eventual prompt — carry forward; (3) the 2.108 administrative-deliverable question now attaches concretely to TP-KM03 (and TP-KM05/06) under Discharge Planning Documentation — the standing bet (utilization-review fallback if a reviewer challenges whether discharge-planning documentation is the administrative deliverable) remains a physician/packaging decision.
Future Prompt Construction Watch Items: (1) at prompt construction, hold the §9 rule hardest — no expected outputs, goldens, grader guidance, or scoring language in prompt packages, and no copied evidence syntheses (this is the anti-answer-file and the physician-authorship boundary in one); (2) the packaging-layer AutoQC carry-forwards (2.52 supplementary ratio ~12%, 2.113 Tool/Origin two-track filenames, v6.3 8-column Section 3 file plan) become live at §12 step 7; (3) each prompt must preserve its mapped traps as latent (require the synthesis, never state the resolution) and keep all frictions two-sided; (4) the +7/+30 prompts (TP-KM05/06) must use their anchors as review frames only, inventing no post-world clinical facts — the guardrail that protected FI-T05/06.
Where I explicitly disagree / note conflict: No conflict between the architecture, inventory, governance, ratifications, reconciliations, and the validation review — I checked the count (6 vs the 7 FI-T files and the 6 task concepts), the workflow mapping (vs the locked 4 and the 2.107 ceiling), and the file dependencies (vs each FI-T's required-synthesis scope), and they reconcile. My only standing disagreement is the recurring emphasis point: the validation artifact, though improved this round, still doesn't surface the packaging-layer AutoQC items the roadmap points toward. That's a flagging-completeness note, not a defect or a canon conflict.

Would you approve Task Prompt Architecture v1 for ratification and lock? YES — as a structural/architecture approval, with my role staying QC and the prompt text remaining physician-authored at the next phase. The architecture correctly translates the locked 33-file ecosystem into six prompt families: it honors the 2.107 workflow ceiling (6 prompts onto 4 workflows), resolves the FI-T01/FI-T07 redundancy I previously flagged by folding FI-T07 into TP-KM01 as an addendum, maps all five traps and three frictions with explicit anti-collapse and anti-resolution guardrails, defines a file-dependency matrix that matches each FI-T's synthesis scope and keeps FI-W22 visible-but-incomplete and FI-S files non-load-bearing, and sets packaging rules that forbid answer-key/grading/governance leakage into prompts. There is no true defect and no canon conflict.

Task Prompt Architecture v1 Status: LOCK READY.

Clinical Architecture Status: STRONG.

Final Recommendation: GO — with the construction-layer watch-items, the most important of which is the one this whole chain has protected: when prompt construction opens, the prompts, expected outputs, goldens, and grader guidance are physician-authored, and the §9 rule (no answer/rubric/grading content in prompt packages) is the concrete expression of that boundary.

Can Task Prompt Architecture v1 proceed directly to ratification and lock if any identified reconciliation items are resolved? YES. There are no true defects or canon conflicts requiring reconciliation before lock — the findings are physician-preference and future-construction watch-items, not blockers. So it can proceed to ratification and lock on your authorization. Per §12, the next phase after lock is Task Prompt Construction (step 3) — and that is the phase where the boundary becomes operative rather than anticipatory: the prompt text is physician-authored, and I review it against this architecture and the AutoQC checklist for fidelity, trap/friction preservation, file-dependency correctness, and the no-answer-leakage rule. I author none of it. The 33-file world beneath it is complete, internally consistent, and sound; this architecture is a faithful scaffold for the physician-authored prompts that come next.


TP-KM06.md
50 lines

md


TP-KM05.md
49 lines

md


TP-KM04.md
48 lines

md


TP-KM03.md
50 lines

md


TP-KM02.md
51 lines

md


TP-KM01.md
53 lines

md


task-prompt-construction-validation-review.md
112 lines

md


Independent Review — Task Prompt Construction Review only. Do not modify files. Do not create files. Do not ratify. Do not lock. Do not create expected outputs. Do not create goldens. Do not create grader guidance. Do not create AutoQC responses. Do not create DOCX arti

pasted

Independent Review — Task Prompt Construction, follow review prompt as pasted

Jun 2
Independent review of Task Prompt Construction — the six physician-authored task prompts (TP-KM01–06). This is the first time I'm reviewing actual physician-authored task-layer text rather than architecture, so I want to be exact about my role: I am reviewing these prompts for fidelity to the locked architecture and the AutoQC checklist — count, workflow assignment, trap/friction preservation, file dependencies, anti-answer-file, realism — as QC. I am not authoring or rewriting them, and I'm not drafting the expected outputs or goldens that come next. That authorship stays physician-side, which is exactly what these prompts being physician-authored reflects. The review is QC against the locked scaffold.

Taking the independent-verification instruction seriously, I read all six prompts and the validation artifact, and I verified each prompt against the Task Prompt Architecture v1 dependency matrix and the FI-T files rather than trusting the validation PASSes. The check that matters most for prompt text (as opposed to architecture) is the anti-answer-file / no-trap-disclosure one: a prompt can satisfy every structural requirement and still ruin a trap by naming it. So I read each prompt specifically asking "does this tell the solver what to find, or does it ask them to do the work?"

The no-trap-disclosure check — the make-or-break for prompt text — RESOLVED, and handled with discipline. This is where physician-authored prompts most easily slip, so I read each request line against the trap it's meant to preserve:

TP-KM01 (med rec) asks the solver to address "prednisone exposure, taper history, and steroid-risk interpretation" and "timing and sequencing considerations for HFrEF/CAD reintroduction" — it names the domains to reason about, not the answers. It does not say "rheumatology is the authoritative source" or "the holds should be restarted in X order." It preserves Trap #1 and Trap #2 as work to be done. ✓
TP-KM03 (readiness) asks "whether the discharge-facing snapshot (FI-W22) misses caveats found elsewhere" — this is the closest any prompt comes to naming Trap #5, and it's the right side of the line: it asks the solver to evaluate whether W22 is complete, which is the task, without telling them it's incomplete or what's missing. A real care-coordination request would phrase it exactly this way. ✓ (more on this below as the one judgment call)
TP-KM02 (summary) asks for "hospital course evolution by day and clinical change, not merely by copied problem list" — this preserves Trap #4 (anchoring) and the anti-transcription requirement by asking for reasoning, without saying "sepsis was incomplete." ✓
TP-KM04 (synthesis) asks how the consultants "can both be reasonable" and instructs "synthesize rather than defer" — preserves the frictions and the hospitalist-synthesizes governance without naming a winner. ✓
TP-KM05/06 (+7/+30) ask for trajectory/risk reasoning and explicitly forbid inventing new facts — preserving the world-necessity and no-post-world-fact guardrails. ✓
No prompt names a trap, states a friction's resolution, discloses the hierarchy as an instruction, or reveals an expected-discovery path. The prompts request work; they do not contain answers. This is the single most important property for physician-authored prompt text, and it holds across all six.

Now the structured objectives.

Objective 1 — Prompt count — RESOLVED. Exactly six (TP-KM01–06), no extra prompt, and FI-T07 remains an addendum: TP-KM01's header reads "Primary FI-T Files: FI-T01, FI-T07 (addendum)" and its Context Files section lists both, with no separate seventh medication prompt. This implements the architecture's count decision and the resolution of the FI-T01/FI-T07 redundancy I flagged two reviews ago. Verified.

Objective 2 — Workflow fidelity — RESOLVED. Each prompt's stated Primary Workflow matches the architecture: TP-KM01 Discharge Medication Reconciliation, TP-KM02 Hospital Discharge Summary Generation, TP-KM03/05/06 Discharge Planning Documentation, TP-KM04 Interdisciplinary Care Plan. All four locked workflows represented; none missing, duplicated, silently introduced, or narrowed. The three Discharge Planning Documentation prompts stay distinct by anchor/requester/deliverable (verified under Objective 8). 2.107 ceiling preserved.

Objective 3 — Prompt realism — RESOLVED. All six read as genuine clinical work requests, not exam questions. Each opens with a realistic requester and need ("The hospitalist service is preparing for discharge medication reconciliation…," "The quality, safety, or transition team needs a retrospective… review…"), frames a concrete deliverable, and requires chart review. None uses benchmark/educational/challenge framing, none poses a quiz, none signals "this is a test." The requester variety (hospitalist/pharmacy, attending, case management, hospitalist-led team, primary care, quality team) is realistic and matches each workflow. This is the right register — clinician-facing, request-oriented.

Objective 4 — Trap protection — RESOLVED (detail above): traps preserved, not disclosed, not resolved; the #3 vs #5 distinction holds. TP-KM03/06 carry Trap #3 by asking the solver to assess functional/cognitive evidence and whether it "was easy to miss" (TP-KM06) — without summarizing that evidence in the prompt, keeping it buried in the world files. TP-KM03/04/06 carry Trap #5 by asking whether W22 is over-trusted/missing caveats — without stating the answer. No prompt exposes a hidden reasoning target or discovery path.

Objective 5 — Friction protection — RESOLVED. No prompt chooses a winner or biases interpretation. TP-KM01 "acknowledges multiple consultant perspectives (Cardiology, Nephrology, Endocrinology)… without choosing"; TP-KM04 explicitly asks how the consultants "can both be reasonable" and to "synthesize… rather than defer"; TP-KM03/05/06 ask whether "family concerns reflect baseline knowledge rather than generic resistance" — which preserves the Family-vs-Team friction as two-sided (it invites the solver to weigh family concern seriously without declaring it dispositive). All three frictions stay live. No hidden answer path.

Objective 6 — Hierarchy protection — RESOLVED. No prompt elevates a lower-authority source, weakens rheumatology, or creates shortcut reasoning. The prompts don't state the hierarchies at all (correct — stating them would both leak and instruct); they ask for reconciliation work that requires applying the hierarchy from the world files. TP-KM01 asks about "prednisone exposure, taper history, and steroid-risk interpretation" without naming rheumatology as the answer, leaving the solver to discover the hierarchy via FI-W06/W04/W05/W20. Rheumatology authority is preserved by omission-of-instruction, which is the right approach.

Objective 7 — Anti-answer-file — RESOLVED. No prompt is an answer file of any type. Each "Deliverable" section requests a recommendation/assessment/summary/plan/review and explicitly frames it as work to be justified from evidence ("clinically justified based on chart evidence, not merely a list copy"; "a clinical narrative, not a transcribed problem list"; "identify risks, gaps, or coherence issues"). No prompt contains a medication plan, a discharge decision, a consultant resolution, a hierarchy ruling, or a safety conclusion. The prompts request work; they do not contain answers.

Objective 8 — Prompt differentiation — RESOLVED, including the trio I've tracked. I checked the three differentiation pairs the review names plus the broader set:

TP-KM01 vs TP-KM02: distinct — medication reconciliation deliverable vs discharge-summary narrative. Different workflow, different deliverable. ✓
TP-KM03 vs TP-KM05: distinct — TP-KM03 is discharge-day (05/24) readiness/coordination ("is the plan practically coherent now"); TP-KM05 is +7 (05/31) follow-up ("is recovery on the expected trajectory, what needs monitoring"). Different anchor, requester (case management vs primary care/transition), and reasoning frame (point-of-discharge coherence vs one-week-out reassessment). ✓
TP-KM05 vs TP-KM06: distinct — TP-KM05 is +7 prospective follow-up ("monitoring/clarification needs going forward"); TP-KM06 is +30 retrospective safety/readmission-risk ("what risk signals were visible before discharge closed," explicitly retrospective, explicitly not RCA). Different anchor, temporal direction (forward-looking vs backward-looking), and deliverable (follow-up priorities vs risk-signal review). ✓
The three Discharge-Planning-Documentation prompts (TP-KM03/05/06) are genuinely differentiated by anchor, requester, temporal direction, and deliverable surface — they are not three phrasings of one task. This was the validation artifact's lead watch-item and the architecture's, and at the prompt-text level it's satisfied. TP-KM01/FI-T07 differentiation also holds (one task with an addendum, not two).

Objective 9 — File dependency fidelity — RESOLVED. I verified each prompt's "Required Chart Review" and Context File sections against the architecture's §8 dependency matrix. Each prompt names its correct FI-T context file(s) and describes the required world-file families consistent with the matrix (TP-KM01 → the 12-file medication set incl. rheumatology/pharmacy/MAR/trends/consultants/W22; TP-KM05/06 → full-chart reconstruction; etc.). One observation, not a defect: the prompts describe required chart review in prose categories ("admission documentation, verified medication reconciliation, pharmacy records, rheumatology correspondence…") rather than listing FI-W IDs. That's actually correct for prompt realism — a real clinician request says "review the chart," not "review FI-W06" — and the precise FI-ID dependency lives in the architecture/packaging layer, not the clinician-facing prompt. FI-W22 is treated as available-but-to-be-reconciled, never complete ("available but should be reconciled with the broader chart rather than treated as a complete summary/snapshot" — appears in TP-KM01, TP-KM02, TP-KM03). FI-S files are not promoted into answer sources — they're not named in the prompts at all, consistent with the architecture's "optional/supporting, never sole critical evidence" rule (the validation correctly notes FI-S isn't included in prompt text). Verified.

Objective 10 — Validation review accuracy — RESOLVED. The validation artifact accurately describes the prompt package, boundaries, and architecture compliance — I cross-checked each PASS against the actual prompt text and found no misstatement. This validation artifact is again solid: it carries forward the right watch-items (TP-KM03/05/06 differentiation during expected-output construction, FI-T07 addendum relationship during golden construction, no-leak during later phases). No inaccuracy. (Consistent with prior reviews, I'd only add that the packaging-layer AutoQC items — 2.52, 2.113, 2.108, 8-column file plan — remain live for the Packaging step, but those are out of scope for a prompt-construction validation and the artifact isn't wrong to omit them here.)

Objective 11 — Contributor validation test — PASS. The review asks whether a new contributor could construct these prompts using only the locked repository and governance system, without tribal knowledge or reviewer memory. My assessment: yes. Each prompt traces directly to its locked FI-T context file and the Task Prompt Architecture's per-prompt row (workflow, FI-T source, family structure, differentiation guardrail, dependency matrix). The prompt content is derivable from those locked artifacts — the requester, anchor, deliverable, and domains-to-address all map to the FI-T file and the architecture. I don't see prompt logic that depends on undocumented assumptions or on remembering something only a prior reviewer knew; the no-post-world-facts rule (TP-KM05/06), the FI-T07-addendum relationship (TP-KM01), and the anchor differentiation (TP-KM03/05/06) are all written down in the locked architecture and FI-T files. PASS.

Required findings structure:

True Defects: none. Six prompts, correct workflows, FI-T07 folded, all traps preserved-not-disclosed, all frictions two-sided, hierarchies preserved by non-instruction, no answer-file, genuine differentiation, dependencies faithful, FI-W22 incomplete, FI-S not promoted.
Governance / Metadata Inconsistencies: none. The prompts use prose chart-review descriptions rather than FI-W IDs — correct for clinician realism, with precise dependencies held at the architecture/packaging layer; flagged only so it's a conscious choice when packaging maps prompts to file bundles.
Physician Preference Items: (1) TP-KM03's "whether FI-W22 misses caveats found elsewhere" is the one line that comes closest to gesturing at Trap #5 — it's on the correct side (it asks the solver to evaluate completeness, the actual task, rather than asserting incompleteness), and a real care-coordination request would phrase it this way, so I'd leave it; but it's the line a physician might want to eye at expected-output construction to be sure the golden doesn't over-credit simply noticing W22 is incomplete. Physician's call. (2) Whether TP-KM01's explicit naming of all three consultant services ("Cardiology, Nephrology, Endocrinology") is the right level of scaffolding or slightly more than a real terse request would name — defensible as written (a real med-safety request often does flag "multiple consultants involved"), but a style choice the physician owns.
Future Expected-Output Construction Watch Items: (1) the expected outputs and goldens are the next physician-authored artifacts and remain blocked until authorized — and they're where the anti-answer-file discipline matters even more than in the prompts, because a golden is the answer and must reward genuine multi-source synthesis (applying the hierarchy, finding the buried functional evidence, reconciling W22) rather than surface pattern-matching; (2) keep TP-KM03/05/06 goldens genuinely distinct (the differentiation must carry into the expected outputs, not just the prompts); (3) keep the FI-T07 addendum from spawning a second medication golden; (4) the packaging-layer AutoQC items (2.52, 2.113, 2.108, v6.3 8-column file plan) become live at Packaging.
Would you approve Task Prompt Construction for ratification and lock? YES — as a QC approval of physician-authored prompt text against the locked architecture. The six prompts faithfully implement Task Prompt Architecture v1: exactly six families with FI-T07 correctly folded into TP-KM01, all four workflows represented and 2.107-compliant, every trap preserved as work-to-be-done without disclosure (verified line by line), all three frictions kept two-sided with no winner named, hierarchies preserved by not being stated as instructions, FI-W22 treated as available-but-incomplete, FI-S kept out of the prompts, genuine differentiation across the three Discharge-Planning prompts, and a clinician-facing realism that reads as real work requests rather than exam questions. There is no true defect and no answer-file leakage.

Task Prompt Construction Status: LOCK READY.

Clinical Prompt Quality: STRONG.

Contributor Validation Test: PASS.

Final Recommendation: GO — with the watch-items carried to the next phase. And the boundary that has held through all 33 files and now the six prompts remains the one to hold most carefully: the expected outputs, goldens, and grader guidance are physician-authored, and they're the phase where the answer actually gets written — when it opens on your authorization, my role stays QC (verifying the goldens reward real synthesis, preserve the traps' difficulty, apply the hierarchies correctly, and keep the prompts' differentiation), not authorship. The prompts are a faithful, lockable implementation of the architecture, and the world and task scaffold beneath them is complete and consistent.


expected-output-architecture-v1.md
md


expected-output-architecture-validation-review.md
102 lines

md


Independent Review — Expected Output Architecture v1 Review only. Do not modify files. Do not create files. Do not ratify. Do not lock. Do not create expected outputs. Do not create golden responses. Do not create grader guidance. Do not create AutoQC responses. Do not

pasted

Independent Review — Expected Output Architecture v1 as pasted

Jun 2
I notice the upload block lists expected-output-architecture-v1.md twice as a path, but only two documents actually came through in the message: the validation review and the independent review prompt. The architecture file itself — the primary artifact under review — didn't render. Let me check whether it reached the workspace before I proceed, because I can't review an architecture I haven't read.


Check whether the expected output architecture file reached the workspace, since it did not render in the message
Check whether the expected output architecture file reached the workspace, since it did not render in the message
It's on disk — the architecture file reached the workspace even though it didn't render in your message (same as the FI-S construction batch last time). I'll read it from disk. Note for the record: I'm reviewing the actual expected-output-architecture-v1.md, not inferring its content from the validation artifact — which matters especially here, given the independent-verification instruction not to defer to the validation review.


Read the full Expected Output Architecture v1 from disk
Read the full Expected Output Architecture v1 from disk
I need to read the truncated middle (lines 113–136) — that's the anti-overanswer section and likely the physician-perspective handling, which is exactly where the answer-leakage risk concentrates.


Read the truncated section lines 112-136 — hierarchy handling and anti-overanswer protections
Read the truncated section lines 112-136 — hierarchy handling and anti-overanswer protections
Read in full, including the truncated hierarchy-handling and anti-overanswer sections. Per the independent-verification instruction, I verified the architecture against the locked TP-KM prompts, the FI-T/FI-W/FI-S dependencies, and the trap/friction canon directly — not via the validation artifact.

First, the role note I've made at each task-layer artifact: this is expected-output architecture — it defines the shape of each expected output (deliverable type, reasoning domains, source dependencies, handling rules) and explicitly writes no expected-output text, no ideal answers, no goldens, no scoring (§9 of the file, lines 9, 134–146, 176–183). I verified that: there is no answer text anywhere in the file. Reviewing the architecture for structural soundness is QC; the expected-output text and goldens remain physician-authored at later phases. This review is QC against the locked scaffold, not authorship.

The check that matters most for an expected-output architecture (more than for the prompt architecture) is the anti-answer-file one in a sharper form: an expected-output architecture sits one step closer to the golden than anything I've reviewed, so the risk is that defining "what a good answer contains" tips into "here is the answer." I read §5 (trap-handling) and §8/§9 (over/under-answer) specifically against that.

The answer-leakage check — RESOLVED, and correctly calibrated. The architecture defines expected outputs at the level of reasoning domains the answer must engage, not conclusions the answer must reach. Two verifications:

§3/§5 specify, for each EO, the domains ("prednisone source reconstruction," "HF/AKI medication timing," "buried functional/cognitive evidence") — never the resolved answer ("restart sacubitril/valsartan on day X," "discharge is unsafe," "rheumatology says 5mg"). It requires the solver to do the reconstruction, not reproduce a pre-stated result.
§5 and §8 explicitly forbid the leakage: "Do not label traps. Do not declare an algorithmic restart rule. Do not treat latest consultant note or FI-W22 as automatically authoritative" (EO-KM01); §8 forbids "present a complete golden answer," "make FI-W22/FI-T/FI-S answer files," "collapse mixed physiology into a single dominant diagnosis." So the architecture bars the expected outputs from becoming answer keys and bars them from exposing trap labels in the eventual output text.
Critically, the architecture holds both failure directions — which is the right design for an expected-output layer. §8 (anti-overanswer) prevents the expected output from being a complete golden or fabricating post-world facts; §9 (anti-underanswer) prevents it from being a generic under-synthesized response ("provide only a bullet list when a narrative is required," "treat medical improvement as equivalent to operational discharge safety," "rely only on FI-W22"). That two-sided framing is what makes an expected-output architecture useful: it defines the band a real answer must fall in without writing the answer.

Now the objectives.

Objective 1 — Expected-output count — RESOLVED. Six (EO-KM01–06), one-to-one with TP-KM01–06 (§1 table verified against the locked prompts). FI-T07 stays an addendum source for EO-KM01, not EO-KM07 (lines 40, 211). No seventh expected output. This carries the count discipline correctly down from the prompt architecture.

Objective 2 — Deliverable surface — RESOLVED. Each EO defines a realistic senior-clinician deliverable (§2): medication-reconciliation recommendation, discharge summary, readiness/coordination assessment, interdisciplinary care plan, follow-up assessment, safety/readmission review. Each aligns to its locked workflow. No deliverable duplicates or collapses into another — verified against the differentiation I checked at prompt construction (the three Discharge-Planning EOs differ by deliverable: readiness assessment vs follow-up assessment vs retrospective risk review). No silent workflow broadening — each "must not" clause caps scope (EO-KM03 "must not issue a final disposition order"; EO-KM06 "must not create… RCA").

Objective 3 — Workflow fidelity — RESOLVED. All four locked workflows represented (§2, §12); none missing, duplicated, broadened, or narrowed; no new workflow. §12 explicitly confirms no Patient Risk Stratification, RCA, coding, billing, or prior-auth workflow was added — the exact scope-creep risks for a safety-review EO, correctly fenced. 2.107 preserved.

Objective 4 — Clinical reasoning domains — RESOLVED. §3 domains are appropriate to each EO and derivable from the locked world (I checked EO-KM01's domains against FI-W04/05/06/12/13/14/15/16/19/22 — each domain maps to evidence that exists in those files). No new clinical facts introduced (the architecture defines what to reason about, adding no values, diagnoses, or outcomes). The domains are complete for each deliverable and don't drift beyond canon. They don't tip into answer-files because they name reasoning targets, not conclusions (verified above).

Objective 5 — Source-synthesis architecture — RESOLVED. §4's FI-T/FI-W/FI-S mappings match the locked Task Prompt Architecture §8 dependency matrix exactly — I cross-checked all six rows (EO-KM01's 12 FI-W files, EO-KM05/06's full-chart reconstruction, etc.) against both the prompt architecture and the prompts themselves; they align. Optional FI-S role preserved ("may add background texture but cannot supply sole critical evidence," lines 84–85). FI-W22 remains visible-but-incomplete (lines 80, 119: "must not treat FI-W22 as complete"). No file becomes a sole answer source. Verified.

Objective 6 — Trap-handling — RESOLVED. §5 preserves all five trap domains as reasoning requirements, with the explicit rule (line 89) that future outputs handle them "without exposing trap labels, trap numbers, or grading logic in the output text." Trap labels/numbers are not to be exposed; hidden discovery paths are not disclosed. The #3 vs #5 distinction holds (EO-KM03/06 carry both: buried functional evidence and visible-but-incomplete discharge plan, kept distinct). Trap coverage neither broadens nor narrows vs the locked prompt architecture (same primary/secondary distribution), and difficulty doesn't collapse — the "forbidden collapse" column on each row prevents the expected output from resolving the trap (e.g., "Do not declare an algorithmic restart rule," "Do not make the visible discharge plan the complete answer").

Objective 7 — Friction-handling — RESOLVED. §6 keeps all three frictions active and defensible, with per-EO "prohibited friction handling" that prevents naming winners or bias ("Do not make one consultant careless or automatically correct," "Do not make family concerns independently dispositive or make primary team obviously unsafe"). EO-KM04 correctly requires synthesis "not resolved by hierarchy alone." No architecture-level winner; no bias introduced.

Objective 8 — Hierarchy-handling — RESOLVED. §7 preserves authority, source-of-truth, and prednisone hierarchies, with the critical distinction restated (lines 120, 126–129): authority hierarchy governs role/decision ownership; source-of-truth governs factual conflicts; consultant disagreements are "not resolved automatically by authority rank" — the governance rule that keeps the frictions alive. Rheumatology stays highest for prednisone (line 128). The architecture does not transform the hierarchy into answer logic — it requires the solver to apply the hierarchy, not reproduce a pre-resolved ranking. Lower-authority sources not promoted; rheumatology not weakened.

Objective 9 — Anti-overanswer / anti-underanswer — RESOLVED (detail above): both directions protected. §8 forbids golden-answer leakage, fabricated post-world facts, single-diagnosis collapse, and answer-file conversion of FI-W22/FI-T/FI-S. §9 forbids generic under-synthesis, FI-W22-only reliance, omission of consultant tensions/family/functional evidence, and treating medical improvement as discharge safety. Protections are sufficient and two-sided.

Objective 10 — Downstream architecture safety — RESOLVED. §10/§11 correctly position this artifact as upstream of goldens and grader guidance: it "may inform" them by defining count/IDs/domains/handling, but "must not write ideal answer text, decide exact phrasing, define scoring thresholds, assign points, create a rubric, or create pass/fail criteria." That's the right boundary — it scaffolds the physician-authored golden/grader phases without doing their work. It supports those phases without governance/workflow/hierarchy/trap/friction/answer-file drift.

Objective 11 — Validation review accuracy — RESOLVED. The validation artifact accurately reflects the architecture, boundaries, mappings, and prohibitions — I cross-checked its matrix claims against the actual file and found no misstatement. Same minor standing note as prior rounds: the validation focuses on this layer and doesn't surface the packaging-layer AutoQC items (2.52, 2.113, 2.108, 8-column file plan), but those are out of scope for an expected-output-architecture validation, so its omission isn't an error.

Required findings structure:

True Defects: none. Count correct and one-to-one with the prompts, FI-T07 folded, all four workflows preserved, all five trap domains preserved without label exposure or difficulty collapse, all three frictions active and defensible, all three hierarchies preserved with the consultant-disagreement-not-resolved-by-rank rule intact, dependencies matching the locked matrix, FI-W22 incomplete, FI-S non-load-bearing, and two-sided over/under-answer protections. No answer-file leakage.
Governance / Metadata Inconsistencies: none. The EO dependency rows reproduce the prompt-architecture matrix faithfully (I verified rather than assumed).
Physician Preference Items: (1) EO-KM03's hierarchy-handling row uses the authority hierarchy for "disposition evidence" and source-of-truth for "factual conflicts" — correct, but the line between a disposition-readiness assessment (what TP-KM03 asks) and a disposition decision (what it must not issue) is fine, and the physician will want the eventual EO-KM03 expected output and golden to stay on the "assessment" side; worth eyeing at golden construction; (2) the same TP-KM03 Trap #5 gesture I flagged at prompt construction ("whether FI-W22 misses caveats") flows into EO-KM03/06 — fine as a reasoning domain, but the golden should reward demonstrating the reconciliation, not merely asserting W22 is incomplete; physician's call at golden construction.
Future Expected-Output / Golden Construction Watch Items: (1) the expected-output text and the goldens are the next physician-authored artifacts and remain blocked — and the golden is where the two-sided band defined here (§8/§9) must actually be hit: a golden must reward genuine multi-source synthesis (applying the hierarchy, finding the buried functional evidence, reconciling W22, keeping the frictions open) and must itself avoid becoming a single-diagnosis or single-source answer; (2) keep EO-KM03/05/06 goldens genuinely distinct (differentiation must carry from prompts → expected outputs → goldens); (3) keep the FI-T07 addendum from spawning a second medication golden; (4) the packaging-layer AutoQC items become live at Packaging.
Where I explicitly note for the independent-verification requirement: no conflict among the architecture, the locked prompts, the dependency matrix, governance, the reconciliations, and the validation review — I checked the count (6 vs 6 prompts), the dependency rows (vs Task Prompt Architecture §8 and the prompts), the trap/friction distribution (vs canon), and the hierarchy rules (vs Governance), and they reconcile. My only standing emphasis point is the recurring one (packaging-layer AutoQC items not surfaced by the validation), which is a flagging-completeness note, not a defect or conflict.

Would you approve Expected Output Architecture v1 for ratification and lock? YES — as a QC/structural approval, with my role staying QC and the expected-output text plus goldens remaining physician-authored at later phases. The architecture correctly defines the six-slot expected-output system: one-to-one with the locked prompts, FI-T07 folded, all four workflows preserved and 2.107-compliant, all five trap domains preserved as reasoning requirements without label exposure or difficulty collapse, all three frictions active and defensible with no architecture-level winner, all three hierarchies preserved including the consultant-disagreement-not-by-rank rule, dependencies matching the locked matrix with FI-W22 incomplete and FI-S non-load-bearing, and — the defining feature for this layer — two-sided anti-overanswer/anti-underanswer protections that bound what a real answer must contain without writing the answer. There is no true defect and no canon conflict.

Expected Output Architecture v1 Status: LOCK READY.

Clinical Architecture Status: STRONG.

Final Recommendation: GO.

Can Expected Output Architecture v1 proceed directly to ratification and lock if any identified reconciliation items are resolved? YES — there are no true defects or canon conflicts requiring reconciliation before lock; the findings are physician-preference and future-construction watch-items, not blockers. So it can proceed to ratification and lock on your authorization. The next phases (expected-output construction, then golden construction, then grader guidance) are physician-authored and remain blocked until you explicitly open them. The golden phase in particular is the one where the boundary this whole chain has protected becomes most operative: a golden is the answer, so when it opens, my role stays QC — verifying the goldens hit the two-sided band this architecture defines (real synthesis, traps preserved as difficulty, hierarchies applied, frictions kept open, no single-source/single-diagnosis collapse) — not authorship. This architecture is a faithful, lockable scaffold for the physician-authored expected outputs and goldens that come next, and the full 33-file world plus six-prompt layer beneath it remains complete and consistent.


EO-KM01.md
44 lines

md


EO-KM02.md
46 lines

md


EO-KM03.md
46 lines

md


EO-KM04.md
44 lines

md


EO-KM05.md
44 lines

md


EO-KM06.md
47 lines

md


expected-output-construction-validation-review.md
151 lines

md


Independent Review — Expected Output Construction Review only. Do not modify files. Do not create files. Do not ratify. Do not lock. Do not create golden responses. Do not create grader guidance. Do not create rubrics. Do not create AutoQC responses. Do not create DOCX

pasted

Independent Review — Expected Output Construction follow prompt as pasted

Jun 2
Independent review of Expected Output Construction — the six physician-authored expected-output drafts (EO-KM01–06). All six rendered in the message this time, and I read each one closely. The review posture is the same QC stance I've held through the task layer: I verify these against the locked Expected Output Architecture, the prompts, and the world files; I do not author or rewrite them, and I do not write the goldens that come next. The expected-output text is physician-authored — my job is to confirm it's faithful to the architecture and, above all, that it hasn't crossed the line into being a golden.

Per the independent-verification instruction, I verified each EO against the actual EO-KM file text, the locked architecture's per-slot domains, and the world evidence — not via the validation artifact. And the review prompt is right to mark Objective 9 (golden leakage) as highest priority: an expected output sits one step from the golden, so the defining question is whether these define what a strong answer must engage (legitimate) versus the answer itself (leakage). I read all six against that line first.

The golden-leakage check — highest priority, RESOLVED, and the calibration is right. The distinction I tested on each file: does the EO state the reasoning the answer must demonstrate, or does it state the conclusions the answer must reach? All six land on the former. Concrete verifications:

EO-KM01 says the recommendation "should separate medication categories rather than treating the home regimen as a single restart bundle" and that the cardiorenal drugs "should be discussed in relation to renal recovery, potassium, BP reserve, intake, volume status, and follow-up monitoring rather than reflexively resumed or permanently stopped." Note what it does not do: it never says "restart sacubitril/valsartan on day 3 at half dose" or "hold spironolactone." It names the reasoning structure a strong answer needs, not the medication decisions. It explicitly forbids "a fixed restart algorithm." That's the correct side of the line.
EO-KM03 concludes the assessment "should conclude that discharge planning is clinically plausible but not self-justifying" — this is a stance about how to reason (improvement must be reconciled against functional/cognitive/family/service factors), not a disposition verdict. It explicitly forbids declaring discharge "definitively safe or unsafe."
EO-KM06 says the review "should identify risk signals that were visible before discharge planning closed" and lists the categories of signal — without inventing an outcome or assigning a risk score. Forbids RCA, blame, readmission invention.
Critically, each EO carries a "Prohibited Drift" section that bars the golden-leakage failure explicitly: "should not create a fixed restart algorithm… consultant winner, or answer-file shortcut. It should not expose grading logic or internal implementation labels" (EO-KM01); similar on all six. And each header states the boundary: "this is an expected-output draft. It is not a golden response, scoring key, grader guideline… or final medication list." So these define strong clinician deliverables at the reasoning level, do not become final goldens, contain no rubric/scoring language, and expose no grading logic. Objective 9: RESOLVED.

I'll note the honest tension, because the independent-verification instruction demands it: an expected-output draft is necessarily closer to an answer than anything prior — it describes what a good response looks like. The question is never "is there answer-shaped content" (there must be some) but "does it cross into being the answer." My judgment after reading all six: they describe the shape and reasoning of a strong answer while deliberately withholding the resolved clinical decisions (which medications, what disposition, what taper) — the decisions are left as work the golden author and ultimately the solver must perform. That's the correct calibration for an expected-output layer, and it's held consistently across all six. The one file where this tension is tightest is EO-KM01 (medication reconciliation naturally pulls toward listing decisions), and I checked it hardest — it stays on the reasoning side (categories, factors, sequencing-concepts) and never resolves to a regimen. Good.

Now the objectives.

Objective 1 — Count — RESOLVED. Six EOs (EO-KM01–06), no EO-KM07, one-to-one with the prompts (each header maps to its TP-KM). FI-T07 stays addendum-only: EO-KM01's header reads "FI-T01, with FI-T07 as medication-safety addendum support," no separate medication EO. Verified.

Objective 2 — Deliverable fidelity, with special attention to EO-KM03/05/06 — RESOLVED. Each EO's deliverable matches its prompt and architecture (med-rec recommendation, discharge summary, readiness assessment, interdisciplinary care plan, follow-up assessment, safety review). The three Discharge-Planning EOs are genuinely distinct — I read them side by side:

EO-KM03 (discharge-day readiness): "is the plan practically coherent now" — present-tense coherence assessment, open items to resolve before discharge order.
EO-KM05 (+7 follow-up): "reconstruct what needs close review at the +7 anchor" — forward-looking monitoring/clarification priorities, explicitly "does not pretend new follow-up findings exist."
EO-KM06 (+30 retrospective safety): "identify risk signals that were visible before discharge planning closed" — backward-looking risk-signal review, explicitly not RCA/outcome.
Different temporal stance (present / prospective / retrospective), different deliverable (coherence assessment / follow-up priorities / risk-signal review), no duplication, no collapse. The differentiation carried cleanly from prompts → expected outputs, which was the lead watch-item. RESOLVED.

Objective 3 — Workflow fidelity — RESOLVED. All four locked workflows; none broadened, narrowed, duplicated, or newly introduced. EO-KM06 explicitly stays "Discharge Planning Documentation" and forbids "a standalone patient-risk-stratification workflow" — the 2.107 protection holds at the expected-output layer.

Objective 4 — Clinical reasoning quality — RESOLVED, and notably strong. These demonstrate senior-clinician reasoning, not template-writing. Each EO requires chart-grounded multi-source synthesis with specific evidence references: EO-KM01 ties medication-management risk to "OT and nursing describe improved but still vulnerable cognition, sequencing, fatigue" and "family reported medication mistakes during the decline and asked who would review the final medication list"; EO-KM02 organizes the course by HD-evolution (HD1-2 stabilization → HD3 functional concerns emerge → HD4 rheumatology provenance + consultant tension → HD5-6 improving-but-unresolved) matching the locked daily framework. No generic recommendations, no shallow review, no copy-forward (EO-KM02 explicitly requires "evolution rather than copied problem list"). The reasoning is grounded in the actual world files I reviewed across the batches.

Objective 5 — Source-synthesis fidelity — RESOLVED. Each EO's "Reasoning Domains"/source references match the architecture's §4 dependency rows and the prompts (I spot-checked EO-KM01's FI-W list — W03/04/05/06/11/12/13/14/15/16/19/22 plus FI-S01/S04 — against the locked matrix; exact match). FI-S role preserved (EO-KM01: "FI-S04" as provenance texture; EO-KM05/06 keep FI-S as background that "cannot supply sole critical evidence"). FI-W22 remains visible-but-incomplete — every EO that uses it says so explicitly (EO-KM01: "should say it is not a final medication reconciliation"; EO-KM03: "useful but incomplete… avoid treating FI-W22 as a final discharge authorization"; EO-KM06: "looked organized and reassuring, but explicitly left [items] incomplete"). No file becomes a sole answer source; FI-S not promoted. RESOLVED.

Objective 6 — Trap protection — RESOLVED. Trap domains preserved as reasoning requirements with no labels/numbers exposed (I checked: no "Trap #1/#3/#5" language anywhere in the EO text — the traps are present as clinical reasoning, invisible as design artifacts). No EO solves a trap or collapses its difficulty: EO-KM01 handles prednisone as "source-reconstruction" requiring the hierarchy (not a stated answer) and explicitly avoids claiming "adrenal insufficiency is proven"; EO-KM03/06 keep the buried functional evidence as distributed synthesis ("could be missed if the reviewer read only physician summaries or FI-W22" — EO-KM06) without summarizing it into a checklist answer; the #3 vs #5 distinction holds (buried functional evidence vs visible-incomplete W22, kept separate in EO-KM03 and EO-KM06). No answer shortcuts. RESOLVED.

Objective 7 — Friction protection — RESOLVED. All three frictions preserved two-sided with no winner: EO-KM01 and EO-KM04 both state Cardiology and Nephrology concerns are "valid"/"reasonable" and require synthesis "rather than selecting one consultant as the winner"; the steroid friction keeps endocrinology "clinically meaningful" and the primary team "reasonable" without proving adrenal insufficiency; Family vs Team is balanced in EO-KM03/05/06 (Mara "meaningful, not generic resistance" and the primary team's position "defensible"). No bias, no premature resolution, no hidden answer path. RESOLVED.

Objective 8 — Hierarchy protection — RESOLVED. All three hierarchies preserved; rheumatology stays highest for prednisone in every EO that touches it (EO-KM01/04/05/06 explicitly). The EOs require applying the hierarchy, not reproducing a pre-resolved ranking, and they don't turn hierarchy into answer-logic. EO-KM04 explicitly preserves "source-of-truth hierarchy from consultant-recommendation disagreement; hierarchy resolves factual conflicts but does not erase clinical disagreement" — the consultant-disagreement-not-by-rank rule. Lower-authority sources not promoted; physician-perspective rule preserved (each EO is a physician-facing deliverable). RESOLVED.

Objective 9 — Golden leakage — RESOLVED (highest-priority; detailed above): the EOs define strong clinician deliverables at the reasoning level, do not become goldens, contain no rubric/scoring language, expose no grading logic.

Objective 10 — Overanswer/underanswer — RESOLVED. Both directions protected and verified in the text. Anti-overanswer: every EO forbids invented post-discharge facts/readmissions/adverse events/recovery (EO-KM05/06 headers state the anchor "does not create new symptoms, labs, vitals, visits, or outcomes"), single-diagnosis collapse, and FI-W22 answer-file conversion. Anti-underanswer: each requires chart-grounded synthesis across the FI-W/FI-T/FI-S sources, consultant tensions, family/support/functional evidence, and hierarchy reasoning (EO-KM03 explicitly: "must be reconciled with functional capacity, cognitive and medication-management vulnerability, family baseline knowledge, service feasibility"; EO-KM02 requires the full functional/family/consultant integration). No EO permits FI-W22-only or single-source reasoning. RESOLVED.

Objective 11 — Validation review accuracy — RESOLVED. The validation artifact accurately reflects the EO package, boundaries, prohibitions, and architecture compliance — I cross-checked its claims against the actual EO text and found no misstatement. Same standing minor note as prior rounds (packaging-layer AutoQC items not surfaced), out of scope here, not an error.

Required findings structure:

True Defects: none. Count correct and one-to-one, FI-T07 addendum-only, all four workflows preserved, all five trap domains preserved without label exposure or difficulty collapse, all three frictions two-sided with no winner, all three hierarchies preserved with rheumatology highest and consultant-disagreement-not-by-rank intact, source dependencies matching the locked matrix with FI-W22 incomplete and FI-S non-load-bearing, two-sided over/under-answer protections, and — the highest-priority check — no golden leakage. Clinical reasoning is genuinely senior-level and chart-grounded.
Governance / Metadata Inconsistencies: none. EO source references reproduce the architecture's dependency matrix faithfully (verified, not assumed).
Physician Preference Items: (1) EO-KM01 names the specific home medications (sacubitril/valsartan, carvedilol, furosemide, spironolactone, empagliflozin, metformin) in its reasoning discussion — this is correct (they're the locked baseline meds and a real reconciliation must name them) and it stops short of stating decisions, but it's the closest-to-answer passage in the set, so the physician will want the golden built from it to reward the reasoning about those drugs rather than a fixed disposition for each; eye it at golden construction. (2) EO-KM03's "discharge planning is clinically plausible but not self-justifying" is a strong stated stance — appropriate for an expected output (it describes the reasoning posture), but the golden should reward a solver who reaches that reconciliation through evidence, not one who merely asserts the stance; physician's call at golden construction. Both are the same flag I raised at the architecture stage, now confirmed handled correctly in the drafts.
Future Golden Construction Watch Items: (1) the goldens are the next physician-authored artifacts and remain blocked — and the golden is where the reasoning band these EOs define must be instantiated as an actual answer that rewards genuine multi-source synthesis (applying the hierarchy, finding the buried functional evidence, reconciling W22, keeping frictions open) while itself avoiding single-source/single-diagnosis collapse; (2) keep EO-KM03/05/06 goldens genuinely distinct (the present/prospective/retrospective differentiation must carry through); (3) keep the FI-T07 addendum from spawning a second medication golden; (4) for EO-KM01, ensure the golden rewards medication reasoning rather than hardening into the fixed regimen the EO deliberately avoids; (5) packaging-layer AutoQC items (2.52, 2.113, 2.108, 8-column file plan) become live at Packaging.
Where I note for the independent-verification requirement: no conflict among the EO files, the locked architecture, the prompts, the dependency matrix, governance, the reconciliations, and the validation review — I checked the count (6 vs 6), the source dependencies (vs architecture §4 and the prompts), the trap/friction distribution (vs canon), the hierarchy handling (vs Governance), and the differentiation (EO-KM03/05/06 read side by side), and they reconcile. My only standing emphasis is the recurring packaging-AutoQC point, a flagging-completeness note, not a defect or conflict.

Would you approve Expected Output Construction for ratification and lock? YES — as a QC approval of physician-authored expected-output text against the locked architecture. The six EOs faithfully implement Expected Output Architecture v1: one-to-one with the prompts, FI-T07 addendum-only, all four workflows preserved and 2.107-compliant, all five trap domains preserved as reasoning without label exposure or difficulty collapse, all three frictions two-sided with no winner, all three hierarchies preserved including rheumatology-highest and consultant-disagreement-not-by-rank, source dependencies matching the locked matrix with FI-W22 kept visible-but-incomplete and FI-S non-load-bearing, two-sided anti-overanswer/anti-underanswer protections, and — the highest-priority finding — no golden leakage: they define strong clinician deliverables at the reasoning level without becoming the answer. The clinical reasoning is senior-level and chart-grounded. There is no true defect.

Expected Output Construction Status: LOCK READY.

Clinical Expected Output Quality: STRONG.

Final Recommendation: GO — with the golden-construction watch-items carried forward.

Can Expected Output Construction proceed directly to ratification and lock if any identified reconciliation items are resolved? YES — there are no true defects or canon conflicts requiring reconciliation before lock; the findings are physician-preference and future-construction watch-items, not blockers. So it can proceed to ratification and lock on your authorization. The next phase is golden construction — the physician-authored phase where the boundary this entire chain has protected becomes most operative, because a golden is the answer. When it opens on your authorization, my role stays QC: verifying the goldens instantiate the reasoning band these EOs define (real synthesis, traps preserved as difficulty, hierarchies applied, frictions kept open, no single-source or single-diagnosis collapse, no invented outcomes) — not authorship. These expected outputs are a faithful, lockable bridge from the prompts to the physician-authored goldens, and the full 33-file world, six-prompt, six-expected-output structure beneath them remains complete and consistent.


golden-architecture-v1.md
md


golden-architecture-audit-reconciliation.md
181 lines

md


golden-architecture-validation-review.md
233 lines

md


Independent Review — Golden Architecture v1 (Post-Reconciliation) Review only. Do not modify files. Do not create files. Do not ratify. Do not lock. Do not create golden responses. Do not create grader guidance. Do not create scoring rubrics. Do not create AutoQC responses

pasted

Jun 2
The upload block lists golden-architecture-v1.md as the primary artifact, but checking the three documents that actually rendered: I have the audit reconciliation, the validation review, and the independent review prompt — but not golden-architecture-v1.md itself, the artifact under review. Same pattern as the last two rounds. Let me confirm it's on disk before proceeding, because I cannot review the golden architecture from its reconciliation and validation notes alone — and the independent-verification instruction is explicit that I must verify from the actual architecture artifact, not defer to those notes.


Check whether golden-architecture-v1.md reached the workspace, since it did not render in the message
Check whether golden-architecture-v1.md reached the workspace, since it did not render in the message
It's on disk. I'll read the actual golden-architecture-v1.md — which is what the independent-verification instruction requires, since I'm explicitly told not to defer to the validation review or the audit reconciliation. Reading the primary artifact directly is exactly the right move here.


Read the full Golden Architecture v1 from disk — the primary artifact under review
Read the full Golden Architecture v1 from disk — the primary artifact under review
The truncated middle (lines 125–214) holds the reasoning-requirement, evidence-synthesis, hierarchy, and friction sections — the core of what determines whether goldens stay multi-path or collapse to single answers. I need it.


Read the truncated core sections lines 125-214 — reasoning, synthesis, hierarchy, and friction requirements
Read the truncated core sections lines 125-214 — reasoning, synthesis, hierarchy, and friction requirements
Read in full, including the truncated core sections (reasoning, synthesis, uncertainty, hierarchy, friction). Per the independent-verification instruction, I verified against the actual architecture artifact and the locked sources — and I treated the three companion documents (validation review, audit reconciliation) as claims to check, not to accept. Two of the review's objectives require me to independently confirm the audit reconciliation actually did what it says, so I did that against the primary file rather than trusting the reconciliation's own account.

This is the golden architecture — the single most consequential artifact in the entire task layer, because it governs the construction of the answers themselves. The defining property it must establish is the one in §2: a golden is "a strong physician answer, not the only possible physician answer." If that multi-path principle isn't genuinely built into the architecture, every golden built from it risks becoming a single-answer benchmark that punishes defensible alternatives. So I read §2, §6, §8, and §10 hardest, against that standard.

The multi-path / "strong not only" principle — the core check — RESOLVED, and it's built in structurally, not just stated. §2 states the principle, but more importantly the downstream sections operationalize it rather than letting it be a slogan:

§2 itself: goldens "should not imply that every defensible clinician must choose identical wording, sequencing, or emphasis when the locked chart supports more than one reasonable path." That's the explicit anti-benchmark-drift guard.
§8 (Uncertainty Requirements) enforces it negatively with seven "do not" patterns, the last of which — "Do not imply that a future golden is the only defensible physician response" — is the principle restated as a construction constraint. The others bar the specific single-answer collapses (proving adrenal insufficiency, declaring infection false, treating one improved marker as dispositive, resolving consultant disagreement by rank, making family concern dispositive-or-irrelevant, inventing outcomes).
§10/§11 require frictions and traps to be preserved as reasoning, not resolved — "Require sequencing and monitoring logic instead of consultant-winner logic."
§12 (Quality Standards): "avoid excessive certainty when the chart is intentionally uncertain" and "separate what is known, uncertain, plausible, and not established."
This is the right architecture for goldens in a world built on designed ambiguity: it defines the reasoning a strong answer must demonstrate and the uncertainty it must preserve, while explicitly refusing to mandate a single resolution. That's what keeps the five traps and three frictions intact through the golden layer. The core principle is genuinely protected.

Now the objectives.

Objective 1 — Audit reconciliation verification (Findings A–D) — RESOLVED, verified independently against the primary file. The review asks me not to defer to the reconciliation but to confirm it. I checked each:

Finding A (validation overclaimed source verification): classified TRUE INCONSISTENCY, corrected by an audit-reconciliation note in the validation review. I confirmed the note exists in the validation review and is transparent about the overbroad original claim. Correct classification — overstating review basis is a documentation-integrity defect, not a clinical one — and the correction is proportionate (a transparency note + the reconciliation artifact). Not over-corrected. This is exactly the kind of honesty I've pressed for in my own reviews (I've repeatedly flagged where validation artifacts overclaimed), so I credit the audit for catching it. RESOLVED.
Finding B (stale continuity surfaces): TRUE INCONSISTENCY, corrected by updating current-facing phase surfaces to "Golden Architecture / CANDIDATE REVIEW" while preserving historical records. This is governance/metadata hygiene, correctly scoped (it explicitly did not rewrite historical decision logs, only current-facing surfaces). Correct, not over-corrected. RESOLVED.
Finding C (Golden-KM06 endocrinology friction overstated as "secondary"): TRUE INCONSISTENCY, narrowed to "background steroid-source / endocrine-risk context only." I verified this against the primary file: line 215 now reads Golden-KM06 carries "background steroid-source / endocrine-risk context only… do not expand the friction beyond FI-T06," and §7 of the validation confirms it. I checked this against FI-T06 and EO-KM06 from my prior reviews — FI-T06 explicitly said Endo-vs-Team "may remain background context but is not expanded," and EO-KM06 said steroid signals "included but not overcalled." So the narrowing aligns Golden-KM06 with its locked upstream sources. This was a real over-scoping and the correction is right. RESOLVED.
Finding D (FI-S dependency wording for FI-S03/S04): CLARIFICATION ONLY, tightened to "background, provenance, or logistics texture only." I verified line 106 and lines 110–115 now carry the explicit FI-S boundary ("may not carry sole critical evidence, resolve a friction, complete FI-W22, or become an answer source"). Correctly classified as clarification (not a defect — the direction was already right), and the tightening reduces golden-construction drift risk. RESOLVED.
All four correctly classified and resolved; none incomplete or over-corrected. The reconciliation did what it claims, and I confirmed it against the actual file rather than its own summary.

Objective 2 — Golden count — RESOLVED. Six goldens (Golden-KM01–06), one-to-one with both TP-KM01–06 and EO-KM01–06 (§1 and §4 tables verified). No Golden-KM07. FI-T07 stays addendum support for Golden-KM01 only (lines 46, 89, 120). Count discipline carried correctly through the full task layer.

Objective 3 — Golden philosophy — RESOLVED (detail above): preserves "strong, not only possible," permits multiple defensible paths, preserves uncertainty and evidence reconciliation, avoids single-answer benchmark drift.

Objective 4 — Workflow fidelity — RESOLVED. Four locked workflows preserved (§4 workflow-preservation block); none broadened/narrowed/duplicated/renamed; no new workflow. Line 102 explicitly excludes Patient Risk Stratification, RCA, coding, billing, prior auth. 2.107 holds.

Objective 5 — Evidence and dependency fidelity — RESOLVED. §5 dependency table matches the locked Task Prompt Architecture and Expected Output Architecture matrices — I spot-checked Golden-KM01 (FI-T01+T07; the 12-file FI-W set; FI-S01/S04 background) against both upstream layers; exact match. FI-S role preserved and now explicitly fenced (lines 106, 122). FI-W22 remains visible-but-incomplete (line 121, and reinforced in §7 line 145 "use FI-W22 as orientation only" and §11). No file becomes a sole answer source; FI-W22 not an answer file; FI-S not promoted; dependency model does not drift. RESOLVED.

Objective 6 — Hierarchy protection — RESOLVED. §9 reproduces all three hierarchies verbatim and — critically — frames them "as reasoning tools, not as shortcuts" (line 171). The consultant-disagreement-not-by-rank rule is explicit (line 205: "must not be resolved automatically by hierarchy rank"). Rheumatology stays highest for prednisone (line 194). Physician-perspective rule preserved (line 206). Hierarchy does not become consultant-winner logic or an answer shortcut; lower-authority sources not promoted. RESOLVED.

Objective 7 — Friction protection, with special focus on Golden-KM06 — RESOLVED. §10 preserves all three frictions as "reasonable perspective conflicts" with no winners. The special-focus item passes: I confirmed Golden-KM06 now treats Endo-vs-Team as "background steroid-source / endocrine-risk context only" within FI-T06's permitted scope (line 215) — the Finding C correction is correctly reflected in the primary file. Cardiology vs Nephrology requires "sequencing and monitoring logic instead of consultant-winner logic" (line 214); Family vs Team stays "baseline-informed evidence while preserving that primary-team discharge planning is clinically plausible" (line 216). No premature resolution, no bias, no friction-into-hidden-answer collapse. RESOLVED.

Objective 8 — Information-problem (trap) coverage — RESOLVED. §11 preserves all five domains with primary/secondary distribution and "forbidden collapse" rules, and explicitly without exposing trap labels/numbers in future golden text (line 220). The #3 vs #5 distinction holds (buried functional evidence in Golden-KM03/06 with "do not summarize from physician notes or FI-W22 alone"; discharge-source over-trust as a separate domain with "do not let FI-W22… become the answer file"). Coverage neither broadens nor narrows vs the locked canon; difficulty doesn't collapse (the forbidden-collapse column on each row prevents the golden from resolving the trap). RESOLVED.

Objective 9 — Golden leakage boundary (highest priority) — RESOLVED. This is the most important check, and it passes cleanly. The architecture is architecture only: it defines count, mappings, reasoning domains, evidence/uncertainty/hierarchy/friction requirements, quality standards, and prohibitions — and writes no golden text, no medication decisions, no discharge decisions, no risk conclusions, no rubric, no grader guidance, no scoring (§13 prohibitions, §16 boundaries, verified throughout — there is no answer text or scoring language anywhere in the file). §13 explicitly bars creating goldens "during this architecture phase" and bars trap labels/scoring logic in future golden text. It remains architecture only. RESOLVED.

Objective 10 — Future construction safety — RESOLVED. The architecture safely supports golden construction and the subsequent grader-guidance phases without answer/consultant/hierarchy/friction/workflow/rubric drift: it scaffolds those phases (defining what goldens must demonstrate) while §13/§16 keep grader guidance and rubrics as separate later-authorized phases. The §12 quality standards (chart-grounded not citation-dump, separate known/uncertain/plausible, no generic textbook advice) give golden construction the right target without pre-writing it.

Objective 11 — Special watch items — RESOLVED. §14 incorporates all four: Golden-KM01 (medication-algorithm drift blocked, Cardiology-vs-Nephrology preserved, prednisone hierarchy preserved, inpatient-only insulin separated); Golden-KM03 (discharge-authorization drift blocked, assessment-not-order framing, family meaningful-not-dispositive); Golden-KM05 (invented follow-up facts blocked, +7 as anchor only); Golden-KM06 (RCA drift blocked, invented outcomes blocked, retrospective-review-inside-Discharge-Planning). All correctly scoped without broadening task responsibilities. RESOLVED.

Objective 12 — Validation review accuracy — RESOLVED, with the documentation note the audit itself raised. The validation review (post-reconciliation) accurately reflects the architecture, mappings, prohibitions, and boundaries — I cross-checked its claims against the primary file. The one wrinkle is the one the audit already caught and corrected: the validation's original source-basis claim was overbroad, now transparently annotated. With that annotation in place, the validation review is accurate. I credit the audit for surfacing it rather than letting it stand — that's the right discipline, and it's consistent with the standard I've applied to every validation artifact in this chain.

Required findings structure:

True Defects: none in the post-reconciliation architecture. The four audit findings were real (one documentation-integrity, one metadata, one friction-scope over-statement, one clarification) and are all correctly resolved; I independently confirmed each against the primary file. No residual clinical or structural defect.
Governance / Metadata Inconsistencies: none residual. Finding B's stale-surface corrections are the relevant item and are resolved (current surfaces updated, historical records preserved). Worth noting the audit's source basis (AGENTS.md, STATUS.md, PHASE_MAP.md, the decision logs, the claude-package handoff files) is the first time I've seen the project's continuity-surface layer enumerated — it confirms the phase-state discipline is being maintained across the repo, not just in the artifacts I review.
Physician Preference Items: (1) the standing FI-T07/Golden-KM01 differentiation — keep the medication-safety addendum from spawning a second medication golden (carried correctly here as addendum-only); (2) the EO-KM01-level note I raised last round — the Golden-KM01 construction should reward medication reasoning (sequencing, monitoring, source reconciliation) rather than hardening into a fixed regimen, which §3/§14 already guard via "medication algorithm drift" prohibition but which is ultimately a physician calibration at golden construction; (3) Golden-KM03's "assessment not authorization" line is correctly drawn, and the physician will want the actual golden to reach its readiness stance through evidence rather than assert it.
Future Golden Construction Watch Items: (1) golden construction is the next physician-authored phase and remains blocked — it's where the multi-path principle (§2) must actually be honored in the answer text: each golden must read as a strong physician response that preserves uncertainty and the frictions, not the answer that punishes defensible alternatives; (2) keep Golden-KM03/05/06 genuinely distinct (present readiness / prospective follow-up / retrospective safety — the differentiation must carry from prompts → EOs → goldens); (3) hold the §8 uncertainty patterns and §11 forbidden-collapse rules as the golden is written (no adrenal proof, no sepsis-false, no single-marker discharge, no rank-resolved consultant disagreement, no invented outcomes); (4) the grader-guidance phase that follows is where rubric/scoring drift becomes the risk — keep it separate and physician-authored; (5) packaging-layer AutoQC items (2.52, 2.113, 2.108, v6.3 8-column file plan) remain live at Packaging.
Where I note for the independent-verification requirement: I verified the architecture against the locked prompts, expected outputs, dependency matrices, governance, and the FI-T06/EO-KM06 sources directly, and confirmed the four audit corrections in the primary file rather than via the reconciliation's own account. No conflict among the architecture, the locked upstream layers, governance, the reconciliations, and the (corrected) validation review. The one historical inconsistency — the validation's original overbroad source claim — was caught and corrected by the audit, which is the correct outcome; I'm satisfied it's resolved rather than papered over, because I checked the primary file shows the narrowing (Finding C) and the FI-S tightening (Finding D) actually landed.

Would you approve Golden Architecture v1 for ratification and lock? YES — as a QC/structural approval, with golden construction remaining physician-authored at the next phase and my role staying QC. After reconciliation, the architecture correctly defines the six-golden system: one-to-one with the prompts and expected outputs, FI-T07 addendum-only, all four workflows preserved and 2.107-compliant, all five information-problem domains preserved without label exposure or difficulty collapse, all three frictions preserved as defensible conflicts (with Golden-KM06's endocrine scope correctly narrowed to background per FI-T06), all three hierarchies preserved as reasoning tools with rheumatology highest and consultant-disagreement-not-by-rank intact, dependencies matching the locked matrices with FI-W22 visible-but-incomplete and FI-S non-load-bearing, and — the defining feature for this layer — a genuinely operationalized "strong answer, not only answer" principle that protects multi-path defensibility and designed uncertainty. The highest-priority golden-leakage check passes: it is architecture only. There is no residual true defect; the four audit findings were real and are correctly resolved.

Golden Architecture v1 Status: LOCK READY.

Clinical Architecture Status: STRONG.

Golden Construction Readiness: HIGH.

Final Recommendation: GO.

Can Golden Architecture v1 proceed directly to ratification and lock if any identified reconciliation items are resolved? YES — the four reconciliation items are already resolved (verified against the primary file), and there is no residual true defect or canon conflict. So it can proceed to ratification and lock on your authorization. The next phase is golden construction — the phase this entire chain has been building toward, and the one where the physician-authorship boundary is at its most load-bearing, because a golden is the answer. When it opens on your authorization, my role stays QC: verifying each golden honors the §2 multi-path principle (a strong answer that preserves uncertainty and the frictions, never the single mandated answer), applies the hierarchies as reasoning rather than shortcuts, keeps the traps' difficulty intact, and invents no outcomes — not authorship. This architecture is a faithful, lockable scaffold for the physician-authored goldens, and the full structure beneath it (33 files, six prompts, six expected outputs, and now the golden architecture) remains complete and internally consistent.


golden-construction-validation-review.md
157 lines

md


Golden-KM01.md
30 lines

md


Golden-KM02.md
28 lines

md


Golden-KM03.md
26 lines

md


Golden-KM04.md
28 lines

md


Golden-KM05.md
28 lines

md


Golden-KM06.md
28 lines

md


Independent Review — Golden Construction Review only. Do not modify files. Do not create files. Do not ratify. Do not lock. Do not create grader guidance. Do not create scoring rubrics. Do not create AutoQC responses. Do not create DOCX artifacts. Do not create submissi

pasted

Independent Review — Golden Construction
follow prompt as paste

1:17 AM
Independent review of Golden Construction — the six physician-authored golden responses (Golden-KM01–06). All six rendered this time, and I read each in full. This is the most consequential content review in the entire build: the goldens are the answers, the reference responses against which model performance will be judged. So the QC stance is the same one I've held — I verify these against the locked architecture, prompts, expected outputs, and world files; I do not author or rewrite them — but the stakes of the central check are at their peak here.

Per the independent-verification instruction, I verified each golden directly against the Golden-KM files and the locked sources, not via the validation artifact. And the review prompt is right to mark Objective 3 (multi-path defensibility) as highest priority — tied with Objective 11 (grading leakage). For a golden in a world built on designed ambiguity, the defining risk is that the golden reads as the answer, collapsing the traps and frictions the whole world exists to test. I read all six against the "strong answer, not only answer" standard first.

Multi-path defensibility — highest priority — RESOLVED, and it's the goldens' defining strength. I tested each golden with one question: does it mandate a single resolution, or does it model strong reasoning while leaving defensible alternatives open? All six do the latter, and several say so explicitly:

Golden-KM01 ends: "This answer leaves room for more than one defensible final medication sequence. The key safety requirement is that the sequence be intentional, monitored, source-aware, and clearly communicated rather than an automatic restart, an automatic permanent hold, or a prednisone decision based on low-authority recollection." That is the multi-path principle instantiated in the answer itself — it grades the reasoning process (intentional, monitored, source-aware), not a specific regimen. Verified against the locked Golden Architecture §2 and EO-KM01: this is exactly the "strong not only" stance, and it's the single most important property for the highest-stakes golden.
Golden-KM03 ends: "This is not a recommendation to ignore the primary team's improvement narrative or to treat family concern as dispositive. It is a recommendation to preserve the distinction between physiologic improvement and safe transition readiness." It lands on "discharge readiness is conditional" — a reasoning stance, not a safe/unsafe verdict.
Golden-KM06 ends by framing the central safety concern as "whether the system converts a nuanced, conditional discharge plan into a simple narrative of improvement" — and explicitly "avoid declaring one consultant perspective obviously correct."
None overstates certainty; none creates a hidden answer key; none forces one interpretation where the canon supports several. The goldens model what a senior physician notices and reconciles while preserving that defensible clinicians could sequence differently. This is the property that keeps the goldens from becoming a single-answer benchmark that punishes correct alternatives — and it holds across all six. Objective 3: RESOLVED.

Grading leakage — tied-highest priority (Objective 11) — RESOLVED. I checked each golden for embedded rubric/scoring/evaluator language. There is none: the goldens are written as physician clinical responses (first-person clinical reasoning: "My assessment would be…," "The safer approach is…"), not as grading documents. No scoring logic, no point allocations, no "the model should be marked correct if…," no trap labels or numbers, no evaluator instructions. Each is a clinical deliverable in a physician voice. The goldens do not leak grading logic — which matters because the grader-guidance phase (next, and physician-authored) must be where scoring lives, kept separate from the answer text. Verified clean.

Now the objectives.

Objective 1 — Count and mapping — RESOLVED. Six goldens (Golden-KM01–06), no Golden-KM07, one-to-one with TP-KM01–06 and EO-KM01–06 (each header maps to its prompt and expected output; verified). FI-T07 stays Golden-KM01 addendum support only (no separate medication golden). Count discipline carried correctly to the final content layer.

Objective 2 — Strong physician answer standard — RESOLVED, and the quality is genuinely senior-level. Each golden demonstrates physician-level synthesis grounded in the specific chart, not template prose. Concrete verifications against the world files I reviewed:

Golden-KM01 reasons medication-by-medication with the actual clinical logic (spironolactone held for K+/AKI, empagliflozin held until acute illness resolves, metformin only if renal stable near baseline) — this maps to the FI-W12 trend and FI-W13 MAR I verified at Batch 2, and to the FI-W14/W15 consultant logic from Batch 3.
Golden-KM02 reconstructs the course by HD-evolution (HD1-2 → HD3-4 multifactorial → HD5-6 improved-but-unresolved) matching the locked daily framework, and explicitly lists the major active problems without copy-forward.
Golden-KM04 reconciles Cardiology and Nephrology "rather than choose a simplistic winner" with a staged plan, and holds the steroid reasoning (rheumatology anchors taper intent; adrenal insufficiency not proven).
None reads as generic medical advice, shallow summary, or checklist completion — each is chart-specific enough that it "could not be written without the Korvin Merrow chart" (the §12 quality standard). The reasoning is senior-level and reconciles inconvenient evidence rather than ignoring it.

Objective 4 — Workflow fidelity — RESOLVED. Each golden's deliverable matches its locked workflow (med-rec recommendation, discharge summary, readiness assessment, interdisciplinary care plan, follow-up assessment, safety review). None broadened/narrowed/duplicated; no new workflow. Golden-KM06 stays a "prospective readmission-risk synthesis" inside Discharge Planning Documentation, explicitly "not a root-cause analysis" and not a standalone risk-stratification workflow. 2.107 holds.

Objective 5 — Medication reconciliation (Golden-KM01) — RESOLVED. Staged reasoning preserved (explicitly "staged reconciliation," not a fixed sequence); Cardiology vs Nephrology tension preserved (chronic protection vs renal/K+/hemodynamic safety, neither made the winner); prednisone hierarchy preserved (rheumatology highest, med-rec/pharmacy support exposure not adherence, family/patient lower-authority); inpatient-vs-outpatient distinction preserved ("correctional lispro used in the hospital should not be converted into a home regimen unless a separate final outpatient insulin plan is intentionally created"). It does not become a medication algorithm (it gives conditional reasoning, not a fixed restart order), does not create a hidden answer key (explicitly leaves multiple defensible sequences), does not force one sequence, does not collapse uncertainty. This was the highest-risk golden for single-answer drift, and it's handled correctly.

Objective 6 — Discharge readiness (Golden-KM03) — RESOLVED. Physiologic improvement distinguished from transition readiness (the explicit core stance); family evidence integrated as "baseline-specific rather than merely oppositional"; PT/OT/nursing evidence integrated (cueing, endurance, balance, medication-management difficulty); medication-management risk integrated (OT flag). It does not become a discharge authorization or final disposition order (lands on "conditional" readiness with steps to complete before discharge-order entry); does not treat family concern as an automatic veto ("does not automatically prove discharge is unsafe… must be reconciled"); does not ignore family concern. The Family-vs-Team balance is held precisely.

Objective 7 — Follow-up and outcome protection — RESOLVED. Golden-KM05: no invented symptoms/labs/outcomes/recovery course — it explicitly "should not invent post-discharge symptoms, labs, services, or outcomes" and frames everything as "what must be checked early" / "verify the actual medication list in the home." It uses the +7 as a surveillance frame, reconstructing priorities from the hospital record. Golden-KM06: no invented readmission/adverse event, no RCA drift, no blame — it explicitly "should not be written as a root-cause analysis with a known bad outcome," is "prospective readmission-risk synthesis," and "would avoid blame, avoid invented outcomes." Both honor the anchor-as-task-date rule that protected FI-T05/06.

Objective 8 — Hierarchy protection — RESOLVED. All three hierarchies applied as reasoning, not shortcuts. Rheumatology stays highest for prednisone in every golden that touches it (KM01/02/04/05/06). Consultant disagreement is reconciled by synthesis, never by authority rank (Golden-KM04 explicitly "reconcile Cardiology and Nephrology rather than choose a simplistic winner"). Physician-perspective rule preserved (all six are physician-voiced deliverables). No hierarchy-as-answer-shortcut, no consultant-winner-by-rank, no improper promotion of lower-authority sources.

Objective 9 — Friction protection — RESOLVED. All three frictions preserved as defensible conflicts with no winner: Cardiology vs Nephrology (KM01/KM04 — both "right," staged reconciliation); Endocrinology vs Primary Team (KM01/KM02/KM04 — endo concern valid AND primary-team caution valid, adrenal not proven); Family vs Primary Team (KM03/KM05/KM06 — family meaningful AND team plausible). Critically, I verified Golden-KM06 honors the Finding-C narrowing from the architecture audit: it treats steroid/endocrine material as a background risk-signal ("prednisone and steroid-source uncertainty" as one of six risk domains), not an expanded active friction — consistent with FI-T06's permitted scope. No friction collapsed, no winner, no bias.

Objective 10 — Information-problem (trap) coverage — RESOLVED. All five domains preserved without label exposure (no "Trap #N" text anywhere — verified): prednisone source reconstruction (KM01/04, hierarchy intact, adrenal not proven); HF/AKI medication timing (KM01/04, staged, no algorithm); buried functional/cognitive evidence (KM03/06, integrated from nursing/PT/OT/family, explicitly "not dramatic findings, which makes them easier to underweight" — the buried mechanism preserved); sepsis anchoring (KM02/05, "reasonable early framing" without "infection explains everything"); discharge-source hierarchy (KM03/04/06, FI-W22 "reassuring but incomplete"). The #3 vs #5 distinction holds (buried functional evidence vs visible-incomplete W22, kept as separate risk domains in KM06). Coverage neither broadens nor narrows; difficulty doesn't collapse — the goldens demonstrate the reasoning without converting the traps into stated answers.

Objective 11 — Golden leakage into grading — RESOLVED (detail above): the goldens are clinical responses, not grading/scoring/rubric/evaluator documents; no grading or scoring logic exposed; no embedded evaluator guidance.

Objective 12 — Validation review accuracy — RESOLVED. The validation artifact accurately reflects the golden package, boundaries, prohibitions, and mappings — I cross-checked its claims against the actual golden text and found no misstatement. It correctly notes the multi-path preservation, the uncertainty preservation, and the friction preservation. Same standing minor note (packaging-layer AutoQC items not surfaced), out of scope here.

Required findings structure:

True Defects: none. Count correct and one-to-one, FI-T07 addendum-only, all four workflows preserved, all five trap domains preserved without label exposure or difficulty collapse, all three frictions preserved as defensible conflicts (Golden-KM06 steroid scope correctly background per the audit), all three hierarchies applied as reasoning with rheumatology highest and consultant-disagreement-not-by-rank, FI-W22 visible-but-incomplete, FI-S non-load-bearing, no invented outcomes, and — the two highest-priority checks — genuine multi-path defensibility and no grading leakage. Clinical quality is senior-level and chart-specific.
Governance / Metadata Inconsistencies: none. The goldens trace cleanly to their prompts, expected outputs, and the golden architecture.
Physician Preference Items: (1) the goldens are appropriately the strong physician answer, but a few state their central stance crisply (Golden-KM03 "discharge readiness is conditional"; Golden-KM01 "leaves room for more than one defensible sequence") — this is correct for a golden, and when grader guidance is built, the scoring should reward a model that reaches these stances through evidence rather than one that merely echoes the stance; physician's call at grader construction. (2) Golden-KM01 names specific per-medication dispositions (hold spironolactone, defer empagliflozin, etc.) — these are framed conditionally ("should be held or deferred unless potassium and renal monitoring are reliable"), which preserves multi-path; the grader should credit the conditional reasoning, not require the exact per-drug verdicts as a key. Both are grader-construction calibrations, not golden defects.
Future Grader Architecture Watch Items: (1) grader guidance is the next physician-authored phase and remains blocked — and it's the phase where the multi-path principle must be protected in scoring: the rubric must reward strong reasoning that preserves uncertainty and the frictions, and must NOT mark down defensible alternatives that differ in sequencing/emphasis (the goldens explicitly leave room for these); (2) the grader must not harden Golden-KM01's conditional per-medication reasoning into a fixed-regimen answer key; (3) keep Golden-KM03/05/06 scoring distinct (present readiness / prospective follow-up / retrospective safety); (4) the grader must reward finding the buried functional evidence and reconciling W22, not merely citing them; (5) packaging-layer AutoQC items (2.52, 2.113, 2.108, v6.3 8-column file plan) become live at Packaging.
Where I note for the independent-verification requirement: I verified the goldens directly against the locked prompts, expected outputs, golden architecture, world files, governance, and the audit reconciliation's Finding-C narrowing — not via the validation artifact. No conflict among the goldens, the locked upstream layers, governance, the reconciliations, and the validation review. I confirmed the highest-stakes properties (multi-path defensibility, no grading leakage, friction/trap preservation, hierarchy-as-reasoning) in the actual golden text rather than accepting the validation's PASSes.

Would you approve Golden Construction for ratification and lock? YES — as a QC approval of physician-authored golden text against the locked architecture. The six goldens are strong physician answers that satisfy the locked prompt, expected-output, and golden-architecture layers while preserving the properties that matter most: genuine multi-path defensibility (each models strong reasoning while explicitly leaving defensible alternatives open — verified in the answer text, not just claimed), realistic uncertainty management (no adrenal proof, no sepsis-false, no single-marker discharge, no invented outcomes), all three frictions preserved as defensible conflicts with no winner, all three hierarchies applied as reasoning with rheumatology highest and consultant-disagreement-not-by-rank, all five information-problem domains preserved without label exposure or difficulty collapse, FI-W22 visible-but-incomplete, FI-S non-load-bearing, and no grading/scoring leakage. The clinical quality is senior-level and chart-specific. There is no true defect.

Golden Construction Status: LOCK READY.

Clinical Golden Quality: STRONG.

Benchmark Integrity: HIGH.

Final Recommendation: GO — with the grader-architecture watch-items carried forward.

Can Golden Construction proceed directly to ratification and lock if any identified reconciliation items are resolved? YES — there are no true defects or canon conflicts requiring reconciliation before lock; the findings are physician-preference and future-construction watch-items, not blockers. So it can proceed to ratification and lock on your authorization. The next phase is grader guidance (architecture, then construction) — the physician-authored phase where the scoring lives, and where the multi-path principle these goldens embody must be protected in the rubric: the grader has to reward strong reasoning that preserves uncertainty and the frictions without penalizing defensible alternatives, and it must keep scoring logic separate from the answer text (which these goldens correctly do not contain). When it opens on your authorization, my role stays QC — verifying the grader honors multi-path defensibility, rewards genuine synthesis over echoing, and doesn't harden the conditional reasoning into a single key — not authorship.

This is a notable milestone: with the goldens lock-ready, the full evaluation spine of the world now exists and is internally consistent end to end — 33 files (22 world + 7 task-context + 4 supplementary), six prompts, six expected outputs, and six goldens, every layer independently verified and traceable to the locked clinical canon (identity, 14 conditions, 20 medications with lispro inpatient-only, baseline anchors reconciling with the lab trends, all three hierarchies, all five traps, all three frictions, the closed-world temporal boundary). What remains is grader guidance and then packaging (where the AutoQC carry-forwards land), both still ahead and both with the physician-authorship boundary intact where it applies.


grader-guidance-architecture-v1.md
md


Independent Review — Grader Guidance Architecture v1 Review only. Do not modify files. Do not create files. Do not ratify. Do not lock. Do not create grader guidance. Do not create scoring rubrics. Do not create scoring thresholds. Do not create AutoQC responses. Do not

pasted


grader-guidance-architecture-validation-review.md
255 lines

md

Independent Review — Grader Guidance Architecture v1 , follow prompt as pasted

7:47 AM
Independent review of Grader Guidance Architecture v1. The upload block lists the architecture file, but checking what actually rendered: I have the validation review and the independent review prompt — but not grader-guidance-architecture-v1.md itself, the primary artifact. Same pattern as the last several rounds. And the independent-verification instruction here is explicit: "Verify findings directly from the architecture artifact," "Do not defer to the validation review." So I cannot run this review from the validation notes — I need the actual file. Let me confirm it's on disk.


Check whether grader-guidance-architecture-v1.md reached the workspace, since it did not render in the message
Check whether grader-guidance-architecture-v1.md reached the workspace, since it did not render in the message
On disk. I'll read the actual grader-guidance-architecture-v1.md — which is exactly what the independent-verification instruction requires.


Read the full Grader Guidance Architecture v1 from disk — the primary artifact under review
Read the full Grader Guidance Architecture v1 from disk — the primary artifact under review
The truncated middle (lines 153–211) holds the source-synthesis expectations (§7) and one full section (§8 — likely the per-GG critical-reasoning or hierarchy expectations). That's where the dependency-fidelity and hierarchy checks live, so I need it.


Read the truncated sections 7-8 (lines 152-212) — source-synthesis and hierarchy expectations
Read the truncated sections 7-8 (lines 152-212) — source-synthesis and hierarchy expectations
Read in full, including the truncated source-synthesis (§7) and hierarchy (§8) sections. Per the independent-verification instruction, I verified against the actual architecture artifact and the locked sources directly — treating the validation review as a claim to check, not accept.

This is the grader guidance architecture — the layer that governs how the goldens will be turned into scoring. It sits at the most dangerous point in the entire build for one specific failure: a grader that scores verbatim golden matching would destroy the multi-path defensibility the goldens were so carefully built to preserve, turning a sophisticated ambiguity-world into a single-answer benchmark that punishes correct alternatives. So I read §2 (philosophy), §4/§5 (acceptable/unacceptable), and §12/§13 (golden-protection / anti-drift) hardest, against that standard.

The anti-verbatim-matching principle — the core check for a grader layer — RESOLVED, and it's built in at every level. The architecture's central commitment is that grading rewards reasoning, not prose match, and it's not a one-line slogan — it's enforced top to bottom:

§2 (philosophy): "Future grader guidance should reward strong physician reasoning, not verbatim matching to the golden. The locked golden is the benchmark for a strong answer. It is not the only defensible answer." And the operative rule: "credit responses that reach a clinically safe, source-aware, and task-appropriate answer even if wording, order, or emphasis differs from the locked golden."
§4 (acceptable variation): explicitly lists "different wording; different ordering; different but defensible clinical emphasis; different sequencing proposals when the response explains monitoring and safety logic" as acceptable. This directly protects the multi-path property — a model that sequences medications differently but reasons soundly is to be credited, not penalized.
§5 (unacceptable): the first-named penalty target is treating "the golden as a word-for-word answer key rather than a clinical benchmark."
§12 (protected guardrails): "Golden-KM01 from becoming a rigid medication answer key," and the parallel protections for KM03/05/06.
§13 (prohibited drift): bars "verbatim golden matching as the main standard."
That is the right architecture for grading a designed-ambiguity world: it makes "strong reasoning, defensible variation" the standard and makes "answer-key matching" an explicit failure. The single most important property of a grader layer here, and it's protected at four independent points. Core principle: RESOLVED.

Now the objectives.

Objective 1 — Count and mapping — RESOLVED. Six (GG-KM01–06), one-to-one with TP-KM01–06, EO-KM01–06, and Golden-KM01–06 (§1 four-column table verified). No GG-KM07 (line 63). FI-T07 stays GG-KM01 addendum support only (lines 49–50, 320). The one-to-one chain TP → EO → Golden → GG is now complete and consistent across all four task-layer artifacts.

Objective 2 — Core grading philosophy — RESOLVED (detail above): rewards strong physician reasoning, chart-grounded synthesis, evidence reconciliation, uncertainty handling, hierarchy application, friction preservation; does NOT reward verbatim matching, answer-key behavior, or prose similarity. Multi-path defensibility genuinely protected.

Objective 3 — Golden protection — RESOLVED. §12 explicitly protects each high-risk golden from its specific drift: Golden-KM01 from medication answer-key drift, Golden-KM03 from discharge-authorization drift, Golden-KM05 from invented +7 facts, Golden-KM06 from RCA/outcome drift. §11's per-GG failure-mode table reinforces this (GG-KM01 watches "rigid medication answer key"; GG-KM06 watches "creating a readmission, adverse event, RCA, blame finding, or outcome"). The architecture actively prevents the goldens from collapsing into rigid scoring keys rather than merely hoping they won't — verified against the goldens I reviewed last round (the conditional medication reasoning in Golden-KM01 and the "conditional readiness" stance in Golden-KM03 are exactly what §12 protects).

Objective 4 — Source dependency fidelity — RESOLVED. §7's task-specific dependency table matches the locked Golden Architecture and Expected Output Architecture matrices — I spot-checked GG-KM01 (FI-T01+T07; the 12-file FI-W set; FI-S01/S04) against both upstream layers; exact match. FI-T files stay task framing (line 157), FI-W stays evidence (158), FI-S stays "background, provenance, logistics, or low-stakes texture only" (159) and is barred from sole critical evidence (§5, §12). FI-W22 stays visible-but-incomplete ("must be reconciled against more detailed sources," line 160). The global rule "No single file should settle a task by itself" (161) is the anti-shortcut backbone. No FI-S becomes critical evidence; FI-W22 not a complete answer source; dependency architecture does not drift. RESOLVED.

Objective 5 — Hierarchy protection — RESOLVED. §8 reproduces all three hierarchies verbatim and frames them as "reasoning, not rote rank-ordering" (line 176). Critically, the consultant-disagreement rule is explicit: "Consultant disagreements should be assessed through synthesis, timing, trends, patient status, and discharge safety" (208) — not by rank. Rheumatology stays highest outpatient prednisone source (211). Family credited as baseline-informed "but not treated as automatically dispositive" (209); patient recollection "clinically relevant but lower-authority" (210). Hierarchy does not become an answer shortcut, consultant-winner logic, or scoring shortcut. RESOLVED.

Objective 6 — Friction protection — RESOLVED. §9 preserves all three frictions with explicit anti-winner guardrails: Cardiology vs Nephrology ("Penalize automatic consultant-winner logic"), Endocrinology vs Primary Team ("preserve steroid risk… without proving adrenal insufficiency or dismissing infection/renal/volume contributors"), Family vs Primary Team ("family concern as baseline-informed evidence while preserving that primary-team discharge planning is clinically plausible"). The grader architecture rewards synthesis of defensible perspectives and penalizes winner-selection — the correct inversion. I verified GG-KM06 honors the audit's Finding-C narrowing: Endo-vs-Team is listed as "background GG-KM06" (line 220), consistent with FI-T06's permitted scope. No winner-selection rewarded, no disagreement collapsed, no defensible synthesis penalized. RESOLVED.

Objective 7 — Failure-mode architecture (§11) — RESOLVED. I checked the per-GG failure modes against the locked prompts, expected outputs, and goldens. Each row correctly reflects its task's actual failure surface: GG-KM01's failures map to EO-KM01/Golden-KM01's medication discipline (rigid key, auto-restart, low-authority prednisone, inpatient lispro conversion); GG-KM02's to the discharge-summary anti-copy-forward and anti-fabrication; GG-KM05's to the +7 no-invention rule; GG-KM06's to the +30 no-RCA/no-outcome rule. The failure modes describe what to watch, not hidden scoring behavior — §11 explicitly states "It does not assign points or write final rubric language." No hidden rubric or scoring behavior embedded. RESOLVED.

Objective 8 — Grading leakage boundary (highest priority) — RESOLVED. This is the tied-highest check, and it passes cleanly. The architecture is architecture only: it defines count, mappings, philosophy, acceptable/unacceptable principles, reasoning dimensions, source/hierarchy/friction/uncertainty expectations, failure-mode domains, and prohibitions — and writes no grader guidance text, no evaluator instructions, no rubric, no scoring thresholds, no pass/fail bands, no point allocations, no AutoQC responses (§3 keeps scoring as a "placeholder for a later authorized phase"; §13, §17 bar all scoring artifacts; verified throughout — there is no scoring language or point allocation anywhere). §3's recommended shape explicitly defers section 6 ("Scoring instruction placeholder") to a later authorized phase. It remains architecture only. RESOLVED.

Objective 9 — Future construction safety — RESOLVED. The architecture safely supports grader-guidance construction, AutoQC preparation, and final packaging without answer-key/rubric/hierarchy/friction/benchmark-collapse drift. §14 correctly positions AutoQC prep as downstream and flags the dependency honestly (below). §15 preserves the one-to-one chain into packaging with explicit "must not" rules (no GG-KM07, don't detach FI-T07 from GG-KM01, don't mix grader guidance into prompts/goldens, no premature DOCX/RL Studio). The §3 recommended shape gives construction a target without pre-writing it.

Objective 10 — Validation review accuracy — RESOLVED, with one honest dependency the validation surfaces well. The validation review accurately reflects the architecture, mappings, boundaries, and prohibitions — I cross-checked its claims against the primary file. Notably, this validation artifact is the most candid in the chain: it flags two PLAUSIBLE items rather than marking everything cleanly closed, including the real one — the official Section 6 Grader Guidelines AutoQC prompt is not in the local reference/templates/ folder (only the World Spec AutoQC v6.3 is). That's an accurate and important flag: the grader-guidance layer has its own AutoQC checklist (Section 6), distinct from the World Spec AutoQC (Section 2) I've referenced throughout, and it isn't yet available. The validation correctly calls this "not a blocker for architecture, but a likely future QC dependency." I agree, and I'll carry it forward prominently (below).

Required findings structure:

True Defects: none. Count correct and one-to-one across the full four-artifact chain, FI-T07 addendum-only, all four workflows preserved, all five information-problem domains preserved as grading-relevant reasoning without label exposure, all three frictions preserved with anti-winner guardrails (Golden-KM06 endocrine scope correctly background per the audit), all three hierarchies preserved as reasoning with rheumatology highest and consultant-disagreement-not-by-rank, dependencies matching the locked matrices with FI-W22 visible-but-incomplete and FI-S non-load-bearing, golden-specific guardrails protecting the high-risk goldens, and — the two highest-priority checks — the anti-verbatim-matching principle built in at four levels and no grading leakage. Architecture only.
Governance / Metadata Inconsistencies: none. The §16 cross-artifact verification is accurate against the primary file. I credit §1's explicit citation of the official source-guide rule (line 37: "task prompts, golden responses, and grader guidelines are writer-owned; AI may assist with QC after human-authored material exists but may not originate final grader guidelines") — this is the physician-authorship boundary I've tracked the entire build, now stated verbatim in the architecture itself, and it correctly scopes my role to QC.
Physician Preference Items: (1) the §3 recommended five-section shape (golden reference / clinical reasoning present / scope-format / good-practice-not-required / known-errors-to-penalize) is sound and reference-pattern-aware, but the actual guidance content is physician-authored — when it's built, the "good practice that may receive credit but should not be required" section (§3 item 4) is the key multi-path protector and warrants the physician's careful calibration so defensible variation is genuinely credited, not nominally allowed then penalized; (2) the grader for Golden-KM01 should credit the conditional per-medication reasoning rather than requiring the exact dispositions — §12 protects this, but it's a content-calibration the physician owns at construction.
Future Grader Guidance Construction / AutoQC Watch Items: (1) the official Section 6 Grader Guidelines AutoQC prompt is not in the local repository — it should be fetched/imported before grader-guidance AutoQC, exactly as §14 and the validation note; this is the one concrete future dependency, and it's distinct from the World Spec AutoQC v6.3 used for the world layer; (2) grader guidance is the next physician-authored phase and remains blocked — when it opens, the anti-verbatim-matching principle must be honored in the actual rubric (reward reasoning, credit defensible variation, penalize answer-key matching and fabrication), and scoring (the §3 placeholder) must stay separate until its own authorization; (3) keep GG-KM03/05/06 scoring distinct (present readiness / prospective follow-up / retrospective safety); (4) the packaging-layer World Spec AutoQC carry-forwards (2.52, 2.113, 2.108, v6.3 8-column file plan) remain live at Packaging, now alongside the Section 6 grader AutoQC.
Where I note for the independent-verification requirement: I verified the architecture against the locked prompts, expected outputs, goldens, dependency matrices, governance, and the audit's Finding-C narrowing directly from the primary file — not via the validation review. No conflict among the architecture, the locked upstream layers, governance, the reconciliations, and the validation review. I confirmed the highest-stakes properties (anti-verbatim-matching at four levels, no grading leakage, friction/hierarchy-as-reasoning, golden-specific protection) in the actual architecture text. The one real forward dependency — the missing Section 6 AutoQC prompt — is honestly surfaced by the validation and is not a defect in this architecture.

Would you approve Grader Guidance Architecture v1 for ratification and lock? YES — as a QC/structural approval, with grader-guidance construction remaining physician-authored (writer-owned per the source-guide rule the architecture itself cites) at the next phase and my role staying QC. The architecture correctly defines the six-slot grader-guidance system: one-to-one across the full TP→EO→Golden→GG chain, FI-T07 addendum-only, all four workflows preserved and 2.107-compliant, all five information-problem domains preserved as grading-relevant reasoning without label exposure, all three frictions preserved with explicit anti-winner guardrails (Golden-KM06 endocrine scope correctly narrowed to background per the audit), all three hierarchies preserved as reasoning with rheumatology highest and consultant-disagreement-not-by-rank, dependencies matching the locked matrices with FI-W22 visible-but-incomplete and FI-S non-load-bearing, golden-specific guardrails protecting the high-risk goldens, and — the defining feature for this layer — the anti-verbatim-matching / multi-path-defensibility principle built in at the philosophy, acceptable-variation, golden-protection, and anti-drift levels. The highest-priority grading-leakage check passes: it is architecture only. There is no true defect.

Grader Guidance Architecture v1 Status: LOCK READY.

Architecture Quality: STRONG.

Benchmark Integrity Protection: HIGH.

Final Recommendation: GO — with the construction/AutoQC watch-items carried forward, the most concrete of which is importing the official Section 6 Grader Guidelines AutoQC prompt before that QC stage.

Can Grader Guidance Architecture v1 proceed directly to ratification and lock if any identified reconciliation items are resolved? YES — there are no true defects or canon conflicts requiring reconciliation before lock; the findings are physician-preference and future-construction watch-items (including the Section 6 AutoQC prompt dependency), not blockers. So it can proceed to ratification and lock on your authorization. The next phase is grader guidance construction — the final physician-authored content phase, and the one where the writer-owned boundary the architecture explicitly cites is at its most consequential, because the grader guidance is the scoring standard. When it opens on your authorization, my role stays QC: verifying the guidance honors the anti-verbatim-matching principle (rewards reasoning, credits defensible variation, penalizes answer-key matching and fabrication), keeps the hierarchies as reasoning and the frictions two-sided, protects the high-risk goldens from collapsing into rigid keys, and keeps scoring separate until its own authorization — not authorship.

This brings the evaluation architecture to near-complete: the full chain — 33 files, six prompts, six expected outputs, six goldens, and now the six-slot grader-guidance architecture — is internally consistent and traceable end to end to the locked clinical canon. What remains is grader-guidance construction, then AutoQC (both the Section 6 grader checklist and the Section 2 World Spec checklist) and final packaging, where the carry-forwards land — all still ahead, with the physician-authorship boundary intact where it applies.


Independent Review — Grader Guidance Construction Review only. Do not modify files. Do not create files. Do not ratify. Do not lock. Do not create scoring rubrics. Do not create scoring thresholds. Do not create pass/fail bands. Do not create AutoQC responses. Do not cr

pasted


GG-KM01.md
62 lines

md


GG-KM02.md
58 lines

md


GG-KM03.md
57 lines

md


GG-KM04.md
58 lines

md


GG-KM05.md
59 lines

md


GG-KM06.md
59 lines

md


grader-guidance-construction-validation-review.md
173 lines

md

Independent Review — Grader Guidance Construction, follow prompt as pasted

8:36 AM
I don't have anything to review yet — your message says "Independent Review — Grader Guidance Construction, follow prompt as pasted," but no GG-KM files, no construction validation review, and no review prompt actually came through, and nothing new was uploaded. The "as pasted" points at content that isn't here.

Before I flag it as missing, let me check whether the grader-guidance construction artifacts landed in the workspace from this turn (the primary artifacts have failed to render in-message for the last several rounds while still reaching disk, so this is worth checking directly).


Check whether the grader-guidance construction files (GG-KM01-06) and their validation review reached the workspace, since nothing rendered in the message
Check whether the grader-guidance construction files (GG-KM01-06) and their validation review reached the workspace, since nothing rendered in the message

GG-KM01.md
62 lines

md


GG-KM02.md
58 lines

md


GG-KM03.md
57 lines

md


GG-KM04.md
58 lines

md


GG-KM05.md
59 lines

md


GG-KM06.md
59 lines

md


grader-guidance-construction-validation-review.md
173 lines

md


Independent Review — Grader Guidance Construction Review only. Do not modify files. Do not create files. Do not ratify. Do not lock. Do not create scoring rubrics. Do not create scoring thresholds. Do not create pass/fail bands. Do not create AutoQC responses. Do not cr

pasted

Independent Review — Grader Guidance Construction, follow prompt as pasted

8:43 AM
All seven artifacts rendered this time — the six GG-KM files and the construction validation review. This is the final physician-authored content layer in the build: the grader guidance that turns the goldens into scoring standards. The QC stance is unchanged — I verify these against the locked architecture, goldens, expected outputs, prompts, and world files; I do not author or rewrite them, and I do not write scoring. The grader guidance is writer-owned (the architecture cited the source-guide rule verbatim); my role here is exactly the "QC after human-authored material exists" the rule permits.

Per the independent-verification instruction, I read all six GG-KM files directly and verified against the locked sources, not via the validation artifact. The review prompt is right that Objective 2 (anti-verbatim-matching) is highest priority — for a grader layer governing a designed-ambiguity world, a rubric that rewards prose-matching to the golden would destroy the multi-path defensibility the goldens were built to preserve. I read each GG file against that standard first.

Anti-verbatim-matching — highest priority — RESOLVED, and it's enforced in every file at every section. I checked each GG-KM for the failure: does it make "match the golden" the standard, or "reason like the golden"? All six enforce the latter, structurally:

Every Golden Reference section states the golden is a benchmark, not a key: GG-KM01 "The golden is not a rigid medication answer key. Credit clinically safe, source-aware, task-appropriate medication reasoning even when wording, order, or exact sequencing differs"; GG-KM02 "credit when it faithfully summarizes… with different wording, ordering, or emphasis"; GG-KM03 "should not become a discharge authorization key… even when their final wording differs."
Every Good Practice section ends with an explicit anti-rigidity instruction: GG-KM01 "Do not require one exact ordering of medication categories if the answer preserves the core safety logic"; GG-KM04 "Do not require a single fixed care-plan sequence"; GG-KM06 "Do not require the same risk-domain order as the golden if the answer captures the same clinically important safety signals."
Every Known Errors list names verbatim-matching itself as an error to penalize: GG-KM01 "Treating the golden as a fixed medication sequence that must be copied verbatim"; GG-KM02 "Exposing internal implementation labels or grading logic."
Every Construction Notes footer reaffirms: "It should not assign credit based on verbatim agreement with [the golden], and this document assigns no points, thresholds, or pass/fail bands."
So the answer to the prompt's direct question — could a clinically strong alternative answer still receive credit? — is yes, explicitly and repeatedly. The guidance rewards reasoning quality, source-aware synthesis, hierarchy application, and uncertainty management; it penalizes prose-matching. This is the single most important property of the grader layer, and it's present four times over in each of the six files. Objective 2: RESOLVED.

Now the objectives.

Objective 1 — Count and mapping — RESOLVED. Six GG-KM files (KM01–06), no GG-KM07, one-to-one with TP-KM01–06, EO-KM01–06, and Golden-KM01–06 (each header maps all three; verified). FI-T07 stays GG-KM01 addendum support only (GG-KM01 header line, and no second medication GG). The full TP → EO → Golden → GG chain is now constructed one-to-one across all four task-layer artifacts.

Objective 3 — Multi-path defensibility — RESOLVED. Alternative defensible reasoning remains creditable (verified above); no hidden answer-key behavior (the guidance grades reasoning anchors and unsafe omissions, not a key); no single-sequence medication logic (GG-KM01 credits "deliberate sequencing and monitoring rather than a single consultant winner" and penalizes "restarting all… at once" and "leaving all held… stopped indefinitely" — both extremes, preserving the middle band of defensible sequences); no single-cause hospital-course logic (GG-KM02 penalizes "copy-forward sepsis-only framing" and "steroids explain everything"). Future graders could reasonably credit different clinically sound approaches. RESOLVED.

Objective 4 — Medication guidance (GG-KM01) — RESOLVED. Cardiology vs Nephrology tension preserved (both "valid," credit sequencing not winner); prednisone hierarchy preserved (rheumatology strongest, others context, penalize prednisone decisions "based on patient recollection, family report, FI-W22, or FI-T07 alone"); inpatient-vs-outpatient distinction preserved (penalize "using inpatient correctional lispro as a home medication by default"); staged reasoning rewarded (credited in Good Practice). It does not become a medication answer key (explicitly penalizes verbatim-copying the golden sequence), does not force one restart sequence (penalizes both all-at-once and indefinite-hold), does not over-credit consultant-winner selection (penalizes "selecting Cardiology or Nephrology as automatically correct"), does not over-penalize defensible alternatives ("Do not require one exact ordering… if the answer preserves the core safety logic"). This was the highest-risk GG file for answer-key drift, and it's handled correctly.

Objective 5 — Discharge readiness (GG-KM03) — RESOLVED. Physiologic improvement distinguished from transition readiness (the core credited reasoning); family concern handled appropriately ("meaningful baseline evidence… not automatically dispositive," and primary team "also remain[s] defensible" — both sides protected); PT/OT/nursing/CM/SW evidence protected (penalize "ignoring nursing, PT, OT, CM/SW, family… evidence"). It does not become a discharge-authorization rubric (penalize "treating improved [markers] as enough for discharge authorization" and "creating… discharge order"), does not create a hidden disposition key (credits "conditional discharge-readiness conclusion," not a safe/unsafe verdict — and explicitly "Do not require a single final conclusion if the response appropriately describes conditional readiness"), does not force one discharge conclusion. RESOLVED.

Objective 6 — Follow-up and outcome protection — RESOLVED. GG-KM05: prohibits invented +7 facts (penalize "inventing +7 symptoms, vitals, labs, exam findings, visits, services, adherence, recovery, readmission… or successful outcome") and preserves transition-risk framing ("transition-risk surveillance rather than retrospective certainty"). GG-KM06: prohibits invented outcomes/readmission ("creating a readmission, adverse event, recovery outcome, non-readmission"), prohibits RCA drift ("RCA… or causal finding," "should not become a root-cause analysis"), prohibits blame assignment ("blame narrative"). Both honor the anchor-as-review-date rule that protected FI-T05/06 and the goldens. RESOLVED.

Objective 7 — Hierarchy protection — RESOLVED. All three hierarchies preserved as reasoning, not shortcuts. GG-KM01/04 explicitly preserve the prednisone hierarchy with rheumatology highest; GG-KM04 penalizes "using source hierarchy as a shortcut to resolve clinical recommendation disagreement" — the precise guard that keeps the authority hierarchy from collapsing the frictions. Physician-perspective rule preserved (each GG credits physician-facing responses). Hierarchy does not become a scoring shortcut, consultant-winner shortcut, or answer shortcut. RESOLVED.

Objective 8 — Friction protection — RESOLVED. All three frictions preserved with anti-winner guardrails in the Known Errors lists: GG-KM01/04 penalize selecting a consultant "as automatically correct" / "automatic winner"; the Endo-vs-Team and Family-vs-Team tensions stay two-sided across the relevant files. Critically, GG-KM06 honors the audit's Finding-C narrowing — its Known Errors explicitly penalize "turning Endocrinology vs Primary Team into the dominant story rather than background steroid-source/endocrine-risk context." So the grader guidance correctly scopes Golden-KM06's endocrine material as background, consistent with FI-T06 and the corrected golden architecture. The guidance rewards defensible synthesis and penalizes winner-selection — no friction collapsed. RESOLVED.

Objective 9 — Source fidelity — RESOLVED. FI-T stays task framing, FI-W stays evidence, FI-S stays background/support (each GG references FI-S only as background/provenance/logistics; none makes FI-S sole critical evidence — GG-KM01 penalizes basing prednisone decisions on "FI-W22, or FI-T07 alone," and the FI-S boundary holds). FI-W22 stays visible-but-incomplete across all six (GG-KM01–04/06 penalize "treating FI-W22 as the completed [X]"; GG-KM05 treats it as "pre-close risk substrate only"). No FI-S becomes sole evidence; FI-W22 not an answer source; source boundaries don't drift. RESOLVED.

Objective 10 — Grading leakage boundary — RESOLVED. The guidance does not become a scoring rubric, point system, threshold system, pass/fail framework, or AutoQC response. Every GG file's Construction Notes footer explicitly states "this document assigns no points, thresholds, or pass/fail bands," and the §3-architecture "Scoring instruction placeholder" is deferred — the GG files carry the reasoning standard and known errors but no scoring math. Construction remains grader guidance only. (This is the boundary that keeps scoring as a separate, later-authorized phase.) RESOLVED.

Objective 11 — Validation review accuracy — RESOLVED, with one honest housekeeping item the validation itself discloses. The validation review accurately reflects the GG files, boundaries, prohibitions, and mappings — I cross-checked each VERIFIED against the actual GG text and found no misstatement. The validation transparently discloses one cleanup: "the locked Grader Guidance Architecture v1 status footer was corrected from CANDIDATE REVIEW to LOCKED to match the ratification record. No grader-guidance architecture substance changed." I checked this — it's a metadata correction to a previously-locked artifact's status footer (bringing the footer in line with its ratification), not a substantive change to locked content, and it's the right kind of correction to disclose rather than make silently. Consistent with the documentation-integrity discipline the golden-architecture audit established. Accurate.

Required findings structure:

True Defects: none. Count correct and one-to-one across the full chain, FI-T07 addendum-only, all four workflows preserved, all five information-problem domains preserved as gradable reasoning without label exposure, all three frictions preserved with anti-winner guardrails (Golden-KM06 endocrine scope correctly background per the audit), all three hierarchies preserved as reasoning with rheumatology highest and consultant-disagreement-not-by-rank, FI-W22 visible-but-incomplete, FI-S non-load-bearing, no invented outcomes, and — the two highest-priority checks — the anti-verbatim-matching principle enforced four times per file and no scoring leakage. The guidance quality is genuinely strong: each file gives a grader concrete reasoning anchors and a precise known-errors list while protecting defensible variation.
Governance / Metadata Inconsistencies: none residual. The architecture-footer status correction (CANDIDATE REVIEW → LOCKED) is disclosed and is a metadata-alignment fix, not a substantive edit — appropriately handled.
Physician Preference Items: (1) the "Good Practice That May Receive Credit But Should Not Be Required" section is the key multi-path protector in each file, and it's well-drawn — when scoring is eventually built, the physician should ensure these stay genuinely optional (credited if present, never penalized if absent in a defensible answer); (2) GG-KM01's known-errors list is appropriately strict on the prednisone-source and inpatient-lispro points — the physician will want the eventual scoring to weight these as the safety-critical anchors they are without making the per-medication dispositions a rigid key (the guidance already guards this, so it's a calibration note for scoring, not a guidance defect).
Future AutoQC Watch Items: (1) the official Section 6 Grader Guidelines AutoQC prompt is still not in the local repository — it must be imported before grader-guidance AutoQC, exactly as the architecture and both validations note; this is the one concrete forward dependency and is distinct from the World Spec AutoQC v6.3 used for the world layer; (2) scoring construction (points/thresholds/pass-fail) remains a separate, later-authorized phase — the GG files correctly stop short of it, and when it opens, the anti-verbatim-matching principle must carry into the actual scoring math (reward reasoning, credit defensible variation, penalize answer-key matching and fabrication); (3) keep GG-KM03/05/06 scoring distinct (present readiness / prospective follow-up / retrospective safety); (4) the packaging-layer World Spec AutoQC carry-forwards (2.52 supplementary ratio, 2.113 Tool/Origin, 2.108 administrative-deliverable, v6.3 8-column file plan) remain live at Packaging, alongside the Section 6 grader AutoQC.
Where I note for the independent-verification requirement: I verified the GG files directly against the locked architecture, goldens, expected outputs, prompts, world files, governance, and the audit's Finding-C narrowing — not via the validation review. No conflict among the GG files, the locked upstream layers, governance, the reconciliations, and the validation review. I confirmed the highest-stakes properties (anti-verbatim-matching enforced per-file, no scoring leakage, friction/hierarchy-as-reasoning, FI-W22 incompleteness, Golden-KM06 endocrine-as-background) in the actual GG text. The one real forward dependency — the missing Section 6 AutoQC prompt — is honestly carried by the validation and is not a defect in this construction.

Would you approve Grader Guidance Construction for ratification and lock? YES — as a QC approval of writer-owned grader guidance against the locked architecture. The six GG-KM files correctly define future grader guidance that rewards strong physician reasoning while preserving the properties that matter most: the anti-verbatim-matching principle is enforced in every file at the Golden-Reference, Good-Practice, Known-Errors, and Construction-Notes levels (a clinically strong alternative answer can receive credit); multi-path defensibility is protected (no single-sequence medication logic, no single-cause course logic, conditional conclusions credited); all three frictions preserved with anti-winner guardrails (Golden-KM06 endocrine correctly background per the audit); all three hierarchies preserved as reasoning with rheumatology highest and consultant-disagreement-not-by-rank; FI-W22 visible-but-incomplete and FI-S non-load-bearing across all six; no invented outcomes; and no scoring leakage (each file explicitly assigns no points/thresholds/bands). The guidance is concrete and senior-level. There is no true defect.

Grader Guidance Construction Status: LOCK READY.

Guidance Quality: STRONG.

Benchmark Integrity: HIGH.

Final Recommendation: GO — with the AutoQC watch-items carried forward, the most concrete being the import of the official Section 6 Grader Guidelines AutoQC prompt before that QC stage.

Can Grader Guidance Construction proceed directly to ratification and lock if any identified reconciliation items are resolved? YES — there are no true defects or canon conflicts requiring reconciliation before lock; the findings are physician-preference and future-AutoQC watch-items (including the Section 6 prompt dependency), not blockers. So it can proceed to ratification and lock on your authorization.

This is the milestone the whole build has been converging on: with the grader guidance lock-ready, the full evaluation artifact set is complete and internally consistent end to end — 33 files (22 world + 7 task-context + 4 supplementary), six prompts, six expected outputs, six goldens, and six grader-guidance documents, every layer independently verified and traceable to the locked clinical canon (identity; 14 conditions; 20 medications with lispro inpatient-only; baseline anchors reconciling with the lab trends; all three hierarchies; all five traps; all three frictions; the closed-world temporal boundary; the TP → EO → Golden → GG one-to-one chain).

What remains is not content construction — it's verification and assembly: AutoQC (both the Section 6 Grader Guidelines checklist, which still needs importing, and the Section 2 World Spec checklist v6.3), then final packaging, where the standing carry-forwards land (the v6.3 8-column Source/Tool file plan, the 2.52 essential/supplementary ratio confirmation, the 2.113 per-file Tool/Origin specification, and the 2.108 administrative-deliverable bet with the utilization-review fallback). Both phases are ahead and both require your explicit authorization. The physician-authorship boundary held through the entire task layer — prompts, expected outputs, goldens, and now grader guidance were all writer-owned, with my role confined to QC against the architecture and the checklists — and that is exactly where it should have held.

autoqc-architecture-validation-review.md
135 lines

md


autoqc-architecture-v1.md
281 lines

md

Independent Review — AutoQC Architecture v1
Review only.
Do not modify files.
Do not create files.
Do not commit.
Do not reconcile.
Do not ratify.
Do not lock.
Do not run AutoQC.
Do not create AutoQC responses.
Do not create DOCX artifacts.
Do not create submission artifacts.
Files Under Review

autoqc-architecture-v1.md
autoqc-architecture-validation-review.md
Review Sources
Verify against:

Governance Package v1
File Inventory v1
FI-W01 through FI-W22
FI-T01 through FI-T07
FI-S01 through FI-S04
TP-KM01 through TP-KM06
EO-KM01 through EO-KM06
Golden-KM01 through Golden-KM06
GG-KM01 through GG-KM06
Grader Guidance Construction ratification
Ecosystem Comparison Audit
World Spec AutoQC v6.3 references
Submission package guidance references
Source of Truth / Instruction Guide
Independent Verification Requirement
Assume no prior review exists.
Do not defer to the validation review.
Verify findings directly from AutoQC Architecture v1.
Primary Question
Does AutoQC Architecture v1 correctly define future AutoQC organization while preserving locked-artifact integrity, benchmark integrity, source fidelity, and governance fidelity?
Review Objectives

AutoQC Scope Integrity
Architecture only?
No AutoQC responses?
No scoring?
No DOCX?
No submission artifacts?
Artifact ID Integrity
AQC-KM01 through AQC-KM07 justified?
No unauthorized AQC-KM08?
Mappings coherent?
World Spec AutoQC Relationship
v6.3 treated correctly?
No overextension beyond available official prompt?
Section 6 Boundary Integrity
Missing prompt acknowledged?
No fabricated Section 6 content?
No reverse-engineering of missing prompt?
Layer Boundary Integrity
File layer
Task layer
Prompt layer
Expected Output layer
Golden layer
Grader Guidance layer
Packaging layer
Locked Artifact Protection
Any implied authority to modify locked artifacts?
Any reconciliation bypass?
Packaging Scope Review
Is AQC-KM07-PKG still AutoQC architecture?
Has it drifted into Packaging Architecture?
Watch Item Completeness
Carry-forward items complete?
Any missing ecosystem-audit dependencies?
Validation Review Accuracy
Does validation review accurately describe architecture?
Any overclaims? Required Findings Structure

True Defects
Governance / Metadata Issues
Watch Items
Clean Areas Verified Final Verdict Would you approve AutoQC Architecture v1 for ratification and lock? YES or NO Then provide: AutoQC Architecture v1 Status: LOCK READY or NOT LOCK READY Architecture Quality: STRONG / ACCEPTABLE / WEAK Governance Fidelity: HIGH / MODERATE / LOW Final Recommendation: GO / GO WITH MINOR NOTES / HOLD Additionally answer: Can AutoQC Architecture v1 proceed directly to ratification and lock if any identified reconciliation items are resolved? YES or NO Review only. Stop after reporting.
Show more
9:48 AM
Independent review of AutoQC Architecture v1. Both artifacts rendered — the architecture and its validation review. This is a meaningful shift in the build: it's the first artifact past the content layers entirely. There are no more prompts, expected outputs, goldens, or grader guidance to author — the full evaluation set is locked. AutoQC architecture is verification-and-assembly organization, not content. So my QC role here is cleaner than at any prior phase: I'm checking that this artifact organizes the QC/packaging work correctly while touching no locked content and authoring nothing — and the physician-authorship boundary is no longer the live risk, because there's no content left to author.

Per the independent-verification instruction, I verified directly against the architecture artifact and the locked sources, not via the validation review. The check that matters most for an AutoQC-organization artifact is different from the content layers: it's whether the architecture correctly respects what it does not have — specifically the missing Section 6 prompt — without fabricating, inferring, or reverse-engineering it, and whether it grants itself any implied authority to modify locked artifacts. I read the Section 6 handling and the locked-artifact-protection language hardest.

The missing-Section-6 boundary — the highest-integrity-risk item for this artifact — RESOLVED, and handled exactly right. The temptation an AutoQC-prep artifact faces is to "helpfully" reconstruct the missing official Section 6 Grader Guidelines AutoQC prompt from the locked grader guidance or from examples. This architecture explicitly refuses, repeatedly and at the right granularity:

The "Relationship to Future Section 6" section: "The missing Section 6 prompt content must not be recreated from memory, inferred from examples, or reverse-engineered from locked grader guidance. Future Section 6 AutoQC findings must be answered only after the actual official prompt or platform diagnostics are available."
AQC-KM06-GG's boundary column: "Do not fabricate Section 6 AutoQC content."
The opening scope: "does not… invent a missing AutoQC checklist… fabricate missing official AutoQC prompts."
Carry-forward item 1 and item 9: the missing prompt is flagged, and "No future AutoQC response may be drafted until the relevant official prompt output or platform diagnostic exists."
This is the correct discipline, and it's the exact dependency I've carried forward in my last three reviews. The architecture treats the absence as a blocking dependency to be resolved by import, not a gap to be filled by inference. That's right — fabricating the checklist would be precisely the kind of authoring-what-isn't-there that the whole governance structure exists to prevent. Section 6 boundary: RESOLVED.

Now the objectives.

Objective 1 — AutoQC scope integrity — RESOLVED. Architecture only: the opening paragraph and the "AutoQC Scope" section both enumerate that it does not run AutoQC, draft responses, create scoring (points/thresholds/pass-fail bands), create DOCX, create submission artifacts, or fabricate prompts. I verified the body contains no AutoQC response text, no scoring math, no DOCX, no manifest — it's organizational labels and boundary statements throughout. Clean.

Objective 2 — Artifact ID integrity — RESOLVED. Seven AQC IDs (AQC-KM01-WS through AQC-KM07-PKG), no AQC-KM08. The IDs are justified and coherent: one per QC surface — World Spec (WS), file layer (FILE), task prompt (TP), expected output (EO), golden (GOLDEN), grader guidance (GG), packaging (PKG). Each carries a "Governing status" that honestly distinguishes what has an official local prompt (only AQC-KM01-WS) from what is "architecture only; official downstream prompt not locally materialized" (the rest) from the special AQC-KM06-GG case (Section 6 referenced but not available). The mapping is coherent and the honesty about which surfaces lack official prompts is exactly right — it doesn't pretend to have checklists it doesn't have. RESOLVED.

Objective 3 — World Spec AutoQC v6.3 relationship — RESOLVED. v6.3 is treated correctly: as "the only official AutoQC prompt currently available locally," governing future World Spec/Section-2 checks and serving as a local preflight map, and as a source for packaging-related constraints that already live inside v6.3 (single DOCX, section headings, placeholder removal, file-plan completeness, traceability, task independence, date consistency, filename conventions). Critically, the architecture states what v6.3 is not: "not a substitute for missing Section 3, Section 4, Section 5, or Section 6 official prompt text," not a completed run, not permission to draft responses or create a DOCX. No overextension beyond the available prompt. This is the correct scoping — it uses v6.3 for what it actually covers without stretching it to cover the sections whose prompts are missing. RESOLVED.

Objective 4 — Section 6 boundary integrity — RESOLVED (detail above): missing prompt acknowledged (carry-forward 1, AQC-KM06-GG governing status), no fabricated content, no reverse-engineering. RESOLVED.

Objective 5 — Layer boundary integrity — RESOLVED across all seven layers. Each layer's QC-boundaries section correctly states what QC includes (count/mapping/fidelity checks against the locked architecture) and what it must not do (revise locked artifacts, add a seventh artifact, create downstream content). I spot-checked each against the locked canon:

File layer: includes FI-W01–22 / FI-T01–07 / FI-S01–04 completeness, FI-W22 visible-but-incomplete, FI-S background role, "no single file becoming an answer file," world-snapshot boundary; must not edit locked files or reinterpret rows. Correct.
Task/Prompt layer: TP-KM01–06 mapping, FI-T07 addendum-only, task independence, anchors-after-snapshot, physician voice, no trap telegraphing; must not add TP-KM07. Correct.
EO/Golden/GG layers: count/mapping, the layer-specific fidelity properties (EO uncertainty/hierarchy; Golden multi-path + the five watch items; GG anti-verbatim-matching + no scoring leakage); must not revise locked artifacts, create a seventh, or create scoring. Correct, and the Golden and GG boundary sections correctly reproduce the high-stakes properties I verified at those layers (multi-path defensibility, anti-verbatim-matching, the Golden-KM06 endocrine-as-background scoping is implied by the GG fidelity check).
Packaging layer: see Objective 7. All seven layer boundaries are accurate and none grants modification authority.
Objective 6 — Locked-artifact protection — RESOLVED. No implied authority to modify locked artifacts anywhere. Every layer's "must not" includes "revise/edit locked [X]." And carry-forward item 10 is the key governance backstop: "Any future correction that would alter locked artifacts requires explicit authorization and a reconciliation record before modification." That's the correct reconciliation-not-bypass discipline — it routes any future locked-artifact change through authorization + reconciliation rather than letting AutoQC findings silently edit locked content. No reconciliation bypass. RESOLVED.

Objective 7 — Packaging scope review (is AQC-KM07-PKG still AutoQC architecture, or has it drifted into Packaging Architecture?) — RESOLVED, and this is the subtle one I checked hardest. The risk is that a "packaging QC" surface quietly becomes packaging construction (creating the DOCX, the manifest, the upload order). It does not. AQC-KM07-PKG and the Packaging QC Boundaries section define packaging-readiness checks (single-DOCX requirement, section headings, placeholder removal, filename convention, per-file upload, manifest/upload-order, transcript clarification, goldens/grader submission-scope) — i.e., what to verify — while the "must not" list bars doing the packaging (no DOCX creation, no template population, no manifest, no upload materials, no RL Studio, no AutoQC run). So AQC-KM07-PKG stays on the QC/verification side of the line: it's "is the package ready and correct," not "build the package." It explicitly carries the v6.3 packaging-relevant check numbers (2.67, 2.70, 2.71, 2.88, 2.103, 2.104) as the source basis for those checks, which is the right way to ground packaging QC in the one official prompt that's available. It has not drifted into Packaging Architecture — packaging construction remains a separate future phase. RESOLVED.

This also correctly resolves where my standing packaging carry-forwards land: the v6.3 8-column file plan, the 2.52 essential/supplementary ratio, the 2.113 Tool/Origin specification, and the 2.108 administrative-deliverable bet are all packaging-QC checks that AQC-KM07-PKG and AQC-KM01-WS would verify — they're correctly held as pending QC topics here, not resolved or constructed.

Objective 8 — Watch-item completeness — RESOLVED. The ten carry-forward items are complete and capture the real dependencies: missing Section 6 prompt (1), v6.3 as only local prompt (2), pending packaging/manifest/DOCX (3-5), transcript ambiguity (6), goldens/grader submission-scope ambiguity (7), the ecosystem audit's multi-layer-AutoQC-undefined finding (8), the no-response-before-official-prompt rule (9), and the locked-artifact-change-requires-authorization rule (10). Checking against the ecosystem-comparison audit references: the architecture carries forward the audit's unresolved items (multi-layer AutoQC spec, packaging checks, submission manifest, DOCX population, transcript ambiguity, goldens/grader submission scope) — Finding 8 of the validation confirms this and I verified the items appear in the carry-forward list. I don't find a missing ecosystem-audit dependency. One observation I'd add as a watch item rather than a gap: the architecture notes (correctly) that official prompts for Sections 3/4/5 are also not locally materialized (the v6.3 relationship section says v6.3 is "not a substitute for missing Section 3, Section 4, Section 5, or Section 6 official prompt text") — the carry-forward list foregrounds Section 6 specifically; it would be marginally more complete to also flag Sections 3/4/5 prompt availability explicitly in the carry-forward list, though they're implicitly covered by the "architecture only; official downstream prompt not locally materialized" status on the relevant AQC IDs. Minor completeness note, not a defect.

Objective 9 — Validation review accuracy — RESOLVED. The validation review accurately describes the architecture — I cross-checked its ten findings against the actual architecture text and found no overclaim. Its Finding 2 (v6.3 relationship correct), Finding 3 (Section 6 boundary correct), and Finding 7 (packaging boundaries preserved as pending topics only) match what I independently verified. The validation is appropriately scoped and doesn't assert anything the architecture doesn't support. No overclaim. (Notably, the validation's source-review list includes the ecosystem audit and the submission-package-requirements reference, which is the right basis for checking an AutoQC-organization artifact.)

Required findings structure:

True Defects: none. Architecture-only scope honored, seven coherent AQC IDs with no AQC-KM08, v6.3 correctly scoped without overextension, Section 6 missing-prompt boundary handled correctly (no fabrication/inference/reverse-engineering), all seven layer boundaries accurate with no modification authority, locked-artifact protection with reconciliation-not-bypass discipline, AQC-KM07-PKG correctly QC-not-construction, complete carry-forward watch items, and the full TP→EO→Golden→GG chain plus FI-T07 addendum-only / FI-W22 incomplete / FI-S background properties all preserved. No content was authored, edited, or fabricated.
Governance / Metadata Issues: none material. The architecture's source basis and the validation's source review are accurate. The reconciliation-and-authorization gate on locked-artifact changes (carry-forward 10) is exactly the right governance backstop for the verification phase.
Watch Items: (1) the missing official Section 6 Grader Guidelines AutoQC prompt remains the one concrete blocking dependency before grader-guidance AutoQC can run — it must be imported/obtained, not reconstructed; (2) Sections 3/4/5 official prompt availability is worth flagging explicitly alongside Section 6 in the carry-forward list (currently implicit in the AQC ID statuses); (3) the packaging-layer checks — including my standing carry-forwards (v6.3 8-column file plan, 2.52 supplementary ratio, 2.113 Tool/Origin, 2.108 administrative-deliverable with UR fallback) — are correctly held as pending AQC-KM07-PKG/AQC-KM01-WS topics and will be exercised when packaging is authorized; (4) the transcript requirement and the goldens/grader submission-scope ambiguity remain genuinely unresolved and depend on submission-package guidance that isn't fully materialized locally — these should be clarified before packaging, not guessed; (5) no AutoQC response may be drafted for any surface until its official prompt output or platform diagnostic exists (carry-forward 9), which means the next phase produces QC organization/preflight, not answers.
Clean Areas Verified: architecture-only scope; seven-ID structure with no AQC-KM08; v6.3 relationship (governing for Section 2, not a substitute for missing sections); Section 6 anti-fabrication boundary; all seven layer QC boundaries; locked-artifact protection; AQC-KM07-PKG as QC-not-construction; carry-forward completeness; validation accuracy; preservation of the six-chain mapping, FI-T07 addendum-only, FI-W22 visible-but-incomplete, FI-S background role, the hierarchies, the physician-perspective rule, and no scoring/DOCX/submission leakage.
Where I note for the independent-verification requirement: I verified the architecture directly against the locked layers, the ecosystem-comparison audit, and the v6.3/submission references — not via the validation review. No conflict among the architecture, the locked artifacts, governance, and the validation review. I confirmed the highest-integrity-risk properties (Section 6 anti-fabrication, no locked-artifact-modification authority, AQC-KM07-PKG staying QC-not-construction, v6.3 not overextended) in the actual architecture text. The one real forward dependency — the missing Section 6 prompt (and, more broadly, Sections 3/4/5 official prompts) — is honestly surfaced and correctly treated as import-required, not a gap to fill by inference.

Would you approve AutoQC Architecture v1 for ratification and lock? YES. It correctly defines future AutoQC organization while preserving locked-artifact integrity, benchmark integrity, source fidelity, and governance fidelity: architecture-only with no responses/scoring/DOCX/submission artifacts; seven coherent QC-surface IDs honestly distinguishing what has an official prompt from what doesn't; v6.3 scoped correctly as the only available official prompt without overextension; the missing Section 6 prompt acknowledged and explicitly protected from fabrication, inference, or reverse-engineering; all seven layer boundaries accurate with no implied authority to modify locked content; a reconciliation-and-authorization gate on any future locked-artifact change; AQC-KM07-PKG kept as packaging QC rather than packaging construction; and the full locked structure (six-chain mapping, FI-T07 addendum-only, FI-W22 incomplete, FI-S background, hierarchies, physician-perspective rule) preserved. There is no true defect and no governance bypass.

AutoQC Architecture v1 Status: LOCK READY.

Architecture Quality: STRONG.

Governance Fidelity: HIGH.

Final Recommendation: GO — with the watch-items carried forward, the most concrete being that the official Section 6 Grader Guidelines AutoQC prompt (and the Section 3/4/5 prompts) must be imported before those surfaces' AutoQC can run, and the transcript/submission-scope ambiguities should be clarified before packaging rather than guessed.

Can AutoQC Architecture v1 proceed directly to ratification and lock if any identified reconciliation items are resolved? YES — there are no true defects or governance conflicts requiring reconciliation before lock; the findings are watch-items and one minor completeness note, not blockers. So it can proceed to ratification and lock on your authorization.

A note on where this leaves the build. With the AutoQC architecture lock-ready, the project has moved cleanly out of content construction and into the verification-and-assembly organization phase — the full evaluation set (33 files, six prompts, six expected outputs, six goldens, six grader-guidance documents, all one-to-one and traceable to the locked clinical canon) is complete, and this artifact correctly organizes how that set will be QC'd and prepared for submission without touching any of it. The defining constraint going forward is no longer the physician-authorship boundary (the content is done) but the no-fabrication / import-don't-reconstruct boundary: the next steps depend on obtaining the official AutoQC prompts that aren't yet local (Section 6 most concretely), and on resolving the genuinely-open packaging questions (transcript requirement, goldens/grader submission scope, and the standing v6.3 packaging carry-forwards) — each of which should be resolved with the actual official materials and your explicit authorization, not inferred. This architecture sets that up correctly.

autoqc-construction-v1.md
169 lines

md


autoqc-construction-validation-review.md
118 lines

md


Independent Review — AutoQC Construction v1 Review only. Do not modify files. Do not create files. Do not commit. Do not reconcile. Do not ratify. Do not lock. Do not run AutoQC. Do not create AutoQC responses. Do not create platform responses. Do not create DOCX art

pasted

Independent Review — AutoQC Construction v1, follow prompt as pasted.

12:41 PM
Independent review of AutoQC Construction v1. Both artifacts rendered — the construction package and its validation review. This is the operational counterpart to the AutoQC architecture I reviewed last turn: where the architecture defined the QC surfaces, this organizes the execution order, dependency tracking, and routing. It remains pre-execution scaffolding — no AutoQC is run, no responses drafted, no content touched. My QC role is the same clean verification posture: confirm it organizes correctly while authoring nothing and respecting what it doesn't have.

Per the independent-verification instruction, I verified directly against the construction artifact and the locked sources, not via the validation review. The review prompt correctly marks Objective 4 (no-fabrication / import-not-inference) as highest priority — for a construction package sitting next to missing official prompts, the dominant integrity risk is that it "operationalizes" by quietly filling the gaps. I read the Core Rules and the AQC Surface Map's dependency columns hardest against that.

No-fabrication / import-not-inference — highest priority — RESOLVED, and it's elevated to a named Core Rule rather than buried in boundaries. The construction package opens with three Core Rules, two of which are exactly this discipline:

No-Fabrication Rule: "Missing official prompts must remain missing until imported or produced by the platform. In particular, the official Section 6 Grader Guidelines AutoQC prompt is not locally available and must not be recreated from memory, inferred from examples, or reverse-engineered from locked GG-KM files."
Import-Not-Inference Rule: "Future AutoQC execution must use imported official prompts, local locked sources, or platform diagnostics. It must not infer missing checklist text or platform expectations from architecture summaries."
And the discipline is enforced operationally, not just stated: the AQC Surface Map's "Official Prompt Dependency" column honestly marks five of seven surfaces as having no separate official prompt locally available (FILE, TP, EO, GOLDEN, and GG/Section-6), and the "Current Blocked Dependencies" column repeats "no official prompt imported" for each. The Blocked Dependencies section lists the missing Section 6 prompt (item 3) and — importantly — "Any separate official File, Task Prompt, Expected Output, Golden, or Packaging AutoQC prompts if they exist outside the local repository" (item 4). That item 4 is the right move: it acknowledges that even the file/prompt/EO/golden surfaces may have official prompts that simply aren't local, rather than assuming the locked architecture is a sufficient substitute. The package treats every missing prompt as an import-required block, never an inference opportunity. Objective 4: RESOLVED.

Now the objectives.

Objective 1 — Construction scope integrity — RESOLVED. Preparation-only: the opening paragraph and the closing "Construction Boundary Confirmation" both enumerate that it created only an execution-order map, dependency routing, response/reconciliation/packaging routing paths, blocked-dependency tracking, and watch items — and did not create AutoQC runs, platform responses, response text, scoring (rubrics/thresholds/bands/points), DOCX, submission artifacts, or fabricated Section 6 content. I verified the body contains none of these — it's routing logic and dependency tracking throughout, no response language, no scoring math, no locked-artifact edits. Clean.

Objective 2 — AQC surface integrity — RESOLVED. Seven surfaces (AQC-KM01-WS through AQC-KM07-PKG), no AQC-KM08, each mapping to the locked AutoQC Architecture v1. I checked the surface map: each row has Required Inputs identified (e.g., AQC-KM05-GOLDEN → Golden Architecture v1, Golden-KM01–06, EO dependencies, special golden watch items), a dependency state identified (official prompt available vs not, blocked dependencies), and a Future Output Type identified (finding list / reconciliation queue / preflight findings / packaging checklist). The map is coherent and complete against the architecture's seven IDs. RESOLVED.

Objective 3 — Execution order — RESOLVED. The seven-step order is dependency-aware and correctly sequenced: AQC-KM01-WS (World Spec v6.3) first because it's the only official prompt locally available, then file → prompt → expected-output → golden → grader-guidance → packaging. That ordering is sensible (verify the world substrate before the task layer before packaging) and the package explicitly states "This order does not authorize running any AutoQC. It defines the future dependency sequence only." No execution authorized. RESOLVED.

Objective 5 — Response routing — RESOLVED. The five response-routing paths are correct and, crucially, all defer drafting: valid-finding-against-unlocked → authorized correction if that phase is open; valid-finding-against-locked → reconciliation before any edit; false-positive-against-canon → evidence-backed response only after official diagnostic text exists; ambiguous-due-to-missing-prompt → dependency block, not response drafting; packaging-only → packaging prep. The package explicitly states "This package does not draft any response language." The "ambiguous → dependency block, not response drafting" path is the key one — it routes uncertainty caused by a missing prompt to waiting for the prompt, not to guessing, which is the operational expression of the no-fabrication rule. No response language drafted. RESOLVED.

Objective 6 — Reconciliation routing — RESOLVED. Reconciliation is triggered for the full set of canon-affecting changes: modifying any locked layer (World Spec/FI-W/FI-T/FI-S/TP/EO/Golden/GG), broadening/narrowing workflows/traps/frictions/hierarchy/source-dependencies/task-responsibilities, reinterpreting File Inventory rows, and changing each of the standing invariants — FI-T07 addendum-only, FI-W22 visible-but-incomplete, FI-S background role, physician-perspective rule, and the source-of-truth/prednisone hierarchies. I cross-checked this list against the invariants I've tracked the entire build; it's complete. And reconciliation outputs must "identify the authoritative source, rationale, and smallest canon-supported correction" — the same minimal-correction discipline the golden-architecture audit used. No reconciliation result is created here. RESOLVED.

Objective 7 — Packaging routing — RESOLVED, routing-only confirmed. The same check I applied to AQC-KM07-PKG at the architecture layer: does packaging routing stay routing, or does it drift into packaging construction? It stays routing. The Packaging Routing Paths section lists what routes to a future Submission/Packaging Preparation phase (DOCX population, single-DOCX requirement, page numbering, landscape tables, placeholder removal, filename convention, manifest, upload order, per-file-not-zip, reference/template curation, transcript handling/scope/format/requirement, goldens-GG submission scope) and explicitly states "Packaging routing must not create DOCX artifacts, manifests, upload packages, submission files, or RL Studio actions in this phase." It identifies where packaging issues go; it does not do the packaging. The standing v6.3 packaging carry-forwards (8-column file plan, 2.52 ratio, 2.113 Tool/Origin, 2.108 administrative-deliverable) are correctly held within AQC-KM07-PKG's scope as pending routing topics, not resolved or constructed. No packaging artifact created. RESOLVED.

Objective 8 — Blocked dependency review — RESOLVED. The nine blocked dependencies are complete and accurate: formal-run authorization (1), platform diagnostic output (2), official Section 6 prompt (3), any separate official File/TP/EO/Golden/Packaging prompts that exist outside the repo (4), DOCX-population authorization (5), submission-manifest authorization (6), transcript-format clarification (7), goldens/GG submission-scope clarification (8), and authorization to reopen/modify locked artifacts (9). This matches the architecture's carry-forwards and the ecosystem-audit dependencies, and item 4 again correctly captures the possibility of missing official prompts beyond Section 6. Complete and accurate. RESOLVED.

Objective 9 — Claude transcript carry-forward — RESOLVED, and this is the one genuinely new item versus the architecture review, so I checked it specifically. The construction package surfaces docs/claude-transcript.md as a concrete submission-phase carry-forward (Carry-Forward Watch Items, and Packaging Routing) and explicitly states it "must not be formatted, converted, or submitted until authorized." It is acknowledged only as a carry-forward item — not formatted, rewritten, styled, converted, staged, or submitted — and transcript handling is deferred to Submission/Packaging Preparation. This is the right treatment: the transcript requirement was flagged as ambiguous (does it need to be submitted? in what format?), and the package correctly routes that ambiguity to clarification rather than guessing a format and pre-staging the file. Deferred correctly. RESOLVED.

Objective 10 — Validation review accuracy — RESOLVED. The validation review accurately reflects the construction package — I cross-checked its ten findings against the actual construction text and found no overclaim. Its Finding 4 (official prompt dependencies preserved, Section 6 not fabricated), Finding 6 (import-not-inference preserved), and Finding 10 (transcript carry-forward, not formatted/staged) match what I independently verified. The validation is appropriately scoped to a preparation-package review and doesn't assert execution or resolution that didn't happen. No overclaim.

Required findings structure:

True Defects: none. Preparation-only scope honored; seven coherent AQC surfaces with no AQC-KM08; dependency-aware execution order that authorizes no run; no-fabrication and import-not-inference elevated to Core Rules and enforced operationally (ambiguous-finding → dependency block); response routing that defers all drafting; reconciliation routing covering the full canon-invariant set with minimal-correction discipline; packaging routing that stays routing-not-construction; complete and accurate blocked-dependency list including non-local official prompts beyond Section 6; transcript correctly deferred; and all standing invariants (six-chain mapping, FI-T07 addendum-only, FI-W22 incomplete, FI-S background, hierarchies, physician-perspective) preserved. Nothing was authored, edited, fabricated, or run.
Governance / Metadata Issues: none material. The package's source basis and the validation's source review are accurate. The reconciliation-before-edit gate (Locked-Artifact Protection Core Rule + Reconciliation Routing) and the authorization gate on reopening locked artifacts (Blocked Dependency 9) are the correct governance backstops for the execution phase. I'll note one consistency point I verified rather than assumed: the AQC Surface Map and the Blocked Dependencies section agree with each other and with the architecture on which surfaces have official prompts (only WS) — no internal contradiction.
Watch Items: (1) the missing official Section 6 Grader Guidelines AutoQC prompt remains the one concrete blocking dependency for grader-guidance AutoQC — import-required, not reconstructable (Core Rule + Blocked Dependency 3); (2) the broader open question of whether separate official File/TP/EO/Golden/Packaging AutoQC prompts exist outside the repo (Blocked Dependency 4) should be resolved before those surfaces' formal QC — if they exist, import them; if they don't, that itself needs confirmation rather than assumption; (3) the transcript requirement (format, scope, whether submission is required) and the goldens/grader-guidance submission-scope ambiguity remain genuinely unresolved and depend on submission-package guidance that isn't fully materialized locally — clarify with official materials before packaging, don't guess; (4) the standing v6.3 packaging carry-forwards (8-column file plan, 2.52 ratio, 2.113 Tool/Origin, 2.108 administrative-deliverable with UR fallback) are correctly held within AQC-KM07-PKG and will be exercised when packaging is authorized; (5) no AutoQC response may be drafted for any surface until its official prompt output or platform diagnostic exists — the next phase produces QC organization/preflight findings, not answers or runs.
Clean Areas Verified: preparation-only scope; seven-surface structure with no AQC-KM08; dependency-aware execution order; no-fabrication/import-not-inference as enforced Core Rules; the five response-routing paths (all deferring drafting); the reconciliation-routing trigger set (complete against canon invariants); packaging routing as routing-not-construction; the nine-item blocked-dependency list; transcript deferral; validation accuracy; and preservation of the six-chain mapping, FI-T07 addendum-only, FI-W22 visible-but-incomplete, FI-S background role, the hierarchies, the physician-perspective rule, and no scoring/DOCX/submission/response leakage.
Where I note for the independent-verification requirement: I verified the construction package directly against the locked AutoQC architecture, the locked layers, the ecosystem-comparison audit, and the v6.3/submission references — not via the validation review. No conflict among the construction package, the architecture, the locked artifacts, governance, and the validation review. I confirmed the highest-integrity-risk properties (no-fabrication/import-not-inference as Core Rules, ambiguous-finding-routes-to-dependency-block, packaging-routing-not-construction, reconciliation-before-locked-edit, transcript deferral) in the actual construction text. The forward dependencies — missing Section 6 prompt, possible non-local official prompts, transcript and submission-scope ambiguities — are honestly surfaced and correctly treated as resolve-by-import/clarification, not gaps to fill by inference.

Would you approve AutoQC Construction v1 for ratification and lock? YES. It correctly organizes future AutoQC execution, dependency tracking, response routing, reconciliation routing, and packaging routing while preserving the disciplines that matter most at this phase: no-fabrication and import-not-inference are elevated to Core Rules and enforced operationally (ambiguous findings route to dependency-block, not drafting); locked-artifact protection routes any canon-affecting change to reconciliation before edit; the execution order is dependency-aware and authorizes no run; packaging routing stays routing rather than construction; the blocked-dependency list is complete and honest (including non-local official prompts beyond Section 6); the transcript is correctly deferred; and all standing invariants are preserved. There is no true defect and no governance bypass.

AutoQC Construction v1 Status: LOCK READY.

Construction Quality: STRONG.

Governance Fidelity: HIGH.

Final Recommendation: GO — with the watch-items carried forward, the most concrete being that the official Section 6 prompt (and confirmation of whether other official section prompts exist outside the repo) must be obtained before those surfaces' AutoQC runs, and the transcript/submission-scope ambiguities clarified with official materials before packaging.

Can AutoQC Construction v1 proceed directly to ratification and lock if any identified reconciliation items are resolved? YES — there are no true defects or governance conflicts requiring reconciliation before lock; the findings are watch-items, not blockers. So it can proceed to ratification and lock on your authorization.

A note on where this leaves the build. AutoQC Construction v1 completes the organization of the verification-and-assembly phase: the architecture defined the QC surfaces, and this package sequences them, tracks their dependencies, and routes their future findings — all without running anything, drafting any response, or touching locked content. The full evaluation set (33 files, six prompts, six expected outputs, six goldens, six grader-guidance documents, one-to-one and traceable to the locked clinical canon) remains complete and untouched. What stands between here and submission is no longer construction of any kind — it's the import of the missing official AutoQC prompts, the authorized formal AutoQC runs against them, any reconciliation those runs surface (routed through authorization, never silent edits), and finally packaging (DOCX population, manifest, upload order, transcript handling, and the standing v6.3 packaging checks). The governing constraint for all of it is the one this package correctly enshrines: execute against real official prompts and platform diagnostics, reconcile through authorization, and never fabricate or infer what isn't yet there. This package sets that up cleanly and is ready to lock on your authorization.
